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Investigation into the role of the SUMO-like domains of the Schizosaccharomyces 
pombe DNA repair protein Rad60 
Summary 
 
Ubiquitin and ubiquitin-like (UBLs) proteins are post-translational modifiers that share 
a characteristic ββαββαβ fold. SUMO (small ubiquitin-like modifier) is one of a 
number of ubiquitin-like proteins. Unlike ubiquitin, SUMO does not appear to have a 
role in protein degradation. Instead it has been shown to have roles in facilitating 
protein-protein interactions, altering protein localisation and modulating protein 
activity. Analysis of protein databases indicates the existence of ubiquitin-fusion 
proteins, which act to functionally mimic ubiquitination by interacting with the 
proteosome. During the course of this project a family of SUMO-like domain (SLD) 
proteins has been identified and termed the RENi family after its best-studied members 
S. pombe Rad60, S. cerevisiae Esc2 and M. musculus Nip45.  
 
I have initiated an investigation into the importance of the two SUMO-like domains for 
S. pombe Rad60 function. A rad60 mutant deleted for SLD1 (rad60-SLD1Δ) is not 
viable suggesting that SLD1 is required for the essential role of Rad60. A rad60 mutant 
deleted for SLD2 (rad60-ct) is viable but cells are sensitive to DNA damaging agents. 
This implies that SLD2 is not required for the essential function of Rad60 but is 
required for the response to DNA damage. The C-terminally truncated Rad60 protein 
(Rad60-ct) is mis-localised in rad60-ct cells. Provision of an NLS to the C-terminus of 
the Rad60-ct protein restores nuclear localisation but does not rescue the HU and MMS 
sensitivity of rad60-ct cells. Instead, expression of the Rad60-ctNLS protein has a 
dominant-negative effect in both wild-type and rad60-ct cells. The same phenomenon 
was observed when SLD2 was replaced with SUMO. This suggests that SLD2 is 
required not only to localise Rad60 to the nucleus, but also for the DNA damage 
response itself.  
 
Molecular modelling suggests that SLD1 and SLD2 can adopt the characteristic 
ββαββαβ fold. A novel ‘recombinase-mediated cassette-exchange’ system was used to 
initiate a structure/function study of Rad60 SLD2 by mutating residues predicted to help 
maintain the hydrophobic core. The DNA damage sensitive phenotype of L348G, 
L338G, L346G and I334G substitutions support the hypothesis that the SLD2 adopts a 
SUMO-like fold.  
 
Sumoylation of Rad60, in vitro, can be enhanced by the SUMO E3 ligase, Pli1 but not 
Nse2. Rad60 is sumoylated in a manner dependent on the C-terminus, which has is 
required to interact with the Hus5 conjugator, in vitro. This suggests that SLD2 may act 
to recruit Hus5 for sumoylation of itself and/or other proteins.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 Introduction  
The integrity of the genome is under constant threat from both endogenous and exogenous 
sources, which can result in damage to the DNA. DNA lesions must be repaired to prevent 
the loss, or incorrect transmission, of genetic information, which could result in 
developmental abnormalities, tumourigenesis and even cell death. To prevent aberrations of 
the DNA from occurring, organisms have developed a number of complex cellular 
processes allowing DNA damage to be detected and, if necessary, repaired. In recent years, 
the mechanisms controlling the cell cycle and DNA repair have been the focus of much 
research, which is providing valuable insight into the cause and potential therapeutic 
treatments of many diseases including cancer. 
 
The work in this thesis focuses on an investigation of the role of the SUMO-like domains 
of the S. pombe DNA repair protein Rad60. In this chapter, I shall provide an introduction 
into the cell cycle, DNA damage and the mechanisms that exist to ensure that genomic 
integrity is not compromised, as well as an introduction into some of the functional roles of 
the small ubiquitin-like modifier (SUMO). 
 
1.2 S. pombe as a model organism 
The mechanisms controlling the cell cycle and DNA repair have been the focus of scientists 
for many years, but, as with many other fields of research, the study of the human cell cycle 
is technically and ethically difficult. To overcome the problems associated with human 
research, ‘model organisms’ have proved invaluable as experimental systems to allow basic 
research to be carried out. This has enabled the study of a number of cellular processes that 
would otherwise be impossible. Since many features of eukaryotic life are conserved to 
some extent, ‘basic research’ using simpler ‘model organisms’ has often provided a basis 
for the study of more complex organisms Frequently used model organisms include 
prokaryotes such as E. coli, unicellular eukaryotes including the budding yeast S. cerevisiae 
and fission yeast S. pombe, multicellular eukaryotes, such as the nematode C. elegans and 
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vertebrates such as the mouse M. musculus. The fission yeast S. pombe has a number of 
characteristics that make it the ideal tool to study eukaryotic life and in particular the cell 
cycle and DNA damage repair processes. 
 
S. pombe was first isolated from an East African millet beer, called Pombe. One advantage 
of using the fission yeast is its simplicity. S. pombe is a single rod-shaped cell that grows in 
length and divides by medial fission at a constant length. Cell size and length can therefore 
give a good visual indication of cell-cycle stage. The S. pombe cell cycle does, however, 
differ from other eukaryotic cell cycles by having a shorter G1 phase and a longer G2 
phase. S. pombe spends approximately 70% of its cell cycle in the G2 phase, where bulk 
DNA replication has been completed. Due to the short generation time of S. pombe, it is 
easy to culture a large number of cells for study. The S. pombe cell cycle is discussed in 
further detail in section 1.4.2. 
 
Another advantage of using S. pombe as a model for studies is the ability to perform 
genetic analysis. Unlike mammalian cells, S. pombe exists predominantly in a haploid state, 
allowing the phenotypic analysis of recessive mutants. Under conditions of nitrogen 
starvation, the haploid yeast is able to undergo mating and forms diploid zygotes, which 
form four spores when they undergo meiosis. The individual spores can be analysed by 
tetrad dissection, which is useful for genetic analysis and for the study of genetic 
recombination. The publication of the whole genome sequence in 2002 (Wood, Gwilliam et 
al. 2002) makes S. pombe an ideal tool to study eukaryotic cellular processes. Knowledge 
of the S. pombe genome sequence has simplified many existing techniques and allowed the 
development of new scientific approaches making S pombe a useful model.  
 
1.3 Introduction to DNA damage 
DNA lesions can occur as a result of damage from both endogenous and exogenous 
sources. Exogenous sources of DNA damage include UV and γ-irradiation (IR). UV-C light 
causes covalent joining of adjacent bases, forming mainly cyclobutane pyrimidine dimers 
(CPDs) and pyrimidine(6-4)pyrimidine photodimers ((6-4)PDs). Such lesions can distort 
the DNA helix and, therefore, can lead to mis-pairing and mis-incorporation during DNA 
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synthesis. Exposure to IR can also cause a variety of base alterations including both single-
stranded breaks (SSBs) and double-stranded breaks (DSBs) in the phosphodiester 
backbone. DSBs are highly toxic lesions, which if left unrepaired can result in chromosome 
breakage and subsequent loss during cell division.  
 
Endogenous processes can also induce DNA damage, for example, hydrolysis can lead to 
spontaneous DNA depurination. Base damage can occur from the action of reactive oxygen 
species, which can be generated as a result of some intracellular reactions, as well as IR and 
UV. In addition, the intricate processes of replication and mitotic chromosome segregation 
frequently introduce mutations into the genome. Alternatively, abnormal DNA 
intermediates, such as stalled or collapsed replication forks or unresolved Holliday 
junctions, may form resulting in DNA, which cannot be replicated. Collapsed replication 
forks can also result in DNA breaks.  
 
When damage to the DNA is detected during the cell cycle a DNA damage checkpoint is 
activated and also, if necessary, a DNA repair pathway. DNA repair pathways act mainly 
on duplex DNA and rely on the excision and subsequent re-synthesis of the damaged 
sequence based on the information encoded by the complementary strand. However, during 
DNA replication, unrepaired lesions can impede the progress of replicative DNA 
polymerases. Stalled replication forks present dangerous structures that can result in either 
permanent cell cycle arrest or major chromosomal abnormalities. A method to overcome 
replication blocks is therefore required to ensure genome integrity and cell survival. The 
cell cycle, checkpoints and DNA repair pathways are discussed in more detail in sections 
1.4 and 1.5. 
 
1.4 Sensing DNA damage during the cell cycle 
1.4.1 Introduction to the cell cycle 
The process of DNA replication and segregation of replicated chromosomes into two 
identical daughter cells is known as the cell cycle and occurs at distinct and regulated 
intervals. The eukaryotic cell cycle consists of four phases (Norbury and Nurse 1992). S 
phase is the phase during which the DNA is replicated and a complete copy of each 
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chromosome is made. S-phase is preceded by a gap phase called G1, during which the cell 
prepares for DNA synthesis, and is followed by a gap phase called G2, during which the 
cell prepares for mitosis (M-phase). During mitosis the newly replicated chromosomes are 
segregated equally between the two daughter cells as the cells divide. Before commitment 
to DNA replication, cells in G1 can enter a resting state called G0. 
 
Progression through the cell cycle is a complex process and occurs in a highly ordered 
series of events that require tight regulation. The alternation of S and M phases and the 
coordination of growth and division is accomplished by cyclin-dependent kinases (Cdks) 
and their association with different cyclins during different stages of the cell cycle (Pines 
1995). In the Cdk-cyclin pairing, Cdks act as the catalytic subunit for the phosphorylation 
of serine/threonine residues on target proteins. Cyclins act as the regulatory subunit and are 
required for targeting Cdks to their target proteins. The cyclic assembly and disassembly of 
Cdk-cyclin complexes at defined cell stages occur as a consequence of their synthesis, 
inhibition and ubiquitin-mediated degradation. Furthermore, superimposed onto the cell 
cycle are a number of ‘checkpoints’ that act to assess the readiness of the cell to proceed to 
the next stage in the cycle. I will discuss checkpoints in further detail in section 1.4.3. 
 
1.4.2 The S pombe cell cycle 
In S. pombe the only Cdk directly involved in cell regulation is Cdc2. Cdc2 associates with 
four different cyclins Cig1, Cig 2, Puc1 and Cdc13. Although there are four cyclins in S. 
pombe, only Cdc13 is essential for progression through the cell cycle. This suggests that a 
single Cdk-cyclin complex (Cdc2-Cdc13) can trigger both S- and M-phase. Progression of 
the cell cycle is mediated by Cdc2-Cdc13 (Figure 1.1). During G1, Cdc2-Cdc13 activity is 
low due to the low level of Cdc2. Cdc2 activity is inhibited in two ways. Firstly, any 
residual Cdc2-Cdc13 activity from the previous M-phase is inhibited by ubiquitin-mediated 
proteolysis of Cdc13 (Yamaguchi, Murakami et al. 1997; Kitamura, Maekawa et al. 1998). 
Secondly, the Cdc2 inhibitor Rum1 inhibits the kinase activities of Cdc2-Cdc13 and Cdc2-
Cig2 and targets Cdc13 for degradation (Correa-Bordes, Gulli et al. 1997; Benito, Martin-
Castellanos et al. 1998). At the G1/S transition, Rum 1 is degraded, thus, increasing Cdc2-
Cdc13 activity and sending the cells into S-phase (Benito, Martin-Castellanos et al. 1998). 
Figure 1.1: Cell cycle regulation in S. pombe 
 
Progression of the S. pombe cell cycle is mediated by Cdc2-Cdc13 activity. During G1, 
Cdc2-Cdc13 activity is inhibited by Rum1. At the G1/S transition, Rum 1 is degraded, 
thus, increasing Cdc2-Cdc13 activity and promoting entry into S-phase. During G2, 
phosphorylation on Cdc2 Tyr15 by Wee1 inactivates Cdc2-Cdc13. At the G2/M 
transition the inactivating phosphate group is removed by Cdc25 phosphatase, 
promoting Mitosis At the end of mitosis, the ubiquitin ligase (APC) targets mitotic 
cyclins for degradation, thus, lowering the levels of Cdc2-Cdc13. 
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Active S-phase Cdc2-Cdc13 complexes phosphorylate proteins that make up the pre-
replication complex, which is assembled during G1. During G2, phosphorylation on Tyr15 
of Cdc2 by the Wee1 kinase renders Cdc2-Cdc13 inactive. At the G2/M transition the 
inactivating phosphate group is removed by Cdc25 phosphatase, further increasing the 
activity of Cdc2-Cdc13 (Moreno, Nurse et al. 1990). The increased activity of Cdc2-Cdc13, 
which is synthesised but inactivated during G1 and S phase, promotes the initiation of 
Mitosis by stimulating downstream proteins required for chromosome condensation and 
mitotic spindle assembly. At the end of M-phase, the ubiquitin ligase known as the 
anaphase promoting complex (APC) targets mitotic cyclins for degradation, thus, lowering 
the levels of Cdc2-Cdc13 and ensuring that telophase and cytokinesis can continue.  
 
1.4.3  DNA damage checkpoints 
The periodic activation of cyclins acts to control cell cycle progression. However, the 
faithful transmission of genetic information from one cell to its daughters requires not only 
accuracy in DNA replication and chromosome distribution, but also the ability to survive 
both spontaneous and induced DNA damage. Cells have evolved a number of mechanisms 
that ‘sense’ DNA damage during the cell cycle and consequently slow or arrest the cell 
cycle, thereby, allowing cells to repair the damage (Weinert and Hartwell 1988). The 
precise ‘checkpoint’ response is dependent on both the stage of the cell cycle and the exact 
type of DNA damage encountered. Different types of DNA damage are discussed in further 
detail in section 1.5.  
 
The best-defined checkpoints are the G1/S, intra-S and G2/M checkpoints. When DNA 
damage is sensed in G1, the G1/S checkpoint is activated to prevent cells from entering S-
phase, therefore inhibiting the initiation of DNA replication. The G2/M checkpoint (also 
known as the DNA damage checkpoint) is activated in G2 and acts to prevent cells from 
undergoing mitosis when damage is present. The intra-S-phase checkpoint is activated 
when DNA damage is detected in S-phase. Unlike the G1/S and G2/M checkpoints, which 
respond to DNA damage, the intra-S-phase checkpoint also has to recognise and respond to 
replication intermediates and stalled replication forks that can prevent the progression of 
replicative polymerases that can cause DNA breaks. Although these checkpoints are 
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distinct, many of the proteins required for the response to DNA damage are shared. There 
are three main classes of checkpoint proteins: sensors that detect replication blocks or DNA 
damage; transducers that relay this signal; and effectors that act on targets of the 
checkpoint. At any point in the cell cycle, the response to DNA damage follows the same 
sequence of events; 1) DNA damage is first detected by ‘sensor’ proteins, 2) a group of 
‘signal transducer’ proteins convey the signal to specific ‘effector’ proteins, 3) The 
‘effector’ proteins activate a cascade of events that result in cell cycle arrest and DNA 
repair. In addition to the signal transduction proteins mentioned above, a number of other 
‘mediator’ proteins are involved in the DNA damage response. These proteins are mainly 
cell cycle specific and associate with the sensors, signal transducers and effector proteins at 
particular phases of the cell cycle to provide signal transduction specificity. Conserved 
proteins of the signal transduction pathway (and S. pombe homologues) can be seen figure 
1.2. 
 
1.4.3.1 The checkpoint response  
The checkpoint mechanism is best understood for its role in the response to DSBs. 
Checkpoint initiation is dependent on the transient recruitment of the Mre11/Rad50/Nbs1 
(MRN) complex to sites of DSBs followed by the recruitment and activation of the ataxia-
telangiectasia mutated (ATM) protein (Lee and Paull 2005). ATM is a member of the 
phosphoinositide 3-kinase (PI3K) protein family and is considered to function as a DNA 
damage ‘sensor’ protein in the checkpoint response. Two other PI3K ‘sensor’ proteins, 
ATM and Rad3-related’ (ATR) and DNA-dependent protein kinase (DNA-PK), are 
activated in response to DSBs. However, unlike ATM and DNA-PK, which function in 
response to DSBs, the primary function of ATR is in the initiation of the DNA damage 
response to stalled replication forks. The S. pombe homologues of ATM and ATR are Tel1 
and Rad3 respectively. In contrast to the H. sapiens sensor proteins ATM and ATR, which 
activate checkpoints in response to DSBs and UV/replicative stress respectively, S. pombe 
Rad3 activates both checkpoint pathways (al-Khodairy and Carr 1992).  
 
ATM exists as inactive dimers, which, when recruited to sites of DNA damage, dissociate 
and autophosphorylate on multiple residues. This autophosphorylation is believed to be 
Figure 1.2: The checkpoint response 
 
(A) The signal transduction pathway (B) Checkpoint proteins identified in H. sapiens 
and their S. pombe homologues.  
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important for maintaining ATM activation (Bakkenist and Kastan 2003). Active ATM 
phosphorylates target proteins, which are essential for the response to DNA damage and its 
subsequent repair. For example, histone H2AX is phosphorylated at sites of damage by 
ATM, ATR or DNA-PK (Rogakou, Pilch et al. 1998). Phosphorylated H2AX (γ-H2AX) 
signals for the recruitment of other proteins that are essential for the chromatin remodelling 
process that is necessary for the process of DNA repair. Other proteins recruited to sites of 
DSBs include the so-called ‘mediator’ proteins, which act downstream of ATM and ATR 
(Stewart, Wang et al. 2003). Checkpoint mediators may assist in promoting interactions 
between ATM/ATR and their substrates by recruiting additional substrates and acting as 
scaffolds upon which to assemble complexes. Mediator proteins include Claspin and the 
BRCA1 C terminus (BRCT) repeat domain proteins 53BP1, Mdc1, BRCA1 and TopBP1. 
Different mediator proteins associate with proteins of the signal transduction pathway in 
response to DNA damage at specific stages of the cell cycle. The DNA damage checkpoint 
mediators Mdc1, 53BP1, and BRCA1 are largely linked to the ATM pathway, whereas 
TopBP1 and Claspin have been proposed to co-regulate the ATR pathway (Kumagai, Kim 
et al. 2004; Stucki and Jackson 2004; Garcia, Furuya et al. 2005). S. pombe homologues of 
Claspin, BRCA1, and TopBP1 are Mrc1, Crb2 and Rad4 respectively. 
 
As well as functioning upstream, the MRN complex is also a substrate of ATM. 
Phosphorylation of the MRN complex by activated ATM is important for downstream 
signalling (Uziel, Lerenthal et al. 2003). MRN complex mediated resection of DSBs is 
followed by the coating of single-stranded DNA with replication protein A (RPA) (Byun, 
Pacek et al. 2005). RPA binding protects the DNA ends from further processing and acts to 
recruit ATR and its binding partner ATRIP (ATR-interacting protein) (Zou and Elledge 
2003), subsequently leading to ATR-dependent phosphorylation of proteins such as the 
mediator proteins Claspin and BRCA1. Additionally, the ssDNA-RPA complex recruits the 
Rad17 clamp loader and the PCNA-like (proliferating cell nuclear antigen) 9-1-1 (Rad9-
Rad1-Hus1) complex onto DNA (Melo, Cohen et al. 2001; Zou and Elledge 2003). ATR 
phosphorylates Rad17 and the 9-1-1 complex, which is important for down-stream 
signalling (Caspari, Dahlen et al. 2000). The ATR, ATRIP, Rad17, Rad9, Rad1 and Hus1 
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are conserved in S. pombe and are encoded by the rad3, rad26, rad17, rad1 and hus1 genes 
respectively. 
 
Activated ATM and ATR mediate the phosphorylation and activation of the so-called 
‘tranducer’ proteins, Chk1 and Chk2. Chk1 and Chk2 are serine threonine kinases that act 
to phosphorylate target proteins, such as p53 and the Cdc25 family of proteins that control 
cell cycle arrest (Bartek and Lukas 2001). Although there is some redundancy, Chk1 and 
Chk2 function in different pathways. In mammalian cells, Chk1 is phosphorylated and 
activated in an ATR dependent manner in response to UV or replication stress, whereas 
Chk2 is and activated in an ATM-dependent manner in response to IR induced DSBs (Liu, 
Guntuku et al. 2000; Melchionna, Chen et al. 2000). In S. pombe the ATR homologue, 
Rad3 activates both Chk1 and Cds1 (Chk2 homologue). However, Chk1 and Cds1 respond 
to different checkpoint signals (Brondello, Boddy et al. 1999). Chk1 activation occurs most 
commonly when DNA damage is detected after the DNA damage has been replicated 
(Walworth and Bernards 1996). In contrast, Cds1 is activated in response to replication 
stress, (Lindsay, Griffiths et al. 1998). Under conditions where Cds1 activity is lost, 
replication damage results in the collapse of stalled replication forks and Chk1 can be 
activated (Lindsay, Griffiths et al. 1998). 
 
Below the level of signal transduction is a group of proteins termed the ‘effector’ proteins. 
Activated transducer kinases Chk1 and Chk2 (Cds1 in S. pombe), act upon effector proteins 
to produce a number of different cellular responses, including signalling for DNA repair, 
regulation of transcription, inducing apoptosis and controlling cell cycle transitions. The 
best-studied examples of effector proteins in mammalian cells are the p53 tumour 
suppressor protein and the Cdc25 family of phosphatases. In mammalian cells, the p53 
tumour suppressor plays an important role in the decision to undergo either cell cycle arrest 
or apoptosis in response to stresses including DNA damage (Giaccia and Kastan 1998). 
Under normal conditions the level of p53 is kept low by Mdm2-mediated ubiquitination 
and degradation. When DNA damage is detected, ATM and ATR phosphorylate Ser15 of 
p53 (Banin, Moyal et al. 1998; Canman, Lim et al. 1998). Phosphorylation of p53 inhibits 
its interaction with Mdm2, thus, resulting in p53 stabilisation (Shieh, Taya et al. 1999). 
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Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent 
kinases, Cdk2 and Cdk4, thus inhibiting G1/S transition (el-Deiry, Tokino et al. 1993; 
Harper, Adami et al. 1993) The Cdc25 family of protein phosphatases act to remove the 
phosphate group from Cdks that act to regulate the cell cycle transitions (Boutros, Dozier et 
al. 2006). For example, when DNA damage is detected in G2, Chk1 and/or Chk2 
phosphorylate Cdc25-A, resulting in its ubiquitination and subsequent degradation. 
Inactivation of Cdc25-A leads to an accumulation of Tyr15 phosphorylated Cdc2, resulting 
in mitotic arrest. (Zhao, Watkins et al. 2002; Xiao, Chen et al. 2003). In an analogous 
manner, S. pombe Cdc25 is phosphorylated in a Rad3-Crb2-Chk1- (sensor-mediator-
transducer) dependent manner, thereby mediating cell cycle arrest by promoting Tyr15 
phosphorylation of Cdc2. 
 
1.4.3.2 Targets of the S. pombe Cds1 checkpoint kinase  
The S. pombe checkpoint kinase Cds1 plays an important role in stabilising stalled 
replication forks and promoting recovery (Kai and Wang 2003). Three proteins have been 
identified as targets of Cds1 and they are likely to play an important role in preventing 
mutations during replication and promoting recovery after replication stalling. These 
proteins are the Mus81-Eme complex, Rqh1 and Rad60 (Murray, Lindsay et al. 1997; 
Boddy, Shanahan et al. 2003). 
 
When replication is perturbed, Cds1 interacts with the nuclease Mus81 via its FHA 
(forkhead associated) domain. Cds1 regulated phosphorylation of Mus81 reduces the 
chromatin binding ability of the Mus81-Eme1 complex (Boddy, Shanahan et al. 2003; Kai 
and Wang 2003). This suggests that one of the ways that Cds1 may prevent the occurrence 
of deletion mutations caused by the Mus81-Eme1 nuclease in replication stressed cells is 
by reducing the chromatin binding ability of Mus81. Like Mus81, in response to replication 
stress, Cds1 interacts with the Rad60 via its FHA domain (Boddy, Shanahan et al. 2003). 
Rad60 is associated with the Smc5/6 complex (Section 1.6 and section 1.9) and is required 
for the repair of DSBs by recombination repair (Morishita, Tsutsui et al. 2002). In response 
to replication stress by HU treatment, Cds1-dependent phosphorylation of Rad60 by Cds1 
results in Rad60 delocalisation from the nucleus (Boddy, Shanahan et al. 2003). This 
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suggests that removal of Rad60 from the nucleus, may be another method by which Cds1 
acts to prevent non-productive and inappropriate recombination repair events during 
replication stalling (Boddy, Shanahan et al. 2003; Kai and Wang 2003). The S. pombe 
RecQ helicase, Rqh1, is required for the recovery from HU-induced S-phase arrest 
(Stewart, Chapman et al. 1997). In S. cerevisiae, following HU treatment, the Rqh1 
homologue, Sgs1, is required to maintain polymerases α and ε at stalled replication forks 
(Cobb, Bjergbaek et al. 2003). This suggests that after replication fork stalling, Sgs1 plays a 
role in resolving aberrant strand exchange events and a third way in which Cds1 may act to 
allow recovery from replication induced arrest.  
  
1.5  DNA damage repair pathways 
Due to the diverse nature of DNA damage a number of different DNA repair pathways 
have evolved to ensure faithful transmission of the genome. In this section, I will discuss 
the different DNA repair mechanisms known to exist in the cell. 
 
1.5.1 Nucleotide excision repair 
Nucleotide excision repair (NER) occurs in both prokaryotes and eukaryotes and exists to 
remove bulky DNA lesions that distort the DNA helix. This includes lesions induced by 
UV damage such as 6-4 photoproducts and CPDs, and also other types of damage such as 
inter- and intra-strand cross-links. In brief, the NER repair mechanism acts by making 
incisions on both sides of the damaged nucleotide, removing the fragment containing the 
damage and then re-synthesising the excised fragment. In humans, defects in the NER 
pathway are associated with several disorders including Xeroderma pigmentosum, which is 
characterised by an extreme sensitivity to sunlight and an elevated risk of skin cancer 
(Cleaver 1968). Other NER associated disorders include Trichothiodystrophy and 
Cockayne Syndrome (Lehmann 1995; Lehmann 2003) 
 
Two sub-pathways of NER pathways have been identified; global genome NER (GG-NER) 
and transcription-coupled NER (TC-NER). As their names suggest, GG-NER repairs DNA 
lesions throughout the genome whereas TC-NER is confined to the repair of DNA lesions 
in transcribed strands and is coupled to active transcription. The main difference between 
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the TC-NER and GG-NER pathways is the requirement of different factors for the 
recognition of the DNA lesion. Following recognition, both pathways require the same core 
NER factors for the assembly of a functional NER complex. TC-NER specific factors are 
recruited when the RNAPII complex is stalled at a DNA lesion. The stalled polymerase 
must be displaced to make the lesion accessible for repair. Recognition requires the CSA 
and CSB proteins along with XAB2 and HMGN1 (Nakatsu, Asahina et al. 2000; Bustin 
2001; Fousteri, Vermeulen et al. 2006). In GG-NER, XPC-Rad23B along with UV-DDB 
recognises the site of DNA damage. Once the lesion has been recognised XPA, TFIIH and 
RPA are recruited (Park, Mu et al. 1995; Sugasawa, Okamoto et al. 2001; Volker, Mone et 
al. 2001). The basal transcription factor TFIIH has an essential role in NER as two of its 
components XPB and XPD exert their DNA-dependent ATPase and helicase activity 
respectively to unwind about 20-25 bp of DNA around the DNA lesion (Drapkin, Reardon 
et al. 1994; Wang, Buratowski et al. 1995). In an ATP-dependent reaction, XPG recruits 
the heterodimer ERCC1-XPF to form Pre-initiation complex I. The XPG and XPF-ERCC1 
endonucleases make incisions 3’ and 5’ to the lesion respectively (O'Donovan, Davies et al. 
1994; Sijbers, van der Spek et al. 1996). This results in the release of the DNA fragment 
containing the lesion. Following excision of the lesion, replication factor C (RFC), 
proliferating cell nuclear antigen (PCNA), DNA polymerase δ or ε, DNA ligase and RPA 
are required for gap filling and ligation (Aboussekhra, Biggerstaff et al. 1995; Shivji, 
Podust et al. 1995; Araujo, Tirode et al. 2000).  
 
The NER pathway has been well characterised in S. pombe. The S. pombe homologues of 
XPA, XPB, XPD, XPF, XPG and ERCC1 are Rhp14, Ptr8, Rad15, Rad16, Rad13, and 
Swi10 respectively (Marti, Kunz et al. 2002).  
 
1.5.2 UV damage excision repair 
In contrast to S. cerevisiae, S. pombe NER mutants are still able to excise UV-induced 
damaged DNA, suggesting the existence of an alternative pathway for the excision of UV 
lesions in S. pombe (Murray, Doe et al. 1992; McCready, Carr et al. 1993; Carr, Schmidt et 
al. 1994; Murray, Tavassoli et al. 1994). The UV damage excision repair (UVER) pathway 
is dependent on an S. pombe specific protein known as the UV damage endonuclease 
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(UVDE) (Freyer, Davey et al. 1995; Yonemasu, McCready et al. 1997). UVDE shares 
structural similarity to the AP endonucleases, recognising both 6-4 photoproducts and 
CPDs, and functions by nicking the phosphodiester backbone 5’to the DNA lesion. 
Following cleavage, Rad2 is required to process the UVDE nick (Alleva and Doetsch 
1998). The DNA is then re-synthesised through the action of DNA polymerases and ligases. 
 
A rad2 rad13 double mutant is repair proficient suggesting the existence of an alternative 
Rad2-independent pathway exists to process UVDE nicks. This pathway requires 
functional Rhp51, Rqh1 and TopIII proteins for activity, although the precise mechanism of 
action is unknown (McCready, Osman et al. 2000).  
 
1.5.3 Base excision repair 
The majority of cellular DNA damage occurs as a consequence of cellular metabolism. 
Small lesions, including apurinic and apyrimidinic (AP) sites, form as a result of 
spontaneous hydrolysis and oxidative damage to bases by reactive oxygen species (ROS), 
as well as from IR and UV damage. The most common way to remove such damage is 
through the action of the BER pathway. In BER, the damaged base is removed through the 
action of a group of DNA glycosylases. DNA glycosylases can be subdivided by their 
ability to recognise a particular type of base modification. For example, thymine DNA 
glycosylase specifically recognise and remove thymine residues found in G:T mispairs, 
which arise through deamination of 5-methylcytosine (Krokan, Nilsen et al. 2000; Norbury 
and Hickson 2001). The DNA glycosylase cleaves the N-glycosidic bond between the 
modified base and the deoxyribose sugar, leaving an AP site in the DNA. An AP-
endonuclease (APE) cleaves the AP site to generate 3’ OH and 5’ deoxyribose phosphate 
termini (Doetsch and Cunningham 1990). Following cleavage, the AP site is removed by a 
phosphodiesterase and the gap in the DNA is re-synthesised through DNA polymerase and 
DNA ligase activity. 
 
Two different BER mechanisms exist: short-patch and long-patch BER. In the short-patch 
BER model, only the damaged base is excised leaving a 1-nucleotide gap (Kubota, Nash et 
al. 1996). In this situation, the DNA strand is re-synthesised by DNA polymerase β and 
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ligated by the ligase III/XRCC1 complex (Kubota, Nash et al. 1996). In the long-patch 
BER model, excision of the damaged base leaves a repair patch of 2-8 nucleotides. DNA 
polymerase β, DNA polymerase δ/ε, PCNA and the FEN1 endonuclease are required for 
long-patch repair synthesis, and DNA ligase I is required to close the gap (Krokan, Nilsen 
et al. 2000; Sokhansanj, Rodrigue et al. 2002). The choice between long-patch and short-
patch BER may depend on whether cleavage by the APE occurs 5’ or 3’ to the AP site 
respectively.  
 
The BER pathway is conserved from bacteria to mammals. In mammals the balance 
between the use of long-patch and short-patch BER repair may be tissue specific, but it is 
generally believed that short-patch BER is the more commonly used (Karahalil, Hogue et 
al. 2002).  
 
1.5.4 Mismatch repair  
Errors can occur during normal DNA metabolism and DNA processing reactions, including 
DNA replication, recombination and repair. Cells have evolved a DNA repair mechanism 
known as mismatch repair (MMR) to remove such mismatches and thus prevent mutations 
becoming permanent. Because MMR reduces the number of replication-associated errors, 
mutations associated with the inactivation of human MMR proteins have been associated 
with hereditary and sporadic cancers such as HNPCC (Fishel, Lescoe et al. 1993; Leach, 
Tokino et al. 1993; Papadopoulos, Nicolaides et al. 1994).  
 
The MMR pathway has been extensively studied in E. coli and is initiated by the MutS, 
MutL and MutH proteins. A homodimer of the ‘mismatch recognition’ protein, MutS, 
recognises base-base mismatches and small nucleotide insertion/deletion loops (Modrich 
and Lahue 1996). After MutS binding, MutL interacts with MutS to enhance mismatch 
recognition and recruit MutH. MutL functions as a homodimer and possesses ATPase 
activity. MutL binding facilitates the assembly of a functional MMR complex, by 
stimulating the loading and processivity of helicase II at the MMR initiation site (Dao and 
Modrich 1998). MutL is able to interact with the clamp loader subunits of pol III, 
suggesting that MMR is coupled with DNA replication. Upon its recruitment and activation 
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by MutS and MutL in the presence of ATP, MutH specifically cleaves the daughter strand 
at a hemimethylated dGATC 5’ or 3’ to the located mismatch (Modrich and Lahue 1996; 
Junop, Obmolova et al. 2001). This strand-specific nick provides the initiation site for 
mismatch excision. The precise method in which the mismatched base is cleaved remains 
unclear. However, it is believed that in the presence of MutL, helicaseII loads at the nick 
and unwinds the duplex DNA from the nick towards the site of mismatch, generating single 
stranded DNA, which is rapidly bound by the single-stranded binding (SSB) protein and, 
thus, protected from nuclease attack (Ramilo, Gu et al. 2002). Depending on the position of 
the nick, relative to the mismatch, ExoI or ExoX (3’-5’ exonuclease), or ExoVII or RecJ (5’ 
-3’ exonuclease) excise the nicked strand, from the initial dGATC, up to and slightly 
beyond the mismatch. The resulting single-stranded gap is repaired by the action of DNA 
pol III, SSB and DNA ligase (Modrich and Lahue 1996).  
 
The mismatch repair pathway is conserved in eukaryotes. However, differences are present. 
For example, whilst E.coli MutS and MutL are homodimers, they function as hetrerodimers 
in eukaryotes. To date, no homologues of MutH have been identified in eukaryotes. In H. 
sapiens, the MutS related heterodimers; MSH2-MSH6 (MutSα) and MSH2-MSH3 
(MutSβ) recognise the mismatch site. S. pombe does not require the MSH2-MSH3 
heterodimer for MMR. Although most eukaryotes utilise the MutL-related heterodimer, 
MLH1-PMS1, multiple MutL-related proteins have been identified (Marti, Kunz et al. 
2002).  
 
1.5.5 Post replicative repair  
Most types of DNA damage cannot be accommodated by the active site of the replicative 
DNA polymerases. Under normal circumstances the DNA lesion is removed by DNA 
repair pathways, such as BER and NER, before the replicative machinery encounters it. 
However, if the damage fails to be removed before the polymerase encounters it, the 
replication fork will stall. The post replicative repair (PRR pathway) allows the replication 
fork to bypass the site of damage, preventing prolonged stalling of DNA replication.  
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PCNA is an essential replication factor and an important factor for S-phase DNA repair. 
PCNA is regulated by both ubiquitin and SUMO modification (Section 1.7 and section 
1.8). In S. cerevisiae, stalled DNA replication forks induce monoubiquitination of PCNA 
Lys164, catalysed by the Rad6 ubiquitin conjugating enzyme and the Rad18 RING finger 
E3 ligase (Bailly, Lamb et al. 1994; Ulrich and Jentsch 2000; Hoege, Pfander et al. 2002). 
PCNA monoubiquitination of Lys164 signals for the replacement of the replicative 
polymerase by translesion synthesis (TLS) family polymerases that are capable of 
bypassing DNA lesions in an ‘error-prone’ manner (TLS). Alternatively, in the presence of 
the Rad18/Rad6 complex, MMS2-Ubc13 ubiquitin conjugating enzyme and the Rad5 
RING finger E3 ligase can catalyse the formation of K63-linked polyubiquitin chains onto 
the monoubiquitin on PCNA K164 (Bailly, Lamb et al. 1994; Ulrich and Jentsch 2000; 
Hoege, Pfander et al. 2002). Polyubiquitination of PCNA directs a second ‘error-free’ PRR 
pathway (also referred to as the error-free damage avoidance pathway), which uses the 
newly synthesised sister chromatid as a template to bypass the DNA lesion through a 
template switching mechanism. PCNA, therefore, acts to initiate and choose between an 
error-prone pathway, translesion synthesis, and an error-free DNA damage tolerance 
pathway (Hoege, Pfander et al. 2002; Stelter and Ulrich 2003).  
 
Mammalian homologues of the PRR proteins have been identified suggesting that PRR is 
well conserved through evolution.  
 
1.5.6 Double-strand break repair 
Double-stranded breaks (DSBs) are amongst the most deleterious damage that cellular 
DNA repair systems must contend with. In fact, a single unrepaired DSB can result in cell 
death. Double stranded breaks can be induced by both exogenous sources, such as IR, and 
endogenous processes of DNA metabolism. If in a dividing cell the damage is left 
unrepaired, the chromosomal region unconnected to the centromere is unable to segregate 
to the daughter cell. This can lead to chromosomal deletions and potentially to cell death. If 
incorrectly repaired, DSBs can lead to other aberrations such as translocations (Pierce, 
Stark et al. 2001). In H. sapiens defects in the DSB repair pathway can result in disorders 
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such as Nijmegen Breakage Syndrome and Ataxia telangiectasia (Shiloh 1997; Carney, 
Maser et al. 1998). 
 
In eukaryotes, DSBs can be repaired either by non-homologous end-joining (NHEJ) or by 
homology-dependent repair mechanisms such as homologous recombination (HR), and the 
HR-associated, single-strand annealing (SSA) and synthesis-dependent strand-annealing 
(SDSA) pathways. NHEJ joins two DNA ends irrespective of their sequence, 
consequentially generating errors if the two ends are unrelated. HR on the other hand is an 
error free DSB repair mechanism that uses homologous DNA sequences, often from sister 
chromatids, as templates for repairing broken ends. Although it is not clear which factors 
determine the choice between HR and NHEJ for DSB repair, it is believed that the stage of 
the cell cycle must play an important role. This is because the homologous template, which 
is necessary for HR, is only present during the S and G2 phases of the cell cycle. This 
suggests that NHEJ is the predominant repair pathway in G1 and M phases. 
 
1.5.6.1 Homologous recombination  
Whilst the primary role of HR in mitotic cells is the repair of double stranded breaks, HR is 
also essential for a number of other processes required for the maintenance of genomic 
stability such as telomere maintenance. In meiotic cells, HR is required to ensure the 
correct disjunction at the first meiotic division by establishing a physical connection 
between homologous chromosomes. In addition, HR is necessary for meiotic crossover 
events required to generate genetic diversity. The current model for HR-dependent double-
strand break repair can be described in 6 stages; 1) DSB detection, 2) 5’-3’-resection, 3) 
strand-invasion/ D-loop formation, 4) branch migration, 5) gap filling and ligation/ double 
Holiday Junction formation 6) Holliday junction resolution (Figure 1.3).  
 
When a DSB is detected, the DNA damage checkpoint is activated resulting in the 
phosphorylation of histone H2AX and the recruitment of proteins required for the repair of 
the DSB. The MRN complex is required for the initiation of DSB repair events, including 
both HR and NHEJ. Mre11 displays both 3’-5’ exonuclease and endonuclease activity and 
is important for the processing of DSB ends. Rad50 shows structural similarity to the SMC 
Figure 1.3 Homology-mediated double strand break repair in S. pombe 
Overview of the homology-mediated double strand break repair mechanisms in S. 
pombe. HR: homologous recombination, SDSA: synthesis dependent strand annealing, 
SSA: single strand annealing. Figure adapted from (Raji and Hartsuiker 2006). 
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(structural maintenance of chromosomes) proteins (Section 1.6), and is thought to form a 
globular ATPase domain. Nbs1 is a substrate of ATM (Tel1 in S. pombe) and is able to 
recruit the MRN complex to the site of a DSB through interaction of its FHA and BRCT 
domains with γ-H2AX. Despite having 3’-5’ nuclease activity, the MRN complex has been 
implicated in the processing of the DSB ends by 5’ to 3’ resection. The resulting 3’ single-
stranded overhangs are able to invade a homologous DNA strand (Furuse, Nagase et al. 
1998; Moreau, Ferguson et al. 1999). Following resection, the 3’ single-stranded DNA 
overhangs are subsequently coated with the single-stranded binding protein RPA, which is 
thought to help remove secondary structures before Rad51 (Rhp51 in S. pombe) is loaded 
onto the DNA. Since RPA has a higher affinity for ssDNA than Rad51 does, recombination 
mediator proteins are required to overcome RPA inhibition and assist Rad51 binding. One 
such mediator protein is Rad52 (Rad22 in S. pombe), which interacts with Rad51. Loading 
of the Rad52-Rad51 complex onto single-stranded DNA facilitates the formation of Rad51 
nucleoprotein filaments (Essers, Houtsmuller et al. 2002; Jackson, Dhar et al. 2002). Once 
assembled, the Rad51 nuceloprotein filament is capable of interacting with the homologous 
template DNA, thus initiating strand exchange. When the damaged DNA strand invades the 
undamaged DNA duplex a structure known as the D-loop forms. Using the undamaged 
homologous strand as a template, DNA Polymerase I extends the damaged strand and the 
ends are ligated by DNA ligase I. A double Holliday junction (HJ) is formed when a single 
crossover covalently joins two recombining duplexes. Following HR, structure specific 
endonucleases, such as Mus81, resolve the HJs into two duplexes (Haber 1999). 
 
According to this HR model, equal crossover and non-crossover events are generated due 
to the alternate Holliday junction resolution. However, recent studies suggest that crossover 
and non-crossover events are generated from different recombination intermediates (Allers 
and Lichten 2001). To explain the low level of associated crossover events in mitotic cells, 
the synthesis-dependent strand-annealing (SDSA) model has been proposed (Section 
1.5.6.3). 
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1.5.6.2 Synthesis-dependent strand-annealing 
According to the HR model above, resolution of the HJ results in gene conversion, thus, 
yielding both crossover and non-crossover products. The synthesis-dependent strand-
annealing (SDSA) model was proposed to explain the low number of associated crossovers 
seen in non-meiotic cells (Ferguson and Holloman 1996). Like HR, SDSA is initiated by 
strand invasion, but after branch migration, the newly synthesised DNA strand is displaced 
from the template and returned to the broken DNA molecule. This event results in 
homologous repair without associated crossovers (Figure 1.3). 
 
1.5.6.3 Single-strand annealing  
The Rad51-dependent recombination pathway discussed in section 1.5.6.1 is the most 
efficient pathway to repair DSBs. However, an alternative Rad51-independent 
recombination pathway does exist. The single-strand annealing (SSA) pathway can repair 
DSBs found between two nearly homologous repeats. Like HR, SSA is initiated by DSB 
detection, followed by 5’-3’-resection. However, 5’-3’-resection is followed by further 
resection of the DSB ends by an endonuclease until two small regions of homology are 
revealed on either side of the break. The homologous sequences anneal in a Rad52-
dependent manner, leaving long single-stranded non-homologous DNA ends. The 
endonuclease activity of Rad1-Rad10 is required to trim off the 3’ non-homologous ssDNA 
tails that can form after annealing (Baumann and West 1998; Norbury and Hickson 2001). 
Like HR, duplex DNA is restored through the action of DNA Pol I and DNA ligase I. 
Unlike HR, SSA is error prone and results in the deletion of the sequence between the 
homologous sequences flanking the DSB (Figure 1.3). 
  
1.5.6.4 Non-homologous end-joining  
Unlike HR, NHEJ requires little or no sequence homology and joins two DNA ends 
irrespective of their sequence. NHEJ is, therefore, potentially a less accurate form of DSB 
repair. NHEJ consists of three stages; 1) the capture of capture of both ends of the broken 
DNA molecule, 2) the formation of a molecular bridge to bring the two DNA ends back 
together and 3) the re-ligation of the broken DNA molecule. The NHEJ pathway has been 
well characterised in H. sapiens and is Rad52-independent. Instead, NHEJ requires the 
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action of XRCC1, Ku70, Ku80, DNA ligase IV and DNA-PKcs (DNA protein kinase 
catalytic subunit). The NHEJ process is initiated by the binding of the Ku70/Ku80 
heterodimer to both ends of the broken DNA molecule. Binding of the Ku70/80 
heterodimer protects the ends of the DSB from further processing and creates a scaffold for 
the recruitment of other NHEJ proteins. In an early stage of NHEJ, the DNA-dependent 
protein kinase catalytic subunit (DNA-PKcs) is recruited to the site of the DSB (Gottlieb and 
Jackson 1993; Singleton, Torres-Arzayus et al. 1999). This kinase facilitates the formation 
of a synaptic complex, which brings the DNA ends together. Finally, the ligase IV/XRCC4 
complex catalyses the ligation of the two DNA ends, regardless of homology (Ramsden 
and Gellert 1998; Nick McElhinny, Snowden et al. 2000). 
 
1.6 The Smc5/6 complex and its role in DNA repair 
1.6.1 Introduction to SMC proteins 
The structural maintenance of chromosomes (SMC) protein family is well conserved across 
eubacteria, archaea, and eukaryotes. SMC proteins form a superfamily of proteins sharing a 
common structure. Globular N- and C-terminal domains, containing Walker A and B 
motifs respectively, are separated by two long coiled-coils joined by a flexible ‘hinge’ 
(Haering, Lowe et al. 2002; Hirano and Hirano 2002; Sergeant, Taylor et al. 2005). The 
hinge allows the molecule to fold back on itself, allowing the two coiled-coils to interact in 
an anti-parallel manner bringing the N- and C-terminal domains into close proximity of one 
another thus generating an ATPase active site (Melby, Ciampaglio et al. 1998).  
 
In eukaryotes six SMC proteins comprise three SMC complexes; Smc1/Smc3 (cohesin), 
Smc2/Smc4 (condensin) and the Smc5/Smc6 complex (Michaelis, Ciosk et al. 1997; 
Hirano 1999; Fousteri and Lehmann 2000). The SMC heterodimers are formed by 
intermolecular interactions of the hinge domains of the two SMC proteins. Unlike 
eukaryotes, only one smc gene exists in prokaryotes where the SMC protein forms a 
homodimer rather than a heterodimer (Hirano and Hirano 1998). SMC proteins are 
conserved in all eukaryotes and are essential for viability. The Smc1 and Smc3 proteins 
form the core of cohesin, a complex required to hold the sister chromatids together, and 
Smc2 and Smc4 form the core of condensin, which as the name suggests has an important 
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role in condensing the chromosomes during mitosis (For reviews see (Nasmyth and 
Haering 2005; Hirano 2006)). The Smc5 and Smc6 proteins form the core of the 
Smc5/Smc6 complex, whose role has been implicated in the repair of DNA damage 
(Michaelis, Ciosk et al. 1997; Fousteri and Lehmann 2000; Sergeant, Taylor et al. 2005). 
Although, each of the three complexes is required for a different aspect of chromosome 
segregation and repair, interplay between DSB repair and segregation seems to be well 
conserved since many prokaryotes also contain SMC-like proteins involved in both 
processes (Cobbe and Heck 2004).  
 
1.6.2 The Smc5/6 complex 
1.6.2.1 Architecture of the Smc5/6 complex 
The Smc5/6 complex was initially defined in S. pombe by a hypomorphic allele of smc6, 
formally known as rad18 (Lehmann, Walicka et al. 1995). The Smc5/6 complex is 
composed of eight subunits including the structural maintenance of chromosomes proteins 
Smc5 and Smc6 and six non-SMC proteins Nse1-6 (McDonald, Pavlova et al. 2003; 
Sergeant, Taylor et al. 2005; Pebernard, Wohlschlegel et al. 2006). Like Smc5 and Smc6, 
Nse1-4 are essential for viability in S. pombe, whereas Nse5 and Nse6 are not essential but 
are required for the DNA repair function of the Smc5/6 complex. An additional, loosely 
associated subunit, Rad60, is required for both DNA repair and the essential function of the 
complex (Morishita, Tsutsui et al. 2002; Boddy, Shanahan et al. 2003). Rad60 is discussed 
in further detail in section 1.9. 
 
Prior to the identification of the Nse5 and Nse6 subunits, in vitro studies indicated that the 
Smc5/6 complex consists of two sub-complexes (Sergeant, Taylor et al. 2005). In the first 
sub-complex, Smc5 and Smc6 interact via their hinge domains to form the core of the 
complex. Nse2 was also found bound to the coiled-coil region of the Smc5 protein. The 
second sub-complex consists of Nse1, Nse3 and Nse4, which bind to one another. The two 
complexes were thought to be bridged by a weak interaction between Nse2 and Nse3 
(Sergeant, Taylor et al. 2005).  
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More recently, the Nse1-Nse3-Nse4 sub-complex has been shown to bind directly to Smc5, 
independently of Nse2 (Pebernard, Wohlschlegel et al. 2006). Two additional Nse proteins, 
designated Nse5 and Nse6, were identified by their ability to interact with the Smc5 and 
Nse4 proteins (Pebernard, Wohlschlegel et al. 2006). This is consistent with there being six 
Nse proteins in the S. cerevisiae Smc5/6 complex (Hazbun, Malmstrom et al. 2003). The S. 
pombe Nse5 and Nse6 proteins form a heterodimer that binds directly to Smc5/6, 
independently of Nse1-4, although the site of interaction is not known (Pebernard, 
Wohlschlegel et al. 2006). The binding of Nse5 and Nse6 to both Smc5 and Smc6 was 
confirmed in a separate study (Palecek, Vidot et al. 2006). In this study, Nse4 was shown to 
bind both SMC proteins. Structural predictions suggest Nse4 is related to the cohesin 
kleisin, Scc1, with a helix turn helix motif at its N-terminus and a winged helix domain at 
its C-terminus (Palecek, Vidot et al. 2006). Kleisins are found in both cohesin and 
condensin, and act to bridge the head domains of the SMC proteins, allowing them to form 
closed ring-like structures. Scc1 has a separase cleavage site that allows opening of the 
cohesin complex so that sister chromatids can separate (Uhlmann, Wernic et al. 2000). No 
such cleavage sites have been identified in Nse4 (Palecek, Vidot et al. 2006). This suggests 
that, if the Smc5/6 complex does open and close, a different mechanism is likely to be in 
place. The current model (Palecek, Vidot et al. 2006) for the architecture of the Smc5/6 
complex can be seen in Figure 1.4. 
 
1.6.2.2 Nse components of the Smc5/6 complex 
Studies of the Smc5/6 complex have revealed six non-SMC proteins associated with the 
complex. Characterisation of these Nse proteins has revealed motifs that may provide a 
functional role for their association with the Smc5/6 complex. 
 
The Nse1 protein contains a RING finger domain suggesting that it functions as an E3 
ubiquitin ligase (Fujioka, Kimata et al. 2002). Although no functional evidence for this 
activity exists, an S. cerevisiae nse1 allele (nse1-C274A) carrying a mutation in the 
conserved RING-finger motif shows a higher degree of UV sensitivity than is observed in 
other non-ubiquitin ligase domain mutants of nse1 (Santa Maria, Gangavarapu et al. 2007). 
The UV sensitivity of the PRR mutants rad18-d and rad5-d is enhanced when they are 
Figure 1.4: Architecture of the Smc5/6 complex 
 
The Smc5/6 complex is composed of eight subunits, including the Smc5 and Smc6 
proteins and six non-SMC proteins, Nse1-6. The N- and C-terminal globular domains of 
each SMC subunit self-associate to generate an ATPase. Smc5 and Smc6 interact via 
their hinge domains to form the core of the complex. Nse2 functions as an SUMO ligase 
and associates with the coiled-coil region of Smc5. Nse1, Nse3 and Nse4 form a sub-
complex that binds to Smc5 independently of Nse2. Nse4 resembles a kleisin and may 
form a bridge by interacting with both SMC proteins. Nse5 and Nse6 form a 
heterodimer, independent of the other Nse proteins. Nse5 and Nse6 associate with the 
head domains of both Smc5 and Smc6, potentially forming a second bridge. An 
additional loosely associated subunit, Rad60, is required for both the DNA repair and 
essential function of the Smc5/6 complex 
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Key
 22 
combined with the nse1-C274A mutation. In contrast, the UV sensitivity of the rad52-d 
mutant is not altered in combination with nse1-C274A (Santa Maria, Gangavarapu et al. 
2007). This suggests that, in S. cerevisiae at least, the putative ubiquitin ligase, Nse1, 
contributes to the Rad52 dependent-PRR pathway.  
 
S. pombe Nse2 and its homologues in S. cerevisiae and H. sapiens (Mms21 and Nse2) 
contain a PIAS RING-finger like domain attributing to the E3 SUMO ligase function 
(Andrews, Palecek et al. 2005; Potts and Yu 2005; Zhao and Blobel 2005). Several proteins 
have been identified as targets of Nse2-dependent sumoylation, including Smc6, Nse3 and 
Nse2 itself (Andrews, Palecek et al. 2005). It is possible that the weak interaction identified 
between Nse2 and Nse3 may be a consequence of the Nse2-dependent sumoylation of Nse3 
(Andrews, Palecek et al. 2005; Sergeant, Taylor et al. 2005). nse2-SA cells which express a 
ligase-dead variant of Nse2 are partially defective in DSB-repair after IR (Andrews, 
Palecek et al. 2005). In human cells, Nse2 is not required for the stability of the Smc5-6 
complex (Taylor, 2008). Furthermore, in S. pombe the Nse2-SA protein is still associated 
with the Smc5/6 complex, suggesting that Nse2-dependent sumoylation is not required to 
maintain an intact complex (Andrews, Thesis). 
 
Nse3 contains a MAGE (Melanoma Antigen-Encoding Gene) homology domain 
(Pebernard, McDonald et al. 2004; Sergeant, Taylor et al. 2005) MAGE domains are found 
in a large number of mammalian proteins that are highly expressed in tumours. Nse3 is the 
first example of a MAGE family protein in yeast, although the function of the MAGE 
domain is currently unknown. Like Smc6, Nse3 has been implicated in the UVER pathway 
(Lehmann, Walicka et al. 1995; Morikawa, Morishita et al. 2004).  
 
Nse4, previously referred to as Rad62, has no domains predictive of a particular function. 
Recently, structural predictions suggest that Nse4 may be related to Scc1, with a helix-turn-
helix motif at its N-terminus and a winged helix domain at its C-terminus (Palecek, Vidot 
et al. 2006). This may suggest that like Scc1 of cohesin, Nse4 acts as a kleisin molecule for 
the Smc5/6 complex. No experimental evidence for this exists at present.  
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Nse5 and Nse6 are the most recently identified subunits of the Smc5/6 complex. Like the 
Nse1-4 subunits Nse5 and Nse6 are essential for viability in S cerevisiae. In S. pombe, 
however, Nse5 and Nse6 are not essential. Mutants of these proteins display many of the 
phenotypes observed for hypomorphic mutants of Smc5/6, suggesting that the Nse5/6 
heterodimer specifically facilitates some of the DNA repair functions of the Smc5/6 
complex (Pebernard, McDonald et al. 2004). Nse6 is a member of the ARM/HEAT repeat 
family. ARM/HEAT repeats provide protein-protein interfaces and are found in factors 
associated with both cohesin and condensin. Like Rad60, Nse5/6 mutants are dependent on 
Mus81 and Rqh1 for viability (Pebernard, McDonald et al. 2004). This would suggest that, 
since Mus81 and Rqh1 have been implicated in the processing of Holliday junctions that 
can form as a result of HR, Holliday junctions accumulate in Nse5/6 mutant cells 
(Pebernard, McDonald et al. 2004).  
 
1.6.2.3 Functional roles of the Smc5/6 complex 
Unlike the other SMC complexes, the Smc5/6 complex has a poorly defined role in DNA 
repair. The Smc5/6 complex was first identified in S. pombe when smc6 was shown to 
complement a DNA-damage sensitive mutant (Lehmann, Walicka et al. 1995). Epistasis 
analysis of smc6 mutants with an rhp51-d strain implicated the Smc5/6 complex in the HR 
pathway (Lehmann, Walicka et al. 1995). nse1, nse2, nse4 and nse6 are also epistatic with 
rhp51-d in response to IR (McDonald, Pavlova et al. 2003; Morikawa, Morishita et al. 
2004; Pebernard, Wohlschlegel et al. 2006). Following IR-induced DNA damage in G2, 
hypomorphic smc5, smc6 and nse mutants are unable to repair damaged chromosomes 
(Verkade, Bugg et al. 1999; Morikawa, Morishita et al. 2004; Lindroos, Vinnere et al. 
2006). Smc6-X mutant cells are proficient in Cds1-dependent mitotic arrest in response to 
HU. However, after release from HU they undergo aberrant mitosis (Miyabe, Morishita et 
al. 2006). These aberrant mitoses can be suppressed by deletion of rhp51 or rhp55 
(Ampatzidou, Irmisch et al. 2006; Miyabe, Morishita et al. 2006). This is consistent with 
the requirement of Smc6 during a late stage in recombination at a subset of stalled 
replication forks that collapse. A similar phenomenon has been observed for rad60 
mutants, suggesting Rad60 functions with the Smc5/6 complex at a late stage of repair 
(Miyabe, Morishita et al. 2006). Rad60 is discussed in further detail in section 1.8.1. 
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Ambiguously, both S. cerevisiae and S. pombe can accommodate the complete loss of HR 
but loss of Smc5/6 function is lethal. Furthermore, the lethality caused by Smc6 loss cannot 
be reversed by the additional loss of HR function (Torres-Rosell, Machin et al. 2005; Cost 
and Cozzarelli 2006). This suggests an additional, HR-independent, role of the Smc5/6 
complex. 
 
Two mutant alleles of smc6 have been extensively characterised in S. pombe, namely smc6-
X and smc6-74 (Lehmann, Walicka et al. 1995; Verkade, Bugg et al. 1999). smc6-X cells 
have a R706C mutation in the second coiled-coil region close to the hinge and are sensitive 
to DNA damaging agents including UV, IR and MMS. UV-induced damage is removed 
less efficiently in smc6-X than in wild type cells (Lehmann et al, 1995). However, smc6 
mutants are not epistatic to mutants in the conserved NER pathway (Section 1.4.3). Instead, 
Smc6 is thought to be involved in UVER (Section 1.4.4), a secondary UV damage removal 
pathway that involves the rad2 and rhp51 genes (Lehmann, Walicka et al. 1995; Murray, 
Lindsay et al. 1997). Deletion of rhp51 rescues the sensitivity of nse6-d, nse2-1and nse4-1 
cells to UV at low doses, suggesting that in the mutant cells, UV damage is converted into 
a toxic structure by the HR protein Rad51 (Morikawa, Morishita et al. 2004; Pebernard, 
Wohlschlegel et al. 2006).  
 
smc6-74 cells have an A151T mutation that maps to the highly conserved arginine finger in 
the N-terminal globular domain, and have a phenotype similar to that observed for smc6-X 
(Verkade, Bugg et al. 1999). Unlike smc6-X, which remains cell cycle arrested after 
induction of DNA damage, smc6-74 cells show a DNA damage checkpoint of wild-type 
duration. However, smc6-74 cells re-enter the cell cycle following aberrant mitoses, 
suggesting that smc6-74 cells are proficient in initiating the checkpoint but deficient in 
maintaining checkpoint arrest (Verkade, Bugg et al. 1999). In S. pombe Brc1 has been 
identified as an allele-specific multi-copy suppresser of the smc6-74 allele (Verkade, Bugg 
et al. 1999). Brc1 is a protein consisting of six BRCT repeats and is required for mitotic 
fidelity. Brc1-dependent smc6-74 suppression is dependent on the activity of structure-
specific nucleases (Slx1/4 and Mus81/Eme1) and HR function. brc1-d is synthetic lethal 
with both smc6-X and smc6-74 (Verkade, Bugg et al. 1999). Taken together, these 
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observations suggest that Brc1 acts downstream of Smc6 in a function that is defective in 
smc6-74 but not smc6-X. 
 
It would appear that the HR defect of Smc5/6 mutants is a genome-wide phenomenon. 
Several studies have focused on the consequence of Smc5/6 defects for ribosomal DNA 
(rDNA) replication and stability. Chromatin IP (ChIP) studies show that Smc5/6 is 
enriched on the S. cerevisiae rDNA, although this is not evident at the rDNA in S. pombe 
(Torres-Rosell, Machin et al. 2005; Ampatzidou, Irmisch et al. 2006). However, in both S. 
pombe and S. cerevisiae a significant proportion of Smc6 localises to the nucleolus, which 
is home to ~200 rDNA repeat units (Torres-Rosell, Machin et al. 2005; Ampatzidou, 
Irmisch et al. 2006). Smc5/6 complex has implied functions not only in response to DNA 
damage and collapsed replication forks during mitosis`, but also during meiosis (Taylor, 
Moghraby et al. ; Pebernard, McDonald et al. 2004).  
 
The Smc5/6 complex is architecturally similar to cohesin. Until recently, studies of cohesin 
have focused on its function in unchallenged cells, whereas Smc5/6 function has been 
investigated from a DNA repair perspective. Recently, the defect in recombination of 
Smc5/6 mutants has been attributed to a defect in the ability of Smc5/6 mutants to recruit 
cohesin to sites of DSBs (Potts, Porteus et al. 2006). In mammalian cells, decreased levels 
of Nse2 or Smc5 disrupt the localisation of cohesin subunits to a site-specific DSB in 
human cells (Potts, Porteus et al. 2006). This indicates that at least one aspect of the 
Smc5/6 complex’s repair function is to indirectly confer sister chromatid cohesion at the 
site of damage i.e. to promote damage-induced cohesion. Since the absence of functional 
Smc5/6 complex delays sister chromatid separation, it is unlikely that the Smc5/6 complex 
confers sister chromatid cohesion in undamaged cells.  
 
1.7 Ubiquitin  
Reversible post-translational modifications are widely used to allow cells to enable them to 
respond to rapid changes in both their internal and external environments. Post-translation 
modification of proteins is one such way of regulating protein function. The first example 
of a protein acting as a post-translational modifier was ubiquitin, which is best known for 
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its catabolic role in protein degradation via the 26S proteasome (Hershko and Ciechanover 
1998). The ubiquitin-proteasome pathway is highly conserved from yeast to mammals. 
 
1.7.1 The ubiquitin pathway  
Ubiquitin is synthesised as a precursor molecule that must be processed by de-
ubiquitinating enzymes (DUBs) to reveal a diglycine motif at the C-terminus. It is this 
diglycine motif that acts as the site of attachment to target molecules. Protein ubiquitination 
is catalysed by the sequential action of E1, E2 and E3 enzymes that activate and transfer 
ubiquitin to the target protein (Figure 1.3). The activating enzyme (E1) adenylates the C-
terminus of ubiquitin, which is then transferred to the E1 cysteinyl side chain via a 
thiolester linkage (Haas and Siepmann 1997). The ubiquitin moiety is then transferred to a 
cysteinyl group on the conjugating enzyme (E2). Finally, through the action of an E3 ligase 
ubiquitin is covalently attached to the ε-amino group of a lysine residue in the target 
protein. Since the isopeptide bond between ubiquitin and a target protein can be cleaved by 
deubiquitinating enzymes (DUBs) ubiquitination is a reversible process.  
 
1.7.2 Role of ubiquitin modification 
The best-defined role for ubiquitin-conjugation is the targeting of proteins for degradation 
via the 26S proteasome (Wilkinson 1995; Hochstrasser 1996). Since ubiquitin itself 
contains 7 lysine residues, the formation of ubiquitin chains is possible. Ubiquitin-mediated 
targeting of proteins to the proteasome generally requires the assembly of K48-linked 
ubiquitin chains on target proteins such poly-ubiquitination has been best characterised for 
K48-linked chains such as p53 (Dulic, Kaufmann et al. 1994).  
 
Ubiquitination has also been shown to play an important role in altering protein function by 
mechanisms independent of the proteasome. Ubiquitination has been implicated in roles in 
regulating membrane protein trafficking, signal transduction, transcription, nuclear 
transport and DNA repair. For example, mammalian histones H2A and H2B are modified 
by a single ubiquitin moiety (Goldknopf and Busch 1977; Busch and Goldknopf 1981). In 
S. cerevisiae histone H2B mono-ubiquitination functions to regulate chromatin structure 
Figure 1.5: The ubiquitin and SUMO modification pathways 
 
The ubiquitin (A) and SUMO (B) conjugation pathways are analogous. Ubiquitin and 
SUMO are synthesized as precursor molecules (U*/S*) that are cleaved by proteases (P) 
to reveal a diglycine motif. The mature form of ubiquitin (U) and SUMO (S) are 
activated by an E1 activating enzyme. They are then transferred to an E2 conjugator 
enzyme and with the aid of an E3 ligase, conjugated onto the target protein. Proteases 
can remove the ubiquitin or SUMO from the target. 
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and transcription by recruiting a distinct group of methylases, thus, enabling lysine 
methylation of histone H3 (Briggs, Xiao et al. 2002; Sun and Allis 2002).  
 
The existence of non K48-linked poly-ubiquitin chains, in vivo, suggests that simply 
discriminating between poly- and mono-ubiquitination events is not sufficient to determine 
the ubiquitin-mediated fate of a protein. Ubiquitin-K63 linkages, mediated by the ubiquitin 
conjugating heterodimer Mms2-Ubc13, have been observed for a number of cell signalling 
proteins. For example, in mammalian cells, activation of NFκB requires formation of 
formation of K63-linked ubiquitin chains on TRAF6 (Wang, Deng et al. 2001). 
Furthermore, in response to DNA damage, different forms of S. pombe PCNA ubiquitin 
modifications channel DNA lesions into different DNA repair pathways. Mediated by 
Rad18 and Rad6, mono-ubiquitination of PCNA K164 signals for translesion synthesis 
(Hoege, Pfander et al. 2002). When Ubc13–Mms2 and Rad5 are present, the K164 
ubiquitin monomer is extended into a K63 linked ubiquitin polymer and initiates an error-
free DNA damage tolerance pathway (Hoege, Pfander et al. 2002; Stelter and Ulrich 2003). 
PCNA regulation of PRR is discussed in more detail in section 1.5.5. 
  
1.7.3 Ubiquitin-like domains 
Analysis of protein databases suggests that ubiquitin is encoded not only by genes 
comprising ubiquitin coding sequences, but ubiquitin-like sequences can also be found 
fused to other open reading frames, e.g. in the case of the S. cerevisiae DNA repair proteins 
Rad23 and Dsk2. 
 
Rad23 is a highly conserved protein involved in NER (Section 1.4.3). It functions in the 
NER pathway through its interaction with Rad4, the S. cerevisiae homologue of H. sapiens 
XPC, through its XPC-binding domain (Masutani, Araki et al. 1997; Sugasawa, Ng et al. 
1997). At its N-terminus Rad23 contains an ubiquitin-like (UBL) domain that shares 23% 
sequence identity with ubiquitin. This domain has been shown to participate in the 
association of Rad23 with the proteasome (Lambertson, Chen et al. 2003). Like Rad23, 
Dsk2 has an N-terminal ubiquitin-like domain that is capable of interacting with the 
proteasome (Funakoshi, Sasaki et al. 2002; Rao and Sastry 2002). 
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As well as having ubiquitin-like domains (UBLs), Rad23 and Dsk2 also contain ubiquitin-
associated (UBA) domains. The UBA domains interact with poly-ubiquitin chains on 
proteins destined for proteolysis and the UBLs facilitate the interaction between of the 
Rad23 or Dsk2 with the proteasome (Bertolaet, Clarke et al. 2001; Chen, Shinde et al. 
2001; Rao and Sastry 2002). An adaptor model has therefore been proposed for Rad23, 
Dsk2 and their orthologues. The UBL-UBA proteins deliver polyubiquitinated proteins to 
the proteasome through binding of their UBA domain to poly-ubiquitinated species and 
interaction of the ubiquitin-like domain with subunits of the proteasome (Madura 2004).  
 
1.7.4 Ubiquitin-like proteins 
Ubiquitin is phylogenetically very well conserved between different organisms, differing 
only by a small number of conservative substitutions. Besides ubiquitin, 13 more divergent, 
ubiquitin-like proteins (UBLs) have been identified to date (Kirkin and Dikic 2007). All 
share the characteristic ββαββαβ fold (also known as the ubiquitin/β-grasp fold) and are 
conjugated, via their C-terminal diglycine motif, to internal lysine residues of target 
proteins. The conjugation pathways of the ubiquitin-like proteins are comparable to that of 
ubiquitin, requiring E1-E2 enzyme activity. (Yeh, Gong et al. 2000). Unlike ubiquitination, 
E3 ligase activity is not always necessary for conjugation by other UBLs.  
 
The first ubiquitin-like protein to be identified, ISG15, consists of two ubiquitin-like 
domains. The first of these domains has lost the C-terminal sequence of mature ubiquitin 
preventing deubiquitinating enzymes from separating the two domains. ISG15 modification 
has been implicated in a diverse number of biological functions, although the precise role 
of modification is unknown. Targets include JAK and STAT proteins, suggesting that 
ISG15 modification has a role in JAK-STAT signal transduction in response to interferon 
(Malakhov, Kim et al. 2003). An increased level of ISG15 conjugates lead to neurological 
disorders, whereas decreased levels of ISG15 conjugation has been shown to result in 
improper monoblast differentiation and possibly to tumorigenic progression of lung 
tumours (Liu, Ilaria et al. 1999; McLaughlin, Helfrich et al. 2000; Ritchie, Malakhov et al. 
2002) 
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Of the ubiquitin-like proteins, NEDD8 shares the most sequence identity with ubiquitin 
(~57%). The NEDD8-binding protein, NUB1, contains an N-terminal ubiquitin-like 
domain, allowing NEDD8 to interact with the proteasome (Kamitani, Kito et al. 2001). 
Thus, like ubiquitin, NEDD8 can target proteins for degradation. Known targets of NEDD8 
include p53 and the cullins. Cullins are subunits of SCF (Skp1-cullin-F-box protein) or 
SCF-related ubiquitin ligases (Osaka, Kawasaki et al. 1998). NEDD8 modification of the 
cullin subunit of SCF complexes is necessary for the activity of the ubiquitin ligase (Gagne, 
Downes et al. 2002). Therefore, modification of ubiquitin E3s by NEDD8 is evidence for 
cross regulation between the ubiquitin-like proteins.  
 
Two of the most divergent UBLs are APG8 and APG12, which share ~20% sequence 
identity to each other but no obvious sequence similarity to ubiquitin. Despite the lack of 
sequence similarity, APG12 folds with a characteristic ubiquitin fold (Paz, Elazar et al. 
2000) and like the other UBLs, APG8 and APG12 require E1 and E2 enzymes for their 
conjugation (Huang and Klionsky 2002). Both APG8 and APG12 function in the starvation 
response known as autophagy (Mizushima, Noda et al. 1998). 
 
Of all the UBLs, SUMO is the most widely studied. Sumoylation is discussed in more 
detail in section 1.8. 
 
1.8 SUMO 
NMR studies have shown that, like other UBLs, SUMO is structurally similar to ubiquitin 
(Bayer, Arndt et al. 1998). H. sapiens SUMO-1 shares ~18% sequence identity with 
ubiquitin and contains the characteristic ββαββαβ ubiquitin-fold. SUMO differs from 
ubiquitin in its surface-charge topology. SUMO has a large negatively charged surface 
formed by E83, E84, E85 and D86 giving it a much more acidic surface than ubiquitin 
(Bayer, Arndt et al. 1998). In addition SUMO has a flexible N-terminal extension 
protruding from the hydrophobic core, which is not found in ubiquitin (Bayer, Arndt et al. 
1998). The N-terminal tail is not required for sumoylating activity and can be deleted with 
only modest effects on SUMO conjugation, indicating the ubiquitin-like domain alone is 
sufficient for conjugation to most substrates (Bylebyl, Belichenko et al. 2003). These 
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differences are likely to account for the distinction between SUMO and ubiquitin function 
and the enzymes that mediate them. 
 
In lower eukaryotes and yeast SUMO is encoded by a single gene, while in higher 
eukaryotes, such as H. sapiens, four isoforms of the protein exist. SUMO-1, SUMO-2 and 
SUMO–3 may modify both common and different substrates. For example, RanGAP1 is 
predominantly modified by SUMO-1, whereas Topoisomerase II is predominantly 
modified by SUMO-2/SUMO-3, which share ~95% sequence identity with each other 
(Saitoh and Hinchey 2000; Azuma, Arnaoutov et al. 2003; Vertegaal, Ogg et al. 2004; 
Zhao, Kwon et al. 2004). Cells contain virtually no free SUMO-1, suggesting that the 
majority of SUMO-1 is conjugated to target proteins. In contrast, cells contain a large pool 
of SUMO-2 and SUMO-3 (Matunis, Coutavas et al. 1996; Saitoh and Hinchey 2000). 
Conjugation of SUMO-2 and SUMO–3 is strongly induced in response to stress conditions, 
suggesting that these isoforms may serve to provide a free pool of SUMO for such stress 
responses (Saitoh and Hinchey 2000). Unlike SUMO-1, SUMO-2 and SUMO–3 contain a 
ψKXE SUMO-consensus motif (Section 1.8.5) in their N-terminal extensions, providing a 
possible site for SUMO-chain formation (Tatham, Jaffray et al. 2001). While poly-SUMO 
chains are formed predominantly from SUMO-2 and SUMO-3 monomers, the SUMO 
chains can be terminated by SUMO-1 (Matic, van Hagen et al. 2008). The fourth isoform, 
SUMO-4, has a restricted level of expression with its highest levels being identified in 
kidney cells (Bohren, Nadkarni et al. 2004). Unlike the gene encoding the S.cerevisiae 
SUMO-1 homologue, which is essential for viability, the gene encoding the S. pombe 
SUMO-1 homologue (Pmt3) can be deleted. However, cells deleted for this gene are 
extremely sick exhibiting slow growth and severe defects in genome maintenance (Johnson 
and Blobel 1997; Tanaka, Nishide et al. 1999).  
 
The SUMO conjugation pathway is analogous to that of ubiquitin (Figure 1.5). However, 
the enzymes of the SUMO pathway are unique to SUMO and play no role in the 
conjugation of ubiquitin or any other UBLs. Proteins of the SUMO conjugation pathway 
are discussed in more detail in sections 1.8.1-1.8.4. Unlike ubiquitination, sumoylation 
does not target proteins for degradation via the proteasome. However, the precise function 
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of SUMO conjugation remains unclear and appears much more diverse than that of 
ubiquitin. SUMO has been implicated with roles in cellular localisation, transcriptional 
regulation, control of protein stability, and DNA repair to name a few. The role of SUMO 
modification is discussed in more detail in section 1.8.6. 
 
1.8.1 SUMO proteases 
SUMO conjugation is a dynamic process, changing throughout the cell cycle in response to 
different stimuli (Li and Hochstrasser 1999). Similar to other UBLs, precursor SUMO must 
first be processed by SUMO-specific C-terminal hydrolases to reveal a diglycine motif. 
The C-terminal diglycine motif is necessary for SUMO conjugation to occur (Kamitani, 
Nguyen et al. 1997). Following conjugation, SUMO can be removed from target proteins in 
a reaction catalysed by SUMO-proteases (Melchior, Schergaut et al. 2003). Some of these 
proteases function to both process SUMO to its mature form and to cleave the isopeptide 
bond between SUMO and its target protein (Melchior, Schergaut et al. 2003). All known 
SUMO-cleaving enzymes contain a ~200 amino acid C-terminal domain, termed the Ulp 
domain. The Ulp1 domain has SUMO cleaving activity (Mossessova and Lima 2000).  
 
In yeast, two SUMO proteases have been identified, Ulp1 and Ulp2 (Li and Hochstrasser 
1999; Li and Hochstrasser 2000; Taylor, Ho et al. 2002). Although Ulp1 exhibits both 
protease functions mentioned above, the primary role of the S. pombe Ulp1 protein is to 
process SUMO to its mature form (Li and Hochstrasser 1999; Taylor, Ho et al. 2002). 
Unlike Ulp1, Ulp2, does not cleave the precursor but de-sumoylates a distinct set of 
conjugates and prevents the accumulation of SUMO chains (Li and Hochstrasser 1999; 
Bylebyl, Belichenko et al. 2003). Interestingly, Ulp1 and Ulp2 localise to different sub-
cellular compartments. Ulp1 is present at the nuclear pore complex, while Ulp2 is present 
in the nucleoplasm. The two proteases cannot compensate for each other functionally. 
Whilst deletion of ulp1 in S. cerevisiae is lethal (Li and Hochstrasser), S. pombe ulp1-d 
cells are viable but are deficient in processing precursor SUMO to its mature form and, 
therefore, show a reduction in the level of SUMO modified species(Taylor, Ho et al. 2002). 
ulp2-d cells are viable in both S. cerevisiae and S. pombe and show chromosome 
segregation defects (Bachant, Alcasabas et al. 2002). 
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1.8.2 The SUMO activating enzyme 
The SUMO activating enzyme is a heterodimer containing SAE1 and SAE2 subunits 
(Dohmen, Stappen et al. 1995; Johnson and Blobel 1997; Desterro, Rodriguez et al. 1999; 
Gong, Li et al. 1999). The SAE1 and SAE2 subunits are conserved from yeast to human 
and are related to the N- and C-terminal domains of the yeast ubiquitin E1 activating 
enzyme Uba1. When assembled together form a functional SUMO activating enzyme. The 
E1 SUMO-activating enzyme (SAE) initiates the SUMO conjugation process. First, the C-
terminal carboxyl group of SUMO attacks ATP, forming a SUMO C-terminal adenylate 
and releasing pyrophosphate. Next, the thiol group of the active site cysteine in the E1 
attacks the SUMO adenylate, releasing AMP and forming a high-energy thiolester bond 
between the E1 and the C-terminus of SUMO (Johnson and Blobel 1997). The activated 
SUMO is then ready to be transferred to a cysteine of the E2 enzyme. Most organisms 
contain a single SUMO-activating enzyme, which is sufficient for the conjugation of all 
SUMO variants to target proteins. In S. pombe the SUMO activating enzyme consists of the 
Rad31 and Fub2 subunits (Tanaka, Nishide et al. 1999; Ho, Warr et al. 2001).  
 
1.8.3 The SUMO conjugating enzyme  
In the second step of the SUMO conjugation pathway SUMO is transferred from the E1 
activating enzyme to the active site cysteine of the SUMO-conjugating enzyme (E2), 
forming a thiolester intermediate (Desterro, Thomson et al. 1997; Johnson and Blobel 
1997). Unlike the E2 of other UBL-conjugation pathways, the SUMO-conjugating enzyme 
can directly recognise substrate proteins and the E2-SUMO thiolester can catalyse the 
formation of an isopeptide bond between the C-terminal carboxyl group of SUMO and the 
ε-amino group of the target lysine in the substrate protein, provided that the lysine is part of 
a SUMO-consensus motif ψKXE (Rodriguez, Dargemont et al. 2001; Bernier-Villamor, 
Sampson et al. 2002). The SUMO-consensus motif is discussed in further detail in section 
1.8.5.  
 
In contrast to ubiquitination, where multiple conjugation enzymes exist, there is only one 
SUMO-conjugating enzyme (Desterro, Thomson et al. 1997; Johnson and Blobel 1997). In 
S. pombe the SUMO-conjugating enzyme is known as Hus5 (Ho and Watts 2003). Unlike 
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most organisms, the SUMO-conjugating enzyme is not essential in S. pombe, although 
hus5 mutants, are very sick and highly sensitive to DNA damaging agents (al-Khodairy, 
Enoch et al. 1995; Ho and Watts 2003). This implies that sumoylation has a role in the S. 
pombe DNA damage response 
 
1.8.4 The SUMO ligases 
In the ubiquitin-conjugation system, substrate recognition is mediated by a family of E3 
ubiquitin ligases. The E3 ligase must bind to the E2 conjugator and the target protein, and 
facilitate the transfer of ubiquitin from the conjugating enzyme to the substrate (Hershko 
and Ciechanover 1998). Unlike ubiquitination, the requirement of an E3 ligase for the 
attachment of SUMO to target proteins is not as strict. Although the E2 is sufficient to 
directly bind and sumoylate the target substrate in vitro (Sampson, Wang et al. 2001), E3 
SUMO ligases do exist. Ligase activity is likely to play an important role for modulating 
the efficiency of SUMO attachment to target proteins (Melchior, Schergaut et al. 2003). 
 
Unlike ubiquitin ligases, only a small number of SUMO ligases have been identified to 
date. The first SUMO ligases to be identified were Siz (S. cerevisiae) and PIAS (H. 
sapiens), which define the Siz/PIAS-RING (SP-RING) class of SUMO ligases. The SP-
RING family of proteins contain a region homologous to the RING domains of ubiquitin 
E3 ligases (Hershko and Ciechanover 1998; Hochstrasser 2001). Members of the SP-RING 
SUMO ligase family include the mammalian PIAS proteins, the S. cerevisiae Siz1, Siz2, 
Mms21 and Zip3 proteins and the S. pombe Pli1 and Nse2 proteins. There are a number of 
other SUMO ligases, which do not conform to the SP-RING class. These include RanBP2, 
Pc2 and HDAC2 (Pichler, Gast et al. 2002; Kagey, Melhuish et al. 2003; Zhao and Blobel 
2005). Interestingly, the different E3 SUMO ligases have distinct sub-cellular localisations; 
RanBP2 is associated with the nuclear pore complex, the PIAS (SP-RING) proteins are 
found in the nucleoplasm and nuclear bodies and Pc2 is found in the subnuclear structure 
called a Polycomb body (Sachdev, Bruhn et al. 2001; Pichler, Gast et al. 2002; Kagey, 
Melhuish et al. 2003). Localisation of the SUMO ligases may contribute to functional 
specificity.  
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S. pombe Pli1 and Nse2 are homologues of S. cerevisiae Siz1 and Mms21 respectively, and 
are the only ligases identified to date in S. pombe (Xhemalce, Seeler et al. 2004; Andrews, 
Palecek et al. 2005). Pli1 sumoylation activity is dependent on its SP-RING domain 
(Xhemalce, Seeler et al. 2004). Deletion of pli1 results in only a very subtle phenotype 
despite the level of sumoylation, being dramatically reduced (Xhemalce, Seeler et al. 
2004). Unlike pli1, nse2 is essential for cell viability. However, it is unlikely that the 
essential function of Nse2 is its ligase activity since nse2-SA, a strain in which the RING 
domain has been mutated to cause loss of SUMO ligase activity, is viable (Andrews, 
Palecek et al. 2005). The essential function of Nse2 is more likely to be its role a part of the 
Smc5/6 complex. Nse2 facilitates the sumoylation of some of the members of the Smc5/6 
complex, namely Smc6, Nse3 and Nse2 itself. Nse2 is discussed in further detail in section 
1.6.2.2. 
 
1.8.5 Substrate specificity of SUMO.  
Typically, the target for SUMO conjugation is a lysine found in a short ‘SUMO-consensus 
motif’, ψKxE, where ψ represents a large hydrophobic residue, generally isoleucine, 
leucine or valine; K is the target lysine; x is any residue; and E is a glutamic acid 
(Rodriguez, Dargemont et al. 2001). The  ψKxE consensus motif is recognised by the E2 
conjugating enzyme, which makes key interactions with the motif and transfers SUMO to 
the target lysine residue (Bernier-Villamor, Sampson et al. 2002; Lin, Tatham et al. 2002). 
Potential SUMO targets can, therefore, be identified by their interaction with the E2 in the 
yeast-two hybrid system. However, the ψKXE motif is very short and has been found in 
many proteins that are not SUMO targets. Several proteins are modified at sites other than 
the classic ψKxE. PCNA has two sumoylation sites, one of which conforms to the ψKxE 
motif, whilst the other is a TKET sequence (Hoege, Pfander et al. 2002). In addition a 
number of proteins have been identified as SUMO targets despite not having a ψKxE 
motif. This suggests that interactions other than that of the E2 with the target may be 
necessary for determining substrate specificity.  
 
Many groups have suggested an extended SUMO consensus motif although the functional 
relevance is not yet known. For example, the synergy consensus motif (SC) is defined by 
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the presence of proline residues flanking the core SUMO motif (Subramanian, Benson et 
al. 2003). Similarly an extended motif based on the R-motif repression domain of the 
transcription factor Elk-1 and the CRD1 domain of p300 has been proposed in which 
clusters of acidic residues are found downstream of the core SUMO consensus motif 
(Yang, Jaffray et al. 2003). Recently, a phosphorylation-dependent sumoylation motif 
(PDSM) has been identified in a subset of substrates that conforms to the extended motif 
ψKxExxSP (Hietakangas, Anckar et al. 2006). Phosphorylation of the SP motif within the 
extended consensus has been shown to play an important role in the sumoylation of a 
number of substrates (Gregoire, Tremblay et al. 2006; Hietakangas, Anckar et al. 2006; 
Shalizi, Gaudilliere et al. 2006)  
 
1.8.6 Role of SUMO modification  
Post-translational modification of target proteins by SUMO has been identified as an 
important mechanism for regulating a plethora of cellular processes, including cellular 
localisation, transcription, DNA repair and cell cycle progression. The precise way in 
which SUMO regulates cellular functions remains poorly understood. A few examples of 
the role of SUMO modification are described below. 
 
1.8.6.1 Cellular localisation 
Post-translational modification by SUMO regulates sub-cellular localisation of many 
targets including RanGAP1, the first protein identified as a target for sumoylation 
(Matunis, Coutavas et al. 1996). RanGAP1 is a small GTPase-activating protein for Ran 
and in its unmodified state is primarily located in the cytoplasm (Matunis, Coutavas et al. 
1996; Mahajan, Delphin et al. 1997). During interphase, RanGAP1 is modified on K26 by 
SUMO-1 (Matunis, Coutavas et al. 1996; Mahajan, Delphin et al. 1997). Modification of 
RanGAP1 greatly enhances its interaction with the nuclear pore protein RanBP2 (Also 
known as Nup358) localising RanGAP1 to the nuclear pore (Matunis, Coutavas et al. 1996; 
Mahajan, Delphin et al. 1997). RanBP2 binding to the modified form of RanGAP1 is 
dependent on a SUMO-binding motif (section 1.8.7) in RanBP1 (Song, Durrin et al. 2004). 
This suggests that the SUMO moiety conjugated to RanGAP1 interacts with the SUMO-
binding motif on RanBP2 to facilitate the nuclear transport of RanGAP1.  
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Another example of SUMO-dependent subcellular localisation comes from studies of the 
tumour suppressor protein PML (promyelocytic leukaemia). PML is a major component of 
PML nuclear bodies. Sumoylation of PML on K65, K160 and K490 is required for the 
targeting of PML to nuclear bodies (Muller, Matunis et al. 1998). Mutation of the SUMO-
acceptor lysines also causes nuclear body components such as CBP or Sp100 to re-localise 
in the nucleus (Zhong, Muller et al. 2000; Best, Ganiatsas et al. 2002). This suggests that 
SUMO-modification of PML supports protein-protein interactions important for either the 
assembly or stability of the PML bodies. 
 
Whilst sumoylation is most often implicated in promoting localisation of proteins to the 
nucleus and nuclear bodies, there is evidence to suggest that SUMO modification can 
function as a signal for nuclear export. Dictyostelium MEK1 (Map kinase kinase) is 
required for the aggregation response and promotes the chemotaxis of cells towards cAMP 
(Ma, Gamper et al. 1997). MEK1 is transiently sumoylated on K105 in response to cAMP 
(Sobko, Ma et al. 2002). Unlike many other proteins it is the cytoplasmic and not nuclear 
fraction of MEK1 that is sumoylated. A MEK1 K105R is retained in the nucleus, 
suggesting that modification of MEK1 is required for nuclear export into the cytoplasm 
(Sobko, Ma et al. 2002).  
 
1.8.6.2 Transcriptional regulation  
Over half of the SUMO substrates identified to date are transcriptional factors or co-
repressors (Shih, Chang et al. 2007). The activity of many transcriptional factors is 
regulated by their association with PML nuclear bodies. Since the assembly of PML 
nuclear bodies is dependent on the sumoylation of the PML protein (Section 1.8.6.1), the 
loss of PML modification has a great effect on transcriptional regulation. For example, 
sumoylation of the PML protein recruits co-repressor Daxx to PML nuclear bodies, thereby 
relieving Daxx-mediated transcriptional repression (Seeler and Dejean 2003).  
 
Sumoylation of Elk-1 is required for the repression of genes activated by the MAPK 
signalling cascade. In the basal state, Elk-1 is modified on K249 and K230, resulting in the 
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recruitment of histone deacetylase HDAC2 (Yang, Jaffray et al. 2003). SUMO 
modification of Elk-1 hence influences local histone acetylation levels and repression of 
target genes (Yang, Jaffray et al. 2003; Yang and Sharrocks 2004). When the pathway is 
activated by ERK, Elk1 becomes phosphorylated signalling the loss of SUMO-
modification and therefore loss of HDAC2 interaction, leading to the activation of target 
genes (Yang, Jaffray et al. 2003). Alternatively, if the pathway is activated by stress, then 
SUMO-modification, leading to only partial activation of target genes (Gostissa, 
Hengstermann et al. 1999). 
 
In general SUMO modification is associated with transcriptional repression. However, in a 
growing number of cases, SUMO has been shown to play a role in transcription activation. 
The tumour suppressor p53 is a transcription factor that can inhibit cell cycle progression 
and in some cases induce apoptosis. p53 is modified at K386, in a region that regulates its 
DNA binding activity (Muller, Berger et al. 2000). Sumoylation of p53 stimulates its ability 
to activate reporter genes possibly by competing with Mdm2-mediated ubiquitination, 
which targets p53 for degradation (Muller, Berger et al. 2000). A p53 K386R mutant that is 
defective in SUMO conjugation showed a slightly impaired apoptotic activity (Muller, 
Berger et al. 2000).  
 
1.8.6.3 Cell cycle control 
Sumoylation has always had a strong link with mitosis. In fact, the gene encoding SUMO 
in S. cerevisiae was first isolated in a screen for high-copy suppressors of mutations in the 
gene encoding the centromere binding protein Mif2 (Meluh and Koshland 1995). In 
addition, mutants in the S. cerevisiae E1 (Uba2) and E2 (Ubc9) display cell cycle defects 
(Seufert, Futcher et al. 1995; Johnson and Blobel 1997). In S. pombe hus5 and rad31 
mutants exhibit mitotic defects and impaired growth (al-Khodairy, Enoch et al. 1995; 
Shayeghi, Doe et al. 1997; Ho and Watts 2003).  
 
A number of mitotic targets of SUMO exist. Topoisomerase II (Top 2 in yeast) functions to 
relax both positive and negative supercoils in DNA. In S. cerevisiae ulp2-d strains show 
loss of centromeric cohesion that can be suppressed by over-expression of a non-
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sumoylatable version of Top2 (Topoisomerase 2). SUMO modification of Top2 is, 
therefore, required to establish the appropriate chromatin environment for centromeric 
cohesion (Bachant, Alcasabas et al. 2002). This observation suggests that SUMO 
deconjugation also has a critical role in mitosis. 
 
Septins are required for cytokinesis and bud site selection in S. cerevisiae and were the first 
yeast proteins shown to be sumoylated (Johnson and Blobel 1999; Takahashi, Iwase et al. 
1999). SUMO-conjugated forms of the septins Cdc3, Cdc11 and Shs1 are abundant during 
mitosis (Johnson and Blobel 1999). Conjugation of the septins appears to be tightly 
regulated and cell cycle dependent with modified forms appearing just before anaphase 
onset and disappearing abruptly at cytokinesis (Johnson and Blobel 1999). A mutant that 
eliminates SUMO-conjugation of Cdc3, Cdc11 and Shs1 abolishes almost all mitotic 
sumoylation at the bud neck and decreases the overall level of SUMO conjugation within 
G2/M phase (Johnson and Blobel 1999). Despite the drastic loss of sumoylation, the triple 
sumoylation mutant has near wild-type characteristics and show no sensitivity to conditions 
of stress. It is possible that a low level of SUMO-conjugation to Septins Cdc10 and Cdc12 
is sufficient to compensate for the loss of Cdc3, Cdc11 and Shs1 modification. This is 
consistent with the synthetic lethality seen between the triple mutant and a cdc12 
temperature sensitive mutant (Johnson and Gupta 2001) 
 
1.8.6.4 Maintaining genomic integrity  
Initial genetic experiments indicated that cells lacking components of the SUMO-
modification pathway have an impaired ability to repair DNA damage. S. pombe pmt3 
mutants were characterised by aberrant mitosis and defects in chromosomal segregation 
(Tanaka, Nishide et al. 1999). Furthermore, cells with mutations in the genes encoding 
Rad31, a component of the SUMO-activating enzyme, and Hus5, the SUMO-conjugating 
enzyme, exhibit an increased sensitivity to UV, IR and the DNA synthesis inhibitor HU (al-
Khodairy, Enoch et al. 1995; Shayeghi, Doe et al. 1997).  
 
Several proteins known to be required for DNA replication and DNA damage repair are 
modified by SUMO. In S. cerevisiae, sumoylation of PCNA occurs during S-phase at K127 
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and K164 (Hoege, Pfander et al. 2002). K164 is also the site of PCNA ubiquitination, 
however, ubiquitination is not observed during S-phase. This suggests that sumoylation of 
PCNA inhibits ubiquitin-dependent post-replicative repair (Section 1.5.5) (Hoege, Pfander 
et al. 2002). It has been proposed that modification of K164 by SUMO and ubiquitin direct 
PCNA for different functions (Stelter and Ulrich 2003). Whilst ubiquitination directs 
PCNA either for translesion synthesis (monoubiquitination) or an error-free DNA damage 
tolerance pathway (ubiquitin chains), sumoylation of PCNA recruits the Srs2 helicase to 
disrupt the Rad51-ssDNA filament and prevent inappropriate homologous recombination 
(Haracska, Torres-Ramos et al. 2004; Papouli, Chen et al. 2005; Pfander, Moldovan et al. 
2005). However, there is no evidence to suggest that S. pombe PCNA is sumoylated. 
Instead, S. pombe PCNA is ubiquitinated in S-phase. Furthermore, in contrast to S. 
cerevisiae, the DNA-damage sensitivity of mutants in the PRR pathway cannot be 
suppressed by the deletion of srs2 (Frampton, Irmisch et al. 2006). This suggests that either 
polyubiquitination in S. pombe has the same function as sumoylation in S. cerevisiae, or 
that the recombination system in S. pombe may be less active in S-phase than in S. 
cerevisiae, and it may not be necessary to have a mechanism to suppress it (Frampton, 
Irmisch et al. 2006). 
 
Another example of how SUMO modification can affect the function of DNA repair 
proteins is in the case of thymine-DNA glycosylase (TDG), which has an important role in 
base excision repair. TDG removes thymine and uracil from mismatched G-T and G-U 
base pairs. Human TDG does not readily dissociate from its product in vitro despite the 
need for dissociation to allow repair of the abasic site generated by TDG. TDG is 
sumoylated on K330 and the SUMO-modified form of TDG shows a reduced affinity for 
the DNA substrate suggesting that the TDG reaction cycle is regulated by a SUMO-
dependent conformational change (Hardeland, Steinacher et al. 2002). 
 
1.8.7 SUMO-binding motifs  
The physiological consequences of SUMO modification are typically mediated by effector 
proteins that recognise SUMO through SUMO-binding motifs (SBMs), also referred to as 
SUMO-interacting motifs (SIMs). The first SBM was identified in proteins able to interact 
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with sumoylated p73 in a yeast-two hybrid screen (Minty, Dumont et al. 2000). Interacting 
proteins shared a common SXS motif, where S represents a serine residue and X represents 
any amino acid, flanked by a hydrophobic core on one side and acidic residues on the other. 
The SXS motif was shown to interact strongly with SUMO in a two-hybrid assay (Minty, 
Dumont et al. 2000). Subsequently, a second SBM was identified. This SBM is more 
widely accepted by the scientific community and contains three hydrophobic residues, 
typically valine, leucine or isoleucine, in a sequence of four amino acids V/I-V/I-X-V/I/L 
or the reverse orientation V/I-X-V/I-V/I (Song, Durrin et al. 2004; Song, Zhang et al. 
2005). This suggested that it was the hydrophobic core flanking the SXS motif that gave it 
the property of an SBM.  
 
Several proteins including the SUMO-ligases PIASX and RanBP2 and the SUMO-
activating enzyme subunit Uba2 contain the V/I-V/I-X-V/I/L motif. In addition, many of 
the known SBM-containing proteins have nuclear functions, consistent with the general 
role of sumoylation in the nucleus. Sumoylation of PCNA is important for error-free DNA 
replication in a process that is dependent on the Srs2 helicase, which is able to disrupt the 
Rad51 nucleofilaments. Srs2 contains three distinctive domains: a helicase domain, a 
Rad51 binding domain and a C-terminal PCNA-interaction domain. Sumoylation of PCNA 
is not a pre-requisite for its interaction with Srs2 (Pfander, Moldovan et al. 2005). 
However, deletion of the six C-terminal, SBM-containing, residues of Srs2 results in a 
greatly reduced PCNA binding affinity (Pfander, Moldovan et al. 2005). This suggests that 
at least one SBM may contribute to the functional interaction between Srs2 and PCNA. 
More recently, the identification of RING-finger containing proteins, which contain one or 
more SBM, led to the suggestion that these proteins could target SUMO-modified proteins 
for ubiquitin mediated proteolysis (Prudden, Pebernard et al. 2007; Sun, Leverson et al. 
2007; Uzunova, Gottsche et al. 2007; Xie, Kerscher et al. 2007), SUMO-targeted ubiquitin 
ligases are discussed in further detail in section 1.8.8. 
 
The structure of SUMO-1 in complex with an SBM-containing PIASX peptide reveals that 
the residues of the SBM form a β-strand, which are incorporated into a β-sheet together 
with the second β-strand of SUMO (Song, Zhang et al. 2005). The SBM-binding surface of 
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SUMO is formed by a groove formed between its α-helix and second β-sheet. A number of 
hydrophobic residues, including F36 and V38 line the groove to form a conserved 
hydrophobic patch to accommodate the hydrophobic side chains of the SBM (Song, Durrin 
et al. 2004; Song, Zhang et al. 2005). Many SBM-containing proteins have a cluster of 
acidic residues juxtaposed with the hydrophobic core, which may contribute to the 
specificity of the SBM-SUMO interactions (Song, Zhang et al. 2005; Hecker, Rabiller et al. 
2006). 
 
1.8.8 SUMO-targeted ubiquitin ligases. 
A novel family of E3 ubiquitin ligases that recognise sumoylated species has recently been 
identified. The SUMO–targeted ubiquitin ligases (STUbLs) were first identified in S. 
cerevisiae. Two RING-finger domain proteins Slx5 (also known as Hex3) and Slx8 were 
identified to function as a heterodimer and to be essential for viability in cells lacking the 
Sgs1 DNA helicase (Rqh1 in S. pombe) (Mullen, Kaliraman et al. 2001). The Slx5 protein 
has also been shown to interact with the homologue of S. pombe Nse5 (Hazbun, 
Malmstrom et al. 2003). In fission yeast, a homologue of Slx8 but not Slx5 can be detected 
through bioinformatic approaches. In a yeast-two hybrid screen, using Nse5 as bait, an 
uncharacterised RING-finger protein (Rfp1) was identified and shown, both in vitro and in 
vivo, to interact with Slx8 (Prudden, Pebernard et al. 2007). A second S. pombe RING-
finger protein (Rfp2) has been identified and shown to form a heterodimer with Slx8 
(Prudden, Pebernard et al. 2007). Unlike deletion of slx8, cells deleted for rfp1and rfp2 are 
viable. Deletion of both rfp1 and rfp2 together results in cells that can survive only a 
limited number of cell divisions, suggesting a functional redundancy of the Rfp subunits 
(Sun, Leverson et al. 2007). The Slx8-Rfp1 and Slx8-Rfp2 complexes have been termed 
collectively Slx8-Rfp. H. sapiens RNF4 (RING-finger protein 4) has been identified as a 
homologue of S. pombe Rfp1 and Rfp2 and has been shown to functionally complement S. 
pombe Slx8-Rfp mutants (Kosoy, Calonge et al. 2007; Prudden, Pebernard et al. 2007; Sun, 
Leverson et al. 2007). This suggests that the STUbL pathway is functionally conserved 
between yeast and humans.  
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Several putative STUbLs have been identified in other higher eukaryotes, revealing a 
common feature of the STUbL family; yeast STUbLs comprise of two proteins, whereas 
STUbLs in higher eukaryotes consist of a single protein (Perry, Tainer et al. 2008). The 
yeast Slx8-Slx5 and Slx8-Rfp dimers form via contacts between their RING-finger 
domains (Yang, Galanis et al. 2006; Prudden, Pebernard et al. 2007). Like Slx5, the Rfp1 
and Rfp2 proteins contain a SUMO-binding motif (Section 1.8.7) that has been shown to 
interact with SUMO in a non-covalent manner (Prudden, Pebernard et al. 2007). In higher 
eukaryotes, the single bifunctional STUbLs contain a C-terminal RING-finger domain and 
an N-terminal SUMO-binding motif (Perry, Tainer et al. 2008). It is the presence of the 
SUMO-binding motif, which distinguishes the STUbL family from other ubiquitin E3 
ligases.  
 
By ubiquitinating and promoting the de-sumoylation and/ or degradation of sumoylated 
target proteins, STUbLs provide cross talk between the ubiquitin and SUMO pathways. 
STUbL dysfunction causes a specific accumulation of sumoylated protein species and has 
concomitant defects in DNA repair and genomic integrity (Prudden, Pebernard et al. 2007). 
In S. pombe the lethal phenotype of the slx8 deletion can be suppressed by deleting the 
major SUMO ligase, Pli1 (Prudden, Pebernard et al. 2007). In addition over-expressing the 
isopeptidase Ulp2, which reduces global sumoylation, can suppress the phenotypes 
associated with deletion of rfp1 and rfp2 (Kosoy, Calonge et al. 2007). While this suggests 
that the maintenance of SUMO pathway homeostasis is critical and that STUbLs are potent 
regulators of this pathway, the precise mechanism of STUbL function has not been 
determined.  
 
1.8.8.1 STUbL targets 
To date, only a limited number of STUbL targets have been identified. PML is the first 
protein shown to be degraded by the ubiquitin-mediated pathway. Arsenic triggers SUMO-
dependent polyubiquitination of PML through the recruitment of RNF4 (Lallemand-
Breitenbach, Jeanne et al. 2008; Tatham, Geoffroy et al. 2008). RNF4 only ubiquitinates 
the PML protein when it is conjugated to SUMO-2 and preferentially when conjugated to 
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SUMO-2 polymers (Tatham, Geoffroy et al. 2008). The four N-terminal SUMO-binding 
motifs of RNF4 are required for this interaction (Tatham, Geoffroy et al. 2008).  
 
Another protein identified as a target of the STUbL protein family is the S. pombe DNA 
repair protein Rad60 (Section 1.9). Rad60 is ubiquitinated in vitro by Slx8 in an Rfp1- and 
SBM-dependent manner (Prudden, Pebernard et al. 2007). Rad60 and Slx8-Rfp mutants 
display a similar spectrum of DNA damage sensitivities (Prudden, Pebernard et al. 2007). 
Further more, Rad60 and Slx8-Rfp functions are required for cell viability in the absence of 
a functional Rqh1 helicase (Prudden, Pebernard et al. 2007). Interestingly, Rad60 belongs 
to the RENi family of proteins that contain two SUMO-like domains in their C-terminus 
(Section 1.8.9) (Novatchkova, Bachmair et al. 2005). Like Rad60, H. sapiens NIP45 is a 
member of the RENi family and has been shown to interact with the RNF4 protein. The 
NIP45-RNF4 interaction is dependent on the C-terminal SUMO-like domains and is 
enhanced by the co-expression of the mature from of SUMO-1 (Prudden, Pebernard et al. 
2007). A mutation in the predicted SBM binding pocket of Rad60 SUMO-like domain 1 
abolishes Rfp1 interaction in vitro, suggesting that the SUMO-like domains are recognised 
by the STUbLs. Rad60 is discussed in further detail in section 1.9. 
 
1.8.9 RENI family of proteins 
During the course of this project, a family of SUMO-like domain (SLD) proteins have been 
identified (Novatchkova, Bachmair et al. 2005). The RENi family of proteins has been 
named after its three best-studied members S. pombe Rad60, S. cerevisiae Esc2 and M. 
musculus NIP45. All RENi proteins share a similar sequence architecture having an N-
terminal low complexity region with many polar and positively charged residues and a C-
terminal globular region consisting of one or more SUMO-like domains (Novatchkova, 
Bachmair et al. 2005). RENi proteins typically contain two SUMO-like domains in their C-
terminus. However, only the second SUMO-like domain can be identified in plant 
members. This second SUMO-like domain has a large negative charged cluster 5-15 
residues from the very C-terminus, typical of a SUMO-interaction surface (Bayer et al, 
1998). The SUMO-like domains of the RENi proteins lack the C-terminal diglycine motif 
required for conjugation of SUMO to its substrate, suggesting that the SUMO-like domains 
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are non-cleavable SUMO fusions that can not be conjugated to target proteins 
(Novatchkova, Bachmair et al. 2005).  
 
Functional information about RENi proteins is restricted to the S. pombe Rad60, S. 
cerevisiae Esc2 and M. musculus NIP45 proteins. Despite their shared SUMO-like 
domains, proteins of the RENi family superficially appear to share no functional similarity. 
However, evidence is emerging to suggest that functional similarities may exist. Esc2 has a 
role in chromatin silencing via the recruitment or stabilisation of the Sir complex (Dhillon 
and Kamakaka 2000; Cuperus and Shore 2002). Esc2 is known to interact with the Sir 
complex protein Sir2, a histone NAD-dependent deacetylase. Sir2 proteins are recruited to 
chromatin by DNA-bound factors and act by deacetylating histones and transcription 
factors such as p53 (Imai, Armstrong et al. 2000; Vaziri, Dessain et al. 2001; Rosenberg 
and Parkhurst 2002). M. musculus NIP45 has a role in gene regulation. The binding of 
tumour necrosis factor TRAF1 to NIP45 blocks the transactivation of the IL-4 promoter 
(Lieberson, Mowen et al. 2001). TRAF1 may negatively regulate Th2 differentiation by 
sequestering NIP45 in the cytosol. This prevents translocation of NIP45 into the nucleus, 
thereby down-regulating the expression of NIP45-dependent Th2 cytokines (Bryce, Oyoshi 
et al. 2006).  
 
S. pombe Rad60 is an essential protein, associated with the Smc5/6 complex and is required 
for the repair of DSBs (Morishita, Tsutsui et al. 2002; Boddy, Shanahan et al. 2003). Rad60 
is discussed in further detail in section 1.8.1. Whilst functionally different, NIP45 and 
Rad60 have both been shown to interact with STUbLs (section 1.8.8.1), suggesting that the 
evolutionary conserved SUMO-like domains of the RENi family can functionally mimic 
SUMO in their interaction with STUbLs. 
 
1.9 Rad60 
The gene encoding the Rad60 protein was first identified in a screen to identify S. pombe 
mutants hypersensitive to MMS and synthetically lethal with rad2, suggesting a role in 
recombinational repair (Morishita, Tsutsui et al. 2002). The rad60 gene is essential for 
viability in S. pombe (Morishita, Tsutsui et al. 2002). The rad60-1 mutant shows 
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hypersensitivity to MMS, UV and IR and is epistatic with rhp51-d (Morishita, Tsutsui et al. 
2002). In addition, when irradiated with IR to induce DSBs, rad60-1 cells are unable to 
repair fragmented chromosomes, suggesting a role for Rad60 in the repair of DSBs via HR 
(Morishita, Tsutsui et al. 2002).  
 
The observations that the rad60-1 mutant is synthetically lethal with smc6-X, and that the 
MMS sensitivity of smc6-X cells can be partially suppressed by the over-expression of the 
Rad60 protein, implies a genetic interaction between the two genes (Morishita, Tsutsui et 
al. 2002). Like rad60-1, a rad60-3 mutant is synthetically lethal with smc6-X and like 
smc6-X, rad60-3 is synthetically lethal with brc1-d, mus81-d and rqh1-d (Morishita, 
Tsutsui et al. 2002; Boddy, Shanahan et al. 2003). Although Rad60 is not part of the 
Smc5/6 complex, it has been shown to interact with ~2% and ~0.5% of Smc5 and Smc6 
respectively, suggesting that Rad60 is loosely or transiently associated with the complex 
and may act co-dependently with the complex in a cell cycle specific manner (Boddy, 
Shanahan et al. 2003). 
 
In addition to the physical interaction identified with the Smc5/6 complex, Rad60 interacts 
with the checkpoint kinase Cds1 in an FHA-domain specific manner (Boddy, Shanahan et 
al. 2003). In response to HU treatment, Rad60 is hyperphosphorylated in a Cds1-dependent 
manner, concomitant with its delocalisation from the nucleus (Boddy, Shanahan et al. 
2003). Cds1 is able to phosphorylate Rad60 on multiple N-terminal sites. T72 has been 
identified as the mediator of the Cds1-Rad60 interaction and phosphorylation of S32 and 
S34 has a critical role in the survival of the activities of the recombinational repair factors 
Rqh1 and Mus81-Eme1 (Raffa, Wohlschlegel et al. 2006). Interestingly, Rad60 S32 and 
S34 are found within a putative SXS SUMO-binding motif (Section 1.7.7), which is 
conserved in other RENi family members including Esc2 and Nip45.  
 
The rad60-4 mutant (T72A, I232S, Q250R, K312N), that is unable to interact with Cds1, is 
defective in survival of replication arrest induced by HU, and proficient for survival of 
DNA damage caused by UV (Boddy, Shanahan et al. 2003). This strongly suggests that 
interaction with Cds1 is not required for the role of Rad60 in DSB repair but that Cds1-
 46 
mediated phosphorylation and nuclear delocalisation is important for the survival of 
replication fork arrest (Boddy, Shanahan et al. 2003). Unlike rad60-4, rad60-1 cells are 
proficient in Cds1-dependent mitotic arrest in response to HU. However, after release from 
HU, rad60-1 cells enter aberrant mitosis in which septation occurs without proper 
chromosome segregation (Miyabe, Morishita et al. 2006). This suggests that Rad60 
function is required after release from replication arrest. The lethality of a rad60-1 rqh1-d 
double mutant can be suppressed by the deletion of rhp51 or rhp55 (Miyabe, Morishita et 
al. 2006). In addition, Rhp51-dependent DNA structures that cannot activate the mitotic 
checkpoints accumulate in rad60-1 cells suggesting that rad60 is required at a step 
downstream of rhp51 (Miyabe, Morishita et al. 2006). A similar phenomenon has been 
observed for smc6 mutants, suggesting that Rad60 re-enters the nucleus upon HU arrest to 
carry out a late repair role in concert with the Smc5/6 complex (Ampatzidou, Irmisch et al. 
2006; Miyabe, Morishita et al. 2006).  
 
Rad60 has recently been identified as a potential target of the Slx8-Rfp SUMO-targeted 
ubiquitin ligase (Section 1.8.8). A robust interaction between Rfp1 and the Rad60 SLDs 
has been detected in vitro and shown to be dependent on the Rfp1 SBMs (Prudden et al, 
2007). In vivo, both full-length Rad60 and the SLDs have been shown to interact with Slx8 
(Prudden et al, 2007). During the course of this project, Rad60 has been classified as a 
member of the RENi protein family, having two SUMO-like domains in its C-terminus 
(Novatchkova, et al 2005). It has been suggested, that STUbLs may recognise SUMO-like 
domains as well as SUMO-conjugated species. (Prudden et al 2007). The C-terminal region 
of Rad60, encompassing the SUMO-like domains, is required and sufficient for Rad60 
homodimerisation (Raffa et al, 2006). Three putative SUMO-binding motifs (Section 1.8.7) 
contribute to Rad60 dimerisation (Raffa, Wohlschlegel et al. 2006). This suggests that 
dimerisation of Rad60 may be the result of SUMO-binding motifs in one molecule 
interacting with a SUMO-like domain of another. 
 
1.10 Aims 
The aim of this project was to undertake an investigation into the functional roles of the 
two Rad60 SUMO-like domains. First, I wanted to create SUMO-like domain-deletion 
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mutants to identify whether or not the SUMO-like domains are required for the essential 
role of Rad60, and if not whether they are required for the role of Rad60 in the DNA 
damage response. The second aim of this project was to undertake sequence comparisons 
and molecular modelling of the SLDs to initiate a structure-function study of the Rad60 
SUMO-like domains. Since Rad60 is a target of STUbL activity and is associated with the 
Smc5/6 complex, which includes the E3 SUMO ligase Nse2, the final aim of this project 
was to investigate whether or not Rad60 is itself a target of sumoylation. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1  YEAST METHODS 
Standard fission yeast techniques and media were employed (Moreno, Klar et al. 1991) 
 
2.1.1 S. pombe Media 
 
2.1.1.1 Rich media 
 
Yeast Extract (YE) 
5 g/l Yeast extract (Formedium) 
20 g/l Glucose 
200 mg/l  Adenine 
100 mg/l Leucine, uracil, histidine, arginine 
 
For solid YE media, 25 g/l DIFCO agar was added. 
 
2.1.1.2 Selective media 
 
 Yeast Nitrogen Base (YNB) 
1.9 g/l YNB (Formedium) 
4 g/l Ammonium sulphate 
20 g/l  Glucose 
 
For solid YNB media, 30 g/l DIFCO Bactoagar and 0.2 ml/l 10 M NaOH were 
added to liquid YNB. 
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Edinburgh Minimal Media (EMM2) 
 
50 ml/l  20 X EMM2 salts 
25 ml/l  20% NH4Cl 
25 ml/l  0.4 M Na2HPO4 
12.5 ml/l  40% Glucose 
1 ml/l   1000 x Vitamins 
100 µl/l  10,000 x Trace elements 
 
For solid EMM2 media, 30 g/l DIFCO Bactoagar was added. 
 
20 x EMM2 Salts  
61.2 g/l  Potassium hydrogen phthalate 
20 g/l   KCl 
21.4 g/l  MgCl2.6H2O  
0.20 g/l  Na2SO4 
0.26 g/l  CaCl2.2H2O 
 
10,000 x Trace elements 
 5 g/l  H3BO3 
 4 g/l  MnSO4 
 4 g/l ZnSO4.7H2O  
2 g/l FeCl3.6H2O 
1.5 g/l Na2MoO4 
1 g/l KI 
0.4 g/l CuSO4.5H2O 
10 g/l Citric acid 
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1000 x Vitamins 
 1 g/l Pantothenic acid 
 10 g/l Nicotinic acid 
 10 g/l Inositol 
 10 mg/l Biotin 
 
2.1.1.3 Sporulation media 
 
Extra low nitrogen (ELN)  
27.3 g/l EMM Broth (Formedium) 
0.05 g/l Ammonium chloride 
200 mg/l Adenine 
100 mg/l Leucine, uracil, histidine, arginine 
30 g/l Bactoagar 
 
2.1.1.4 S. pombe media supplements  
The wild-type S. pombe strain used in this study has the genotype; ade6-704, leu1-32, 
ura4-D18 and can not grow unless in the presence of adenine, leucine and uracil. Therefore, 
when grown in selective media the media must be supplemented. Strains containing 
markers (e.g. a LEU2 gene) can be selected for by using selective media restricted for a 
particular supplement (e.g. leucine). Supplementing media with 5-fluoroorotic-acid (5FOA) 
can counterselect for strains containing an ura+ gene. Similarly, strains marked with an 
antibiotic resistance gene, e.g. kanamycinr can be selected for by growing cells in the 
presence of that particular antibiotic. The same principles can be applied when selecting for 
plasmid containing cells. PhloxinB can be added to media to stain dead cells/diploids. 
Table 2.1 lists the supplements used in this study and the concentrations at which they are 
used. 
 
2.1.2 S. pombe strains 
Table 2.2 indicates the S. pombe strains used during this study. All S. pombe strains were 
stored in 50% glycerol stocks and maintained at –80oC. 
Table 2.1:  Supplements for S. pombe media  
 
Supplement Stock Concentration Working Concentration Storage 
Adenine hydrochloride 100 mg/ml in water 100 g/ml Room temperature 
L-leucine 100 mg/ml in water 100 g/ml Room temperature 
Uracil 50 mg/ml in water 100 g/ml Room temperature 
Thiamine 10 mg/ml water 10 g/ml 4oC, store in dark 
G418 100 mg/ml in water 100 g/ml -20oC  
5-FOA  1 mg/ml Dissolve powder 
directly in warm media 
PhloxinB 20 mg/ml in water 5 g/ml 4oC, store in dark 
 
Table 2.2:  S. pombe strains used in this study 
 
Strain Common name Genotype 
sp.011 wild-type h- ade6-704, leu1-32, ura4-D18, h- 
sp.012 wild-type h+ ade6-704, leu1-32, ura4-D18, h+ 
sp.226 rhp51-d  rhp51-d::ura4,  ade6-704, leu1-32, ura4-D18, h- 
sp.418 chk1-d cds1-d::ura4, ade6-704, leu1-32, ura4-D18, h- 
sp.437 cds1-d cds1-d::ura4, ade6-704, leu1-32, ura4-D18, h+ 
sp.481 brc1-d brc1-d::Leu2, ade6-704, leu1-32, ura4-D18, h+ 
sp.557 rad3-d rad3-d::ura4, ade6-704, leu1-32, ura4-D18, h+ 
sp.715 pli1-d pli1-d::ura4,  ade6-704, leu1-32, ura4-D18, h- 
sp.1124 nse2-SA  nse2-SA:ura4, ade6-704, leu1-32, ura4-D18, h+ 
sp.1125 smc6-X  smc6-X, leu1-32, ura4-D18, h+ 
sp.1126 smc6-74 smc6-74, ade6-704, leu1-32, ura4-D18, h- 
sp.1174 rad60-ct rad60-ct:G418+, ade6-704, leu1-32, ura4-D18, h- 
sp.1175 rad60-FL rad60-FL:G418+, ade6-704, leu1-32, ura4-D18, h- 
sp.1178 crb2-T215A crb2-T215A, ade6-704, leu1-32, ura4-D18, h+ 
sp.1179 rad60-1 rad60-1, ade6-704, leu1-32, ura4-D18, h- 
sp.1303 rqh1-d rqh1-d::ura4, ade6-704, leu1-32, ura4-D18, h+ 
sp.1305 rad60-ct nse2-SA rad60-ct:G418+, nse2.SA:ura4, ade6-704, leu1-32, ura4-D18 
sp.1371 rad60-FL-GFP rad60-FLGFP:G418+, ade6-704, leu1-32, ura4-D18, h- 
sp.1372 rad60-ct-GFP rad60-ctGFP:G418+, ade6-704, leu1-32, ura4-D18, h- 
sp.1327 rad60-ct chk1-d rad60.ct:G418+, chk1-d::ura4, ade6-704, leu1-32, ura4-D18 
sp.1328 rad60-ct cds1-d rad60-ct:G418+, cds1-d::ura4, ade6-704, leu1-32, ura4-D18 
sp.1330 rad60-ct rad3-d  rad60-ct:G418+, rad3-d::ura4, ade6-704, leu1-32, ura4-D18 
sp.1372 rad60-ct rhp51-d  rad60-ct:G418+, rhp51-d::ura4, ade6-704, leu1-32, ura4-D18  
sp.1384 rad60-ct-GFP chk1-d rad60-ctGFP:G418+, chk1-d::ura4, ade6-704, leu1-32, ura4-D18 
sp.1385 rad60-FL-GFP chk1-d rad60-FLGFP:G418+, chk1-d::ura4, ade6-704, leu1-32, ura4-D18 
sp.1386 rad60-ct-GFP cds1-d rad60-ctGFP:G418+, cds1-d::ura4, ade6-704, leu1-32, ura4-D18 
sp.1387 rad60-FL-GFP cds1-d rad60-FLGFP:G418+, cds1-d::ura4, ade6-704, leu1-32, ura4-D18 
sp.1388 rad60-ct crb2T215A rad60-ct:G418+, crb2-T215A, ade6-704, leu1-32, ura4-D18 
sp.1409 top1-d top1-d::Leu2, leu1-32, h+ 
sp.1482 GFP rad60-FL  GFPrad60-FL:G418+, ade6-704, leu1-32, ura4-D18, h- 
sp.1483 GFP-rad60-ct  GFPrad60-ct::G418+, ade6-704, leu1-32, ura4-D18, h- 
sp.1701 rad60 base rad60:ura4+, ade6-704, leu1-32, ura4-D18 h- 
sp.1702 rad60 wt a ade6-704, leu1-32, ura4-D18, h- 
sp.1703 rad60 wt b ade6-704, leu1-32, ura4-D18, h- 
sp.1704 rad60-SBM2 a rad60-SBM2a,  ade6-704, leu1-32, ura4-D18, h- 
sp.1705 rad60-SBM2 b rad60-SBM2b,  ade6-704, leu1-32, ura4-D18, h- 
sp.1706 rad60-L348V a rad60-L348V,  ade6-704, leu1-32, ura4-D18, h- 
sp1707 rad60-L348V b rad60-L348V,  ade6-704, leu1-32, ura4-D18, h- 
sp.1708 rad60-L348G a rad60-L348G,, ade6-704, leu1-32, ura4-D18, h- 
sp.1709 rad60-L348G b rad60-L348G,  ade6-704, leu1-32, ura4-D18, h- 
sp.1710 rad60-L338V a rad60-L338V,  ade6-704, leu1-32, ura4-D18, h- 
sp.1711 rad60-L338V b rad60-L338V,  ade6-704, leu1-32, ura4-D18, h- 
sp.1712 rad60-I350L a rad60-I350L,  ade6-704, leu1-32, ura4-D18, h- 
sp.1713 rad60-I350L b rad60-I350L,  ade6-704, leu1-32, ura4-D18, h- 
sp.1714 rad60-I350G a rad60-I350G,  ade6-704, leu1-32, ura4-D18, h- 
sp.1715 rad60-I350G b rad60-I350G,  ade6-704, leu1-32, ura4-D18, h- 
sp.1716 rad60-I334L a rad60-I334L,  ade6-704, leu1-32, ura4-D18, h- 
sp.1717 rad60-I334L b rad60-I334L,  ade6-704, leu1-32, ura4-D18, h- 
sp.1718 rad60-I334G a rad60-I334G,  ade6-704, leu1-32, ura4-D18, h- 
sp.1719 rad60-I334G b rad60-I334G,  ade6-704, leu1-32, ura4-D18, h- 
sp.1778 rad60-SBM1 a rad60-SBM1ade6-704, leu1-32, ura4-D18, h- 
sp.1779 rad60-SBM1 b rad60-SBM1 ade6-704, leu1-32, ura4-D18, h- 
sp.1780 rad60-SBM3 a rad60-SBM3 ade6-704, leu1-32, ura4-D18, h- 
sp.1781 rad60-SBM3 b rad60-SBM3 ade6-704, leu1-32, ura4-D18, h- 
sp.1782 rad60-L336V a rad60-L336V ade6-704, leu1-32, ura4-D18, h- 
sp.1783 rad60-L336V b rad60-L336V ade6-704, leu1-32, ura4-D18, h- 
sp.1784 rad60-L336G a rad60-L336G ade6-704, leu1-32, ura4-D18, h- 
sp.1785 rad60-L336G b rad60-L336G ade6-704, leu1-32, ura4-D18, h- 
sp.1786 rad60-Y363F a rad60-Y363F ade6-704, leu1-32, ura4-D18, h- 
sp.1787 rad60-Y363F b rad60-Y363F ade6-704, leu1-32, ura4-D18, h- 
sp.1788 rad60-Y363G a rad60-Y363G ade6-704, leu1-32, ura4-D18, h- 
sp.1789 rad60-Y363G b rad60-Y363G ade6-704, leu1-32, ura4-D18, h- 
sp.1790 rad60-L359V a rad60-Y359V ade6-704, leu1-32, ura4-D18, h- 
sp.1791 rad60-L359V b rad60-Y359V ade6-704, leu1-32, ura4-D18, h- 
sp.1792 rad60- L359G a rad60-Y359G ade6-704, leu1-32, ura4-D18, h- 
sp.1793 rad60-L359G b rad60-Y359G ade6-704, leu1-32, ura4-D18, h- 
sp.1794 rad60-L346V a rad60-Y346V ade6-704, leu1-32, ura4-D18, h- 
sp.1795 rad60-L346V b rad60-Y346V ade6-704, leu1-32, ura4-D18, h- 
sp.1796 rad60-L346G a rad60-Y346G ade6-704, leu1-32, ura4-D18, h- 
sp.1797 rad60-L346G b rad60-Y346G ade6-704, leu1-32, ura4-D18, h- 
sp.1845 diploid rad60 base rad60+ rad60+:ura4+, ade6-M216 ade6-M210, leu1-32 leu1-32, ura4-D18 ura4-D18, h+ h- 
EH353 EH353 ade6-M216, leu1-32, ura4-D18, h+ 
EH358 EH358 ade6-M210, leu1-32, ura4-D18, h+ 
EH682 EH682 ade+, leu1-32, ura4-D18, h+ 
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2.1.3 S. pombe vectors 
 
2.1.3.1 pREP41 and pREP42 
pREP41 and pREP42 are derivatives of the S. pombe expression vectors pREP1 and pREP2 
respectively (Maundrell 1993). The pREP vectors contain a thiamine repressible nmt1 (no 
message in thiamine) promoter. The pREP41/42 vectors contain a T4 mutation in the nmt1 
promoter resulting in a weaker promoter than pREP1 and pREP2. pREP81 and pREP82 
contain a T81 mutation in the promoter, resulting in a weaker promoter than pREP41/42. 
pREP41 contains the S. cerevisiae LEU2+ gene and pREP42 contains a ura4+ gene 
allowing selection of plasmid containing cells. The tagged pREP vectors pREP41HA and 
pREP42MH were also used in this study. These vectors allow the protein of interest to be 
N-terminally tagged with HA3 and Myc2-His6 tags respectively. The pREP41EGFP(C) 
vector was used to C-terminally tag the protein of interest with an EGFP tag allowing 
visualisation of the protein within the cell. 
 
2.1.3.2 pFA6 vectors- PCR based gene targeting  
The pFA6a series of plasmids (Bahler, Wu et al. 1998) contain the heterologous selectable 
marker kanMX6 and are designed to be used as templates for PCR-based gene targeting in 
S. pombe as described by Bahler et al, 1998. The pFA6 series includes plasmids containing 
a number of different markers, for example; 3 copies of the influenza virus hemaglutinin 
(HA) epitope, 13 copies of the human c-myc epitope and a copy of the Aequorea victoria 
jellyfish gene encoding green fluorescent protein (GFP). Through PCR amplification of the 
heterologous module with primers flanked with 80 bp of sequence homologous to target 
sequences within the S. pombe genome, epitopes can be introduced at gene loci via 
homologous integration. 
 
2.1.3.3 pGEM-EGFP- N-terminal tagging  
The pGEM-EGFP vector is a derivative of the pGEM3zf cloning vector (Pharmacia 
Biotech) and was devised for use in the ‘simple Cre-loxP method for chromosomal N-
terminal tagging’ system (Werler, Hartsuiker et al. 2003). pGEM-EGFP has two loxP sites 
separated by a copy of the sup3-5 cassette, which suppresses the ade6-704 non-sense 
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mutation. The sequence encoding the EGFP tag has been cloned immediately before the 
first loxP site and an nmt promoter has been placed following the sup3-5 cassette. Primers 
flanked with 80 bp of sequence homologous to target sequences within the S. pombe 
genome are used to PCR amplify the tagging construct. Fusion PCR of this tagging 
construct with fragments amplified from genomic DNA containing a) 500 base pairs of 
sequence immediately upstream of the ATG of the targeted gene, and b) 500 base pairs of 
the coding sequence including the ATG result in a targeting construct for integration into 
the genome. Following integration of the construct in an ade6-704 background, ade+ 
transformants, in which the gene is under the control of the nmt promoter, can be selected. 
Transformation with a plasmid containing the Cre recombinase allows excision of the both 
the promoter and the sup3-5 cassette located between the two loxP sites thus leaving the 
newly tagged gene under the control of its native promoter.  Other N-terminal tagging 
plasmids exist, in which the EGFP of the pGEM-EGFP vector has been replaced with 
another tag, e.g. TAP tag. 
 
2.1.3.4 pAW vectors- Recombinase-mediated cassette exchange system 
The pAW series of vectors are for use in the ‘recombinase-mediated cassette exchange 
(RCME) system‘(Watson, Garcia et al. 2008)pAW11 and pAW12 are used as PCR 
templates for generating a ‘rad60 base strain’ in which a ‘loxP-rad60-ura4+-loxM3’ 
cassette has been introduced into the S. pombe genome.  Creating the rad60 base strain is a 
two-step process; first the loxP site is integrated ~300 bases upstream of the ATG and then 
the ura4+ gene is integrated immediately downstream of the rad60 coding sequence.  
 
pAW11 contains a sup3-5 cassette flanked by 2 loxP sites. Through PCR amplification of 
the heterologous module, with primers flanked with 80bp of sequence homologous to target 
sequences within the S. pombe genome, the cassette is introduced via homologous 
integration ~300 base pairs upstream of the rad60 start codon. Ade+ transformants are 
selected and transformed with the Cre-expressing plasmid pAW8 to excise the sup3-5 
cassette leaving a single lox-P site upstream of the rad60 coding sequence.  
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pAW12 contains a ura4+ gene followed by a loxM3 site. Through PCR amplification of 
the heterologous module, with primers flanked with 80bp of sequence homologous to target 
sequences within the S. pombe genome, the ura4+-loxM3 cassette is introduced via 
homologous integration immediately downstream of the rad60 coding sequence. Ura4+ 
transformants are selected. 
 
pAW8 contains the S. cerevisiae LEU2+ gene and is a Cre-expression plasmid When the 
rad60 coding sequence is cloned into the pAW8 plasmid it is consequnectly flanked by 
loxP and loxM3 sites. Site-directed mutagenesis on this pAW8 cassette (pAW8prad60) 
followed by cassette exchange between this plasmid cassette and the chromosomal cassette 
allows a simple method for integrating point mutations into the rad60 gene. 
 
2.1.4 S. pombe transformation  
 
2.1.4.1 S. pombe plasmid transformation- standard LiAc method 
S. pombe cells were grown overnight in YE until they were in mid-log phase. 10 ml (~1 x 
108) cells were used per transformation. Cells were harvested at 3,000 rpm for 5 minutes. 
The cells were than washed with 1 ml distilled water, followed by 1 ml freshly prepared 
LiAc/EDTA. The cell pellet was then re-suspended in 100 µl LiAc/EDTA and ~1 µg 
plasmid DNA was added. The sample was incubated at room temperature for 5 minutes 
before adding 300 µl fresh PEG/EDTA/LiAc. The sample was then incubated for 30-45 
minutes at 30oC with shaking. The cells were then heat shocked at 42oC for 15 minutes and 
centrifuged at 3,000 rpm for 5 minutes. The cell pellet was washed in 1 ml water and re-
suspended in 100 µl distilled water before being plated on appropriate selective media. 
Plates were incubated at 30oC for 3 days, or until transformants appeared. 
 
LiAc/EDTA 
0.1 M  LiAc, pH4.9 
1 mM EDTA 
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PEG/EDTA/LiAc 
40%  PEG 4000 (filter sterilised) 
0.1 M LiAc, pH 4.9 
1 mM EDTA 
 
2.1.4.2 S. pombe transformation- Bahler method (Bahler, Wu et al. 1998) 
S. pombe cells were grown overnight in YE until the cell density was ~1 x 107 cells/ml. 10 
ml (~1 x 108 ) cells were used per transformation. Cells were harvested at 3,000 rpm for 5 
minutes and washed with 1 ml distilled water, followed by 1 wash with 1 ml freshly 
prepared LiAc/EDTA. The cell pellet was then re-suspended in 100 µl LiAc/EDTA and ~ 
15 µg DNA was added with 2 µl 10 mg/ml sheared herring testes DNA. The sample was 
incubated at room temperature for 10 minutes before adding 260 µl fresh 
PEG/EDTA/LiAc. The sample was then incubated for a 30-45 minutes at 30oC with 
shaking. 43 µl DMSO was added to the sample before heat shocking at 42oC for 5 minutes. 
The cells were then centrifuged at 3,000 rpm for 5 minutes and the cell pellet was re-
suspended in 500 µl distilled water. The transformation sample was plated between three 
YEA plates. Plates were incubated at 30oC overnight before being replica plated onto 
appropriate selective plates. These plates were incubated for a further 3 days at 30oC or 
until transformants appeared. 
 
LiAc/EDTA 
0.1 M  LiAc, pH7 .5 
1mM EDTA 
 
PEG/EDTA/LiAc 
40%  PEG 4000 (filter sterilised)  
0.1 M LiAc, pH 7.5 
1 mM EDTA   
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2.1.5 Recombination-mediated cassette exchange (Watson, Garcia et al. 2008) 
A pAW8 vector containing the sequence for exchange was transformed into the base strain 
as described in section 2.1.4.1. Following transformation, cells were plated directly onto 
EMM containing adenine and thiamine to repress transcription of the Cre-recombinase 
from the nmt promoter. When transformants appeared after ~72 hours, colonies were re-
streaked onto fresh EMM (plus adenine, plus thiamine) plates. The transformants were 
grown to saturation in 10 ml YE for ~36 hours at 30oC. Cells were counted and 1 x105, 1 
x104 and 1 x103 cells were plated onto YEA plates containing 5FOA at a concentration of 1 
mg/ml. Following incubation at 30oC for ~72 hours, 5FOA resistant colonies were re-
streaked onto fresh YEA plates containing 5FOA for further analysis. 
 
2.1.6 Genomic DNA extraction from S. pombe 
  
Genomic DNA extraction from S. pombe (Moreno, Klar et al. 1991) 
A 10 ml S. pombe culture was grown overnight in YEP until the cells reached stationary 
phase. The cells were harvested at 3,000 rpm for 5 minutes and washed once with 2 ml SP1 
buffer. The cell pellet was then re-suspended in 2 ml SP1 buffer containing 2 mg/ml 
zymolyase (T 20,000) and incubated at 37oC for 45-60 minutes until ~80% cell lysis was 
observed. Spheroplasting was checked by removing 10 µl of sample onto a microscope 
slide with 1 µl 10% SDS and viewing by a light microscope. Once the cells were 
sufficiently lysed the protoplasts were harvested at 3,000 rpm for 5 minutes. The pellet was 
re-suspended in 900 µl 5x TE and 100 µl 10% SDS was added. The sample was incubated 
for 5 minutes at room temperature before 300 µl KAc was added to the sample. The sample 
was then incubated for 10 minutes on ice and then centrifuged at 4,500 rpm for 15 minutes. 
The supernatant was transferred to a clean falcon tube and one volume (~2 ml) of 
isoproponol was added. After centrifuging at 4,500 rpm for 15 minutes the pellet was 
washed with 500 µl 70% ethanol. The pellet was air dried and re-suspended in 250 µl 1 x 
TE.  
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SP1 Buffer: 
1.2 M Sorbitol 
50 mM Sodium citrate 
50 mM Sodium phosphate 
40 mM EDTA 
Buffer was adjusted to pH 5.6 with NaOH 
 
5x TE 
50 mM  Tris, pH 8.0 
5 mM EDTA 
 
2.1.6.2 Genomic DNA extraction from S. pombe (for use in Southern blots) 
Genomic DNA was extracted as detailed in section 2.1.5.1. After re-suspending the DNA 
pellet in 250 µl 1 x TE, 4 µl RNase (10 mg/ml) was added and incubated for 20 minutes at 
37oC. 4 µl proteinase K (20 mg/ml) was then added and the sample incubated overnight at 
30oC. An equal volume of phenol chloroform was added and the DNA sample was spun for 
10 minutes at 4,500 rpm. The supernatant was transferred into two new micro-centrifuge 
tubes. After 625 µl 100% EtOH plus 25 µl 3 M NaOAc was added to each tube, the 
samples were placed at –20oC for 1 hour. Following a 10-minute spin at 13,000 rpm the 
supernatant was discarded and the pellet washed with 500 µl 70% EtOH. Following a 5 
minute spin at 13,000 rpm each pellet was air dried before being re-suspended in 25 µl 1 x 
TE. The two tubes were combined and 5 µl was checked on a 0.8% TBE gel. 
 
2.1.7 Colony PCR 
Colonies identified as successfully growing on the appropriate selective media were 
streaked onto the selective media and grown for a further 3 days at 30oC. A small loop of 
cells was used inoculate 100 µl water. The sample was boiled for 7 minutes and then 
cooled on ice for 5 minutes. 10 µl of this boiled sample was added to a master mix 
containing; 0.25 µl forward primer (100 µM), 0.25 µl reverse primer (100 µM), 2.5 µl 2.5 
mM dNTPs, 2.5 µl 10 x PicoMax buffer (Stratagene), 0.25 µl Taq polymerase (Abgene) 
and 9.25 µl dH2O. The PCR programme consisted of 45 cycles of; 94o C for 10 seconds, 
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54oC for 15 seconds and 72oC for 1 minute. 10 µl PCR product was analysed on a 1% TBE 
gel. 
 
2.1.8 S. pombe genetic mating crosses 
S. pombe crosses were set up by mixing two strains of opposite mating types on extra low 
nitrogen (ELN) media. The plates were incubated for 3 days at 25oC until spore-containing 
asci could be observed by a light microscope. 
 
2.1.8.1 Random spore analysis 
For mating crosses between strains with different selectable markers random spore analysis 
was used to select for double mutants. 1 ml of water, with 1 µl helicase (S.P.P. Helix 
pomatia juice) was inoculated with a loop of mating mixture. The sample was incubated on 
a rotating wheel overnight at room temperature. Serial dilutions of the spores were plated 
onto YEA and incubated at 30oC for 3 days. Colonies were then replica-plated onto 
selective media plates and double mutants selected.  
 
2.1.8.2 Tetrad analysis 
For mating crosses between strains without different selectable markers tetrad dissection 
analysis was used to select for double mutants. Following sporulation, a small loop of cells 
was streaked on one side of a YEA plate and incubated at 30oC for ~3 hours to allow the 
ascus wall to break down. Each ascus was then micro-manipulated to separate the four 
individual spores on the YEA plate. The spores were incubated for 3-4 days at 30oC until 
colonies formed. Depending on the phenotype of the individual mutant strains, double 
mutants were identified by replica plating onto suitable selection plates and/or exposing to 
UV radiation following replica plating onto phloxine B plates and the progeny analysed. 
 
2.1.9 Survival analysis 
 
2.1.9.1 UV survival analysis 
Cells were grown in appropriate media overnight to exponential phase and diluted to 5x103 
cells/ml (or a dilution suitable for the strain). To test UV sensitivity, 100 µl cells (~500 
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cells) were plated in duplicate onto yeast extract agar (YEA) plates and irradiated at a dose 
of 25 Jm-2 /min for doses ranging between (0 and 200 Jm-2). Colonies were counted 
following incubation for 72 hours at 30oC and percentage survival calculated with reference 
to the non-irradiated sample. 
 
2.1.9.2 Ionising radiation (IR) survival analysis  
Cells were grown in appropriate media overnight to exponential phase and diluted to 5x103 
cells/ml (or a dilution suitable for the strain). To test γ sensitivity, cells were irradiated with 
γ rays from a 137Cs source at a dose of 10 Gy/min for doses ranging from 0-1,000 Gy. 100 
µl cells (~500 cells) were plated in duplicate onto yeast extract agar (YEA) plates. Colonies 
were counted following incubation for 72 hours at 30oC and percentage survival calculated 
with reference to the non-irradiated sample. 
 
2.1.9.3 Sensitivity to genotoxins 
To determine the sensitivity of cells to DNA damaging agents by spot tests, exponentially 
growing cultures were adjusted to an equal cell density and four successive tenfold 
dilutions were spotted onto YEA or YEA plates containing hydroxyurea (HU), 
thiabendazole (TBZ), 4-nitroquinoline-1-oxide or methyl methanesulfonate (MMS).  Plates 
were incubated at 30oC for 3 days. Table 2.3 lists the genotoxins used in this study. 
 
2.1.10 Microscopy 
Cells were observed using an Applied Precision Deltavision Spectris microscope using 
deconvolution software. 
 
2.1.10.1 Live cell imaging 
1 ml of exponentially growing cells was harvested for 1 minute at 3,000 rpm and the 
supernatant removed. The cells were washed with 1 ml PBS and re-suspended in 100 µl 
EMM2 media supplemented with the appropriate amino acids and containing Hoechst 
33442. 5 µl of the cell suspension was placed on a microscope slide. A coverslip was 
placed on top and the cells visualised.  
 
Table 2.3: Genotoxins used in this study 
 
Genotoxin Stock Concentration Working 
Concentration 
Storage 
HU 3 M in water 4-6 mM (plates) 
20 mM (liquid culture) 
-20oC 
MMS / 0.005- 0.01% Added directly to media 
TBZ 20 mg/ml in DMSO 15-20 g/ml -20oC 
4NQO 1mM in DMSO 0.0M -20oC 
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2.1.10.2 DAPI staining of S. pombe cells 
1 ml of exponentially growing cells was harvested for 1 minute at 3,000 rpm and the 
supernatant removed. The cells were washed with 1 ml PBS and resuspended in 1 ml cold 
methanol. Following centrifugation for 1 minute at 3,000 rpm, the supernatant was 
discarded and the cells were re-suspended in 100 µl mounting mix. 5 µl of the cell 
suspension was placed on a microscope slide. Once the sample was dry a small drop of 
vectashield (Vecta) was added to the slide and covered with a coverslip. The coverslip was 
sealed with clear nail varnish and the cells visualised. 
 
Mounting Mix 
0.5 µg/ml DAPI 
2.5 µg/ml Calcofluor 
In PBS 
 
2.1.10.3 Immunofluorescence (Hagan 1998) 
Cells were grown in appropriate media to A595 0.125. 5.5 ml 30% paraformaldehyde was 
added to 40 ml cells and the sample was incubated at room temperature on a rotating wheel 
for 10 minutes. The cells were harvested at 2,000 rpm for 2 minutes and the supernatant 
discarded. The cells were washed briefly in 10 ml PBS, followed by 1 wash in 1 ml PEM 
solution and 1 wash in 1 ml PEMS solution with spins between washes at 3,000 rpm for 1 
minute. The cell pellet was re-suspended in 1 ml PEMS containing 1.25 mg/ml zymolyase 
T 20,000 and incubated at 37oC for 70 minutes or until the cells wall had become digested. 
The sample was centrifuged at 3,000 rpm for 1 minute and the supernatant discarded. The 
cells were washed gently in 1x 1 ml PEMS, 1 x 1 ml PEMS containing 1% triton, 2 x 1ml 
PEM and finally 2 x 1 ml PEMBAL. The cell pellet was re-suspended in 1 ml PEMBAL 
and incubated at room temperature for 1 hour on a rotating wheel. 1 µl primary antibody 
was added to 100 µl of cells and left overnight at room temperature on a rotating wheel. 
The following day, the cells were washed 3 x 1ml PEMBAL with spins at 3,000 rpm for 1 
minute in-between washes. The cell pellet was then re-suspended in 1 ml PEMBAL and 
incubated for 20 minutes at room temperature on a rotating wheel. The cells were then 
centrifuged for 1 minute at 3,000 rpm and the cell pellet re-suspended in 100 µl PEMBAL. 
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1 µl secondary antibody (1:100) was then added and the sample was wrapped in foil and 
incubated at room temperature for 3 hours on a rotating wheel. The cells were washed in 1 
ml 1 x PEM and 1x PBS and re-suspended in 100 µl PBS. The cells were incubated at room 
temperature for 10 minutes on the rotating wheel. The cells were then centrifuged for 1 
minute at 3,000 rpm and the cell pellet re-suspended in 100 µl PBS containing DAPI (0.5 
µg/ml) 5 µl cells were spotted onto polylysine coverslips. Once dried, a small drop of 
vectashield  (Vecta) was added to the slide and covered with the coverslip. The coverslip 
was sealed with clear nail varnish and when dry the slide visualised under a microscope. 
 
30 % Paraformaldehyde  
15 g paraformaldehyde was dissolved in 50 ml PEM solution. To aid dissolving 
the mixture was heated to 65oC for 5 minutes and 300 µl 10 M NaOH was added. 
The mixture was heated for a further 20 mins at 65oC. When the 
paraformaldehyde was fully dissolved, the solution was neutralized with 100 µl 
conc. HCl. The paraformaldehyde solution was cooled before use. 
 
PEM Solution 
100 mM PIPES 
1 mM EGTA 
1 mM MgCl2 
 Solution was adjusted to pH 6.9 with NaOH and filter sterilised 
 
PEMS Solution 
100 mM PIPES 
1 mM EGTA 
1 mM MgCl2 
1.2 M Sorbitol 
 Solution was adjusted to pH 6.9 with NaOH and filter sterilized. 
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PEMBAL Solution 
100 mM PIPES 
1 mM EGTA 
1 mM MgCl2 
1 % BSA 
0.1 % NaN3 
100 mM Lysine 
Solution was adjusted to pH 6.9 with NaOH and filter sterilised  
 
2.2  BACTERIAL METHODS 
 
2.2.1 Bacterial media 
 
L-Broth (LB) 
10 g/l Tryptone 
5 g/l Yeast extract 
5 g/l NaCl 
 
For solid LA media 8 g/l agar was added. 
 
2.2.2 Antibiotics 
To select for plasmids containing a resistance marker, antibiotics were added to media prior 
to use. All antibiotics were stored at -20oC.  
 
Antibiotic Stock Concentration Working Concentration 
Ampicillin 100 mg/ml in water 100 µg/ml 
Chloramphenicol 34 mg/ml in ethanol 34 µg/ml 
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2.2.3 Blue-white selection 
For blue-white selection using insertional activation of the LacZ gene, IPTG and X-Gal 
were added to media containing the appropriate selective antibiotic. Both IPTG and X-Gal 
were stored at -20oC. 
 
Additive Stock Concentration Working Concentration 
IPTG 20 mg/ml in water 40 µg/ml 
X-Gal 20 mg/ml in dimethylformamide 100 µg/ml 
 
2.2.4 E.coli strains 
The E. coli strains used in this study are listed in table 2.4. 
 
2.2.5 Bacterial cloning vectors 
 
pGEM-T Easy (Promega) and pTOPO (Invitrogen) 
The pGEM-T Easy and pTOPO cloning vectors are high copy number plasmids that can be 
used for the cloning of PCR products. The vectors have a 3´ terminal thymidine at both 
ends providing a compatible overhang for PCR products generated by polymerases, which 
add single deoxyadenosine, to the 3´-ends of the amplified fragments. The vectors contain 
both T7 and SP6 RNA polymerase promoters in addition to the α-peptide coding region of 
the enzyme β-galactosidase. Insertional inactivation of the α-peptide allows selection of 
recombinant clones by blue-white screening. 
 
2.2.6 Bacterial expression vectors 
The bacterial expression vectors used in this study are under the control of the T7 promoter, 
which is activated by the T7 polymerase. The bacterial expression strain BL21 is a λDE3 
lysogen containing an integrated copy of the T7 polymerase gene, which is under the 
control of the lacZ promoter. Expression of the T7 polymerase, and therefore the protein of 
interest, is induced by the addition of IPTG. 
 
 
Table 2.4: E. coli strains used in this study 
 
Strain Genotype Additional selection
NM522 F- lacIqD(lacZ)M15, proA+B+ / supE, thiD, (lac-
proAB)D, (hsdMS-mcrB)5. 
- 
BL21 (DE3 lysogen/pLysS) F-  ompT rB- mB- Chloramphenicol 
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pET-15B (Novagen) 
The pET-15B vector carries a 6His-tag allowing affinity purification of N-terminally tagged 
proteins on Ni2+ agarose beads. A thrombin cleavage site allows cleavage of the tag 
following purification. An Ampr gene allows selection of the plasmid. 
 
pGEX (Pharmacia Biotech) 
The pGEX vector encodes a 26 kDa GST tag allowing purification of the N-terminally 
tagged proteins on glutathione sepharose beads. A thrombin cleavage site allows cleavage 
of the tag following purification. An Ampr gene allows selection of the plasmid. 
 
pEPEX 
The pEPEX vector contains a T7 promoter and is a good vector for use in the In vitro 
transcription dependant translation reaction (Section 2.4.13). An Ampr gene allows 
selection of the plasmid. The pEPEXHA vector places a single HA tag at the N-terminus of 
the expressed protein.  
 
2.2.7 Preparation of competent E.coli cells 
Competant cells were prepared based on a modified version of a protocol by D. Hanahan 
(Hanahan 1983). 
 
A single colony was used to inoculate 5 ml LB and grown overnight in a 37oC shaker. The 
5 ml pre-culture was used to inoculate 1 litre pre-warmed LB and grown at 37oC with 
shaking for 2-4 hours until the OD550 reached 0.5-0.6. The cells were chilled on ice for 1 
hour and centrifuged at 5,000 rpm for 5 minutes at 4oC. The supernatant was discarded and 
the cell pellet re-suspended in 25 ml ice-cold TRNS 1 solution. The sample was centrifuged 
at 3,000 rpm for 5 minutes at 4oC. The supernatant was again discarded and the cell pellet 
re-suspended in 25 ml TRNS 1 solution. After incubating on ice for 5 minutes, the sample 
was centrifuged at 3,000 rpm for 5 minutes at 4oC. The supernatant was discarded and the 
cell pellet re-suspended in 6 ml ice cold TRNS 2. The sample was incubated on ice for 10 
minutes before aliquoting into volumes of 300 µl. The cells were then snap-frozen in liquid 
nitrogen and stored at –80oC. 
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TRNS 1 Solution 
12.1 g/l  RbCl 
9.6 g/l MnCl2 
1.48 g/l CaCl2  
2.88 g/l CH3COONa 
66 ml/l Glycerol 
Solution adjusted to pH 5.8 with acetic acid, and then filter sterilized. 
 
TRNS 2 Solution 
1.2 g/l  RbCl 
11 g/l CaCl2 
2.1 g/l MOPS 
66 ml/l Glycerol 
Solution adjusted to pH 6.8 with acetic acid, and then filter sterilized. 
 
2.2.8 E. coli transformation 
Competent E. coli cells were thawed on ice for 15 minutes. Approximately 0.5 µg of 
plasmid DNA was added to 100 µl cells. The sample was incubated on ice for 15 minutes 
before being ‘heat shocked’ at 37oC for 2 minutes. The cells were then incubated on ice for 
a further 5 minutes. 0.5 ml L-Broth was added and the sample incubated for 45 minutes at 
37oC. After incubation, the cells were spun at 3,000 rpm for 5 minutes and the supernatant 
poured off. The cell pellet was re-suspended in 100 µl LB and the cells plated onto LB agar 
plates supplemented with the appropriate selective antibiotic. Plates were incubated at 37oC 
for ~16 hours. 
 
2.3  DNA METHODS 
 
2.3.1 Agarose gel electrophoresis 
Typically, 200 ml 0.8% agarose gels were used to analyse DNA samples, although 
occasionally, a 1% agarose gel was used to analyse small (<500bp) DNA fragments. 
Agarose (Melford) was dissolved, by heating, in 1 x TBE buffer. Prior to pouring in a pre-
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prepared agarose gel cast, ethidium bromide was added to a final concentration of 0.25 
µg/ml. Once set, the gel was submerged in a gel tank containing 1 x TBE buffer. Typically, 
DNA samples were loaded as a 20 µl volume with one-tenth volume of 10 x loading buffer 
and were run against 1 µl of a 1 kb ladder (Invitrogen). Electrophoresis was carried out at 
150 V for ~ 45 minutes or until DNA bands were well separated. The DNA was visualised 
using a UV transilluminator. 
 
10 x TBE Buffer 
108 g/l Tris base 
55 g/l Boric acid 
0.2 M EDTA, pH 8. 
 
10 x Loading Buffer 
0.1%  SDS 
40% Sucrose 
1 mM EDTA 
1 mM Tris, pH 7.5 
0.25 % Bromophenol blue 
 
2.3.2 PCR-Amplifying DNA fragments 
PCR was generally carried out using the DNA polymerase, Expand (Roche). 
Approximately 50 ng template DNA was used per 100 µl reaction containing; 1 µl forward 
primer (10 µM), 1 µl reverse primer (10 µM), 10 µl 10 x Expand buffer, 5 µl 2.5 mM 
dNTPs, 10 µl 10 X BSA and 1 µl Expand enzyme, which was added last. The PCR 
programme consisted of 18 cycles of; 94oC for 1 minute, XoC for 30 seconds and 68oC for 
Y minutes where X, the annealing temperature, is dependent of the melting temperature of 
the primer pair, and Y, the elongation time, is dependent on the length of desired product. 
Typically, the extension time was calculated as 2 minutes per kb product. 5 µl of the PCR 
product was analysed on a 0.8% TBE agarose gel.  
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2.3.3 PCR- Site-directed mutagenesis  
Site-directed mutagenesis was carried out based on the ‘QuickChange site-directed 
mutagenesis’ technique (Stratagene). Complementary primer pairs were designed to 
contain the DNA sequence encoding the mutation of choice flanked either side by ~ 12 
bases that will hybridise to the original DNA sequence. PfuTurbo (Stratagene) was used to 
amplify the entire template plasmid. Approximately 50 ng template DNA was used per 50 
µl reaction containing; 1 µl forward primer (1 µM), 1 µl reverse primer (1 µM), 5 µl 10 x 
Pfu buffer, 3 µl 2.5 mM dNTPs, and 1 µl PfuTurbo enzyme, which was added last. The 
PCR programme consisted of 18 cycles of; 94o C for 1 minute, XoC for 30 seconds and 
72oC for Y minutes where X (the annealing temperature) is dependent of the melting 
temperature of the primer pair, and Y (the elongation time) is dependent on the length of 
desired product. 5 µl of the PCR product was analysed on a 0.8% TBE agarose gel. The 
remaining PCR product was digested with 1 µl DpnI (Stratagene), which digested the 
methylated parental DNA template, leaving only the newly amplified ‘mutagenic’ DNA 
product. 20 µl of the mutagenic PCR product was transformed into E. coli NM522 cells and 
the DNA extracted using a QIAGEN miniprep kit as according to the manufacturer’s 
instructions. The presence of the desired mutation was confirmed by sequencing (Section 
2.3.11). 
 
2.3.4  Fusion PCR for N-terminal tagging 
Approximately 400 ng tagging construct, 150 ng of PCR fragment containing the upstream 
region of the gene and 150 ng of PCR fragment containing the downstream region of the 
gene were fused in a two step PCR reaction. In the first ‘fusion’ step the PCR reaction 
mixture consisted of template DNA at the aforementioned concentrations, 5 µl of 10 x 
KOD buffer, 5 µl 2.5 mM dNTPs, 2.5 µl DMSO, 8 µl MgSO4 and 1 µl KOD polymerase in 
a total volume of 50 µl. The PCR programme consisted of 5 cycles of; 95o C for 5 minute, 
55oC for 1 minute and 68oC for 4 minutes followed by 10 minutes at 68o C. In the second 
‘amplification’ step the PCR reaction mixture consisted of 50 µl product from the ‘fusion’ 
step, 5 µl of 10 x KOD buffer, 5 µl 2.5 mM dNTPs, 2.5 µl DMSO, 4 µl MgSO4, 1.5 µl 
forward primer (10 µM), 1.5 µl reverse primer (10 µM) and 1 µl KOD polymerase in a total 
volume of 100 µl. The PCR mixture was heated at 95o C for 2 minutes followed by 24 
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cycles of; 95o C for 30 seconds, 55oC for seconds and 68oC for 4 minutes followed by 10 
minutes at 68oC. 5 µl of the fusion PCR product was analysed on a 0.8% TBE gel. 
 
2.3.5 PCR purification 
PCR products were purified using a QIAGEN PCR purification column according to the 
manufacturer’s guidelines. 
 
2.3.6 Ethanol precipitation 
2.5 x sample volumes EtOH (100%) was added to the DNA sample with 1/10th volume 3 M 
NaOAc. Samples were incubated at –20oC for ~ 1 hour and then spun at 13,000 rpm for 10 
minutes at 4oC. The supernatant was removed and the DNA pellet washed with 500 µl 
EtOH. The supernatant was removed and the DNA pellet was dried for ~ 10 minutes before 
being re-suspended in 50 µl  (or desired volume) 1 x TE. 
 
2.3.7 Restriction enzyme digests 
Typically, 1 µg of DNA was digested in a total volume of 30 µl. Restriction enzymes (New 
England Biolabs) were used as according to the manufacturers guidelines with 1 µl 
restriction enzyme, 3 µl of the relevant 10 x restriction enzyme buffer, and if required 3 µl 
of 10 x BSA. Digests were incubated at 37oC for 2 hours. For double digests, where the 
enzyme buffers were not compatible the DNA was cleaned, following the first enzyme 
digest, using a QIAGEN PCR purification column as according to the manufacturer’s 
guidelines.  
 
2.3.8 Purification of DNA fragments 
DNA fragments were isolated by electrophoresis. Typically on a 0.8% TBE gel. For DNA 
fragments less than 500 base pairs, a 1% TBE gel was used. The DNA fragments were 
analysed using a UV transilluminator. The DNA band was excised using a clean scalpel 
and purified from the gel using a QIAGEN gel purification kit, according to the 
manufacturer’s instructions.  
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2.3.9 Ligations 
Ligations were carried out using T4 DNA ligase (Roche) according to the manufacturer’s 
guidelines. Typically, the vector and insert were ligated in a 1:3 molar ratio with 2 µl 10 x 
T4 ligase reaction buffer (Roche) and 1 µl T4 DNA ligase (Roche) (1 unit/µl) in a final 
reaction volume of 20 µl. The ligation mixture was incubated at room temperature for a 
minimum of 4 hours before being transformed into NM522 cells. 
 
2.3.10 Amplifying plasmid DNA 
  
2.3.10.1 DISH minipreps 
A 2 ml L-Broth culture, supplemented with the appropriate selective antibiotic was 
inoculated with a single colony and grown for ~4 hours at 37oC, with shaking. 1 ml of the 
cell culture was harvested at 13,000 rpm for 5 minutes and the supernatant discarded. The 
cell pellet was re-suspended in 100 µl DISH I solution. 200 µl DISH II was added and the 
sample mixed by inversion. 150 µl ice cold DISH III was added and the sample mixed by 
inversion. 200 µl phenol chloroform was added and the sample vortexed. The sample was 
then spun at 13,000 rpm for 15 minutes and the top aqueous layer removed to a clean 
microcentrifuge tube containing 750 µl 100% ethanol. The sample was spun for a further 5 
minutes at 13,000 rpm and the supernatant removed. The DNA pellet was dried for 
approximately 10 minutes in a dessicator before being re-suspended in 40 µl 1x TE 
containing 20 µg/ml RNase. 5 µl of the DNA sample was analysed on an agarose gel. 
 
DISH I 
 9 g/L Glucose 
 3 g/L Tris-base 
 3.72g/L EDTA 
 
DISH II 
 0.2 M NaOH 
 1% SDS 
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DISH III 
 3 M KOAc 
 11.5% Glacial acetic acid 
 
Phenol/chloroform 
24 Volumes Equilibrated phenol 
25 Volumes Chloroform 
1 Volume Isoamyl alcohol. 
 
Phenol equilibration 
Phenol (Pre-equilibrated with 10 mM Tris-HCl, pH 8, 1 mM EDTA) (Sigma-
Aldrich) was adjusted to pH 7.9 by incubating overnight at room temperature with 
equilibration buffer as according to manufacturer’s guidelines. 
 
2.3.10.2 Qiagen minipreps 
If the DNA was to be sequenced, minipreps were carried out using a QIAGEN miniprep kit 
according to the manufacturer’s guidelines. 
 
2.3.10.3 Midipreps 
Midipreps were carried out using a QIAGEN midiprep kit according to the manufacturers’ 
guidelines. 
  
2.3.11 Sequencing 
 
2.3.11.1 In-house sequencing 
Sequencing was carried out using the BigDye Terminator v1.1 kit (Applied biosciences). 
Approximately 500 ng of the DNA to be sequenced was used per 20 µl sequencing 
reaction. 5 µl reaction buffer, 3 µl primer (10 µM), and 2 µl enzyme mix were added to the 
template DNA in a 20 µl final volume. The PCR programme and subsequent ethanol 
precipitation of the PCR product was carried out as according to the manufacturers 
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guidelines. The sample was re-suspended in 25 µl highly deionised formamyde and heated 
to 95oC for 2 minutes before analysis by an ABI PRISM 310 Genetic Analyser. 
  
2.3.11.2 Sequencing by GATC 
DNA samples and sequencing primers were sent to GATC for sequencing. 30 µl DNA (30-
100 ng/µl) and 30 µl corresponding primer (30 pmol/µl) were required. 
 
2.3.12 Southern blot 
Genomic DNA was extracted and the DNA fragment of interest was isolated by restriction 
enzyme digest. 5 µg DNA was digested with BclI in a reaction volume of 30 µl. The 
digested DNA was run on a 0.8% TBE gel. The gel was then washed for 30 minutes in 
depurination buffer, 30 minutes in denaturation buffer and finally 30 minutes in 
neutralisation buffer with gentle shaking at room temperature. The gel was blotted onto a 
genescreen (PerkinElmer) membrane overnight in 20 x SSC buffer. Following blotting, the 
DNA was crosslinked to the membrane by exposure to 1200 µJ. To prehybridise the 
membrane, the membrane was incubated for 30 minutes in 80 ml hybridisation buffer with 
266 µl 30 % BSA added.  The membrane was then incubated overnight at 65oC in 20 ml 
hybridisation buffer containing 50 µl DNA probe (Section 2.3.13). Following 
hybridisation, the membrane was washed in 500 ml wash buffer 1 for 15 minutes at 65oC, 
followed by 2 x 20 minutes in 500 ml wash buffer 2 at 42oC. The membrane was then 
exposed to a phosphocassette overnight. The signal was detected by a phosphoimager. 
 
Depurination Buffer 
0.25 M HCl 
 
Denaturation Buffer 
0.5 M  NaOH 
1.5 M  NaCl  
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Neutralisation Buffer 
1 M  Tris/HCl 
1 M  NaCl. 
 Adjusted to pH 7.4 
 
 20 x SSC 
 3 M NaCl 
0.3 M Sodium citrate 
Adjusted to pH 7 
 
 Hybridisation Buffer (100 ml) 
 30 ml  20x SSC buffer 
 1 ml  Denhardt’s solution 
 3.33 ml  30 % N-Lauryl sarcosine salt solution 
 
 Denhardt’s Solution (100x) 
 20 g/l  Ficoll 
 20 g/l Polyvinylpyrrolidone 
 20 g/l BSA 
  
Wash Buffer 1 (500 ml) 
 50 ml 20x SSC 
 50 ml SDS (10%) 
 
Wash Buffer 2 (1 litre) 
 5 ml 20x SSC 
 10 ml SDS (10%) 
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2.3.13 Labelling DNA Probe 
The ura4+ DNA probe was isolated from the pKSUra plasmid as a HindIII fragment. 100 
ng DNA probe was labelled with 32P using the Radprime Labeling kit (Sigma-Aldrich) 
according to the manufacturer’s guidelines. 
 
2.3.14 Primers 
Table 2.5 indicates the primers used during this study. All primers were diluted in water to 
a concentration of 10 µM and stored at -20oC. 
 
2.4 PROTEIN METHODS 
 
2.4.1 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS PAGE gel electrophoresis was carried out using Biorad Mini Protean II kits. Protein 
samples were resolved on 7.5, 10 or 12.5% separating gels. Polymerisation was achieved 
by the addition of 10% ammonium persulphate (APS) and TEMED to the separating buffer. 
The pre-polymerised gel solution was poured between glass plates separated with 0.75 mm 
plastic spacers and left to set for approximately 30 minutes with a layer of distilled water 
on top to achieve a level surface. Once set, the water layer was poured off and the plates 
dried with Whatman paper. The stacking gel (3%) was poured on top of the separating gel 
and the gel comb positioned. After approximately 30 minutes the comb was removed and 
the gel kit assembled. Protein samples were mixed with 5 x sample buffer and denatured at 
95oC for 5 minutes. 10-25 µl of sample were loaded into each well. 8 µl of benchmark 
protein ladder (Invitrogen) was loaded into the end lane as a size indicator. Gels were run 
in 1 x SDS running buffer at 150 V for approximately 1 hour or until the dye front reached 
the bottom of the gel.  
 
 
 
 
 
 
Table 2.5: Primers used in this study 
 
 
Primer Forward
/reverse 
Primer sequence (5’ to 3’) 
L17 F GTGCTATCTCCTGTGTAA 
L18 F GTTCTCCAGTTAGCCGTA 
L19 F GTTATCCTCGGTAACTGA 
L26 F TCAAAAGAATAAAAGAATTGGAAGTGGAAAAGTTATCCTCGGTAACT
GAAGATTCAACTGCTCAAACGTGTAAACTTTAACGGATCCCCGGGTTA
ATTAA  
L27 R CGTGATCATTCTATAAAAGTATTATGGCGGTAATTAAATATAAGAAAG
AACAATGGTAAAAGTAAGAGCCAAATATCCTTGAATTCGAGCTCGTTT
AAAC 
L28 F GTGAATGGTTAGATCCCAACGATCAAGTGCAAAGCACGGAACTTGAA
GATGAAGATCAAGTTAGTGTTGTTTTGGATTAACGGATCCCCGGGTTA
ATTAA 
L31 F GTTTGGTTGTGCATGCCTACTGTCACTCGG 
L33 F CACTCAAAAGAATAAAAGAATTGGAAGTGGAAAAGTTATCCTCGGTA
ACTGAAGATTCAACTGCTCAAACGTGTAAACTTCGGATCCCCGGGTTA
ATTAA 
L34 F GAAGTGAATGGTTAGATCCCAACGATCAAGTGCAAAGCACGGAACTT
GAAGATGAAGATCAAGTTAGTGTTGTTTTGGATCGGATCCCCGGGTTA
ATTAA 
L35 R GCAGTGTACGAACAAGCAATAATGCC  
L37 F GCTTTTGCGTTCGAGTAGGAGTGAGGATCTTCG 
L38 R CGAAGATCCTCACTCCTACTCGAACGCAAAAGC  
L40 R GGTAAAAGTAAGAGCCAAATGTCGACTTAATCCAAAACAACAC 
L41 F CCGTAATTGCTAAAACTCGCCATATGGACAACCTAGATGAAGATG  
L45 F GCCTAGGTAAAATTGGGTACCTTCCTTAGAATC 
L56 F CCGTCGATTTCACTGTTAGAGATTTGATTAAGAG 
L57 R CTATTAATCAAATCTCTAACAGTCAAATCGACGG  
L58 F CACTGTTAAAGATTTGATTAGGAGATATTGTACTG 
L59 R CAGTACAATATCTCCTAATCAAATCTTTAACAGTG 
L60 F GTACTGAAGTAAGGATTAGTTTTCATGAACGC  
L61 R GCGTTCATGAAAACTAATCCTTACTTCAGTAC 
L63 F GCTTTTGCGTTCGAGTAAGAGTGAGGATCTTCG 
L64 R CGAAGATCCTCACTCTTACTCGAACGCAAAAGC 
L65 F GTACTGAAGTAAAGATTAGTTTTCATGAACGC 
L66 R GCGTTCATGAAAACTAATTCTTACTTCAGTAC 
L68 F GCGTACTCTGAACATATGAAAGTAGATAACG 
L72 F ACATTATACGAAGTTATCGGGCGGCGGGGGTGGTATGGACAACCTAGA
TGAAGATGAC   
L73 R CGTGTGAATTTGTACATCCATATCAC  
L74 R TTCCGCGGCCGCTATGGCCGACGTCGACCCTACCTTCCTCTTCTTCTTC
GGAAGTTTACACGTTTGAGC  
L75 F GGAATATCGGCTGATTAAACC 
L78 F CGTACTCTGAAAGAAGAAGAGTAGATAACG 
L79 R CGTTATCTACTCTTCTTCTTTCAGAGTACG   
L80 R CAGTGAATAATTCTTCACCTTTAGACATTTGGCGAGTTTTAGCAATTAC
GG 
L88 R GCAACGTTATTTATTTACACGTTTGAGC 
L91 R ACCACCCCCGCCGCCCGATAACTT 
L94 F ATGTCTAAAGGTGAATTATTCACTG 
L96 R TTAATTAACCCGGGGATCCG 
L109 F CAAAGCCTATTAGAAGGCCTCCATTAAACTATGCC 
L110 R GGCATAGTTTAATGGAGGCCTTCTAATAGGCTTTC 
L111 F GGTATGCTTAGAGTCGATACCCG 
L112 R CGGGTATCGACTCTAAGCATACC 
L113 F GCTCAAACGTGTAGACTTATAACGTTGC  3’ 
L114 R GCAACGTTATAAGTCTACACGTTTGAGC 
L117 F GACGCGTCGACATGTCTGAATCACCAGCAAAC 
L118 R CGCGGATCCCTAAGGCATAGATGGGTGCAACC 
L125 F CCAGTTATTTCCGCCGCTCTCCAGTTAGCCG       
L126 R CGGCTAACTGGAGAGCGGCGGAAATAACTGG 
L127 F GTAGATAACGTTGCTCTTGCATTTCAAAATTC     
L128 R GAATTTTGAAATGCAAGAGCAACGTTATCTAC 
L129 F GAAGATCAAGCTAGTGCTGTTTTGGATTAA 
L130 R TTAATCCAAAACAGCACTAGCTTGATCTTC 
L140 F GGTGAATGGTTAGATCCCAACGATCAAGTGCAAAGCACGGAACTTGA
AGATGAAGATCAAGTTAGTGTTGTTTTGGATTAAAAGCTTAGCTACAA
ATCCCA  
L141 R CGTGATCATTCTATAAAAGTATTATGGCGGTAATTAAATATAAGAAAG
AACAATGGTAAAAGTAAGAGCCAAATATCCTTGAATTCGAGCTCGTTT
AAAC  
L142 R TGGGATTTGTAGCTAAGCTT 
L143 F ATGGACGGACGCAATGTAGCCGTCGTAAGGTGAGCCAATGTCATTGAA
ATTCATCAAACCTAATGTCTCAGTACAAGAAGTAGAATACTCAAGCTT
GGAC 
L144 R ACCCGATCTTGTCCACTTAGCAAACAGATTTAAGTCTATAGAATTTCAT
TTTTTAGGTTAAGTAATTTGAAAACTCTTTGTTCACCACCCCCGCCGCC
CG  
L150 F ACAAATTATGAATGGCAGTAATGGACGGACGCAATGTAGCCGTCGTAA
GGTGAGCCAATGTCATTGAAATTCATCAAACCTAATGTCTCAGTACAA
GAAGTAGAATACTC AAGCTTGGAC 
L151 R AGTTTGTTTACTTACGCAAAACCCGATCTTGTCCACTTAGCAAACAGAT
TTAAGTCTATAGAATTTCATTTTTTAGGTTAAGTAATTTGAAAACTCTT
TGTTCACCACCCCCGCCGCCCG 
L156 F GTACAAATTCACACGCATAGGAGAGAAATTGAAGAAGACG   
L157 R CGTCTTCTTCAATTTCTCTCCTATGCGTGTGAATTTG TAC 
L158 F CGCTGTATCACTCCAGATCGGAATTCTCAAC 
L159 R GTTGAGAATTCCGATCTGGAGTGATACAGCG 
L170 F GTACCTGAATAGTCTACTACTG 
L172 R GCGACACACCTTAAACTAGG 
L179 R TCAGTTACCGAGGATAAC 
L202 F CAGTTTCGTCGTGGCAGAATAGCGTACTCT  
L210 F CAAACG TGTAAACTTATAACGGTGCTTTTGCGTTCGAG 
L211 R CTCGAACGCAAAAGCACCGTTATAAGTTTACACGT TTG 
L212 F CAAACGTGTAAACTTATAACGGGGCTTTTGCGTTCGAG 
L213 R CTCGAACGCAAAAGCCCCGTTATAAGTTTACACGT TTG 
L214 F GTGAGGATCTTCGTGTCTCAATACCCGTCG 
L215 R CGACGGGTAT TGAGACACGAAGATCCTCAC 
L216 F GTGAGGATCTTCGTGGCTCAATACCCGTCG 
L217 R CGACGGGTATTGAGCCACGAAGATCCTCAC 
L219 F CGATTTCACTGTTAAAGATGTGATTAAGAGATATTGTACTG 
L220 R CAGTACAATATCTCTTAATCACATCTTTAACAGTGAAATGG 
L221 F CGATTTCACTGTTAAAGATGGGATTAAGAGATATTGTACTG 
L222 R CAGTACAATATCTCTTAATCCCATCTTTAACAGTGAAATGG 
L223 F GATTTGATTAAGAGATTTTGTACTGAAGTAAAG 
L224 R CTTTACTTCAGTACAAAATCTCTTAATCAAATC 
L225 F GATTTGATTAAGAGAGGTTGTACTGAAGTAAAG 
L226 R CTTTACTTCAGTACAACCTCTCTTAATCAAATC 
L227 F CGTGTATAACGTTGCTTGTGCGTTCG AGTAAGAG 
L228 R CTCTTACTCGAACGCACAAGCAACGTTATACACG  
L229 F CGTGTATAACGTTGCTTGGGCGTTCGAGTAAGAG 
L230 R CTCTTACTCGAACGCCCAAGCAACGTTATACACG 
L231 F GTAAGAGTGAGGATGTTCGTCTCTCAATACC 
L232 R GGTATTGAGAGACGAACATCCTCACTCTTAC  
L233 F GTAAGAGTGAGGATGGTCGTCTCTCAATACC 
L234 R GGTATTGAGAGACGACCATCTCACTCTTAC 
L235 F CTTCGTCTCTCACTACCCGTCGATTTCAC 
L236 R GTGAAATCGACGGGTAGTGAGAGACGAAG 
L237 F CTTCGTCTCTCAGGACCCGTCGATTTCAC 
L238 R GTGAAATCGACGGGTCCTGAGAGACGAAG 
L239 F GCTCAAACGTGTAAACTTTTAACGTTGCTTTTGCG 
L240 R CGCAAAAGCAACGTTAAAAGTTTACACGTTTGAGC 
L241 F GCTCAAACGTGTAAACTTGGAACGTTGCTTTTGCG 
L242 R CGCAAAAGCAACGTTCCAAGTTTACACGTTTGAGC 
L245 F CATCAAACCTAATGTCTCATATGGAGCTCCAAAGAGTTTTCAAATTACT
TAACC 
L254 F GAGAGATATTGCTGTTTGGCTCGAGAATTCTCTGTCC 
L255 R GGATTTTATATCACTCCTCGAGAAAAGAATAAAAGAATTGG 
L256 F CCAATTCTTTTATTCTTTTCTCGAGGAGTGATATAAAATCC 
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Separating gels: (To make 2 mini gels) 
 
 
 
 
 
 
 
Stacking gels: (To make 2 mini gels) 
 
 
 
 
 
 
 
4 x Separating Buffer  
1.5 M Tris HCl, pH 8.8 
0.4% SDS 
 
4 x Stacking Buffer  
0.5 M Tris HCl, pH 8.8 
0.4% SDS 
 
5 x Sample Buffer 
60 mM  Tris HCl, pH 6.8 
25% Glycerol 
2% SDS 
14.4 mM β-mercaptoethanol 
10% Bromophenol blue 
 
Separating Gel 7.5% 10% 12.5% 
Protogel                       (ml) 2.5 3.3 4.2 
4x separating buffer     (ml) 2.5 2.5 2.5 
Distilled water             (ml) 5.0 4.2 3.3 
10% APS                    (µl) 100 100 100 
TEMED                       (µl) 10 10 10 
Stacking Gel 3% 6% 
Protogel                       (ml) 0.5 1.0 
4x stacking buffer       (ml) 1.3 1.3 
Distilled water             (ml) 3.3 2.8 
10% APS                    (µl) 50 50 
TEMED                       (µl) 10 10 
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10 x SDS-PAGE Buffer 
25 mM Tris HCl, pH 8.3 
192 mM Glycine 
0.1% SDS 
 
2.4.2 Coomassie Brilliant Blue Staining 
An SDS-PAGE gel was placed in Coomassie gel stain at room temperature for ~ 1 hour 
with gentle shaking. The gel was then briefly washed in water and then placed in destain 
solution overnight with gentle shaking. To dry the SDS-PAGE gel, the gel was placed on 
Whatman 3 MM paper and dried for 1 hour on a gel dryer. 
 
Coomassie Gel Stain 
1 g/l Coomassie Brilliant Blue (Sigma) 
45% Methanol 
10% Glacial acetic acid 
 
Destain Solution 
10% Methanol 
10% Glacial acetic acid 
 
2.4.3 Western Blotting 
Twelve pieces of Whatman 3 MM paper and one piece of PVDF membrane (millipore) 
were cut to the same size as the SDS-PAGE protein gel. The Whatman 3MM papers were 
soaked in blotting buffer and 6 pieces were stacking on top of each other and placed on the 
Electroblotter (Biorad). The PVDF membrane soaked in methanol and then placed on top 
of the 6 Whatman sheets. The protein gel was laid on top of the membrane and the 
remaining 6 soaked Whatman papers placed on top. Bubbles were removed by rolling a 
thick marker pan over the stack. The electroblotter was run at 100 mA for 35 minutes per 
gel. Following blotting the PVDF membrane was transferred to a container containing 4% 
milk (in PBS) and was blocked for at least 30 minutes at room temperature or overnight at 
4oC with gentle shaking. 
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Semi-Dry Transfer Buffer 
48 Mm Tris-Base 
39 mM Glycine 
0.04%  SDS 
 Methanol 20%   
 
2.4.4 Incubation of PVDF membrane with antibodies 
Following blocking in 4% milk (in PBS), the PVDF membrane was incubated in 10 ml 
milk containing the primary antibody. Primary antibodies were typically used at a 1:2,000 
dilution in 4% milk (in PBS) and incubated overnight at 4oC with gentle shaking. 
Alterations to this general protocol were made depending on the efficiency of the particular 
antibody. The blot was washed with 3 x 10 minute washes in PBS containing 0.1% Tween 
20 and 1 x minute wash with PBS. Following washing, 10 ml 4% milk (in PBS) was added 
to the membrane and an HRP-conjugated secondary antibody was added to a final dilution 
of 1:2,000. The blot was left to incubate at room temperature for approximately 90 minutes 
with gentle shaking. The previous 10-minute wash steps were repeated (3 x PBS with 0.1% 
Tween, 1 X PBS) and the proteins detected by ECL (Section 2.4.5). 
 
2.4.5 Enhanced Chemi-Luminescence (ECL) 
The washed membrane was placed in 10 ml of 100 mM Tris-HCl, pH 8.5 with 3 µl 
hydrogen peroxide, 50 µl 250 mM luminol and 25 µl 90 mM p-coomaric acid. The blot was 
incubated for ~1 minute with slight agitation before being removed from solution and 
wrapped in Saran wrap. In a dark room, the membrane was exposed to X-ray film (Kodak) 
for varying lengths of time depending on the intensity of the signal.  
 
2.4.6 Determining protein expression and solubility 
A single BL21(DE3) colony, carrying the appropriate expression vector, was used to 
inoculate 2 ml of L-broth media containing chloramphenicol and the appropriate selective 
antibiotic. The culture was grown overnight at 37oC with shaking. The following morning 1 
ml of this pre-culture was used to inoculate 10 ml of media. The cells were incubated at 
37oC, with shaking until an A595 reading of ~0.6 was reached. At this point 1 ml of each 
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culture (non-induced) was removed and placed in a fresh tube. Cells in the remaining 9 ml 
culture were induced with an appropriate concentration of IPTG and grown with the non-
induced samples for either a further 1 or 3 hours at 37oC. 1 ml of cells was harvested at 
13,000 rpm for 5 minutes and the pellet re-suspended in X ml (X =A595 reading/ 4) of an 
appropriate buffer (NETN (section 2.4.8) for GST-fusion proteins). The sample was 
sonicated for 15 seconds on ice and then spun at 13,000 rpm for 5 minutes. The supernatant 
was transferred to a fresh microcentrifuge tube and one-fifth 5 x sample buffer added. The 
pellet was re-suspended in X ml 5 x sample buffer. Samples were boiled for 5 minutes and 
analysed by SDS-PAGE (Section 2.4.1) followed by Coomassie staining (Section 2.4.2). 
 
2.4.7 Bradford assay 
To determine protein concentration of a sample the Bradford assay reagent (Biorad) was 
diluted 1 in 5 with water. 1-5 µl protein sample was added to 1 ml of the diluted Bradford 
reagent. The OD A595 was measured as compared to a 1 ml reagent only ‘blank’. The 
protein concentration of the sample was determined by comparing the sample reading 
against a BSA standard curve. 
 
2.4.8 GST-tagged protein purification  
 
2.4.8.1 GST-tagged protein purification  
A single BL21(DE3) colony, carrying the appropriate expression vector, was used to 
inoculate 2 ml of L-broth containing chloramphenicol and the selective antibiotic (amp). 
This pre-culture was grown at 37oC with shaking for ~8 hours. 1 ml of this was used to 
inoculate 100 ml pre-warmed media, which was grown overnight at 37oC. The following 
day this 100 ml pre-culture was used to inoculate a 1-litre pre warmed culture. When an 
A595 reading of 0.6 was reached, the cells were induced with IPTG at a final concentration 
of 5mM. After incubating for a further 3 hours at 37oC with shaking cells were harvested at 
5,000 rpm for 10 minutes at 4oC and the supernatant discarded. The cell pellet was re-
suspended in 10 ml ice cold NETN (freshly supplemented with PMSF to 0.1 mM, and 1 
complete protease inhibitor cocktail tablet (Roche) per 50 ml buffer). The cells were 
sonicated on ice 3 times for 15 seconds with 1-minute intervals on ice. The cell extract was 
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cleared by centrifugation at 14,000 rpm for 15 minutes at 4oC. The supernatant was then 
added to 100 µl pre-washed glutathione-sepharose beads (Amersham) equilibrated with 
NETN. The beads were incubated for 2 hours at 4oC on a rotating wheel. The beads were 
washed 7 times in total (3 x 1 ml NETN, followed by 3 x 1 ml wash buffer and 1 x PBS). 
Washing was carried with a brief spin at 13,000 rpm to pellet the beads. Following this 
spin, the supernatant was discarded and the beads were incubated with 1 ml of the 
appropriate buffer on a rotating wheel for 5 minutes at 4oC. Protein was collected either by 
glutathione elution of the GST-fusion protein or thrombin cleavage of the protein from the 
GST bound to the beads. 
 
NETN Buffer 
0.5% NP40 
1 mM EDTA 
20 mM Tris-HCl, pH 8.0 
100 mM  NaCl 
freshly supplemented with: 
0.1 mM PMSF  
1     protease inhibitor cocktail tablet (Roche) per 50 ml buffer 
 
Wash Buffer 
100 mM Tris-HCl, pH 8.0 
100 mM  NaCl 
1 mM EDTA 
 
2.4.8.2 Glutathione elution of GST-tagged protein 
Following the final PBS wash step in the GST-tagged protein purification protocol (Section 
2.4.8.1) the GST-fusion protein was eluted from the beads by adding 250 µl of elution 
buffer and incubating on a rotating wheel for 30 minutes at 4oC. After a 15 second spin at 
2,500 rpm the supernatant was kept. This elution step was repeated a further two times and 
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5-10 µl of the elution samples were analysed by SDS-PAGE (Section 2.4.1) followed by 
Coomassie staining (Section 2.4.2). 
 
Elution Buffer 
100 mM Tris-HCl, pH 8.0 
120 mM  NaCl 
20 mM Glutathione 
  
2.4.8.3 Thrombin cleavage 
Following the final PBS wash step in the GST-tagged protein purification protocol (Section 
2.4.8.1). The beads were re-suspended in 200 µl PBS and thrombin (Sigma) added to a 
concentration of ~1 unit/mg protein. The sample was incubated on a rotating wheel for 1 
hour at room temperature. The beads were pelletted by centrifuging at 2,000 rpm for 30 
seconds and the supernatant removed to a clean microcentrifuge tube. To ensure all beads 
were removed the sample was centrifuged again at 2,000 rpm for 30 seconds and the 
supernatant transferred to a clean tube. 5-10 µl of the protein sample was then analysed by 
SDS-PAGE (Section 2.4.1) followed by Coomassie staining (Section 2.4.2). 
 
2.4.9 His-tagged protein purification  
A 10 ml culture of the BL21 strain carrying the appropriate expression vector was grown 
overnight at 37oC in L-broth containing chloroamphenicol and the selective antibiotic. The 
pre-culture was used to inoculate a 1-litre culture of pre-warmed L-broth, containing the 
appropriate selective antibiotic. The culture was incubated at 37oC for ~4 hours until the 
OD550 reached 0.6-0.8. IPTG was added to a final concentration of 1 mM and the cells 
incubated for a further 4 hours at 37oC. The cells were harvested at 5,000 rpm for 5 minutes 
and the supernatant discarded. The cell pellet was placed at –20oC for at least an hour, 
before being re-suspended in 20 ml ice-cold binding buffer freshly supplemented with 0.1 
mM PMSF. The cells were sonicated on ice for 5x 15 seconds, with 30 second intervals on 
ice. The cell extract was cleared by centrifugation at 14,000 rpm for 15 minutes at 4oC. The 
supernatant was gradually applied to a 10 ml column containing pre-washed Ni2+-agarose 
beads equilibrated with binding buffer at 4oC. Once the supernatant has passed through the 
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column by gravity, the column was washed with 10 column volumes of binding buffer, 
freshly supplemented with PMSF, followed by 10 column volumes of wash buffer 
containing PMSF. Elution buffer was added to the column and 0.5 ml fractions were 
collected on ice. The protein concentration of each elution was obtained by Bradford assay 
and ~5 µg protein was analysed by SDS-PAGE. 
 
Binding Buffer 
5 mM  Imidazole 
0.5 M NaCl 
20 mM Tris HCl, pH 7.5 
 
Wash Buffer 
20 mM  Imidazole 
0.5 M NaCl 
20 mM Tris HCl, pH 7.5 
 
Elution Buffer 
500 mM  Imidazole 
0.5 M NaCl 
20 mM Tris HCl, pH 7.5 
 
2.4.10 Affinity purification of crude anti-sera 
 
2.4.10.1 Preparation of the Rad60 affinity column 
Affinity purification of crude anti-sera was carried out using the AminoLinkPlus Coupling 
Gel kit (PIERCE Biotechnology). A column containing 3 ml AminoLinkPlus Coupling 
Gel was equilibrated with 3 column volumes of Coupling Buffer, pH 10. Purified protein 
(His-tagged Rad60) was diluted in a 1:3 ratio with coupling buffer, pH 10. The diluted 
protein sample (final concentration of 1-20 mg/ml) was added to the column. The column 
was sealed and mixed by gentle end-over-end rocking for 4 hours at 4oC. The column was 
then washed with 3 column volumes of Coupling Buffer, pH 7.2. 1 column volume of 
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Coupling Buffer, pH 7.2 and 0.02 column volumes of cyanoborohydride solution was 
added to the column. The column was sealed and mixed overnight by gentle end-over-end 
rocking at 4oC. The column was allowed to drain and the flow through collected. Protein 
content was checked by Bradford assay to ensure protein had been bound. To block the 
remaining active sites, the column was first washed with 2 column volumes of Quenching 
Buffer, and then 1 column volume of Quenching Buffer with 0.02 column volumes of 
cyanoborohydride solution. The column was sealed and mixed gently by end-over-end 
rocking for 30 minutes. The column was allowed to drain before being washed with 20 
column volumes of Wash Solution. To check that the protein would not be immobilised in 
the elution step, the column was washed with 100 mM glycine, pH 2.3. The flow through 
was collected and the protein content determined by Bradford assay. To re-equilibrate, the 
column was washed with 10 column volumes of Quenching buffer followed by 10 volumes 
of Wash buffer. The column was then washed with 10 column volumes of PBS.  
 
2.4.10.2 Affinity purification of crude anti-sera 
6 ml crude anti-sera was diluted in one-tenth volume of 10x PBS and added to the column. 
The column was sealed and incubated at 4oC overnight on an end-over-end rocker. The 
column was drained and the flow-through collected. The column was then washed with 10 
column volumes of PBS. Bound antibody was eluted with 1 column volume of 100 mM 
glycine, pH 2.3 and the flow through collected in 1 ml fractions. The antibody fractions 
were neutralised by adding 100 µl 1 M Tris-HCl, pH 7.5. The antibody concentration was 
analysed by Bradford assay and the purity checked by SDS-PAGE (Section 2.4.1). 
 
2.4.10.3 Regenerating and storing the affinity column 
Following elution with glycine, the column was washed extensively with PBS. PBS 
containing 0.05% sodium azide was added and the column sealed. The column was stored 
upright at 4oC for future use. To regenerate the column for affinity purification, the column 
was washed extensively with PBS, followed by 10 column volumes of Quenching buffer, 
10 volumes of Wash buffer and 10 volumes of PBS. At this stage the column is ready for 
the anti-sera to be added. 
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Coupling Buffer, pH 10 
0.1 M  Sodium citrate 
0.05 M Sodium carbonate 
 Solution adjusted to pH 10 and then filter sterilized 
 
Coupling Buffer, pH 7.2 
 0.1 M  Sodium phosphate 
 0.15 M NaCl 
 Solution adjusted to pH 7.2 and then filter sterilized 
 
Quenching Buffer 
1 M Tris-HCl 
Solution adjusted to pH 7.4 and then filter sterilized. 
 
Cyanoborohydride Solution  
Supplied by PIERCE 
 
Wash Solution: 
1 M NaCl 
 
2.4.11 Concentrating protein samples 
Proteins were concentrated using a vivaspin column (Sartorius), according to the 
manufacturer’s guidelines. 
 
2.4.12 Total Cell Extracts  
S. pombe cells were grown in 10 ml appropriate medium overnight. 1 x 108 cells were 
harvested at 3,000 rpm for 5 minutes and washed in 1 ml 20% (w/v) trichloro-acetic acid 
(TCA). The cell pellet was re-suspended in 200 µl 20% TCA, transferred to a screw cap 
ribolyser tube and an equal volume of glass beads was added. The cells were broken to 
~50% lysis by ribolysing for 3 x 15 seconds, with 1 minute intervals on ice. 400 µl 5% 
(w/v) TCA was added and the bottom of the screw-capped tube was punctured with a hot 
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needle. The cell extract was spun into a clean microcentrifuge tube at 3,000 rpm for 5 
minutes. The extract was then spun for a further 5 minutes at 13,000 rpm. The supernatant 
was discarded and the pellet re-suspended in 200 µl TCA sample buffer. The sample was 
then boiled and analysed by SDS-PAGE (Section 2.4.1).  
 
TCA Sample Buffer 
250 mM  Tris HCl, pH 8.0 
5% Glycerol 
0.4% SDS 
2.9 mM β-mercaptoethanol 
2% Bromophenol blue 
 
2.4.11 Ni 2+ agarose His6-affinity purification from S.pombe  
S. pombe cells transformed with pREP constructs were grown for ~6 hours in 10 ml 
minimal media, supplemented with the appropriate amino acids and containing thiamine 
(30 µM) to inhibit expression of the gene of interest from the nmt promoter of the pREP 
vector. The cells were washed of thiamine to induce protein expression by harvesting at 
3,000 rpm for 5 minutes and washing twice with the appropriate selective minimal media, 
lacking thiamine. The cells were then re-suspended in 1 ml of the selective media and used 
to inoculate 100 ml of the same media. Protein expression was de-repressed by incubating 
the cells at 30oC, with shaking for ~16 hours in the absence of thiamine. 60 OD units (A595) 
of exponentially growing cells were harvested at 3,000 rpm for 5 minutes and washed in 1 
ml binding buffer. The cell pellet was re-suspended in 500 µl binding buffer and an equal 
volume of glass beads was added. The cells were broken to ~50% lysis by ribolysing for 3x 
15 seconds, with 1 minute intervals on ice. The lysed cells were diluted with the addition of 
another 500 µl of binding buffer and centrifuged for 13,000 rpm for 5 minutes. The 
supernatant was then added to a new micro centrifuge tube. 120 µl of charged Ni2+ beads 
(50% slurry) were washed four times in 1 ml binding buffer and re-suspended in 60 µl 
binding buffer (~60 µl beads, 60 µl binding buffer). 120 µl prepared beads were then added 
to the supernatant. The sample was then incubated on a rotating wheel at room temperature 
for 1 hour. The beads were pelleted at 3,000 rpm for 5 seconds and the supernatant was 
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discarded. The beads were washed three times with 1 ml binding buffer, three times with 1 
ml wash buffer A, three times with 1 ml wash buffer B and twice with 1 ml PBS. His 
tagged protein was eluted from the Ni2+ beads by boiling the beads with 50 µl 5x sample 
buffer. The sample was then analysed by SDS-PAGE (Section 2.4.1). 
 
Binding Buffer:  
6 M   Guanidinium hydrochloride 
0.1 M NaH2PO4  
10 mM Tris HCl  
Solution adjusted to pH 8.0 and then filter sterilized 
 
Wash Buffer A: 
8 M Urea 
0.1 M NaH2PO4 
10 mM Tris HCl  
Solution adjusted to pH 8.0 and then filter sterilized 
 
Wash Buffer B: 
8 M Urea 
0.1 M NaH2PO4 
10 mM Tris HCl  
Solution adjusted to pH 6.2 and then filter sterilized 
 
2.4.12 35S-labelled in vitro transcription/translation 
In vitro transcription-coupled translation of a protein of interest from a T7 promoter-
containing plasmid was achieved using a TNT T7 coupled rabbit reticulocyte lysate system 
(Promega). In a typical reaction, 1 µg plasmid DNA was incubated with 2 µl 35S-labelled 
methionine and TNT T7 Quick master mix to a a final volume of 40 µl. the reaction was 
incubated at 30oC for 2 hours and the efficiency of the translation was checked by 
analysing 2 µl of the reaction by SDS-PAGE (Section 2.4.1). The protein gel was fixed in 
Fix solution for 30 minutes and then incubated in Destain (Section 2.4.2) for 10 minutes 
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before drying the gel. The dried gel was then exposed to a phosphoimager screen overnight 
and the results detected by a phosphoimager. 
 
 Fix Solution 
 50%  Methanol 
 10%  Acetic acid 
 
2.4.13 In vitro sumoylation assay 
An in vitro sumoylation assay as described previously (Ho, Warr et al. 2001)was used to 
test the sumoylation status of a protein in vitro. The protein of interest was radiolabelled 
with [35S] methionine using the T7 TnT coupled rabbit reticulocyte lysate system 
(Promega) (Section 2.4.12). Typically, 2 µl of translated protein was incubated with 2 µl 
10x in vitro assay buffer, 3 µg Hus5, 0.5 µg GST-Rad31/GST-Fub1, 0.12 U inorganic 
pyrophosphatase and 0.7 U creatine phosphokinase, with or without 10 µg His-Pmt3. The 
reaction was made to a final volume of 20 µl with dH2O. The reactions incubated at 30 oC 
for 2 hours and analysed by SDS-PAGE (Section 2.4.1). The protein gel was fixed in Fix 
solution (Section 2.4.12) for 30 minutes and then incubated in Destain (Section 2.4.2) for 
10 minutes before drying the gel. The dried gel was then exposed to a phosphoimager 
screen overnight and the results detected by a phosphoimager. 
 
10x in vitro assay buffer 
500 mM Tris-HCl, pH7.5 
50 mM MgCl2 
50 mM ATP 
100 mM Creatine phosphate 
 
2.4.14 In vitro GST-pull down assay 
A 100 ml culture of a BL21 strain carrying the GST-expression construct of choice was 
grown at 37oC, with shaking until A595 0.6 was reached. Cells were then induced with 1 
mM IPTG and grown for a further 3 hours at 37oC, with shaking. Cells were harvested at 
5,000 rpm for 5 minutes at 4oC and the supernatant discarded. The cell pellet was re-
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suspended in 1 ml binding buffer freshly supplemented with a protease inhibitor cocktail 
tablet (Roche). The cells were sonicated on ice for 3 x 15 seconds with 1-minute intervals 
on ice.  The cell debris was cleared at 13,000 rpm for 3 minutes at 4oC. The supernatant 
was transferred to a new microcentrifuge tube. 20 µl of this supernatant was added to 180 
µl binding buffer and incubated for 1 hour at 4oC with 30 µl glutathione-sepharose beads 
that had been pre-equilibrated in binding buffer. The beads were then harvested at 3,000 
rpm for 5 seconds and washed twice with 1 ml binding buffer containing protease 
inhibitors. 5 µl 35 S- labelled protein was added to fresh binding buffer containing 1 mM 
ATP, 50 mM creatine phosphate and 1 U creatine phosphokinase in a 200 µl total volume 
(the input). This 200 µl sample was then added to the pre-bound glutathione beads and 
incubated on a rotating wheel for 1 hour at 4oC. The beads were harvested at 3,000 rpm for 
5 seconds and a 10 µl sample of the supernatant was taken (unbound fraction). The rest of 
the supernatant was discarded and the beads were washed for 15 minutes in wash buffer 1, 
followed by 15 minutes in wash buffer 2. The protein was eluted by boiling in 30 µl 5 x 
sample buffer (bound fraction). The input, unbound and bound fraction were analysed by 
SDS-PAGE (Section 2.4.1) and detected using a phosphoimager and Western blotting 
(Section 2.4.3) with anti-GST antibody (1:2,000).   
 
Binding Buffer 
25 mM HEPES, pH 7.8 
150 mM KCl 
0.4 mM EDTA 
2 mM EGTA 
3 mM MgCl2 
8% Glycerol 
0.1% NP-40 
0.5 mM PMSF 
0.2 mM DTT 
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Wash Buffer 1 
25 mM HEPES, pH 7.8 
200 mM KCl 
0.4 mM EDTA 
2 mM EGTA 
3 mM MgCl2 
8% Glycerol 
0.1% NP-40 
0.5 mM PMSF 
0.2 mM DTT 
 
Wash Buffer 2 
25 mM HEPES, pH 7.8 
100 mM KCl 
0.4 mM EDTA 
2 mM EGTA 
3 mM MgCl2 
8% Glycerol 
0.1% NP-40 
0.5 mM PMSF 
0.2 mM  DTT 
 87 
CHAPTER 3 
The S. pombe Rad60 SUMO-like domain 2 is required for the DNA damage response  
 
3.1 Introduction 
The rad60 gene was first identified in a screen designed to identify novel S. pombe genes 
involved in recombinational repair (Morishita, Tsutsui et al. 2002). Based on the 
observation that strains with mutations in recombination genes are often synthetically lethal 
with rad2-d, mutants both hypersensitive to MMS and synthetically lethal with rad2-d 
were isolated. The rad60-1 mutant is hypersensitive to both MMS and IR, implicating 
rad60 in the repair of DSBs. Rad60 is essential for viability (Morishita, Tsutsui et al. 
2002). When Morishita et al carried out a search using the SSEARCH program of DDBJ no 
proteins homologous to Rad60 were identified. However, when searching for amino-acid 
sequence motifs in the PROSITE profile library, a match between amino acids 336 and 406 
of Rad60 and the ubiquitin-2 motif was identified (Morishita, Tsutsui et al. 2002) During 
the course of this study, Rad60 was identified as a member of a novel family of proteins 
termed the RENi family, after its best-studied members S. pombe Rad60, S. cerevisiae Esc2 
and M. musculus Nip45 (Novatchkova, Bachmair et al. 2005). With the exception of the 
plant members, proteins belonging to the RENi family share the unique feature of 
containing two C-terminal SUMO-like domains. Plant members contain only one SUMO-
like domain. Since the biological functions of the RENi family members appear to be so 
different, the precise role of the SUMO-like domains remains unclear. 
 
In this study I have begun an investigation into the importance of the two SUMO-like 
domains for Rad60 function. To analyse the importance of the Rad60 SLDs, I have created 
domain deletion mutants and analysed their phenotypes. 
 
3.2 Rad60 has two SUMO-like domains 
A ClustalW (http://www.ebi.ac.uk/tools/clustalw2/index.html) alignment of the Rad60 
protein sequence (NCBI accession number NP_595995.1) against the H. sapiens SUMO-1 
(AAC50996) and S. pombe Pmt3 (NP_596035.1) sequences identified two potential 
SUMO-like domains (Figures 3.1 A, B). The first alignment (Figure 3.1A) shows ~14% 
 Figure 3.1: The C-terminal region of Rad60 has two SUMO-like domains 
 
(A, B) A ClustalW sequence alignment of Rad60 (NCBI accession number 
NP_595995.1) against H. sapiens SUMO-1 (AAC50996) and S. pombe Pmt3 
(NP_596035.1) identifies two potential SUMO-like domains (underlined).* identical 
residues, : conserved substitutions, . semi-conservative substitutions. (C) Schematic to 
illustrate the position of Rad60 SLD1 and SLD2. 
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Sp_Rad60_SLD1   HSKSDHSTLYHSKSEFSTNEPVISVVLQLAVIGQRIPNSNISLPRDWEAPLFFKVKSNQQ 251 
                           *. : ..     .         .    .   : :* .  :.**:* . . 
 
Hs_SUMO-1       LKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV-- 101 
Sp_Pmt3         FSKLMKIYCARQGKSMNSLRFLVDGERIRPDQTPAELDMEDGDQIEAVLEQLGGCTHLCL 117 
Sp_Rad60_SLD1   FRRVRIAYSER--KKVDNVVLVFQNQRLWDYGTPKGAGMLKVDTRLVVHAYCHSDFIS-- 307 
                : ::   *. *    ::.: ::.:.:*:    **   .* . *   .      .                
 
 
 
 
 
 
 
Hs_SUMO-1       --------MSDQEAKPSTEDLGD------KKEGEYIKLKVIGQDSSEIHFKVKMTTHLKK  46  
Sp_Pmt3         MSESPSANISDADKSAITPTTGDTSQQDVKPSTEHINLKVVGQDNNEVFFKIKKTTEFSK  60  
Sp_rad60_SLD2   AYCHSDFISLKRIKELEVEKLSSVTEDSTAQTCKLITLLLRSSKSEDLRLSIPVDFTVKD 358 
                                                   *.* : .....:: :.:     ... 
 
Hs_SUMO-1       LKESYCQRQGVPMNS-LRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV--   101 
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Sp_Rad60_SLD2   LIKRYCTEVKISFHERIRLEFEGEWLDPNDQVQSTELEDEDQVSVVLD----------   406 
                * : ** .   .::. :*: .:*: :  :.   .  :*: * :..  :                        
Figure 3.1: The C-terminal region of Rad60 has two SUMO-like domains
B
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sequence identity between amino acid residues 228-307 of Rad60, Pmt3 and SUMO-1. 
Comparing the amino acid sequence of only Rad60 (228-307) and Pmt3, ~16% sequence 
identity was observed, whilst the sequence identity of SUMO-1 and Pmt3 is ~48%. The 
second alignment (Figure 3.1B) shows ~13% sequence identity between amino acid 
residues 334-406 of Rad60, Pmt3 and SUMO-1. Comparing the amino-acid sequence of 
only residues 334-406 of Rad60 and S. pombe Pmt3, ~21% sequence identity was 
observed. Although, by protein standards the sequence identity is low, it is important to 
note that SUMO-1 and ubiquitin share only ~18% sequence identity and, although 
functionally different, the two proteins share the same core structure consisting of a 
ββαββαβ fold. When we look more closely at the alignments between Rad60 and SUMO-
1/Pmt3 there is significant conservation of the biochemical character of the side-chains. For 
example, residues with hydrophobic side chains (I, L, V) are substituted for one another. 
This suggests that the Rad60 SLDs may share a similar fold to that of SUMO/Pmt3. Unlike 
ubiquitin, SUMO contains an N-terminal flexible tail that protrudes from the hydrophobic 
core (Bayer, Arndt et al. 1998). The N-terminal tail is poorly conserved across SUMO 
species and is not required for sumoylating activity (Bylebyl, Belichenko et al. 2003). In 
the SUMO/Pmt3/Rad60 alignment, only the sequence relating to the core ‘ubiquitin’ fold 
of SUMO is conserved with the Rad60 SUMO-like domains. Unlike SUMO-1/Pmt3, the 
Rad60 SLDs do not contain the C-terminal diglycine motif required for covalent 
attachment to target proteins. Further analysis of the Rad60 SLDs is discussed in Chapter 6.  
  
To analyse the importance of the two C-terminal SLDs I have created domain deletion 
mutants and analysed their phenotypes. 
 
3.3 Rad60 SLD2 is not required for the essential function of Rad60. 
Having identified two ‘SUMO-like’ domains in Rad60, the importance of SLD2 for Rad60 
function was first tested. To investigate the role of this domain an S. pombe strain was 
created in which the C-terminal 73 amino acids were deleted (334-406). The C-terminal 
truncation of the essential rad60 gene was introduced into the S. pombe genome by a one-
step PCR-based gene disruption method (Bahler, Wu et al. 1998). The one-step PCR-based 
gene disruption method uses long primers containing 80 nucleotides of gene-specific 
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sequence and 20 nucleotides of sequence homologous to the pFA6a-kanMX6 template 
plasmid. The gene-specific sequence of forward primer L26 corresponded to 77 bases 
upstream of, and including, codon 333 of rad60, followed by a stop codon (TAA). In the 
reverse primer, L27, the gene-specific sequence corresponded to 80 bases immediately 
downstream from the rad60 stop codon. Primers L26 and L27 were used to amplify a ~1.6 
kb heterologous kanMX module from the pFA6a-kanMX6 plasmid. The products of 5 
PCRs were pooled (~20 µg) and gel extracted to a volume of 20 µl. The DNA was 
transformed directly into haploid wild-type cells (sp.011) using the Bahler transformation 
protocol (Bahler et al, 1998). Cells were plated onto YEA plates and grown for 24 hours at 
30oC before being replica plated onto YEA plates containing 100 µg/ml G418. The replica 
plates were incubated at 30oC for 72 hours and large colonies were re-streaked onto fresh 
YEA plates containing G418. Colony PCR, with primers L17 and L96, was used to screen 
transformants for successful integration (Figure 3.2B). Primer L17 anneals within the 
rad60 gene and reverse primer L96 anneals within the kanMX6 cassette to give a PCR 
product of ~710 bp for colonies with the truncated copy of rad60. A wild-type strain, with 
no G418 resistance gene integrated was used as a negative control and gave no bands in the 
colony PCR (Figure 3.2C). The resulting C-terminal truncated Rad60 S. pombe strain was 
termed rad60-ct (sp.1174).  
 
As a control for the integration of the kanMX6 cassette, a control strain (rad60-FL (sp.1175)) 
was created in which the G418 resistance gene was incorporated at the 3’ end of the full-
length rad60 gene. Primers L28 and L27 were used to amplify the kanMX6 module and 
following integration, the presence of a ~940 bp colony PCR product, with primers L17 
and L96, verified correct integration of the cassette (Figure 3.2C).  
 
Although the colony PCR confirmed that the G418 resistance gene had been incorporated 
at the 3’ end of the C-terminally truncated/full-length copy of the rad60 gene, sequencing 
across the integration junction was required. Genomic DNA was extracted from the 
positive colonies and the region surrounding the junction site was PCR amplified from the 
genomic DNA using primers L41 and L96. Sequencing with primers L18 confirmed correct 
integration of the G418 resistance gene in the rad60-ct and rad60-FL strains. The presence 
Figure 3.2: Cells deleted for Rad60 SLD2 are viable 
 
(A) A copy of rad60 deleted for SLD2 was introduced into the S. pombe genome by a 
one-step PCR based gene disruption method. (i) Long primers were used to amplify a 
heterologous kanMX6 module from the pFA6a-kanMX6 plasmid. (ii) The DNA was 
transformed directly into haploid wild-type cells (iii) A copy of the truncated rad60 
gene is incorporated via homologous recombination between the cassette and the 
genomic DNA. (iv) Positive transformants were identified by G418 (kan) resistance. (B, 
C) Colony PCR with primers L17/L96 confirmed the truncated copy of rad60 had been 
incorporated in the rad60-ct cells. Wild-type cells, used as a negative control gave no 
band in the PCR, the rad60-FL control strain gave a PCR product of 940 bp and the 
rad60-ct cells gave a PCR product of ~710 bp (indicated with arrow).  
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of viable rad60-ct colonies indicates that the C-terminal SLD2 is not essential for S. pombe 
viability and is therefore not required for the essential role of Rad60.  
 
3.4 The phenotype of rad60-ct 
The previously published rad60-1 (K263E) mutant is temperature sensitive for growth at 
36oC but grows normally at 26oC (Morishita, Tsutsui et al. 2002). The rad60-3 (F272V) 
and rad60-4 (T72A, I232S, Q250R, K312N) mutants are temperature sensitive, growing 
best at 25oC. The ability of rad60-ct to grow at different temperatures was therefore 
assessed. Single colonies were streaked on YEA, and grown at 25, 30 and 36oC for ~72 
hours. rad60-ct grows in a wild-type manner at 25oC and 30oC and like rad60-1, is 
temperature sensitive for growth at 36oC (Figure 3.3A). Wild-type and rad60-FL cells were 
streaked out as a control and, as expected, both grew well at all three temperatures. This 
suggests that the temperature sensitivity observed for rad60-ct is the direct result of 
deleting SLD2 and is not a consequence of the integrated G418 resistance gene. 
 
Visualisation of rad60-ct cells under the microscope showed a phenotype reminiscent of 
the smc6 mutants (Lehmann, Walicka et al. 1995; Verkade, Bugg et al. 1999). The cells 
were elongated, compared to wild-type and rad60-FL cells, with some cells having 
multiple septa (Figure 3.3B), suggesting a problem in DNA replication. 
 
3.4.1 Rad60 SLD2 is required for the DNA damage response. 
rad60 has been implicated in the response to DNA damage, in association with the Smc5/6 
complex (Morishita, Tsutsui et al. 2002). To characterise the DNA damage response of 
rad60-ct cells to UV and IR, survival analysis was carried out. rad60-ct cells show ~15% 
survival after high doses of UV (200 J/m2) and IR (1,000 Gy) (Figure 3.4A, B). This level 
of survival is comparable to that shown by rad60-1 cells. Although rad60-ct cells are 
sensitive to UV and IR when compared to wild-type cells, they are less sensitive than the 
smc6-X mutant cells. Interestingly, like the smc6-X cells, rad60-ct cells grow more slowly 
than wild-type cells after exposure to UV irradiation, suggesting that they have a DNA 
repair phenotype. The sensitivity of rad60-FL cells was tested and, as anticipated, the 
sensitivity of the rad60-FL strain to UV and IR is similar to that of the wild-type S. pombe 
Figure 3.3: Initial characterization of rad60-ct 
 
(A) rad60-ct cells are temperature sensitive at 36oC, but not at 25 and 30oC. Cells were 
streaked on YEA and incubated at the indicated temperature for ~72 hours before being 
imaged. (B) rad60-ct cells are morphologically similar to smc6 mutants. Cells were 
grown at 30oC to exponential phase in YE medium and imaged using the Applied 
Precision Deltavision Spectris microscope. 
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Figure 3.3: Initial characterisation of rad60-ct
Figure 3.4: Rad60 SLD2 is required for the DNA damage response  
 
(A, B) rad60-ct cells are sensitive to UV and γ irradiation. Cells were grown at 30oC in 
YE medium to mid-exponential phase and irradiated with UV (A) or γ (B) rays at the 
indicated doses. Cells were plated on YEA and grown at 30oC for ~72 hours. Colonies 
were counted and % survival was calculated. (C) rad60-ct cells are sensitive to HU, 
MMS and 4NQO. Cells were grown at 30oC in YE mediium to mid-exponential phase. 
10 µl of 10 fold serial dilutions were spotted onto YEA plates containing supplements at 
the indicated doses. Plates were incubated at 30oC for 72 hours and photographed. 
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cells (Figure 3.4A, B). This observation eliminates the possibility that the rad60-ct 
phenotype may be an indirect result of inserting the G418 resistance gene into the genome 
and suggests that the sensitivity shown by rad60-ct cells is the direct effect of deleting 
SLD2. 
 
To further characterise the phenotype of the rad60-ct strain, spot tests were carried out. As 
expected, the sensitivity of the rad60-FL strain to the genotoxins; hydroxyurea (HU), 
thiabendazole (TBZ), 4-nitroquinoline-1-oxide (4NQO) and methyl methanesulfonate 
(MMS) is identical to that of the wild-type S. pombe cells (Figure 3.4C). In contrast, rad60-
ct cells are hypersensitive to both MMS and HU, and to a lesser extent the UV mimetic 
4NQO. Interestingly, the sensitivity of rad60-ct is comparable to that of rad60-1 in 
response to MMS but not to HU and 4NQO. The rad60-ct cells are slightly more sensitive 
to HU and significantly more sensitive to 4NQO than the rad60-1 cells. rad60-ct cells are 
less sensitive than the smc6-X to MMS, HU and 4NQO. The sensitivity of the rad60-ct 
cells to IR, MMS and HU suggests a defect in DSB repair. rad60-ct cells show no 
significant sensitivity to the microtubule inhibitor TBZ. 
 
To examine whether the sensitivity of the rad60-ct strain can be complemented by rad60+, 
cells were transformed with pREP41HA-rad60. To obtain this, the rad60 cDNA was 
amplified by PCR from a cDNA library (gift from Jan Palecek, University of Sussex) using 
primers L41 and L40, which were designed to introduce an NdeI restriction site at the 5’ 
end of the coding sequence and a SalI site at the 3’ end. The PCR product was cleaned up 
by gel extraction and ligated into the pTOPO vector (Invitrogen). A pTOPO-rad60 clone 
was sequenced and found to contain a silent mutation changing the E150 codon from GAA 
to GAG. The rad60 sequence was subsequently sub-cloned as an NdeI/SalI fragment into 
pREP41HA. The sequence corresponding to the C-terminally truncated rad60 gene (rad60-
ct) was also cloned. The rad60-ct sequence (Rad60 aa 1-333) was amplified by PCR from 
the pREP41HA-rad60 construct using primers L41 and L52. Primer L52 was designed to 
incorporate a stop codon (TAA) immediately after codon 233, followed by a SalI restriction 
site. The PCR product was digested with NdeI/SalI and ligated directly into pREP41HA to 
create the pREP41HA-rad60-ct construct.  
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To look at the effect of over-expressing rad60 and rad60-ct, cells were transformed with 
the pREP41HA constructs. Expression from the nmt1 promoter was de-repressed by 
growing cells for ~16 hours in the absence of thiamine. Wild-type and rad60-ct cells 
transformed with the ‘empty’ pREP41HA vector, have similar sensitivities to those 
previously observed (Figure 3.5). Over-expression of rad60 in a rad60-ct background, 
results in a reversal of phenotype, with wild-type sensitivity to HU and MMS observed. 
Expression of rad60-ct in the mutant cells is unable to rescue cells to the same extent. This 
confirms that the rad60-ct phenotype is not an indirect consequence of secondary mutations 
that may act as extragenic sensitisers. Expression of rad60-ct in the wild-type background 
does not have a dominant negative effect. 
 
3.4.2 rad60-ct epistasis analysis 
To investigate the genetic interactions of rad60-ct, epistasis analysis was carried out. Since 
Rad60 is known to associate with the Smc5/6 complex, analysis was first carried out with 
mutants defective in this complex. Like rad60-1, rad60-3, nse2-SA, and nse4-1 (Morishita, 
Tsutsui et al. 2002; Boddy, Shanahan et al. 2003; Morikawa, Morishita et al. 2004; 
Andrews, Palecek et al. 2005), tetrad analysis suggests that the double mutant of rad60-ct 
with smc6-X is synthetically lethal. In addition, a rad60-ct smc6-74 double mutant is also 
synthetically lethal. In contrast, a double mutant of rad60-ct and nse2-SA is viable and 
rad60-ct and nse2-SA are epistatic in their response to both UV and IR. After exposure to 
UV and IR, the double mutant is no more sensitive than the most sensitive single mutant 
(Figure 3.6A). Like smc6-X, smc6-74, nse2-SA and nse4-1 (Verkade, Bugg et al. 1999; 
Morikawa, Morishita et al. 2004; Andrews, Palecek et al. 2005), rad60-ct is synthetically 
lethal with brc1-d. Brc1 is a multi-copy suppressor of smc6-74 (Verkade, Bugg et al. 1999). 
 
HR is a major pathway for the repair of radiation-induced DSBs in S. pombe and Rhp51 (H. 
sapiens Rad51 homologue) is a key player in this pathway. Mutants of the Smc5/6 complex 
including smc6-X, nse2-SA, nse2-1 and nse4-1 (Lehmann, Walicka et al. 1995; McDonald, 
Pavlova et al. 2003; Morikawa, Morishita et al. 2004; Andrews, Palecek et al. 2005) are all 
epistatic with rhp51-d. rad60-1 is also epistatic to the rhp51-d mutant (Morishita, Tsutsui 
Figure 3.5: rad60-ct can be suppressed by over-expressing rad60   
 
Cells carrying the pREP41HA multicopy plasmid (pEV) or the pREP41HA containing 
rad60 or rad60-ct (prad60/prad60-ct) were grown at 30oC in YNB medium 
supplemented with adenine and uracil to mid-exponential phase. 10 µl of 10 fold serial 
dilutions were spotted onto YNB plates supplemented with adenine and uracil and 
containing supplements at the indicated doses. Plates were incubated at 30oC for 72 
hours and photographed 
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Figure 3.5: rad60-ct can be suppressed by over-expressing rad60
Figure 3.6: rad60-ct epitasis analysis 
 
Cells were grown at 30oC in rich medium to mid-exponential phase and irradiated with 
UV or γ rays at the indicated doses. Cells were plated on rich medium and grown at 
30oC for 72 hours. Colonies were counted and % survival was calculated. rad60-ct is 
epistatic with nse2-SA (A) and rhp51-d (B) in response to both UV and γ irradiation and 
epistatic with cds1-d (C) in response to γ irradiation but not UV. rad60-ct is not 
epistatic to chk1-d (D), crb2-T215A (E) or top1-d (F). 
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et al. 2002), suggesting a relationship between rad60 and rhp51. The same relationship was 
tested for the rad60-ct mutant with rhp51-d. rhp51-d is more sensitive to both UV and IR 
than the rad60-ct mutant but the double mutant is no more sensitive than the single rhp51-d 
mutant after UV and IR treatment, suggesting that rad60-ct is epistatic to rhp51-d (Figure 
3.6B). 
 
In addition to the physical interaction identified with the Smc5/6 complex, Rad60 interacts 
with the checkpoint kinase Cds1 in an FHA-domain specific manner (Boddy, Shanahan et 
al. 2003). cds1-d is more sensitive to both UV and IR than the rad60-ct mutant but in 
response to IR, the cds1-d rad60-ct double mutant is no more sensitive than the single 
mutants. In response to UV the cds1-d rad60-ct double mutant is more sensitive than either 
of the single mutants at low doses (Figure 3.6C). This suggests that rad60 and cds1 are 
epistatic in response to IR but not UV. Epistasis analysis was carried out with chk1-d, a 
strain defective for the other S. pombe checkpoint kinase, Chk1. rad60-ct is not epistatic to 
the chk1.d strain in response to UV or IR (Figure 3.6D). 
 
Crb2 is required for checkpoint arrest and is required for Rad3-dependent activation of 
Chk1 (Saka, Esashi et al. 1997). Crb2 is also required for the regulation of HR in G2 by 
regulating the activity of the Rqh1 helicase (Caspari, Murray et al. 2002). T215 
phosphorylation by Cdc2-cyclin B occurs at mid-mitosis and allows further 
phosphorylation of Crb2 by Rad3. Since Rad60 has been implicated in HR and is 
synthetically lethal with rqh1-d, the relationship between rad60 and crb2 was tested. A 
rad60-ct crb2-T215A double mutant is more sensitive to UV and IR at low doses than 
either of the single mutants suggesting that Rad60 and Crb2 do not act in the same pathway 
(Figure3.6E). 
 
smc6-X, nse2-SA, nse4-1, rad60-1 and rad60-3 (Lehmann, Walicka et al. 1995; Morishita, 
Tsutsui et al. 2002; Boddy, Shanahan et al. 2003; McDonald, Pavlova et al. 2003; 
Morikawa, Morishita et al. 2004) are synthetically lethal with rqh1-d. Like these mutants, 
rad60-ct is also synthetically lethal with rqh1-d. Rqh1 is a member of the RecQ family of 
helicases and has been implicated in the maintenance of replication forks and prevention of 
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illegitimate recombination (Doe, Ahn et al. 2002; Laursen, Ampatzidou et al. 2003). This is 
consistent with a model in which Rad60 is required for recombinational repair of fork 
breaks that acquire in an rqh1-d background (Boddy, Shanahan et al. 2003). 
 
During the course of this project, the S. cerevisiae RENi protein, Esc2 was shown to be 
synthetically lethal with Sgs1 (S. pombe Rqh1) and Mus81. This suggests that like Rad60, 
Esc2 may play have a role in the maintenance of replication forks. Esc2 is also 
synthetically lethal with the topoisomerase1 mutant, top1-d. The relationship between 
rad60 and top1 was therefore tested. The rad60-ct top1-d double mutant is more sensitive 
to UV than either single mutant, implying that they are not epistatic in their response to UV 
(Figure 3.6F). 
 
3.4.3 Rescue of Smc6-X sensitivity by Rad60 is dependent on SLD2 
When the rad60 gene is expressed from a multicopy plasmid in the smc6-X background, 
the MMS hypersensitivity of the smc6-X mutant can be partially suppressed (Morishita, 
Tsutsui et al. 2002). To test whether the Rad60 SLD2 is required for this suppression, 
rad60 and rad60-ct were expressed from the pREP41HA plasmid in smc6-X cells. As 
reported by Morishita et al, expression of rad60 in the mutant background is able to 
suppress the sensitivity of smc6-X cells to 0.001% MMS (Figure 3.7A). In contrast, 
expression of rad60-ct is unable to suppress the MMS sensitivity of smc6-X cells. Neither 
rad60 nor rad60-ct is able to suppress the sensitivity of the smc6-X cells to HU. This 
suggests the Rad60 SLD2 is required to overcome the damage caused by MMS in smc6-X 
cells. The same phenomenon was tested in the smc6-74 background. Unlike in the smc6-X 
background, expression of either rad60 or rad60-ct is unable to suppress the sensitivity of 
the smc6-74 cells to MMS or HU (Figure 3.7A).  
 
Given that nse2-SA and rad60-ct are epistatic in their response to IR and MMS (Section 
3.4.2), the ability of rad60 to suppress the sensitivity of nse2-SA cells was assessed. The 
sensitivity of nse2-SA cells to HU and MMS can be suppressed by the expression of rad60 
and rad60-ct (Figure 3.7B). This suggests that the suppression of the nse2-SA HU and 
MMS by rad60 is not dependent on the Rad60 SLD2. 
Figure 3.7 Rescue of Smc6-X sensitivity by Rad60 is dependent on SLD2 
 
(A) Over-expression of rad60 but not rad60-ct can suppress the sensitivity of smc6-X, 
but not smc6-74 to 0.001% MMS. (B) Over-expression of rad60 and rad60.ct can 
suppress the sensitivity of nse2-.SA to HU and MMS. Cells carrying the pREP41HA 
multicopy plasmid (pEV) or pREP41HA containing rad60 or rad60-ct (prad60/prad60-
ct) were grown at 30oC in YNB medium supplemented with adenine and uracil to mid-
exponential phase. 10 µl of 10 fold serial dilutions were spotted onto YNB plates 
supplemented with adenine and uracil and containing supplements at the indicated 
doses. Plates were incubated at 30oC for 72 hours and photographed.  
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3.4.4 Rad60 can suppress the sensitivity of rhp51-d and rad9-T225C  
Since rad60-ct and rhp51-d are epistatic in their response to UV and IR (Section 3.4.2), the 
ability of rad60 to suppress the sensitivity of rhp51-d cells was tested. Expressing rad60 
from the pREP41HA plasmid is able to suppress the sensitivity of the rhp51-d cells to both 
HU and MMS (Figure 3.8A). In contrast, expression of rad60-ct is unable to suppress the 
rhp51-d phenotype, suggesting the SLD2 of Rad60 is required for the suppression of 
rhp51-d sensitivity to HU and MMS by rad60.  
 
Expression of rad60 in an rqh1-d background is unable to rescue the HU and MMS 
sensitivity of rqh1-d cells. Unlike the expression of rad60, expression of rad60-ct in the 
rqh1-d mutant cells has a dominant negative effect, enhancing the sensitivity of the rqh1-d 
cells to HU and MMS (Figure 3.8B).  
 
Rad9 is one of the proteins that make up the 9-1-1 complex that is required for the DNA 
damage checkpoint. Rad9 Thr225 is required for phosphorylation of Rad9 on replication 
fork collapse and concomitant inhibition of recombination (Furuya, Poitelea et al. 2004; 
Kai, Furuya et al. 2007). The sensitivity of the rad9-T225C mutant to MMS and HU is 
partially suppressed by the expression of rad60. Expression of rad60-ct cannot suppress the 
sensitivity of the rad9-T225C cells (Figure 3.8C).  
 
3.4.5 Suppression of rad60-ct  
To determine whether the sensitivity of the rad60-ct mutant to HU and MMS can be 
suppressed by the expression of any genes of interest, wild-type and rad60-ct cells were 
transformed with pREP41HA constructs containing the gene of interest. Since the HA tag 
affects Brc1 function (Murray, unpublished data) brc1 was transformed on a pREP41 
vector, lacking the HA tag. The sensitivity of cells was assessed by spot tests (Figure 3.9). 
 
Given the emerging relationship between nse2 and rad60, the ability of nse2 to suppress 
rad60 was assessed. Expression of the nse2 gene is not able to suppress the HU and MMS 
sensitivity of the rad60-ct cells. Expression of rad60 can partially suppress the sensitivity 
Figure 3.8 rad60 can suppress rhp51-d and rad9-T225C 
 
(A) Over-expression of rad60 but not rad60-ct can suppress the sensitivity of rhp51-d 
(B) Over-expression of rad60 cannot suppress the sensitivity of rqh1-d cells. (C) Over-
expression of rad60 can partially suppress the sensitivity of rad9-T225C cells. Cells 
carrying the pREP41HA multicopy plasmid (pEV) or pREP41HA containing rad60 or 
rad60-ct (prad60/prad60-ct) were grown at 30oC in YNB medium supplemented with 
adenine and uracil to mid-exponential phase. 10 µl of 10 fold serial dilutions were 
spotted onto YNB plates supplemented with adenine and uracil and containing 
supplements at the indicated doses. Plates were incubated at 30oC for 72 hours and 
photographed 
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Figure 3.9 Suppression of rad60-ct 
 
Wild-type and rad60-ct carrying the pREP41HA multicopy plasmid (pEV) or 
pREP41HA containing the gene of interest were grown at 30oC in YNB medium 
supplemented with adenine and uracil to mid-exponential phase. 10 µl of 10 fold serial 
dilutions were spotted onto YNB plates supplemented with adenine and uracil and 
containing supplements at the indicated doses. Plates were incubated at 30oC for 72 
hours and photographed 
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of smc6-X cells (Section 3.4.3 and (Morishita, Tsutsui et al. 2002)). However, the 
expression of smc6 is unable to complement the sensitivity of rad60-ct cells, suggesting 
that whilst rad60 may be able to functionally compensate for loss of smc6 function in 
smc6-X cells, smc6 cannot compensate for loss of rad60 function. brc1 is a multicopy 
suppressor of smc6-74 (Verkade et al, 1999). brc1 is unable to suppress the MMS and HU 
sensitivity of rad60-ct cells. Expression of the genes coding for Rad3, Rhp51, Cds1 and 
Pli1 are also unable to suppress the MMS and HU sensitivity of rad60-ct cells.  
 
3.5 Rad60 SLD1 is essential for viability. 
Three previously characterised mutants, rad60-1 (K263E), rad60-3 (F272V) and rad60-4 
(T72A, I232S, Q250R, K312N) contain point mutations that lie within the predicted SLD1, 
suggesting that this domain may be of key importance for Rad60 function (Morishita, 
Tsutsui et al. 2002; Boddy, Shanahan et al. 2003). To test the importance of SLD1 for 
Rad60 function, a method for replacing the genomic copy of rad60 with a copy of rad60 
deleted for SLD1 was required. For this reason the ‘recombinase-mediated cassette 
exchange (RMCE) system‘(Watson, Garcia et al. 2008) was utilised. The RMCE is a novel 
system, in which Cre/lox site-specific recombination is utilised to allow an efficient method 
for gene tagging and/or gene replacement. For gene replacement a ‘cassette’ is integrated 
into the S. pombe genome at the gene locus of choice. The ‘cassette’ consists of the S. 
pombe ura4+ selectable marker flanked by a wild-type loxP site at one end and a modified 
heterospecific lox site (loxM3) at the other side of the gene to be replaced. Exchange is 
achieved by introducing a Cre-recombinase expression plasmid containing an equivalent 
‘cassette’ containing the desired copy of the gene and lacking the ura4+ marker. 
Recombinants can be selected by uracil prototrophy on plates containing 5-flouroorotic 
acid (5-FOA). 
 
3.5.1  Creating a ‘rad60 base strain’ for RMCE 
To use the RMCE system a ‘rad60 base strain’, containing the loxP-rad60-ura4+-loxM3 
cassette, was first created. Since rad60 is an essential gene, the construction of the base 
strain was a two-step process requiring two homologous integration steps. First the loxP 
site is placed ~300 bp upstream of the rad60 coding sequence so as to leave the rad60 
 97 
promoter region intact, and secondly the ura4+ marker and loxM3 site are placed 
immediately downstream from the gene sequence (Figure 3.10A, B) 
 
Firstly, primers L143 and L144 were used to amplify by PCR the ~600 bp loxP-Sup3-5-
loxP cassette from the template plasmid pAW11 (Figure 3.10A). Primers L143 and L144 
contain 20 base pairs of sequence homology to the pAW11 plasmid and 80 base pairs of 
sequence homologous to the target sequence within the S. pombe genome (~300 bases 
upstream of the rad60 start codon). The product of 5 PCRs were pooled and ethanol 
precipitated to a final volume of 25 µl and transformed into a wild-type haploid strain 
(sp.011) using the Bahler transformation procedure. Cells were plated on EMM2 medium 
supplemented with uracil and leucine and grown for 3 days at 30oC. The loxP-sup3-5-loxP 
cassette was introduced into the genome via homologous integration and ade+ 
transformants were selected. To check that integration had occurred at the correct locus 
colony PCR was carried out with primer L170 hybridising upstream of the sup3-5 
integration site and L172 hybridising downstream of the integrated sup3-5 site and 
upstream of the rad60 coding sequence. A PCR product of ~1.1 kb was observed (data not 
shown). The positive transformant was then transformed with the Cre-expressing plasmid 
pAW8 to excise the sup3-5 cassette and leave a single lox-P site upstream of the rad60 
coding sequence. Transformants were plated on EMM2 plates containing uracil and 
adenine (10 µg/ml), to allow red/white selection of colonies. Red colonies were picked and 
streaked to rich medium to promote loss of the pAW8 plasmid.  
 
Once the loxP site was correctly integrated into the S. pombe genome, the ura4+ gene was 
placed immediately downstream of the rad60 coding sequence (Figure 3.10B). Primers 
L140 and L141 were used to amplify by PCR the 1.9 kb ura4+-loxM3 cassette from the 
template plasmid pAW12. Primer L140 and L141 contain 20 base pairs of sequence 
homology to the pAW12 plasmid and 80 base pairs of sequence homologous to the target 
sequence within the S. pombe genome. The product of 5 PCRs were pooled and ethanol 
precipitated to a final volume of 25 µl and transformed into the cells containing the loxP 
site. Cells were plated on EMM2 medium supplemented with adenine and leucine and ura+ 
transformants were selected. To check for integration at the correct locus colony PCR was 
Figure 3.10 Creating a rad60 base strain for RMCE 
 
(A) Integration of a loxP site ~300 bases upstream, of rad60 coding sequence. Long 
primers L143 and L144 were used to amplify by PCR the loxP-sup3-5-loxP cassette 
from the pAW11 plasmid. The DNA was transformed directly into haploid wild-type 
cells. The loxP-sup3-5-loxP cassette was introduced into the genome via homologous 
integration. Positive transformants were transformed with the Cre-expressing plasmid 
pAW8 to excise the sup3-5 cassette, leaving a single lox-P site upstream of the rad60 
coding sequence. (B) Integration of a ura4+ immediately downstream of the rad60 
coding sequence. Long primers L140 and L141 were used to amplify by PCR the ura4+-
loxM3 cassette from the pAW12 plasmid. The DNA was transformed directly into 
haploid cells containing the loxP site ~300 bases upstream of rad60 coding sequence. 
The ura4+-loxM3 cassette was introduced into the genome via homologous integration 
to form the rad60 base strain. (C, D) A Southern blot confirmed the presence of a single 
copy of the ura4+ marker in the rad60 base strain. Genomic DNA was extracted from 
the rad60 base strain. A BclI digest was used to isolate a ~3.7 kb fragment containing 
the ura4+ marker and a fragment of the rad60 gene (Seen in C). The digested DNA was 
run on a 0.8% TBE gel and Southern blotted overnight. Following incubation with a 32P 
labelled ura4+ DNA probe, the membrane was exposed to a phosphocassette and the 
signal detected by a phosphoimager (Seen in D). DNA extracted from wild-type and 
Nse2-SA cells was used as negative and positive controls, respectively. 
AB
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carried out with primer L142, hybridising to the newly integrated cassette and L17 
hybridising within the rad60 gene sequence. A PCR product of ~710 bp was observed (data 
not shown).  
 
Although colony PCR confirmed integration at each stage, sequencing across the 
integration sites was necessary to confirm that integration had occurred at the correct sites. 
For this reason, following integration of both the lox P and ura4+-loxM3 cassettes, 
genomic DNA was extracted from two positive colonies and the loxP-rad60-ura4+-loxM3 
cassette was amplified from the genomic DNA with primers L170 and L35.  Sequencing of 
the PCR product with primers L170, L17, L18, L19 and L35 confirmed integration had 
occurred at the correct locus.  
 
The RMCE system relies on loss of the ura4+ marker from the genome. A Southern blot 
confirmed that only one ura4+ marker had been incorporated into the genome of the rad60 
base strain. Genomic DNA was extracted from the rad60 base strain and a BclI digest was 
used to isolate a ~3.7 kb fragment containing the ura4+ marker and a fragment of the 
rad60 gene (Figure 3.10C). For both isolates, a Southern blot probed with a 32P ura4+ DNA 
probe detected only one ~3.7 kb fragment in the digested samples. (Figure 3.10D). gDNA 
from nse2-SA (ura4+ integrated immediately downstream of the nse2-SA allele) was used as 
a positive control. Following BclI digestion a fragment containing ura4+ was observed at 
the expected size of ~7500 bp. A wild-type DNA control showed no signal, suggesting the 
signal detected for the rad60 base strain is not an artefact. 
 
3.5.2 Testing the ‘rad60 base strain’ in the RMCE system 
The RMCE system requires exchange between the genomic copy of the loxP-rad60-ura4+-
loxM3 ‘cassette’ in the rad60 base strain and an equivalent loxP-rad60-loxM3 ‘cassette’ on 
the Cre-expression plasmid pAW8 (Figure 3.11A). To create such a construct the sequence 
equivalent to that flanked by the loxP and loxM3 sites in the rad60 base strain was 
amplified by PCR from genomic DNA using primers L245 and L40. Primers L245 and L40 
introduced a SacI restriction site at the 5’ end of the ~1.5 kb PCR fragment and a SalI 
restriction site at the 3’ end of the PCR fragment respectively enabling ligation of the PCR 
Figure 3.11 Testing the rad60 RMCE system 
 
(A) Recombinase-mediated cassette exchange. The RMCE system relies upon exchange 
between the genomic copy of the loxP-rad60-ura4+-loxM3 ‘cassette’ in the rad60 base 
strain (ii) and an equivalent loxP-rad60-loxM3 ‘cassette’ on the Cre-expression plasmid 
pAW8 (i). Following RMCE, the rad60-ura4+ copy in the base strain is replaced with 
the rad60 copy on the pAW8 plasmid (iii). (B) The rad60 base strain has wild-type 
phenotype. Cells were grown at 30oC in YE medium to mid-exponential phase. 10 µl of 
10 fold serial dilutions were spotted onto YEA plates containing supplements at the 
indicated doses. Plates were incubated at 30oC for 72 hours and photographed.  
Figure 3.11: Testing the rad60 RMCE system
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fragment into the multiple cloning site of pAW8. The Cre-expression plasmid pAW8 
contains the S. cerevisiae LEU2+ gene. When the rad60 coding sequence is cloned into the 
pAW8 plasmid it is consequently flanked by loxP and loxM3 sites. Since the loxP site in 
the rad60 base strain was placed ~300 bases upstream of the ATG, the sequence amplified 
contained the equivalent promoter region as well as the coding sequence. The resulting 
construct was therefore referred to as pAW8prad60. Site-directed mutagenesis on 
pAW8prad60 followed by Cre-recombinase-mediated cassette exchange allows a simple 
method for integrating point mutations into the genomic copy of rad60. 
 
Before introducing mutations into the rad60 locus, the RMCE system was tested by 
replacing the copy of rad60-ura4+ in the base strain with wild-type rad60 from the 
pAW8prad60 construct. RMCE was achieved as described in Section 2.1.5. Two 5FOA 
(ura4-) colonies were selected (rad60a and rad60b) and their phenotype tested. Spot tests 
were carried out. The sensitivity of the two isolates was compared to the rad60 base strain, 
wild-type and rad60-ct cells. As would be expected for a functional rad60, the rad60a and 
rad60b had similar responses to HU, MMS, TBZ and 4NQO as observed for the wild-type 
and rad60 base strain cells (Figure 3.11B). This indicates that the presence of the loxP and 
loxM3 sites flanking the rad60 gene does not confer a mutant phenotype. The rad60 base-
strain could therefore be used for RMCE. 
 
3.5.3 Rad60 SUMO-like domain 1 is essential for viability 
To test whether the Rad60 SLD1 is required for Rad60 function, the rad60 RMCE system 
was used to replace the wild-type copy of rad60 with a copy of the rad60 gene, lacking 
SLD1 (amino acids 228-307). In two consecutive site-directed mutagenesis reactions, 
primer pairs L243/L254 and L255/L256 were used to introduce XhoI sites into the 
pAW8prad60 construct immediately prior to codon 228, and immediately after codon 307 
of rad60 respectively. The resulting construct was digested with XhoI and re-ligated to give 
a pAW8prad60-SLD1Δ construct (Figure 3.12A). Sequencing of pAW8prad60-SLD1Δ 
with primer L17 and L179 confirmed that SLD1 (aa 228-307) had been deleted and the 
remaining sequence (SLD2) was in frame with the N-terminus. Although the previously 
published rad60-1, rad60-3 and rad60-4 strains, carrying mutations within SLD1, are 
Figure 3.12 Rad60 SLD1 is essential for viability  
 
(A) Creating a pAW8prad60-SLD1Δ construct. XhoI sites were introduced into the 
pAW8prad60 construct immediately prior to codon 228, and immediately after codon 
307 of rad60. The resulting construct was digested with XhoI and re-ligated to give a 
pAW8prad60-SLD1Δ construct. (B) A heterozygous diploid rad60 base strain was 
transformed with pAW8prad60-SLD1Δ and RMCE was achieved. Colony PCR, with 
primers L17 and L40, was used to confirm the presence of the rad60-SLD1Δ allele (i). 
Colony PCR reaction with primers L202 and L35 was used to confirm the presence of 
the wild-type rad60 allele (ii). Haploid wild-type cells were used as a control. (C) The 
heterozygous rad60-SLD1Δ cells were sporulated and a dozen asci dissected. Each 
tetrad produced only two viable spores. (D) Viable spores carry the wild-type rad60 
allele. The viable spores from four different tetrads (1-8 boxed in red in (D)) were 
subjected to colony PCR with primers L17/L40. All viable spores gave a PCR product 
consistent with a wild-type (wt) rad60 allele. Heterozygous diploid rad60-SLD1Δ cells 
(Δ) were used as a control.  
Figure 3.12: Rad60 SLD1 is essential for viability. 
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viable, it was possible that deletion of the entire domain would prove to be lethal for cells. 
For this reason, the pAW8prad60-SLD1Δ construct was transformed into a heterozygous 
diploid rad60 base strain.  
 
To create a diploid base strain the haploid rad60 base strain (ade6-704, leu1-32, h-) was 
first crossed with the haploid strain EH682 (leu1-32, ura4-D18, h+) to cross out the ade6-
704 mutation. Following random spore analysis ade+, ura4+ colonies were selected. An h- 
colony was then crossed to the haploid strain EH358 (ade6-M210, leu1-32, ura4-D18, h+) 
and ade-, ura4+ colonies were selected. An h- colony was selected and crossed with the 
haploid strain EH353 (ade6-M216, leu1-32, ura4-D18, h+). Complementation of the ade6-
M210 and ade6-M216 alleles allowed diploid cells to produce white colonies on minimal 
medium containing leucine and adenine at a low concentration (10 µg/ml). ade+, ura4+ 
colonies were selected as the heterozygous diploid rad60 base-strain (sp.1845). 
 
The heterozygous diploid base-strain was transformed with pAW8prad60-SLD1Δ and 
RMCE was achieved as described in section 2.1.5. To ensure the base strain remained 
diploid throughout the RMCE process, transformed cells were maintained on minimal 
medium containing adenine at a low concentration (10 µg/ml) plus thiamine allowing 
‘white’ diploid cells to be distinguished from ‘red’ haploid cells. Instead of growing cells 
for 24 hours in YE medium, cells were grown in minimal medium containing adenine (10 
µg/ml) plus leucine to promote loss of the plasmid. Cells were plated on minimal medium 
containing adenine (10 µg/ml), leucine, uracil, and 5FOA to select for cells lacking a copy 
of the ura4+ gene.  
 
Colony PCR, with primers L17 and L40, was used to confirm the presence of the rad60-
SLD1Δ allele. Following colony PCR of the heterozygous diploid, I expected to observe 
two PCR products, a band of ~900 bp corresponding to the wild-type rad60 allele and a 
band of ~650 bp corresponding to the rad60-SLD1Δ allele. However, all colonies screened 
produced one dominant band of ~650 bp suggesting a single copy of the rad60-SLD1Δ 
allele was present. If this were true, the colonies screened must have become haploid, 
suggesting that deletion of rad60 SLD1 is not lethal. To investigate this, cells were streaked 
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to single colonies on YEA (-adenine) plates to identify between white (ade+) and red (ade-) 
cells. Only diploid cells, containing both copies of the ade6-M210 and ade6-M216 alleles 
should be white. As a control, cells from a haploid wild-type strain were also streaked on 
the YEA (-adenine) medium. As expected, the haploid strain grew ‘red’ but surprisingly, 
the rad60-SLD1Δ cells grew white, like the diploid base strain (data not shown). For further 
characterisation the cells were streaked onto phloxin-B plates. On the phloxin-B plates the 
haploid cells grew as light pink colonies and the rad60-SLD1Δ cells, like the diploid base 
strain grew as dark pink colonies (data not shown). Together, this suggests that the rad60-
SLD1Δ cells are still diploid. To confirm the presence of both the wild-type rad60 and the 
rad60-SLD1Δ alleles, colony PCR with L17/L40 was repeated. Wild-type haploid cells 
were used as a control. The wild-type cells gave a PCR product of ~900 bp, corresponding 
to a wild-type copy of the rad60 gene (Figure 3.12B). As seen previously, and consistent 
with the rad60-SLD1Δ allele, a PCR product of ~650 bp was observed in the rad60-SLD1Δ 
cells. A very faint band equivalent to the wild-type product could also be detected (Figure 
3.12B). In parallel, a second colony PCR with primers L202 and L35 was carried out. 
Primer L202 was designed to anneal within SLD1 whilst L35 anneals ~500 bp downstream 
of the rad60 stop codon. In this reaction, a PCR product of ~900 bp, corresponding to a 
wild-type copy of the rad60 gene, was observed for both the wild-type cells and the rad60-
SLD1Δ cells (Figure 3.12B). If the rad60-SLD1Δ cells were haploid as originally believed, 
this PCR would yield no product. Together, this suggests that the rad60-SLD1Δ cells are in 
fact heterozygous diploid and that the PCR with L17/L40 preferentially amplifies the 
smaller DNA fragment from the rad60-SLD1Δ allele. 1 µl of this small PCR product was 
sequenced with primer L17 to confirm that SLD1 (aa 228-307) had been deleted and that 
the remaining sequencing was in frame.  
 
To determine whether the rad60-SLD1Δ allele was lethal, the heterozygous rad60-SLD1Δ 
cells were placed on ELN medium for ~72 hours at 25oC to induce sporulation. Unlike the 
diploid base-strain cells, which almost all sporulated, the rad60SLD1Δ cells showed a 
severely reduced sporulation frequency (~<1%), suggesting a defect in meiosis. A dozen 
asci were dissected and each tetrad produced only two viable spores (Figure 3.12C). 
Colony PCR (L17/L40) of the viable spores from four different tetrads confirmed that each 
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spore contained a wild-type copy of the rad60 gene (Figure 3.12D). This implies that 
deletion of the rad60 SLD1 is lethal. 
 
3.6 Discussion 
In this chapter, I have identified two potential SUMO-like domains in the C-terminal region 
of Rad60. During the course of this project Rad60 has been characterised as a member of 
the RENi family of proteins, which include the S. pombe Rad60, S. cerevisiae Esc2 and M. 
musculus Nip45 proteins amongst others. Rad60, Esc2 and Nip45 are all ~400 amino acids 
in length and share 2 C-terminal SUMO-like domains. Unlike SUMO, the SUMO-like 
domains of the RENi proteins do not share the C-terminal diglycine motif required for 
covalent attachment to target proteins, suggesting that the SUMO-like domain of these 
proteins is likely to function as a protein-protein interface and is not conjugated to other 
proteins. In this chapter I have created SUMO-domain deletion mutants to analyse the 
importance of the SLDs for Rad60 function. 
 
A Rad60 SLD2 deletion mutant (rad60-ct) is viable, suggesting Rad60 SLD2 is not 
required for the essential function of Rad60. Like the rad60-1 (K263E) mutant, rad60-ct 
cells grow well at 25oC and are temperature sensitive at 36oC. Unlike the rad60-1 cells, 
rad60-ct grows well at 30oC. rad60-ct cells are sensitive to DNA damaging agents UV, IR, 
MMS, 4NQO. These defects are similar to, but not as severe as, the previously 
characterised smc6-X mutant (Lehmann, Walicka et al. 1995). Like other mutants defective 
in the Smc5/6 complex, rad60-ct is epistatic with rhp51-d, implying a role for rad60 in 
homologous recombination that is dependent on SUMO-like domain 2. As is the case with 
the smc6-X and smc6-74 mutants, rad60-ct cells are elongated, suggesting a defect in 
replication that is activating a checkpoint (Lehmann, Walicka et al. 1995; Verkade, Bugg et 
al. 1999). This is consistent with rad60-ct cells showing sensitivity to the replication 
inhibitor HU. 
 
Rad60 is known to associate with the Smc5/6 complex (Morishita, Tsutsui et al. 2002; 
Boddy, Shanahan et al. 2003). Like the other rad60 mutants, rad60-1 and rad60-3, rad60-
ct is synthetically lethal with smc6-X and is also synthetically lethal with smc6-74 
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(Morishita, Tsutsui et al. 2002; Boddy, Shanahan et al. 2003). The point mutations in 
rad60-1 (K263E) and rad60-3 (F272V) are located in SLD1 of Rad60. This suggests that 
either, the genetic interaction of rad60 with smc6 is not SLD2-dependent, or, that mutations 
in SLD1 disrupt the structure and/or function of SLD2. Additionally, expression of rad60 
but not rad60-ct in an smc6-74 background can suppress the sensitivity of smc6-74 to HU 
and MMS, suggesting that suppression is dependent on the SLD2 of Rad60.  
 
Nse2 is a member of the Smc5/6 complex and has E3 SUMO ligase activity (Andrews, 
Palecek et al. 2005). The nse2-SA allele encodes a ligase-dead version of the Nse2 protein 
(Andrews, Palecek et al. 2005). rad60-ct and nse2-SA are epistatic in their response to both 
UV and IR, suggesting that rad60 and nse2 act in the same repair pathway. Interestingly, 
expression of rad60 and rad60-ct in an nse2-SA background can suppress the sensitivity of 
nse2-SA cells to HU and MMS. One possible explanation for the genetic interaction 
between rad60 and nse2 is that Nse2-dependent sumoylation of Rad60 could help establish 
the transient interaction with the Smc5/6 complex. Sumoylation of rad60 is discussed in 
chapter 4. 
 
Although initially the functions of the RENi family proteins do not seem well conserved, 
there is evidence to suggest that rad60 and esc2 may share some genetic interactions and 
hence may be functional homologues. The S. pombe rad60 gene was first identified 
through its synthetic lethal interaction with rad2 (Morishita, Tsutsui et al. 2002). Unlike 
rad60, esc2 is not essential but an esc2-d strain has been shown to be synthetically lethal 
with mutations of the rad27 (rad2 homologue) gene (Tong, Evangelista et al. 2001). In 
addition, esc2-d is synthetically lethal with sgs1-d, (rqh1 homologue). Like rad60-1 and 
rad60-3 (Morishita, Tsutsui et al. 2002; Boddy, Shanahan et al. 2003). I have shown rad60-
ct to be synthetically lethal with rqh1-d. This implies that the SUMO-like domains may be 
required for a conserved function of the RENi protein family. Unlike esc2-d, which is 
synthetically lethal with top1-d, a rad60-ct top1-d double mutant is viable. rad60-ct and 
top1-d are not epistatic, suggesting that the relationship between Esc2 and Top1 is not 
conserved with Rad60.  
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Integrating a Rad60 SLD1 deletion mutant into the S. pombe genome is lethal. The rad60-
SLD1Δ allele can be maintained as a heterozygous diploid. The rad60-SLD1Δ heterozygous 
diploid is defective in meiosis. This suggests that the Rad60 SLD1 is essential for Rad60 
function and may be required for a role in meiosis. 
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CHAPTER 4 
Rad60 is sumoylated in a manner dependent on the C-terminus 
 
4.1 Introduction 
Rad60 interacts both functionally and genetically with the Smc5/6 complex (Morishita, 
Tsutsui et al. 2002; Boddy, Shanahan et al. 2003). Recently Nse2, a component of the 
Smc5/6 complex, has been identified as an E3 SUMO ligase (Andrews, Palecek et al. 
2005). The Smc5/6 complex proteins Smc6, Nse2, Nse3, and Nse4 are sumoylated in an 
Nse2-dependent manner in vitro. Smc5 and Nse1 have been tested but are not targets of 
sumoylation in vitro (Andrews, Palecek et al. 2005). In chapter 3, I have shown that rad60-
ct and nse2-SA are epistatic in response to both UV and IR. The nse2-SA allele encodes a 
ligase-dead version of the Nse2 protein. In addition, the expression of either rad60 or 
rad60-ct in the nse2-SA background can suppress the sensitivity of nse2-SA cells to HU and 
MMS. Based on these observations it is possible that Rad60 may be a target of Nse2-
dependent sumoylation. In this chapter I have tested Rad60 to determine whether it is 
sumoylated, and if so if this is dependent on Nse2. 
 
4.2 Rad60 is sumoylated in vitro 
To determine whether Rad60 can be modified by SUMO, Rad60 was tested as a potential 
substrate in the in vitro sumoylation assay (Ho, Warr et al. 2001). Rad60 was labelled with 
[35S]-methionine by in vitro transcription-coupled translation. The in vitro transcription-
coupled translation requires the gene of interest to be under the control of a T7 promoter. 
For this reason, rad60 was sub-cloned from the pTOPOrad60 construct (Section 3.4.1) into 
the pEPEXHA vector as an NdeI/SalI fragment. 2 µl of the [35S]-labelled Rad60 was 
incubated with the in vitro assay components with (Figure 4.1A, lane 2) and without 
(Figure 4.1, lane 1) the addition of the mature form of SUMO (Pmt3-GG). Rad60 has a 
predicted molecular weight of 46 kDa, but consistently runs at a mass of ~60 kDa when 
analysed by SDS-PAGE. The pEPEXHA vector places a single HA tag at the N-terminus 
of the expressed protein. Since the HA tag is 1.1 kDa, the increase in mass observed is 
unlikely to be the result of the HA tag. In the presence of SUMO (Figure 4.1A, lane 2), two 
slower migrating forms of Rad60 are observed at ~80 and ~100 kDa. SUMO has a 
Figure 4.1: Rad60 is sumoylated in vitro 
 
(A) Rad60 was tested as a potential substrate in the in vitro sumoylation assay. 
Incubation of 35S-labelled Rad60 with the SAE heterodimer, Hus5 and the mature form 
of SUMO (Pmt3-GG) resulted in the appearance of two slower migrating forms with 
sizes consistent with sumoylated forms of Rad60. The products were separated by 7.5% 
SDS-PAGE and detected with a phosphoimager. (B) Schematic to show the relative 
positions of the 27 lysine residues of Rad60. Lysines are indicated by *.
Figure 4.1: Rad60 is sumoylated in vitro
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predicted molecular weight of ~11 kDa but when analysed by SDS-PAGE proteins appears 
much larger. SUMO modification adds ~20 kDa to the apparent molecular weight of most 
substrates. The bands observed for Rad60 modification are therefore consistent with 
sumoylated forms of Rad60. The Rad60 protein consists of 27 lysines, each of which could 
act as an acceptor for SUMO-modification (Figure 4.1B). The two modified forms of 
Rad60 may have arisen due to the use of more than one SUMO acceptor site or to the 
production of a SUMO chain on one lysine.  
 
4.3  Sumoylation of Rad60 in vitro is enhanced by the E3 ligase Pli1, but not Nse2 
To test the possibility that Rad60 sumoylation is enhanced by the SUMO E3 ligase Nse2, 
[35S]-Rad60 was tested as a substrate in the in vitro sumoylation assay. 3 µg Hus5 is 
typically used in standard in vitro sumoylation assays. However, to determine whether 
sumoylation of Rad60 could be enhanced by the SUMO ligase Nse2, the level of Hus5 was 
reduced in the assay to 0.3 µg. In figure 4.2A, the SUMO activator and ATP-regenerating 
system are present in all lanes (1-5). In lane 1, the assay mix loaded includes the typical 
amount of Hus5 (3 µg) and 10 µg His-Pmt3 as a control for Rad60 sumoylation. As 
previously observed, two slower migrating forms of Rad60 were observed at ~80 and ~100 
kDa consistent with SUMO-modified forms of Rad60. In lanes 2-5, the Hus5 concentration 
was dropped to 0.3 µg/reaction. In the presence of SUMO (lane 3), no modified forms of 
Rad60 could be observed, as compared to lane 1 (positive control) and lane 2 (negative 
control with no SUMO). In lane 4, 4 µg Nse2 was added to the sumoylation assay. No 
modified forms of Rad60 were observed. In contrast, when 4 µg Pli1, the only other known 
S. pombe SUMO ligase, was added to the assay mix, the modified forms of Rad60 were 
observed at ~80 and ~100 kDa (lane 5). This suggests that Pli1, but not Nse2, can enhance 
the levels of Rad60 sumoylation in vitro.  
 
To test the genetic interactions of pli1 and rad60, the pli1-d strain was crossed with   
rad60-ct. Following tetrad dissection, spores containing the rad60-ct pli1-d double mutant 
were not viable. This suggests that pli1-d and rad60-ct are synthetically lethal. To further 
test this relationship, rad60 and rad60-ct were expressed from the pREP41HA plasmid in 
the pli1-d background. pli1-d cells exhibit a sensitivity to DNA damaging agents similar to 
Figure 4.2  Sumoylation of Rad60 in vitro is enhanced by the E3 ligase Pli1 
 
(A) 2 µl 35S-labelled Rad60 was incubated with the SAE heterodimer, Hus5 and the 
mature form of SUMO (Pmt3-GG). To determine whether sumoylation could be 
enhanced by the SUMO ligases, the Hus5 concentration was reduced from 3 µg (lane 1 
(++)) to 0.3 µg per reaction (lanes 2-5 (+)). 4 µg Nse2 (lane 4) or Pli1 (lane 5) were 
tested in the assay. The products were separated by 7.5% SDS-PAGE and detected with 
a phosphoimager. (Andi Skilton, University of Sussex, generated this particular image) 
(B) Over-expression of rad60 but not rad60-ct can enhance the sensitivity of pli1-d to 
HU and MMS. Cells carrying the pREP41HA multicopy plasmid (pEV) or pREP41HA 
containing rad60 or rad60-ct (prad60/prad60-ct) were grown at 30oC in YNB medium 
supplemented with adenine and uracil to mid-exponential phase. 10 µl of 10 fold serial 
dilutions were spotted onto YNB plates supplemented with adenine and uracil and 
containing supplements at the indicated doses. Plates were incubated at 30oC for 72 
hours and photographed. 
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Figure 4.2: Sumoylation of Rad60 in vitro is enhanced by the E3 ligase Pli1
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that observed for wild-type cells. However, when rad60 is expressed in the pli1-d 
background, the pli1-d cells are hypersensitive to both HU and MMS (Figure 4.2B). This is 
not observed when rad60-ct is expressed in the pli1-d background, suggesting that the 
dominant negative effect of over-expressing rad60 in pli1-d cells is SLD2 dependent.  
 
4.4 Rad60 is sumoylated in a manner dependent on the C-terminus 
To investigate the biological significance of Rad60 sumoylation, attempts were made to 
identify the site, or sites, of SUMO-modification. Rad60 has 27 lysine residues that could 
act as a SUMO-acceptor site. A systematic approach was therefore needed. One approach 
was to test truncated fragments of Rad60 in the in vitro sumoylation assay. Since a C-
terminally truncated version of rad60 (encoding aa 1-333) was already cloned into 
pREP41HA (Section 3.4.1), the coding sequence was subcloned into the pEPEX HA vector 
as an NdeI/SalI fragment and tested in the in vitro sumoylation assay (Figure 4.3A). The C-
terminally truncated form of Rad60 (Rad60-ct) runs at ~50 kDa. In contrast to Rad60, in 
the presence of SUMO no slower migrating forms of the Rad60-ct were observed (Figure 
4.3B). This suggests that SUMO-modification of the Rad60 protein is dependent on the C-
terminal 73 amino acids.  
 
The C-terminal region contains four lysine residues that may act as potential sites of 
SUMO conjugation (Figure 4.4A). Of these four lysine residues, K342 is the only residue 
that conforms to the ϕKXE SUMO consensus motif with the localised environment of 
SKSE. To try to identify the site of SUMO-modification, site-directed mutagenesis was 
used to introduce lysine (AAA/AAG) to arginine (AGA/AGG) substitutions for each of the 
four lysines coded for in the rad60 gene. The mutagenic primers used are described in 
Table 4.1. Sequencing of pEPEXHArad60, with the T7, L17, L18 and L19 primers was 
necessary to confirm the lysine to arginine substitutions.  
 
When tested in the in vitro sumoylation assay, the Rad60 K342R mutant showed a similar 
sumoylation pattern to that previously seen for the wild-type Rad60 protein (Figure 4.4B). 
This suggests that either K342 is not the site of Rad60 sumoylation, or that it is not the only 
site of Rad60 sumoylation. Rad60 protein with individual K357R, K361R and K368R 
Figure 4.3: Rad60 is sumoylated in vitro, in a manner dependent on the C-
terminus 
 
(A) Schematic to illustrate the C-terminal truncation of Rad60-ct. (B) Rad60-ct was 
tested as a potential substrate in the in vitro sumoylation assay. 2 µl 35S-labelled Rad60 
and Rad60-ct were incubated with the SAE heterodimer, Hus5 and the mature form of 
SUMO (Pmt3-GG). The products were separated by 7.5% SDS-PAGE and detected 
with a phosphoimager. 
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Figure 4.3: Rad60 is sumoylated in vitro in a manner dependent on the 
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Figure 4.4: The Rad60 quadruple mutant is still sumoylated in vitro 
 
(A) The C-terminal region of Rad60 contains four lysine residues. K342 (boxed in red) 
conforms to the ϕKXE SUMO consensus motif. (B, C) Rad60 K342R (C) and Rad60 
K342/357/361/368R mutants (D) were tested in the in vitro sumoylation assay. 2 µl 35S-
labelled mutant Rad60 was incubated with the SAE heterodimer, Hus5 and the mature 
form of SUMO (Pmt3-GG). The products were separated by 7.5% SDS-PAGE and 
detected with a phosphoimager. 
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Figure 4.4: The Rad60 quadruple mutant is still sumoylated in vitro
Table 4.1: Mutagenic primer sequences for mutating potential sumoylation 
sites of Rad60
Mutation Primer Primer sequence (5’ to 3’)
K17/18R L109
L110
F-CAAAGCCTATTAGAAGGCCTCCATTAAACTATGCC
R-GGCATAGTTTAATGGAGGCCTTCTAATAGGCTTTC
K173 L156
L157
F-GTACAAATTCACACGCATAGGAGAGAAATTGAAGAAGACG 
R-CGTCTTCTTCAATTTCTCTCCTATGCGTGTGAATTTGTAC
K204 L158
L159
F -CGCTGTATCACTCCAGATCGGAATTCTCAAC
R-GTTGAGAATTCCGATCTGGAGTGATACAGCG
K263/264R L78
L79
F-CGTACTCTGAAAGAAGAAGAGTAGATAACG
R-CGTTATCTACTCTTCTTCTTTCAGAGTACG
K290 L111
L112
F-GGTATGCTTAGAGTCGATACCCG
R-CGGGTATCGACTCTAAGCATACC
K332R L113
L114
F-GCTCAAACGTGTAGACTTATAACGTTGC
R-GCAACGTTATAAGTCTACACGTTTGAGC
K342R L37
L38
F-GCTTTTGCGTTCGAGTAGGAGTGAGGATCTTCG
R-CGAAGATCCTCACTCCTACTCGAACGCAAAAGC
K357R L56
L57
F-CCGTCGATTTCACTGTTAGAGATTTGATTAAGAG
R-CTATTAATCAAATCTCTAACAGTCAAATCGACGG 
K361R L58
L59
F-CACTGTTAAAGATTTGATTAGGAGATATTGTACTG
R-CAGTACAATATCTCCTAATCAAATCTTTAACAGTG
K368R L60
L61
F-GTACTGAAGTAAGGATTAGTTTTCATGAACGC 
R-GCGTTCATGAAAACTAATCCTTACTTCAGTAC
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mutations also showed the same wild-type sumoylation pattern when tested (data not 
shown). Since two modified forms of Rad60 can be identified by the SUMO assay, it is 
possible that by knocking out single lysine residues, other lysine residues can still be 
modified by SUMO. Further rounds of site-directed mutagenesis on the mutant 
pEPEXHArad60 constructs were therefore undertaken to produce combinations of double 
and triple mutants. Like the single mutants, the double and triple mutants produced the 
same sumoylation pattern as wild-type Rad60 when tested in the in vitro sumoylation assay 
(data not shown). Since the region truncated in the Rad60-ct protein, which showed a loss 
of SUMO-modification, contains only four lysine residues, a Rad60 K342/357/361/368R 
quadruple mutant was tested. Surprisingly, in the presence of SUMO, the wild-type Rad60 
sumoylation pattern was still observed (Figure 4.4C). This suggests that the site of Rad60 
SUMO-modification, in vitro, is not within the C-terminal 73 amino acids, but that SUMO 
modification of Rad60 is dependent on the C-terminus. The site at which Rad60 was 
truncated to create Rad60-ct lies between L333 and I334 in the CKLITL peptide sequence. 
This raises the possibility that, if the site of Rad60 modification is K332, the truncation 
may have altered the local environment of the lysine in such a way that it cannot be 
modified. To test this a K332R mutation was created and tested in the in vitro sumoylation 
assay.  In the presence of SUMO, the wild-type Rad60 sumoylation pattern was still 
observed for the K332R mutation (Figure 4.5B). 
 
4.5  Mutating possible sumoylation sites in Rad60 does not disrupt sumoylation in 
 vitro 
To identify possible sites of SUMO modification, the Rad60 protein sequence was 
submitted to the SUMOplot (http://www.abgent.com/tool/sumoplot) and SUMOsp 
(http://bioinformatics.lcd-ustc/org/sumosp) prediction software. Predicted sites of Rad60 
SUMO-modification are shown in figure 4.5A. The rad60-1 mutant carries a K263E 
mutation in its rad60 coding sequence. Since K263 has been identified as a possible site of 
SUMO-modification, it is possible that the phenotype observed for rad60-1 cells may be a 
consequence of loss of sumoylation. To test this in vitro, site-directed mutagenesis was 
used to create the double K263/264R mutation in the pEPEXHArad60 construct. Since 
K263 is immediately followed by another lysine, K264, a double mutant was created with a 
Figure 4.5: Mutating possible sumoylation sites in Rad60 does not disrupt 
sumoylation in vitro 
 
(A) Table to illustrate the possible Rad60 sumoyltaion sites predicted by SUMOplot 
(http://www.abgent.com/tool/sumoplot) and SUMOsp (http://bioinformatics.lcd-
ustc/org/sumosp). (B) Lysines within the predicted motifs were mutated to arginine and 
tested in the in vitro sumoylation assay. 2 µl 35S-labelled mutant Rad60 was incubated 
with the SAE heterodimer, Hus5 and the mature form of SUMO (Pmt3-GG). The 
products were separated by 7.5% SDS-PAGE and detected with a phosphoimager.  
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single primer pair. The mutagenic primers used are described in Table 4.1. Sequencing of 
pEPEXHArad60, with the T7, L17, L18 and L19 primers was necessary to confirm the 
lysine to arginine substitutions. When tested in the in vitro sumoylation assay, the Rad60 
K263/264R mutant showed a similar sumoylation pattern to that previously seen for the 
wild-type Rad60 protein (Figure 4.5B). Other predicted sumoylation sites were tested in a 
similar manner. Rad60 carrying K17/18R, K204R, K263R and K290R mutations all 
produced a similar SUMO-modification pattern to that of the wild-type protein when tested 
in the in vitro sumoylation assay (Figure 4.5B). This suggests that either Rad60 is not 
modified on one of the predicted sumoylation sites, or, if it is, when that site is no longer 
available for modification, SUMO can be conjugated to another lysine residue. To explore 
this further, double and triple mutants would have to be made and tested. Due to time 
constraints this was not undertaken. 
4.6 Rad60-ct does not interact with Hus5 in vitro 
During the process of SUMO conjugation, the target protein forms a thiolester linkage with 
the SUMO conjugator (Johnson and Blobel 1997). Since Rad60 is sumoylated in vitro, it is 
therefore predicted that it would interact with the S. pombe SUMO conjugator, Hus5. To 
test this, an in vitro GST pull-down assay was carried out. Glutathione-sepharose beads 
were incubated with lysate from cells expressing either GST-Hus5 or GST as a control. 35S-
labelled Rad60 was incubated with the pre-bound beads. Figure 4.6A shows GST-Hus5 
(lane 5 ~40 kDa, lower panel) and a GST control (lane 4 ~26 kDa, lower panel) bound to 
the glutathione-sepharose beads. In the GST-Hus5 lane (lane 5), a small portion of the GST 
has become cleaved from the Hus5 protein producing a faint band at ~26 kDa. When 
incubated with the pre-bound GST-Hus5 beads, a strong band of 35S-labelled Rad60 (~60 
kDa) was detected in the bound fraction (lane 5, upper panel), with substantially less in the 
unbound fraction (lane 6, upper panel). When 35S-labelled Rad60 was incubated with 
control GST beads, Rad60 was detected in the unbound fraction (lane 3) but not the bound 
fraction (lane 4). This suggests that Rad60 can interact with Hus5 in vitro, supporting the 
results obtained from the in vitro sumoylation assay.  
 
The C-terminally truncated Rad60-ct protein is not SUMO-modified in vitro (Section 4.2). 
To determine if the Rad60-ct protein can interact with the Hus5 SUMO conjugator, Rad60-
Figure 4.6: Hus5 interacts with Rad60, but not Rad60-ct, in vitro 
 
(A) An in vitro GST pull-down assay was carried out. Glutathione-sepharose beads 
were incubated with lysate (L) from cells expressing either GST-Hus5 or GST as a 
control. 35S-labelled Rad60 (Input (I)) was incubated with the pre-bound beads in the 
presence of ATP, CPK and CP for 1 hour. Beads were washed and the unbound (U) 
fraction was collected. The beads were boiled in 30 ml 5x sample buffer and 15 µl of 
the bound proteins (B) were separated by 10% SDS-PAGE. The gels were analysed by a 
phosphoimager and Western blotting with anti-GST antibody. (B) 35S-labelled Rad60-ct 
was tested in the in vitro GST pull-down assay.  
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ct was tested in the in vitro GST pull-down assay (Figure 4.6B). As is observed with the 
control GST beads (lane 4), the pre-bound GST-Hus5 beads do not pull down 35S-labelled 
Rad60-ct (lane 5). All Rad60-ct protein remains in the unbound fraction (lane 6). This 
observation that Rad60-ct cannot interact with Hus5 in vitro, suggests that this is why 
Rad60-ct is not modified in the in vitro sumoylation assay. 
 
In parallel with Rad60 and Rad60-ct, Smc6 and Nse2 were tested in the in vitro GST pull-
down assay. Smc6 has previously been shown to be sumoylated both in vitro and in vivo 
and shown to interact with Hus5 in vitro (Andrews, Palecek et al. 2005) (Andrews, E, 
thesis) and was therefore tested as a positive control for the Rad60 and Rad60-ct in vitro 
GST pull-down assay. Figure 4.7A shows that when incubated with the pre-bound GST-
Hus5 beads, a strong band of 35S-labelled Smc6 (~130 kDa) was detected in the bound 
fraction (lane 5), as compared to the unbound fraction (lane 6). When incubated with the 
control GST beads, Smc6 was detected only in the unbound fraction (lane 3). In contrast, 
when the E3 SUMO ligase, Nse2, was incubated with the GST-Hus5 beads (Figure 4.7B) 
no 35S-labelled Nse2 was detected in the bound fraction (lane 5). All Nse2 protein remained 
in the unbound fraction (lane 6). This suggests that Nse2 does not interact with Hus5 in 
vitro.  
 
4.7  High molecular weight forms of Rad60, with sizes consistent for sumoylated 
 species, can be identified in vivo  
Since sumoylation of Rad60 had been shown in vitro, the next step was to try to confirm 
that Rad60 is also sumoylated in vivo. Ni2+pulldown experiments were therefore carried 
out. myc-His-tagged SUMO (MH-SUMO) and HA-tagged Rad60 (HA-Rad60) were co-
expressed by transforming wild-type S. pombe cells with pREP42MHpmt3-GG and 
pREP41HArad60. As controls, cells were also transformed with the empty pREP vectors. 
Expression of the SUMO and Rad60 proteins from the pREP vectors was de-repressed by 
growing cells without thiamine for ~16 hours. Cells were lysed and MH-SUMO was pulled 
down using Ni2+ agarose beads under denaturing conditions. TCA total cell extracts were 
carried out in parallel as a control for protein expression.  
 
Figure 4.7: Hus5 interacts with Smc6, but not Nse2, in vitro  
 
A) An in vitro GST pull-down assay was carried out. Glutathione-sepharose beads were 
incubated with lysate (L) from cells expressing either GST-Hus5 or GST as a control. 
35S-labelled Smc6 (Input (I)) was incubated with the pre-bound beads in the presence of 
ATP, CPK and CP for 1 hour. Beads were washed and the unbound (U) fraction was 
collected. The beads were boiled in 30 ml 5x sample buffer and 15 µl of the bound 
proteins (B) were separated by 10% SDS-PAGE. The gels were analysed by a 
phosphoimager and Western blotting with anti-GST antibody. (B) 35S-labelled Nse2 
was tested in the in vitro GST pull-down assay.  
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Figure 4.8 shows results of the Ni2+ pull-downs and corresponding TCA blots. In lane 1, 
cells were transformed with empty pREP41HA and pREP42MH vectors. The anti-myc and 
anti-HA antibodies therefore detected no signal in this sample. In lane 2 cells were 
transformed with pREP41HArad60 and empty pREP42MH vector. When probed with anti-
HA, a strong band at ~60 kDa, corresponding to HA-tagged Rad60 was observed in the 
TCA extract. Above the Rad60 band is a smear that may correspond to a ladder of modified 
forms of Rad60. As expected, the anti-myc antibodies detected no signal. When the same 
cells were used for the Ni2+ pull-down (lane 2), a weak signal, corresponding to the size 
expected for Rad60, was detected by the anti-HA antibodies. Since only His-tagged species 
should bind to the Ni2+ beads, no signal should be detected. This suggests that Rad60 can 
bind non-specifically to the Ni2+ beads. In lane 3, when cells were transformed with 
pREP42MHpmt3.GG and empty pREP41HA vector, a ladder of SUMO-modified species 
was observed for both the Ni2+ pull-down and the TCA extract when probed with anti-myc 
antibody. As expected, no signal was observed when probed with anti-HA. In lanes 4, 5, 6, 
and 7 cells were transformed with pREP42MHpmt3.GG and pREP41HArad60 constructs. 
In lane 4, a ladder of SUMO-modified species was observed for both the Ni2+ pull-down 
and the TCA extract when probed with anti-myc antibody. When probed with anti-HA, a 
strong band of ~60 kDa, corresponding to HA-tagged Rad60 was observed in the TCA 
extracts. As in lane 2, a smear above Rad60 can be observed. This smear may correspond 
to a ladder of modified Rad60 forms. The HA signals observed in lane 2 and 4 are 
comparable for the TCA extracts. This indicates that cells are expressing Rad60 at a similar 
level. When the same cells were used for the Ni2+ pull-down (lane 4), a strong signal, 
corresponding to the size expected for Rad60, was detected by the anti-HA antibodies. In 
addition, the slower migrating forms of Rad60 are more discrete than observed in the TCA 
samples. Slower migrating bands can be identified. The first two bands correspond to a size 
of  ~80 and ~100 kDa, consistent with the sizes expected for Rad60 modified with one and 
two SUMO molecules respectively. Unfortunately in the Ni2+ pull-downs, the signal for the 
unmodified form of Rad60 is also increased in lanes 4 to 7 relative to that of lane 2. It is 
therefore difficult to say with certainty that these bands are SUMO-dependent. It is possible 
that the increase in signal for the unmodified form of Rad60 is the result of modified forms 
losing their conjugated SUMO species prior to being analysed by SDS-PAGE. In lanes 5, 
Figure 4.8: High molecular weight forms of Rad60, with sizes consistent for 
  sumoylated species, can be identified in vivo  
 
Wild-type S. pombe cells were transformed with pRE42MHpmt3.GG and 
pREP41HArad60 constructs. As controls, cells were also transformed with empty pREP 
vectors. Expression of the SUMO and Rad60 proteins from the pREP vectors was de-
repressed by growing cells without thiamine for ~16 hours. Cells were exposed to 250 
Gy, 0.01% MMS or 20 mM HU as indicated. 60 OD units of cells were lysed and MH-
SUMO was pulled down using Ni2+ agarose beads under denaturing conditions. TCA 
total cell extracts were carried out in parallel. Proteins were separated by 7.5% SDS-
PAGE. The gels were analysed by Western blotting with anti-myc or anti-HA antibody 
as indicated.  
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6, and 7, cells were treated exposed to IR and treated with MMS and HU respectively. A 
similar pattern of modification was observed in all three lanes. Treatment with 0.01% 
MMS (lane 6), resulted in a stronger signal for the modified forms. This is reminiscent of 
Smc6, which shows an increased level of sumoylation following treatment with MMS 
(Andrews, Palecek et al. 2005). 
 
Slower migrating forms of Rad60, consistent with sumoylation, were consistently observed 
in TCAs and Ni2+ pull-down experiments. Due to the time constraints and the fact that 
Rad60 binds non-specifically to the Ni2+ beads, further investigation into the in vivo 
sumoylation of Rad60 was not carried out.  
 
4.8 Discussion 
In this chapter I have tested Rad60 as a potential substrate of sumoylation. When tested in 
the in vitro sumoylation assay, two slower migrating forms of Rad60 were observed with 
sizes consistent with that expected for SUMO-modified forms. The two modified forms 
may have arisen as a result of the use of more than one SUMO-acceptor site, or the 
production of a SUMO chain on one target lysine. In the case of Rad60, it is likely that 
modification is occurring on two separate lysine residues. This is because the lower band 
corresponding to Rad60 modified with a single SUMO is consistently less discreet than the 
upper band. In fact, in figure 4.3, two discrete bands can be identified within the lower 
band, suggesting that SUMO-modification on the two different lysine residues results in a 
slightly different mobility when analysed on SDS-PAGE.  
 
To investigate the biological significance of Rad60 sumoylation, attempts were made to 
identify the site(s) of SUMO-modification. A C-terminally truncated form of Rad60 (aa 1-
333) is not modified in vitro. The C-terminal region contains four lysine residues, one of 
which, K342, conforms to the ϕKXE consensus motif. When tested in the in vitro 
sumoylation assay, the K342R mutant showed a similar modification pattern to that 
previously seen for the wild-type Rad60 protein. A K342/357/361/368R quadruple mutant 
also shows a modification pattern similar to the wild-type Rad60 protein. This suggests that 
although the site(s) of sumoylation are not within the C-terminal 73 amino acids, SUMO 
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modification of Rad60 is dependent on the C-terminus. There are a few possibilities as to 
why Rad60-ct is not sumoylated, but the quadruple mutant is. Firstly, the truncated form of 
the protein may have altered the conformation of the protein in such a manner that the 
protein cannot be sumoylated. Secondly, the site at which rad60 was truncated is in close 
proximity to K332. This raises the possibility that if K332 is the site of SUMO-
modification, the truncation may have altered the local environment of the residue in such a 
way that it can longer be modified. This possibility can be discounted since the K332R 
mutant can still be modified in vitro. A third possibility is that the SUMO conjugator 
cannot bind the truncated Rad60-ct protein. For sumoylation to occur, the conjugator must 
bind Rad60. This possibility is supported by the fact that in an in vitro GST pull-down 
assay, Rad60 but not Rad60-ct is able to bind the Hus5 conjugator.  
 
Despite the genetic interaction of Rad60 and Nse2 (Section 3.4), sumoylation of Rad60 in 
vitro is not enhanced by the Nse2 SUMO ligase. This is in contrast to the situation with 
some of the other proteins of the Smc5/6 complex (Andrews, Palecek et al. 2005). It is 
possible however, that Nse2-dependent sumoylation of Rad60 may require the rest of the 
Smc5/6 complex. Instead sumoylation of Rad60 in vitro can be enhanced by the Pli1 
SUMO ligase. A rad60-ct pli1-d double mutant is synthetically lethal. In addition, 
expression of rad60 but not rad60-ct can enhance the sensitivity of pli1-d cells to HU and 
MMS. One possible explanation for this is that Pli1-dependent sumoylation of Rad60 is 
necessary for Rad60 function. In this scenario, in the absence of Pli1, the unmodified from 
of Rad60 has a dominant negative effect. This is consistent with the loss of SUMO-
modification observed for the truncated Rad60-ct protein. The rad60-ct mutant is sensitive 
to HU and MMS (Section 3.4). 
 
Attempts to identify the site(s) of SUMO-modification were made by mutating lysines 
within motifs predicted to be possible sites of sumoylation. All mutants tested were still 
modified in vitro. Before being able to investigate the biological significance of Rad60 
sumoylation, the site(s) of sumoylation must be identified and sumoylation verified in vivo. 
Since Rad60 appears to be modified on two separate sites, further mutagenesis is required 
to mutate more than one residue at a time. Due to time constraints this was not carried out. 
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Slower migrating forms of Rad60, consistent with sumoylation, were consistently observed 
when Rad60 and SUMO were over-expressed in wild-type cells. As previously observed 
for Smc6 (Andrews, Palecek et al. 2005), modified forms of Rad60 were enhanced after 
treatment of cells with MMS. Due to time constraints further investigation into the in vivo 
sumoylation of Rad60 was not carried out.  
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CHAPTER 5 
SUMO-like domain 2 is required for the correct localisation of the S. pombe Rad60 
protein 
5.1 Introduction 
Rad60 is a nuclear protein that exits the nucleus upon treatment of cells with HU 
(Morishita, Tsutsui et al. 2002; Boddy, Shanahan et al. 2003). HU is an S-phase inhibitor 
that inhibits ribonucleotide reductase, thereby depleting dNTP pools and causing 
replication fork arrest. HU-induced fork stalling triggers a replication checkpoint response 
that leads to the activation of the effector protein kinase Cds1 (H. sapiens Chk2 
homologue). Cds1 interacts with a number of DNA replication and repair factors, including 
Rad60. Interaction with Cds1 results in hyperphosphorylation and concomitant 
delocalisation of Rad60 from the nucleus (Boddy, Shanahan et al. 2003). A rad60-4 (T72A, 
I232S, Q250R, K312N) mutant is proficient for survival of UV-induced DNA damage but 
is uncoupled from Cds1 regulation, therefore unable to delocalise from the nucleus 
following HU treatment (Boddy, Shanahan et al. 2003). This suggests that Rad60 performs 
its DSB repair role in the nucleus and that phosphorylation by Cds1 acts to inhibit this 
activity by delocalising Rad60 from the nucleus. It has been suggested that the role of this 
delocalisation may be to prevent homologous recombination of unfavourable substrates e.g. 
stalled replication forks (Boddy, Shanahan et al. 2003). 
 
I have previously created a rad60-ct strain in which the C-terminal SLD has been deleted. 
Like rad60-1 (K236E), rad60-ct is hypersensitive to DNA damage caused by IR and UV 
and also to treatment with the DNA damaging agents MMS and HU. In this chapter I will 
investigate the localisation of the Rad60 protein in the rad60-ct mutant strain. For 
simplicity, I will refer to the C-terminally truncated Rad60 protein in this strain as ‘Rad60-
ct’. 
 
5.2 Deletion of the C-terminal 73 amino acids results in mis-localisation of the  
 Rad60 protein. 
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5.2.1  Creating C-terminally GFP-tagged Rad60 and Rad60-ct strains  
To determine whether deletion of SLD2 affects the localisation of this protein, C-terminally 
GFP-tagged rad60 and rad60-ct strains were constructed using the one-step PCR-based 
gene disruption method (Bahler, Wu et al. 1998). The one-step PCR-based gene disruption 
method uses long primers containing 80 nucleotides of gene-specific sequence and 20 
nucleotides of sequence homologous to the pFA6a-GFP(S65T)-kanMX6a template 
plasmid.  
 
Primer pairs L34 and L27, and L33 and L27 were used to PCR out the gene specific 
cassette for the rad60 and rad60-ct GFP-tagged strains respectively. The gene specific 
sequences of these forward primers L33 and L34 correspond to 80 nucleotides immediately 
upstream of the sites at which the tag is to be placed, omitting the stop codon. In the reverse 
primer, L27, the gene-specific sequence corresponds to 80 nucleotides immediately 
downstream of the rad60 stop codon. The primer pairs were used to amplify an ~3.6 kb 
heterologous kanMX6 module from the pFA6a-GFP(S56T)-kanMX6 plasmid. The 
products of 5 PCRs were pooled (~20 µg) and gel extracted to a volume of 20 µl. The DNA 
was transformed directly into haploid wild-type cells (sp.011) using the Bahler 
transformation protocol (Bahler, Wu et al. 1998). Cells were plated onto YEA plates and 
grown for 24 hours at 30oC before being replica plated onto YEA plates containing 100 
µg/ml G418. The replica plates were incubated at 30oC for 72 hours and large colonies 
were re-streaked onto fresh YEA plates containing G418. Colony PCR, with primers L17 
and L96, was used to screen transformants for successful integration (Figure 5.1A). The 
forward primer, L17, anneals within the rad60 gene and reverse primer, L96, anneals 
within the kanMX6 cassette to give a PCR product of ~940 bp and ~710 bp for colonies 
containing the full-length, and C-terminally truncated copy of the rad60 gene respectively. 
Since the primer sequence of L96 includes the BamHI and PacI sites of the multiple 
cloning site of pFA6a, which is included at the 5’ end of both the kanMX6 and 
GFP(S56T)-kanMX6 cassettes, colony PCRs with rad60-FL and rad60-ct strains were 
carried out as positive controls and with the wild-type strain as a negative control. As 
expected, no bands were amplified for wild-type cells. The C-terminally GFP-tagged 
strains were named rad60-FL-GFP (sp.1307) and rad60-ct-GFP (sp.1306).  
Figure 5.1: Creating C-terminally GFP-tagged rad60-ct and rad60-FL strains 
 
C-terminally GFP-tagged rad60-FL and rad60-ct strains were created using the one-
step PCR based gene disruption method. (A) Colony PCR with primers L17/L96 
confirmed integration of the kanMX6 cassette in the rad60-FL-GFP and rad60-ct-GFP 
cells. (B) TCA extracts from rad60-FL-GFP and rad60-ct-GFP were separated by 10% 
SDS-PAGE and analysed by Western blotting with anti-GFP antibody. (C) Comparison 
of the HU and MMS sensitivity of tagged and untagged rad60-FL and rad60-ct cells. 
Cells were grown at 30oC in YE medium to mid-exponential phase. 10 µl of 10 fold 
serial dilutions were spotted onto YEA plates containing supplements at the indicated 
doses. Plates were incubated at 30oC for 72 hours and photographed. 
Figure 5.1: Creating C-terminally GFP-tagged rad60-ct and rad60-FL strains
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To ensure that integration had occurred at the correct site and no mutations had been 
introduced, sequencing across the integration junction was required. Genomic DNA was 
extracted from the positive colonies and the region surrounding the junction site was 
amplified by PCR from the genomic DNA with primers L41 and L96. Sequencing with 
primers L18 confirmed correct integration of the GFP(S56T)-kanMX6 cassette in the 
rad60-ct-GFP and rad60-FL-GFP strains.  
 
To confirm that the Rad60-GFP and Rad60-ct-GFP protein is stable, TCA extracts from 
rad60-FL-GFP and rad60-ct-GFP were Western blotted with anti-GFP antibody (Figure 
5.1B). A band of ~95 kDa was observed for the full-length protein (Rad60-FL-GFP). 
Rad60 has a predicted molecular weight of 46 kDa, but consistently runs at a mass of ~60 
kDa when separated by SDS-PAGE (Chapter 4). Since the GFP-tag is ~35 kDa, I would 
expect the Rad60-GFP protein to run at ~95 kDa. A smaller band of ~85 kDa was observed 
for the C-terminally truncated protein (Rad60-ct-GFP).  Since the HA-tagged Rad60-ct 
expressed by TNT migrates with at mass of ~50 kDa (Chapter 4), I would expect the 
Rad60-ct-GFP protein to be ~80 kDa. The Rad60-ct-GFP and Rad60-FL-GFP proteins 
were expressed at similar levels. This suggests that both proteins are stable when C-
terminally tagged with GFP.  
 
To ensure C-terminal tagging does not affect the function of the Rad60/Rad60-ct protein, 
the sensitivities of rad60-FL-GFP and rad60-ct-GFP cells were tested and compared to 
those of both wild-type and rad60-ct cells (Figure 5.1C). The sensitivities of rad60-FL-
GFP and rad60-ct-GFP cells to HU and MMS are similar to that seen for wild-type and 
rad60-ct cells respectively. This suggests that C-terminal tagging of Rad60 does not affect 
Rad60 protein function.  
 
5.2.2  Rad60-ct is mis-localised 
To compare the nuclear localisation of Rad60 and Rad60-ct, exponentially growing cells 
were fixed in methanol and stained with DAPI. Cells were visualised using the Deltavision 
microscope. A large proportion of the GFP signal co-localises with DAPI-stained 
chromosomal DNA (Figure 5.2). This suggests that the majority of the GFP-tagged Rad60 
Figure 5.2: Deletion of the C-terminal 73 amino acids results in mis-localisation 
of the Rad60 protein 
 
Comparison of Rad60 localisation in rad60-FL-GFP and rad60-ct-GFP cells. Cells 
were grown at 30oC in EMM2 medium supplemented with adenine, leucine and uracil. 
1 ml exponentially growing cells were fixed with methanol and stained with DAPI. 
Cells were observed using an Applied Precision Deltavision Spectris microscope using 
deconvolution software. 
Figure 5.2: Deletion of the C-terminal 73 amino acids results in mis-localisation 
of the Rad60 protein.
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protein is localised within the nucleus and is consistent with previous studies (Morishita, 
Tsutsui et al. 2002; Boddy, Shanahan et al. 2003). However, the GFP signal from the 
rad60-ct-GFP cells is pan-cellular (Figure 5.2). This suggests that deletion of the C-
terminal 73 amino acids (SLD2) results in the mis-localisation of the Rad60 protein. 
 
Rad60 exits the nucleus both upon treatment of cells with HU and by over-expressing cds1 
(Boddy, Shanahan et al. 2003). To confirm that the C-terminally GFP-tagged Rad60 
protein behaves in the same way, exponentially growing cells were treated with 20 mM HU 
for 4 hours before being visualised under the microscope. Treatment of cells with HU 
results in the dispersal of Rad60 from the nucleus (Figure 5.3). This further suggests that C-
terminally tagging Rad60 with GFP does not affect protein function.  
 
5.3 N-terminal tagging Rad60 affects protein localisation 
To eliminate the possibility that mis-localisation of the Rad60-ct protein is an artefact of 
the C-terminal GFP tagging, N-terminally GFP tagged rad60-FL and rad60-ct strains were 
generated using the Cre-loxP method (Werler, Hartsuiker et al. 2003). The Cre-loxP 
method allows essential genes to be N-terminally tagged at their genomic locus and under 
the control of their native promoter.  
 
To integrate the tagged gene at the correct locus three PCRs were first carried out. Firstly a 
~2.5 kb fragment containing the GFP tag and sup3-5 marker upstream of the nmt promoter 
was amplified from the pGEM-EGFP template plasmid using primers L94/L91 (Figure 
5.4A). A second PCR using primer pair L75/L80 amplified a fragment from gDNA with 
~500 bp homology to the region immediately upstream of the rad60 ATG and included a 
24 bp region of homology to the 5’ region of the ~2.5 kb fragment (Figure 5.4B). A third 
PCR using primer pairs L72/L73 and L72/L88 (for rad60 and rad60-ct respectively) 
amplified a fragment from genomic DNA with at least 500 bp homology to the rad60 gene 
and 24 bp homology to the 3’ region of the ~2.5 kb fragment (Figure 5.4C). Primers 
L72/L73 were used to amplify a ~500 bp fragment starting from the rad60 ATG. Primers 
L72/L88 were used to amplify a ~1kb fragment that includes codon 1-333 of rad60, 
followed by a stop codon to truncate the protein. The products of the three PCR reactions 
Figure 5.3: Rad60-GFP is able to delocalise from the nucleus following 
replication stress 
 
rad60-FL-GFP and rad60-ct-GFP were grown at 30oC in EMM2 medium 
supplemented with adenine, leucine and uracil. Exponentially growing cells were 
treated with 20 mM HU for four hours. 1 ml cells were fixed in methanol and stained 
with DAPI. Cells were observed using an Applied Precision Deltavision Spectris 
microscope using deconvolution software. 
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Figure 5.3: Rad60-GFP is able to delocalise from the nucleus following 
replication stress
Figure 5.4: N-terminal GFP-tagging of Rad60 and Rad60-ct  
 
N-terminally GFP tagged rad60-FL and rad60-ct strains were generated using the Cre-
loxP method (Werler et al, 2003). To integrate the tagged gene at the correct locus three 
PCRs were first carried out. (A) A ~2.5 kb fragment containing the GFP tag and sup3-5 
marker upstream of the nmt1 promoter was amplified from the pGEM-EGFP template 
plasmid (B) A fragment with ~500 bp homology to the region immediately upstream of 
the rad60 ATG and included a 24 bp region of homology to ~ 2.5 kb fragment was 
amplified from genomic DNA. (C) A fragment with ~500 bp homology to the rad60 
gene and 24 bp homology to the ~ 2.5 kb fragment was amplified from genomic DNA. 
(D) The PCR products were fused together in a fusion PCR to yield a linear gene-
specific cassette. (E) The cassette was transformed into wild-type S. pombe cells 
allowing homologous integration to occur.  Positive colonies were transformed with the 
pREP2-Cre recombinase plasmid (pPW7). The Cre-recombinase allows excision of the 
nmt1 promoter between the two loxP sites, leaving the GFP tagged gene under the 
control of its native promoter. An arrow indicates PCR products of the correct sizes. 
Figure 5.4: N-terminal GFP-tagging of Rad60 and Rad60-ct
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were gel extracted to a final volume of 50 µl. The PCR products were use for fusion PCR 
to yield a linear gene-specific cassette for homologous integration into wild type S. pombe. 
Primers L75 and L73/L88 were used to amplify a ~3.5 kb/ ~4 kb linear product for rad60 
and rad60-ct respectively (Figure 5.4D). 
 
The linear gene-specific cassette was transformed into wild-type S. pombe cells using the 
Bahler transformation protocol (Bahler, Wu et al. 1998). Since the sup3-5 marker of the 
integrated cassette can suppress the ade6-704 nonsense mutation in the wild-type S. pombe 
strain, positive transformants were grown on YNB medium supplemented with leucine and 
uracil and ade+ transformants were selected. Colony PCR with primers L31 and L79 was 
used to screen transformants for successful homologous integration. The forward primer, 
L31, anneals upstream of the rad60 start codon, and reverse primer, L79, anneals 
downstream of the rad60 start codon. If the GFP tag failed to be incorporated a PCR 
product of ~0.8 kb was observed. A PCR product of ~3.3 kb indicated that the GFP tagging 
construct (~2.5 kb) had been successfully integrated upstream of the rad60 start codon. 
Positive colonies were transformed with the pREP2-Cre recombinase plasmid (pPW7). 
Transformants were selected on YNB plus leucine and adenine (10 µg/ml). The YNB 
medium contained no thiamine to allow expression of the Cre Recombinase from the nmt1 
promoter of the pPW7 plasmid. The Cre-recombinase allows excision of the nmt1 promoter 
between the two loxP sites, leaving the GFP-tagged gene under the control of its native 
promoter (Figure 5.4E). Red/white selection was used to select for loss of the sup3-5 
marker, which leads to the formation of red colonies. Red colonies were re-streaked on 
YEA plates to promote loss of the pPW7 plasmid. Genomic DNA was extracted from the 
positive colonies and the region surrounding the junction site was PCR amplified from the 
genomic DNA with primers L72 and L96. Sequencing with primers L177, L178 confirmed 
correct integration of the GFP tagging cassette in the GFP-rad60-FL and GFP-rad60-ct 
strains. 
 
To ensure that N-terminal tagging does not affect the function of the Rad60/Rad60-ct 
proteins, the sensitivities of GFP-rad60-FL and GFP-rad60-ct cells were tested and 
compared to those of both wild-type and rad60-ct cells and to the C-terminally GFP-tagged 
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strains rad60-FL-GFP and rad60-ct-GFP (Figure 5.5A). Whilst lower doses of HU and 
MMS should havealso been tested, the sensitivity of GFP-rad60-FL and GFP-rad60-ct 
cells to HU and MMS is similar to that seen for wild-type and rad60-ct cells respectively. 
This suggests that N-terminal tagging of Rad60 does not affect Rad60 protein function. 
However, when the GFP-rad60-FL cells are visualised using the Deltavision microscope, 
Rad60 does not localise to the nucleus, as previously published (Morishita et al, 2002; 
Boddy et al, 2003). Instead, the GFP signal is dispersed throughout the cell (Figure 5.5B). 
Due to the observation that the GFP-rad60-FL cells have a wild-type phenotype in 
response to HU and MMS, it is possible that the GFP-tag is unstable and may be cleaved 
from the Rad60 protein, resulting in the pan cellular signal. To test this, TCA extracts taken 
from wild-type, rad60-FL-GFP and GFP-rad60-FL cells were Western blotted and probed 
with anti-GFP antibody (Figure 5.5C). In the negative control (wild-type), no GFP signal 
was detected. In the positive control (rad60-FL-GFP) a band running at approximately 95 
kDa was observed. Since Rad60 runs at approximately 60 kDa in yeast extracts and the 
GFP-tag is ~35 kDa this is the expected band size for Rad60 tagged with GFP. A band of 
the same size can be seen for the TCA extract taken from the GFP-rad60-FL cells. 
Therefore it can be assumed that, like the C-terminally tagged Rad60 protein, the N-
terminally tagged Rad60 protein is stable. This does not explain the mis-localisation. Since 
the GFP-Rad60-FL protein does not show the correct localisation, N-terminally tagged 
Rad60-ct cannot be used to confirm the mis-localisation of the Rad60-ct protein. 
 
5.4 Rad60 antibody production 
To eliminate the possibility that the mis-localisation of the Rad60-ct protein is an artefact 
of the C-terminal GFP tagging an attempt to generate a Rad60-specific antibody was 
carried out. In addition to allowing visualisation of the untagged protein by 
immunofluorescence, a Rad60-specific antibody would allow more intricate biochemical 
studies to be undertaken. To obtain Rad60 antisera, ~600 µg of Rad60 antigen was required 
to inoculate two host rabbits. Prior to carrying out large-scale protein purification, the best 
conditions for Rad60 protein expression and solubility were determined.  
 
Figure 5.5: N-terminal GFP-tagging of Rad60 gives a mutant phenotype 
(A) N-terminally GFP-tagged cells do not show a DNA-damage sensitive phenotype. 
Cells were grown at 30oC in YE medium to mid-exponential phase. 10 µl of 10 fold 
serial dilutions were spotted onto YEA plates containing supplements at the indicated 
doses. Plates were incubated at 30oC for 72 hours and photographed. (B) N-terminally 
GFP-tagged Rad60 does not show nuclear localisation. GFP-rad60-FL cells were 
grown at 30oC in EMM2 medium supplemented with adenine, leucine and uracil, with 
and without 20 mM HU. 1 ml of exponentially growing cells were harvested, washed 
and re-suspended in 100 µl EMM2 medium and stained with Hoechst. Cells were 
visualised using an Applied Precision Deltavision Spectris microscope using 
deconvolution software. (C)TCA extracts were taken from wild-type, rad60-FL-GFP 
and GFP-rad60-FL cells. Proteins were separated on a 10% SDS-PAGE gel and 
visualised by Western blotting with anti-GFP antibody 
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5.4.1  Determining the optimum conditions for Rad60 protein expression and 
 solubility  
Rad60 protein was expressed from the pGEX-rad60 construct (Gift from I. Miyabe, 
University of Sussex), which places a 26 kDa GST tag at the N-terminus of the protein. To 
test different conditions for expression of the GST-tagged fusion protein (GST-Rad60), the 
pGEX-rad60 construct was transformed into E. coli BL21(DE3) cells. and 5 10 ml cultures 
were grown at 37oC, with shaking until an A595 reading of ~0.6 was reached. At this point 1 
ml of each culture (non-induced) was removed and placed in a fresh tube. Cells in the 
remaining 9 ml culture were induced with 0.3, 0.5 or 5 mM IPTG.  The cultures were 
grown with the non-induced samples for a further 1 or 3 hours at 37oC. 1 ml of each culture 
harvested and the soluble and insoluble fractions collected. Samples were analysed by 10% 
SDS-PAGE with Coomassie staining and Western blotting with anti-GST antibody. When 
protein expression is induced with 0.3 mM IPTG for 3 hours, a strong ~75 kDa band can be 
detected by Coomassie staining in the insoluble fraction (Figure 5.6A, bottom panel). This 
band is absent in the non-induced sample, suggesting that it corresponds to the GST-Rad60 
protein. Rad60 has a predicted molecular weight of 46 kDa but runs at ~60 kDa in both S. 
pombe extracts and when translated using with the rabbit reticulocyte TNT kit (Chapter 4). 
I would therefore expect the GST-tagged Rad60 to run at ~86 kDa (~60 kDa + 26 kDa). 
Western blotting with anti-GST antibody confirms that the ~75 kDa band observed by 
Coomassie staining corresponds to the GST-Rad60 protein (Figure 5.6A, bottom panel). 
This suggests that in bacterial cells Rad60 migrates at its predicted size of ~46 kDa. The 
Rad60-GST expression level is not increased for cells induced with 3 mM IPTG for 1 hour 
compared with 3 hours. The effect of inducing cells with different IPTG concentrations on 
Rad60 expression was also tested. Induction of cells with 0.5 mM IPTG did not improve 
the Rad60 expression levels as compared to induction with 0.3 mM IPTG. However, 
following induction of cells with 5 mM IPTG, GST-Rad60 was found in both the soluble 
and insoluble fractions. Since the purification of proteins is much simpler to carry out from 
the soluble fraction, the induction conditions chosen for the large-scale protein purification 
were 3 hours induction with 5 mM IPTG.  
 
 
Figure 5.6: Expression and purification of Rad60 antigen for production of 
Rad60 antibodies  
 
(A) Determining the optimum conditions for Rad60 protein expression and solubility.  
BL21 (DE3) cultures carrying the pGEX-rad60 vector were grown at 37oC until an A595 
reading of ~0.6 was reached. Cells were induced with IPTG at the indicated 
concentration and grown at 37oC for one or three hours. Cells were harvested and the 
insoluble and soluble fractions were analysed by 10% SDS-PAGE with Coomassie 
staining (Lower panel) and Western blotting with anti-GST antibody (Upper panel). (B 
and C) Large-scale purification of Rad60. BL21(DE3) cells, carrying the pGEXrad60 
construct, were cultured at 37oC until an A595 reading of ~0.6 was reached. Cells were 
induced with IPTG at a final concentration of 5mM for 3 hours. GST-Rad60 was 
purified on glutathione-sepharose beads. Following elution, the GST-tag was removed 
from the Rad60 protein by thrombin cleavage. (B) 5 µl of the protein sample was 
analysed by 10% SDS-PAGE (lane 1) as compared to a control purification from cells 
carrying the empty pGEX vector (lane 2). An arrow indicates Rad60. (B) The Rad60 
protein sample was concentrated to a volume of ~500 µl and run on a large 10% SDS-
PAGE gel alongside 10, 50 and 100 µg BSA standards (C). Following Coomassie 
staining the Rad60 gel bands were excised. 
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Figure 5.6: Expression and purification of Rad60 antigen for production of 
Rad60 antibodies 
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5.4.2  Large-scale purification of Rad60 
Having identified the best conditions for expression of GST-Rad60, 6 litres of BL21(DE3) 
cells, carrying the pGEXrad60 construct, were cultured at 37oC until an A595 reading of 0.6 
was reached. The cells were induced with IPTG at a final concentration of 5mM and grown 
for a further 3 hours at 37oC. The GST-Rad60 protein was purified from the cell extract 
with glutathione-sepharose beads. GST-Rad60 was eluted from the beads with 3 x 250 µl 
elution buffer. Following elution, the GST-tag was removed from the Rad60 protein by 
thrombin cleavage. 5 µl of the protein sample was analysed by 10% SDS-PAGE (Figure 
5.6B). When visualised by Coomassie staining two bands of ~45 and ~70 kDa were 
observed in the Rad60 protein sample (lane 1). The smaller band of ~45 kDa corresponds 
with the predicted size of the untagged Rad60 protein. In a control purification where cells 
were transformed with the empty pGEX vector (lane 2), only the larger ~70 kDa band is 
present. This suggests that this is a non-specific band from the E. coli cells. The Rad60 
protein sample was concentrated to a volume of ~500 µl and loaded onto a large 10% SDS-
PAGE gel (Figure 5.6C). To help determine Rad60 protein concentration, 10, 50 and 100 
µg BSA standards were also loaded. Following Coomassie staining, four bands of strong 
intensity could be detected. These bands correspond to the Rad60 protein at ~45 kDa, the 
cleaved GST-tag at ~26 kDa and the non-specific E. coli band at ~70 kDa. The source of 
the fourth band at ~30 kDa is unknown. With reference to the BSA standard, ~150-200 µg 
Rad60 was purified from the 6 litre culture. To ensure enough protein for antibody 
production, a further 12 litre purification was carried out. The Rad60 bands were carefully 
excised from the gel and sent to Eurogentec for generation of the Rad60 antibody.  
 
5.4.3  Testing and purifying the anti-Rad60 antisera 
Over a three month period, two host rabbits were injected with ~100 µg Rad60 antigen on 
three separate occasions. Antisera were then collected and returned by Eurogentec. The 
ability of the crude antisera to recognise the Rad60 protein was tested. TCA extracts of 
wild-type cells transformed with the empty pREPHA41 vector and the pREPHA41rad60 
construct analysed on a 10% SDS-PAGE gel, Western blotted and probed with 1:100, 
1:500 and 1:1000 dilutions of the crude anti-Rad60 antisera (Figure 5.7A). A strong signal 
at ~60 kDa was detected in the lanes containing TCA extracts taken from cells exogenously 
Figure 5.7: Testing the anti-Rad60 antibodies 
 
TCA extracts of wild-type cells carrying the empty pREPHA41 vector (-) and the 
pREPHA41rad60 (+) construct were run on a 10% SDS-PAGE gel and analysed by 
Western blotting with 1:100, 1:500 and 1:1000 dilutions of the crude anti-Rad60 
antisera and 1:2000 anti-His antibody. Rad60 is indicated with an arrow. (B) anti-Rad60 
antisera were affinity-purified against His-Rad60. Purified His-Rad60 was run on a 10% 
SDS-PAGE gel and Western blotted with a 1:1000 dilution of the crude antisera (lane 
1), 1:100 dilutions of the purified anti-Rad60 antibody fractions (lanes 2-7), and a 
1:2000 dilution of the anti-His antibody (Lane 8). His-Rad60 is indicated with an arrow. 
(C) Wild-type cells were grown at 37oC and fixed. Cells were stained with anti-Rad60 
(1:100) and anti-tubulin  (1:1000) primary antibodies which were detected with 1:100 
swine anti-rabbit(TRITC) and 1:100 goat anti-mouse(FITC) secondary antibodies and 
then stained with DAPI. Cells were visualised using an Applied Precision Deltavision 
Spectris microscope using deconvolution software 
Figure 5.7: Testing the anti-Rad60 antibodies
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expressing Rad60. The intensity of the signal was greater with the antisera from ‘Rabbit 1’ 
than ‘Rabbit 2’. In lanes containing TCA extracts taken from cells expressing Rad60 at 
endogenous levels, only a very faint band can be detected at ~60 kDa by Rabbit 1. Antisera 
from Rabbit 2 were unable to detect this band.  
 
Affinity purification was carried out in an attempt to increase the specificity of the anti-
Rad60 antibody. Since the Rad60-antibody was made by injecting thrombin-cleaved GST-
Rad60, purifying the antisera against His-Rad60 should enhance the level of purification as 
antibodies raised against the GST protein would not be purified. rad60 was subcloned from 
the pREP41HArad60 construct into the pET15B vector, which places a His6-tag at the N-
terminus of the Rad60 protein. Since SalI and XhoI restriction sites share compatible ends, 
rad60 was subcloned as an NdeI/SalI fragment into the NdeI/XhoI sites of pET15B. His-
Rad60 protein (purified by F. Z. Watts, University of Sussex) was immobilised using the 
AminoLinkPlus Coupling Gel kit (PIERCE Biotechnology). Crude Rad60 antisera were 
incubated overnight on the His-Rad60 affinity column. Flow-through was analysed by 
Bradford assay to confirm the Rad60 antibody had bound to the column. After extensive 
washing, bound antibody was eluted with 100 mM glycine, pH 2.3 and 500 µl fractions 
were collected. Analysis of the collected fractions by Bradford assay identified six 
antibody-containing fractions. The purified anti-Rad60 antibody fractions were tested to 
assess their specificity. Purified His-Rad60 (F. Z. Watts, University of Sussex) was run on 
a 10% SDS-PAGE gel and Western blotted. When probed with the crude antisera (Figure 
5.7B, lane 1), a strong signal was detected at ~50 kDa, corresponding to His-Rad60. This 
was confirmed by probing with an anti-His antibody (Lane 8). In addition, a number of 
faster migrating bands were observed. These may be non-specific bands of the anti-sera or 
may correspond to degradation products of the His-Rad60 protein. When the His-Rad60 
blot was probed with the purified Rad60 antibody fractions (lanes 2-7), no signal was 
detected with antibody from fraction 1 (lane 2). The His-Rad60 was detected by antibody 
from fractions 2-6 (lanes 3-7) but the signal was not greater, nor more specific, than the 
signal seen for the crude antisera (pre-affinity purification). Given that the His-Rad60 
protein had already been purified the number of non-specific bands to be detected should 
be low. The purified antibodies were therefore tested on TCA extracts from cells 
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expressing Rad60 at both endogenous and exogenous levels. As is the case for the crude 
antisera, the purified antibodies strongly detected the exogenously expressed protein and 
only a very faint band was observed at a size consistent with the endogenous protein (data 
not shown). However, when the antibodies were tested on TCA extracts taken from rad60-
ct cells in which a truncated form of rad60 is expressed at endogenous levels, the band did 
not shift. This suggests that the band seen for the endogenously expressed Rad60 protein is 
non-specific. In addition, TCA extracts were taken from cells treated with either 20 mM 
HU, 0.01% MMS or 250 Gy and probed with the purified antibodies to test whether Rad60 
expression is cell-cycle specific or DNA damage induced. No increase in signal was 
detected (data not shown). Together this suggests that the purified antibodies cannot be 
used to detect endogenous levels of Rad60 by Western blotting. 
 
Since the primary reason for creating the anti-Rad60 antibodies was for use in 
immunofluorescence, their ability to be used to image cells was tested. Fractions 4, 6 and 7 
were pooled and concentrated to ~100 µl. Exponentially growing wild-type cells were fixed 
and incubated overnight with primary anti-Rad60 (1:100) and anti-tubulin (1:1000) 
antibodies. Following extensive washing, cells were incubated with swine-anti-
rabbit(TRITC) and goat-anti-mouse(FITC) secondary antibodies and then stained with 
DAPI. Cells were then visualised under the microscope (Figure 5.7C). Tubulin staining of 
the microtubules suggests that the immunofluorescence protocol worked. However, the 
signal from the anti-Rad60 antibody is dispersed throughout the cell and is not nuclear, as 
seen by the DAPI staining. This suggests that the purified Rad60 antibodies are unsuitable 
for use in immunofluorescence as well as Western blotting. Further purification of the anti-
Rad60 antibodies is therefore required. 
 
5.5  Mis-localisation of Rad60-ct is not the result of constitutive activation of 
 Cds1  
Activation of the S-phase checkpoint kinase Cds1 causes hyper-phosphorylation and 
concomitant delocalisation of Rad60 from the nucleus (Boddy, Shanahan et al. 2003). To 
determine whether the mis-localisation of the Rad60-ct protein is due to constitutive 
activation of Cds1 in rad60-ct cells, the localisation of the Rad60 and Rad60-ct protein was 
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observed in the absence of Cds1. rad60-FL-GFP and rad60-ct-GFP were therefore 
introduced into a cds1-d background. As anticipated, Rad60 is localised within the nucleus 
of the cds1-d cells (Figure 5.8). However, as seen for the rad60-ct-GFP cells, Rad60-ct is 
distributed throughout the cell in the cds1-d background (Figure 5.8). This suggests that the 
mis-localisation observed for Rad60-ct is not the result of constitutive activation of Cds1 
 
The delocalisation of Rad60 from the nucleus is S-phase specific and is not observed in G2 
cells treated with IR (Boddy, Shanahan et al. 2003). Inactivation of Rad60 leads to a Chk1 
dependent checkpoint arrest (Boddy, Shanahan et al. 2003). Given that rad60-ct cells have 
a DNA damage sensitive phenotype, it is likely that the role of Rad60 in the DNA damage 
response is compromised (Chapter 3). Therefore, the localisation of Rad60 and Rad60-ct, 
was examined in a chk1-d background (Figure 5.9). Rad60-ct is distributed throughout the 
cell in the chk1-d background, suggesting that the mis-localisation of Rad60-ct in rad60-ct 
cells is not the result of constitutive activation of Chk1. Interestingly, in the chk1-d 
background, Rad60 is not nuclear. This may suggest that Chk1 has a role in maintaining 
Rad60 in the nucleus.  
 
5.6  Provision of a nuclear localisation signal restores wild-type localisation to 
 Rad60-ct but does not rescue the DNA damage sensitive phenotype 
Having established that Rad60-ct mis-localisation is not due to a function of the checkpoint 
kinase Cds1, the question of what is causing the mis-localisation is posed. One possibility 
is that the main role of SLD2 is in localising Rad60 to the nucleus. If this theory is correct, 
by re-establishing nuclear localisation of Rad60, a wild-type DNA damage response should 
be restored. To test this possibility, a nuclear localisation signal (NLS) was incorporated at 
the C-terminus of the truncated Rad60-ct protein. The SV40 large T-antigen NLS, 
(PKKKRKV) has previously been shown to be functional in S. pombe and therefore must 
be recognised by the S. pombe importins (Shiozaki and Yanagida 1992). The nucleotide 
sequence encoding the SV40 NLS was incorporated at the 3’ end of the rad60-ct coding 
sequence by PCR amplification from S. pombe gDNA using primers L41 and L74. The 
forward primer, L41, is designed to introduce an NdeI restriction site immediately before 
the ATG start codon. The reverse primer, L74, is designed to introduce the nucleotide 
Figure 5.8: Mis-localisation of Rad60-ct is not the result of constitutive 
activation of Cds1  
 
rad60-FL-GFP cds1-d and rad60-ct-GFP cds1-d were grown at 30oC in EMM2 
medium supplemented with adenine, leucine and uracil. 1 ml of exponentially growing 
cells were harvested, washed and re-suspended in 100 l EMM2 media and stained with 
Hoechst. Cells were visualised using an Applied Precision Deltavision Spectris 
microscope using deconvolution software. 
HOECHST MERGE
rad60-FL-GFP 
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Figure 5.8: Mis-localisation of Rad60-ct is not the result of constitutive 
activation of Cds1
Figure 5.9: Mis-localisation of Rad60-ct is not the result of constitutive 
activation of Chk1 
 
rad60-FL-GFP chk1-d and rad60-ct-GFP chk1-d were grown at 30oC in EMM2 
medium supplemented with adenine, leucine and uracil. 1 ml of exponentially growing 
cells were harvested, washed and re-suspended in 100 l EMM2 media and stained with 
Hoechst. Cells were visualised using an Applied Precision Deltavision Spectris 
microscope using deconvolution software. 
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Figure 5.9: Mis-localisation of Rad60-ct is not the result of constitutive 
activation of Chk1
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sequence encoding the SV40 NLS immediately after codon 333 of rad60, followed by a 
SalI restriction site. The PCR product was digested and cloned directly into the 
pREP41EGFP(C) expression vector, as an NdeI/SalI fragment. This places the EGFP 
tagging sequence downstream of the rad60-ctNLS fusion .  
 
To examine the localisation of the Rad60-ctNLS protein, the pREP41EGFP(C)rad60-ctNLS 
construct was transformed into wild-type cells. Expression from the nmt1 promoter was de-
repressed by growing cells for ~16 hours in the absence of thiamine. Exponentially 
growing cells were visualised using the deltavision microscope. The Rad60-ctNLS protein 
is located within the nucleus (Figure 5.10). Nuclear localisation is confirmed by the co-
localisation of the EGFP signal with the Hoechst signal. Wild-type cells were also 
transformed with pREP41 EGFP(C)rad60, pREP41 EGFP(C)rad60-ct and the empty 
pREP41EGFP(C) vector as controls. Similar to the cellular localisation pattern seen for 
Rad60 and Rad60-ct at endogenous levels (Section 5.2), exogenously over-expressed 
Rad60 is located in the nucleus while Rad60-ct is dispersed throughout the cell. However, 
it should be noted that the signal detected in the nucleus from the exogenously expressed 
Rad60 is much stronger than that of of the endogenously expressed Rad60. The pan-
cellular localisation of the EGFP tag alone confirms that the nuclear localisation of the 
Rad60-ctNLS protein is not the result of the EGFP tag. To test whether the Rad60-ctNLS 
protein is able to delocalise from the nucleus under regulation of Cds1, exponentially 
growing cells were treated with 20 mM HU for 4 hours. Following HU treatment, the 
Rad60-ctNLS protein fails to delocalise from the nucleus (Figure 5.10). Unfortunately, 
unlike the endogenous Rad60 (Section 5.2.2), exogenously expressed Rad60 also failed to 
delocalise following HU treatment, highlighting a difference between the behaviour of 
endogenously and exogenously expressed Rad60 protein. For this reason it cannot be 
concluded whether the Rad60-ctNLS protein would be able to delocalise. The differences 
observed for endogenous and exogenous Rad60 suggest that studies using over-expression 
of the Rad60 protein may not be biologically significant. Studies at endogenous levels are, 
therefore, required todetremine if Rad60-ctNLS is capable of HU induced nuclear 
delocalisation.  
 
Figure 5.10: Both the provision of a nuclear localisation signal and substitution of 
Rad60 SLD2 with authentic SUMO are capable of restoring wild-
type localisation to Rad60-ctWild-type cells expressing EGFP, Rad60, 
Rad60-ct, Rad60-ctNLS and Rad60-ctPmt3 from the pREP41EGFP(C) vector were 
grown at 30oC in EMM2 medium supplemented with adenine, and leucine with and 
without 20 mM HU. 1 ml of exponentially growing cells were harvested, washed and 
re-suspended in 100 µl EMM2 medium and stained with Hoechst. Cells were visualised 
using an Applied Precision Deltavision Spectris microscope using deconvolution 
software
-HU +HU
EGFP HOECHST MERGE EGFP HOECHST MERGE
Rad60
Rad60-ctPmt3
EGFP
Rad60-ct
Rad60-ctNLS
Fig
u
re
 5
.10
:
B
oth
th
e
p
ro
visio
n
 of
 a
 n
u
clea
r
 lo
calisatio
n
 sig
n
al
 a
nd
 
sub
stitutio
n
 of
 R
ad60
 SLD
2
 w
ith
 a
uth
entic
 SU
M
O
 a
re
 cap
able
 
of
 resto
ring
 w
ild
-typ
e
 lo
calisatio
n
 to
 R
ad60
-ct
 127 
To test the hypothesis that by re-establishing nuclear localisation of Rad60, a wild-type 
DNA damage response should be restored, rad60-ctNLS was expressed in the rad60-ct 
background and the response to DNA damaging agents was tested (Figure 5.11). Wild-type 
and rad60-ct cells were transformed with the pREP41EGFP(C)rad60 (prad60), 
pREP41EGFP(C)rad60-ct (prad60-ct) and pREP41EGFP(C)rad60-ctNLS (prad60-ctNLS) 
constructs as well as the empty pREP41EGFP(C) vector (pEV) as a control. rad60-ct cells 
transformed with pEV, are sensitive to HU and MMS as compared to wild-type. The wild-
type phenotype is seen when wild-type cells are transformed with the empty vector. The 
HU and MMS sensitivity of rad60-ct cells is complemented when rad60-ct cells are 
transformed with prad60, but not prad60-ct. When rad60-ct cells are transformed with 
prad60-ctNLS, growth under normal conditions is impaired. In addition, rad60-ct cells 
expressing rad60-ctNLS are more sensitive to MMS and HU than rad60-ct cells 
transformed with pEV. This suggests that the expression of rad60-ctNLS has a dominant 
negative effect in rad60-ct cells. This dominant negative effect is also seen in wild-type 
cells, suggesting that the C-terminal 73 amino acids (SLD2) of Rad60 is not required just to 
localise Rad60 to the nucleus, but also for the DNA repair function of Rad60.  
 
5.6.1  Rad60 SLD2 is not capable of targeting EGFP into the nucleus 
Following the observation that the deletion of the C-terminal 73 amino acids results in the 
mis-localisation of Rad60 (Section 5.2), and that the addition of the SV40 NLS to the C-
terminal of the truncated protein is able to restore nuclear localisation (Section 5.6), the 
question was raised as to whether Rad60, and in particular the C-terminal SUMO-like 
domain of the protein, contains an NLS. A variety of NLSs have been experimentally 
characterised and bioinformatics software packages can be used to predict potential NLSs 
within a peptide sequence. Typically, NLSs consist of a few short sequences of positively 
charged residues (K/R). No such regions in Rad60 could be identified by eye. When the 
Rad60 peptide sequence was submitted to predictNLS 
(http://cubic.bioc.columbia.edu/predictNLS), no NLS sequences were identified.  
 
Given that the protein does not contain an NLS, it is possible that the C-terminal SLD2 of 
Rad60 is able to interact with proteins that facilitate nuclear import. The C-terminal region 
Figure 5.11: Neither the provision of a nuclear localisation signal nor substitution 
of Rad60 SLD2 with authentic SUMO are capable of rescuing the 
DNA damage sensitive phenotype of rad60-ct cells. 
The HU and MMS sensitivity of rad60-ct cells cannot be rescued by the expression of 
rad60-ctNLS or rad60-ctpmt3. Cells were grown at 30oC in YE medium to mid-
exponential phase. 10 µl of 10 fold serial dilutions were spotted onto YEA plates 
containing supplements at the indicated doses. Plates were incubated at 30oC for 72 
hours and photographed. 
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of Rad60 was therefore tested for its ability to localise EGFP to the nucleus. Under normal 
conditions, EGFP is known to be found throughout the cell and localises to both the 
nucleus and the cytoplasm by fusion to NLSs and NESs (nuclear export signals) 
respectively. The nucleotide sequence encoding amino acids 264-406 of Rad60 was PCR 
amplified from genomic DNA with primers L68 and L40. L68 was designed to place an 
NdeI restriction site immediately upstream of codon 264. L40 was designed to introduce a 
SalI restriction site immediately downstream of the Rad60 TAA stop codon. The 
rad60(264-406) nucleotide sequence was cloned directly into the pREP41EGFP(N) yeast 
expression vector as an NdeI/SalI fragment, which places an EGFP-tag at the N-terminus of 
the protein coded for (Figure 5.12A). The empty pREP41EGFP(N) vector and the 
rad60(264-406) construct were transformed into wild type S. pombe cells and protein 
localisation was visualised using the Deltavision microscope (Figure 5.12B). In cells 
expressing the Rad60(264-400), EGFP signal was also detected throughout the cell, 
suggesting that the C-terminus of Rad60 is not capable of  localising EGFP to the nucleus. 
Is it therefore unlikely that region has an NLS-like property. 
 
5.7  Substitution of Rad60 SLD2 with authentic SUMO restores wild-type 
 localisation to Rad60-ct but does not rescue the DNA damage sensitive 
 phenotype of rad60-ct cells 
Provison of the SV40 NLS to the C-terminal of the truncated Rad60-ct protein is able to 
restore nuclear localisation but not function of the Rad60 protein (Section 5.3). This 
suggests that SLD2 has a functional role in the DNA damage response. If Rad60 SLD2 
really is SUMO-like in structure and function replacing Rad60 SLD2 with authentic SUMO 
(Pmt3) should restore both nuclear localisation and Rad60 function should remain intact. 
To test this, a pREP41EGFP(C)rad60-ctpmt3 construct was created.  
 
The pREP41EGFP(C)rad60-ctpmt3 construct was created in a 5 step process. First, using 
pREPHA41rad60 as a template, primers L150 and L151 were used to introduce a SalI 
restriction site immediately after codon 333 of the rad60 coding sequence by site-directed 
mutagenesis. Second, using pREPHA41pmt3FL (Watts lab, University of Sussex) as a 
template, primers L117 and L118 were used to PCR amplify pmt3. Primer L117 was 
Figure 5.12: Rad60 SLD2 is not capable of targeting EGFP into the nucleus  
(A) Schematic to illustrate the Rad60, Rad60-ct and Rad60-264 (aa 264-406) proteins. 
(B) Wild-type cells expressing EGFP, and Rad60-264 (aa 264-406) from the 
pREP41EGFP(C) constructs were grown at 30oC in EMM2 medium supplemented with 
adenine and leucine. 1 ml of exponentially growing cells were harvested, washed and 
re-suspended in 100 µl EMM2 medium and stained with Hoechst. Cells were visualised 
using an Applied Precision Deltavision Spectris microscope using deconvolution 
software 
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Figure 5.12: Rad60 SLD2 is not capable of targeting EGFP into the nucleus 
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designed to introduce a SalI restriction site, immediately upstream of the ATG start codon. 
Primer L118 was designed to introduce a BamHI restriction site immediately downstream 
of codon 99 and upstream of the diglycine coding sequence. The PCR product was ligated 
directly into the pGEM-T Easy cloning vector. Third, the pREPHA41rad60(SalI) construct 
was digested with SalI/BamHI and the vector gel extracted. The SalI/BamHI digest excised 
the rad60 nucleotide sequence upstream of the newly introduced SalI restriction site. 
Fourth, the pmt3 coding sequence was subcloned as a SalI/BamHI fragment from the 
pGEM-T Easy vector into the SalI/BamHI digested pREPHA41rad60-ct construct. Fifth, 
the rad60-ctpmt3coding sequence was subcloned as an NdeI/BamHI fragment from 
pREPHA41 into the pREP41EGFP(C) vector, which places the EGFP tagging sequence 
downstream of the rad60-ctpmt3 sequence.  
 
To examine the localisation of the Rad60-ctPmt3 protein, the pREP41EGFP(C)rad60-pmt3 
construct was transformed into wild-type cells. Expression from the nmt1 promoter was de-
repressed by growing cells for ~16 hours in the absence of thiamine. Exponentially 
growing cells were imaged. The exogenously expressed Rad60-ctPmt3 protein is located 
within the nucleus (Figure 5.10). Nuclear localisation is confirmed by the co-localisation of 
the EGFP signal with Hoechst signal. Wild-type cells were also transformed with pREP41 
EGFP(C)rad60, pREP41 EGFP(C)rad60-ct and the empty pREP41EGFP(C) vector as 
controls. Similar to the cellular localisation pattern seen by Rad60 and Rad60-ct at 
endogenous expression levels (Section 5.2), Rad60, which is exogenously over-expressed 
is located in the nucleus, whilst Rad60-ct is dispersed throughout the cell. However, the 
signal detected in the nucleus for the exogenously expressed Rad60 is much stronger than 
that of the endogenous protein. The pan-cellular localisation of EGFP confirms that the 
nuclear signal observed is not an artefact of the EGFP tag. To test whether the Rad60-
ctPmt3 protein is able to delocalise from the nucleus under regulation of Cds1, 
exponentially growing cells were treated with 20 mM HU for 4 hours. Following HU 
treatment, the Rad60-ctPmt3 protein fails to delocalise from the nucleus (Figure 5.10). 
Unfortunately, unlike endogenous Rad60 (Section 5.2.2), exogenously expressed Rad60 
failed to delocalise from the nucleus following HU treatment. This difference in the 
endogenously and exogenously expressed Rad60 suggests that studies using over-
 130 
expression of Rad60 may not be biologically significant, and for this reason it cannot be 
concluded whether the Rad60-ctPmt3 protein is proficient for regulation by Cds1. Studies 
at endogenous levels are, therefore, required to answer this question. 
 
If Rad60 SLD2 is ‘SUMO-like’, replacing Rad60 SLD2 with authentic SUMO (Pmt3) 
should leave Rad60 function intact. To test this rad60-ctpmt3 was expressed in the rad60-ct 
background and the response to DNA damaging agents was tested (Figure 5.11). Wild-type 
and rad60-ct cells were transformed with the pREP41EGFP(C)rad60 (prad60), 
pREP41EGFP(C)rad60-ct (prad60-ct) and pREP41EGFP(C)rad60-ctpmt3 (prad60-ctpmt3) 
constructs, as well as the empty pREP41EGFP(C) vector (pEV) as a control. rad60-ct cells 
transformed with pEV, are sensitive to HU and MMS as compared to the wild-type cells 
transformed with the empty vector. As seen previously. the HU and MMS sensitivity of 
rad60-ct cells is complemented by expression of rad60 but not rad60-ct. When rad60-ct 
cells are transformed with prad60-ctpmt3, growth is impaired. In addition, rad60-ct cells 
expressing rad60-ctpmt3 are more sensitive to MMS and HU than rad60-ct cells 
transformed with pEV. This suggests that expression of rad60-ctpmt3 in rad60-ct cells has 
a dominant negative effect. This dominant negative effect is also seen in wild-type cells, 
suggesting that Pmt3 (SUMO) cannot functionally substitute for Rad60 SLD2. The 
dominant negative effect may be due to the inability of Rad60 to delocalise from the 
nucleus.  
 
5.8 Discussion 
Rad60 has been shown to be a nuclear protein (Morishita, Tsutsui et al. 2002; Boddy, 
Shanahan et al. 2003). Morishita et al first showed nuclear loaclisation of Rad60 by 
exogenously expressing an N-terminally tagged Rad60 from a modified nmt1 promoter on 
the pREP42 plasmid. However, when they attempted to express the N-terminally EGFP-
tagged Rad60 from the Rad60 promoter no signal was seen (Morishita, Tsutsui et al. 2002). 
Boddy et al later confirmed that Rad60 was localised to the nucleus during all cell stages 
using an endogenously expressed C-terminally 13myc-tagged Rad60 and showed that the 
C-terminally 13myc-tagged Rad60 delocalises from the nucleus following HU treatment 
(Boddy, Shanahan et al. 2003).  
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In this chapter I have investigated the localisation of the C-terminally truncated Rad60-ct 
protein. For this purpose, rad60-FLGFP and rad60-ctGFP strains expressing C-terminally 
GFP-tagged full-length and C-terminally truncated Rad60 protein, repectively, were 
created. Visualisation of the C-terminally GFP-tagged Rad60 protein, confirms previous 
observations that Rad60 is a nuclear protein (Morishita, Tsutsui et al. 2002; Boddy, 
Shanahan et al. 2003). However, the C-terminally GFP tagged Rad60-ct protein is found 
dispersed throughout the cell. Although epitope tagging is a valuable tool for studying a 
protein of interest, one of the problems associated with attaching a tag to a protein is the 
possibility that it may lead to a mutant phenotype. This may be because the tag alters the 
protein conformation, or disrupts a protein-protein or protein/DNA interaction important 
for function. Comparison of the sensitivity of C-terminally GFP-tagged rad60-FL and 
rad60-ct strains to a range of DNA damaging agents showed no significant difference as 
compared to their untagged counterparts. However, it is not impossible that tagging of the 
protein has resulted in subtle phenotypic differences that cannot be detected by survival 
studies. To eliminate the possibility that the mis-localisation of the Rad60-ct protein is one 
such difference, N-terminally GFP-tagged rad60-FL and rad60-ct strains were created. 
Unfortunately, the full-length N-terminally GFP-tagged Rad60 protein failed to localise to 
the nucleus as previously reported (Morishita, Tsutsui et al. 2002; Boddy, Shanahan et al. 
2003) and, as seen in this study for the C-terminally GFP-tagged Rad60. The mis-
localisation of the C-terminally GFP-tagged Rad60-ct protein could, therefore, not be 
confirmed by N-terminal tagging. Interestingly, whilst Morishita et al were able to show 
nuclear localisation of exogenously expressed N-terminally tagged Rad60, no signal was 
seen when they attempted to express the N-terminally tagged protein from the Rad60 
promoter (Morishita, Tsutsui et al. 2002). In a second attempt to eliminate the possibility 
that the mis-localisation of the Rad60-ct is an artefact of C-terminal GFP tagging, anti-
Rad60 antibodies were produced. However, the specificity of the antibody was not high 
enough to be used for immunofluorescence.  
 
Activation of the S-phase checkpoint kinase Cds1 causes hyper-phosphorylation and 
concomitant delocalisation of Rad60 from the nucleus (Boddy, Shanahan et al. 2003). In a 
cds1-d background Rad60-ct-GFP is observed throughout the cell. This suggests that mis-
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localisation of Rad60-ct-GFP is not the result of constitutive activation of Cds1. With the 
same reasoning, the mis-localisation of Rad60-ct is not the result of constitutive activation 
of Chk1. Unlike in the cds1-d background, Rad60-FL-GFP is not localised within the 
nucleus of chk1-d cells. Since the delocalisation of Rad60 from the nucleus is S-phase 
specific, and is not observed in G2 cells treated with IR, (Boddy, Shanahan et al. 2003), 
this may suggest that Chk1 has a role in maintaining Rad60 in the nucleus.  
 
Provision of a nuclear localisation signal to the Rad60-ct protein is capable of restoring 
wild-type localisation. However, expression of the Rad60-ctNLS protein in rad60-ct cells 
is unable to rescue the DNA damage sensitive phenotype of the rad60-ct cells and instead 
has a dominant negative effect in both wild-type and rad60-ct cells. Since a rad60-4 mutant 
unable to delocalise from the nucleus is proficient for the survival of UV-induced DNA 
damage (Boddy, Shanahan et al. 2003), it is unlikely that the dominant-negative phenotype 
observed is purely a consequence of Rad60-ctNLS being unable to delocalise from the 
nucleus following replication stress. Rather, it would suggest that SLD2 is required not 
only to localise Rad60 to the nucleus for its role in the DNA damage response, but also for 
the DNA damage response itself. This hypothesis is strengthened by the observation that 
rad60-ct cells over-expressing the Rad60-ct protein do not show a dominant-negative 
phenotype. Unfortunately, HU treatment of cells expressing Rad60-ctNLS was unable to 
confirm that the Rad60-ctNLS protein is unable to delocalise from the nucleus following 
replication stress.  
 
Since the Rad60 protein does not contain a recognised NLS it is possible that the C-
terminal SLD2 of Rad60 is required to interact with proteins that facilitate nuclear import. 
However, the Rad60 SLD2 alone is not capable of targeting EGFP into the nucleus. This 
may suggest that although SLD2 is required for Rad60 nuclear localisation, localisation 
may be dependent on the correct folding of the entire protein.  
 
Following the observation that provision of an NLS to the Rad60-ct protein is able to 
restore nuclear localisation but not function of the Rad60 protein it is likely that Rad60 
SLD2 has a functional role in the DNA damage response. Provided Rad60 SLD2 really is 
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SUMO-like in structure and function, I would expect substitution of SLD2 with authentic 
SUMO (Pmt3) to restore both nuclear localisation and a wild-type response to DNA 
damaging agents. Similarly to the provision of an NLS to Rad60-ct, replacement of SLD2 
with SUMO is able to restore wild-type localisation to Rad60-ct but unable to rescue the 
DNA damage sensitive phenotype of rad60-ct cells. In addition, expression of Rad60-
ctPmt3 in both wild-type and rad60-ct cells has a dominant-negative effect. This suggests 
that once in the nucleus, SUMO (Pmt3) cannot functionally substitute for Rad60 SLD2.  
 
It is important to note that the experiments in which either an NLS (Section 5.6) or Pmt3 
(Section 5.7) were tethered to the C-terminus of the Rad60-ct protein were carried out 
using protein exogenously over-expressed from the nmt1 promoter of the pREP41EGFP 
plasmid. As seen for endogenous levels of the protein (Section 5.2), Rad60 over-expressed 
exogenously is located in the nucleus whilst Rad60-ct is dispersed throughout the cell. 
However, the nuclear localisation of the exogenously expressed Rad60 is more discrete 
than that observed for the endogenous protein. Unfortunately, unlike endogenous Rad60 
(Section 5.2.2)(Boddy, Shanahan et al. 2003), exogenously expressed Rad60 failed to 
delocalise from the nucleus following HU treatment. The differences observed for 
endogenous and exogenous Rad60 expression suggest that Rad60 over-expression studies 
may not be biologically significant. Studies at endogenous levels are, therefore, required to 
answer this question. During this study, attempts were made to create a haploid strain 
endogenously expressing a C-terminally tagged Rad60-ctNLS protein, using the Bahler 
method of integration. Unfortunately, when transformants were screened, no colonies 
contained the Rad60-ctNLS allele, suggesting that the provision of an NLS to the C-
terminus of the Rad60-ct protein may be lethal. This is consistant with the dominant 
negative phenotype observed when Rad60-ctNLS is overexpressed in rad60-ct cells. 
Therefore, if further time were permitted, I would integrate the rad60-ctNLS allele as a 
single copy into a diploid strain to check whether cells are viable. Similarly, I would create 
a strain carrying the Rad60-ctpmt3 protein and assess localisation and phenotype. 
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CHAPTER 6 
Further analysis of the Rad60 SUMO-like domains: sequence comparison, molecular 
modelling and preliminary structure-function studies 
 
6.1 Introduction 
Proteins containing at least one ubiquitin-like fold can be distinguished into two different 
categories; ubiquitin-like modifiers and ubiquitin-like domain proteins. As is the case with 
ubiquitin, ubiquitin-like modifiers are post-translational modifiers, which can be covalently 
attached to target proteins via lysine residues. Unlike ubiquitin, other modifiers do not 
directly target proteins for degradation but have a more diverse range of functions. For 
example, SUMO has been implicated in roles in regulating protein localisation, genomic 
integrity, and cell cycle control amongst others. In contrast to the ubiquitin-like modifiers, 
ubiquitin-like domain proteins lack the C-terminal diglycine motif required for conjugation 
to target molecules. Ubiquitin-like domain proteins are a heterogeneous class of proteins 
and are usually multi-domain proteins that are completely unrelated outside of their 
ubiquitin-like domains. Proteins such as Rad23 and Dsk2 have been extensively studied 
and have the unifying role of interacting with the proteosome (Funakoshi, Sasaki et al. 
2002; Rao and Sastry 2002; Lambertson, Chen et al. 2003). This suggests that the 
ubiquitin-like domains fulfil their cellular role by functionally mimicking ubiquitination. 
The emergence of the RENi family of SUMO-like domain proteins suggests the existence 
of a group of proteins that may be able to functionally mimic the role of SUMO 
(Novatchkova et al, 2005). However, the precise role of these SUMO-like domains has yet 
to be determined. 
  
In previous chapters, I have shown the C-terminal SLDs of Rad60 to be important for 
Rad60 function. A rad60 mutant deleted for SLD1 (rad60-SLD1Δ) is not viable. A rad60 
mutant deleted for SLD2 (rad60-ct) is viable but is defective in the response to DNA 
damage (Chapter 3). The SLD2 of Rad60 is also important for the nuclear localisation of 
the Rad60 protein (Chapter 5). Despite the importance of the Rad60 SLDs for Rad60 
function, little evidence exists to suggest the SLDs are in fact ‘SUMO-like’ in structure and 
function. To date, evidence is based only on a very low sequence identity between Rad60 
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and SUMO-1. In this chapter I have carried out preliminary structure-function studies of 
the Rad60 SUMO-like domains.  
 
6.2 The phenotype of rad60-ct cells is not due to the loss of SBM3 
The physiological consequence of SUMO modification is typically mediated by effector 
proteins that recognise SUMO through SUMO-binding motifs. Rad60 contains an SXS 
(Section 1.8.7) motif and three sequences conforming to the V/I-X-V/I-V/I motif (SBM1, 2 
and 3) (Raffa, Wohlschlegel et al. 2006) (Figure 6.1.A). Both motifs have been shown to be 
SUMO-binding motifs (Minty, Dumont et al. 2000; Bi, Song et al. 2004; Song, Durrin et al. 
2004). Unlike SUMO-consensus motifs that allow covalent attachment of SUMO to target 
proteins, SUMO-binding motifs mediate protein-protein interactions by allowing non-
covalent binding to SUMO-conjugated proteins. The three V/I-X-V/I-V/I SBMs have been 
shown to be important for Rad60 self-association (Raffa, Wohlschlegel et al. 2006).  
 
SBM3 (VSVVLD) is located at the very C-terminus of Rad60 (aa 401-406). This raises the 
possibility that the phenotype observed for the previously characterised rad60-ct mutant 
might be the result of losing SBM3 and not of losing SLD2 as believed. To investigate this, 
the RMCE system (Section 3.5) was used to disrupt SBM3. Site-directed mutagenesis of 
the pAW8prad60 construct with primers L129/L130 was used to introduce V401A and 
V403A substitutions within the VSVVLD motif. (Figure 6.1B). SBM1 is located slightly 
upstream of SLD1, whilst SBM2 is located within SLD1 itself. Due to the importance of 
SLD1 for Rad60 viability (Section 3.5.3), mutant strains with a disrupted SBM1 and SBM2 
were made in parallel to the SBM3 mutant. Primers L125/L126 were used to introduce 
V216A and V217A substitutions within the ISVV motif of SBM1 and primers L127/L128 
were used to introduce V269A and V2671A substitutions within the VVLV motif of 
SMB2. (Figure 6.1B). RMCE between the mutated pAW8prad60 constructs and the rad60 
base strain was achieved as described in section 2.1.5. Two 5FOA resistant colonies were 
selected and their phenotype compared to the rad60-ct mutant. The rad60-SBM1 and 
rad60-SBM3 mutants showed no significant sensitivity to HU and MMS at either 30 or 
36oC (Figure 6.1C) and UV and IR (Figure 6.2A, B) as compared to wild-type cells. This 
suggests that the phenotype observed for the rad60-ct mutant is a consequence of deleting 
 Figure 6.1: The HU and MMS sensitivity of rad60-ct is not the consequence of 
loss  of SBM3 
 
(A) Rad60 has three SUMO-binding motifs (SBMs). Schematic to illustrate the relative 
positions of the Rad60 SBMs in relation to the C-terminal SUMO-like domains. (B) 
Table to illustrate the valine to alanine substitutions made in the rad60-SBM1, rad60-
SMB2 and rad60-SBM3 mutants. (C) rad60-SBM3 cells show a wild-type phenotype to 
HU and MMS. Cells were grown at 30oC in YE medium to mid-exponential phase. 10 
µl of 10 fold serial dilutions were spotted onto YEA plates containing supplements at 
the indicated doses. Plates were incubated at 30oC for 72 hours and photographed. 
AB
Figure 6.1: The HU and MMS sensitivity of rad60-ct is not the consequence of 
loss of SBM3
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Figure 6.2: The UV and IR sensitivity of rad60-ct is not the consequence of  loss 
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(A, B) rad60-SBM3 cells show a wild-type sensitivity to UV and γ irradiation. Cells 
were grown at 30oC in YE medium to mid-exponential phase and irradiated with UV 
(A) or γ (B) rays at the indicated doses. Cells were plated on YEA and grown at 30oC 
for ~72 hours. Colonies were counted and % survival was calculated.  
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more than SBM3. Interestingly, when compared to wild-type cells, the rad60-SBM2 
mutants are more sensitive to HU, MMS, UV and IR, but less sensitive than the rad60-ct 
mutant (Figures 6.1C; 6.2A, B). SBM2 is located in SLD1 of Rad60. Since the sensitivity 
of rad60-ct and rad60-1 cells to HU, MMS, IR and UV is similar, rad60-SBM2 cells are 
less sensitive than rad60-1 (K263E) cells. The sensitivity to MMS and HU was no greater 
at 36oC than 30oC, suggesting this is not a temperature sensitive mutation. 
 
6.3   Comparison of the amino-acid sequence of Rad60 SUMO-like domains  with 
 SUMO homologues   
 
6.3.1  Comparison of SUMO-1 homologues identifies conserved features of SUMO 
 molecules 
In section 3.2, a ClustalW alignment of the Rad60 protein sequence against H. sapiens 
SUMO-1 and S. pombe Pmt3 identified two potential SUMO-like domains with low 
sequence identity. Despite the low sequence identity, there is significant conservation of the 
biochemical nature of the amino-acid side chains. However, Rad60 SLD2 was originally 
identified as a ubiquitin-like domain (Morishita, Tsutsui et al. 2002). Although SUMO and 
ubiquitin are functionally very different, they both share a conserved ββαββαβ fold. 
Ubiquitin and SUMO share only ~18% sequence identity but despite the low sequence 
identity, like SUMO and the SLDs, many of the amino-acid side chains of SUMO and 
ubiquitin are biochemically conserved. This raises the question of ‘are we correct in 
assuming the SLDs are in fact SUMO-like, and not ubiquitin-like as first predicted?’. To 
attempt to answer this question, a search for features unique to SUMO, but not ubiquitin, 
was initiated. SUMO-1 homologues from H. sapiens, C. elegans, S. cerevisiae, D. 
melanogastar, and S. pombe were aligned using the online tool, ClustalW 
(http://www.ebi.ac.uk/tools/clustalw2/index.html). As a comparison, H. sapiens ubiquitin 
has been included. The alignment of proteins homologous to SUMO-1 highlights a number 
of residues conserved amongst the SUMO-1 homologues (Figure 6.3B). Of the conserved 
residues, only V26, G56, R63, G68, T76 and the C-terminal diglycine motif G96 G97 of 
SUMO-1 are conserved between both the SUMO-1 homologues and ubiquitin. 
Interestingly, when the residue conserved in the SUMO-1 homologues, but not in ubiquitin, 
Figure 6.3: Amino acid sequence comparison of proteins homologous to SUMO-
1 
(A) A ClustalW alignment of the amino acid sequences of proteins homologous to 
SUMO-1 from H. sapiens (Hs_SUMO-1, Hs_SUMO-2, Hs_SUMO-3), C. elegans 
(Ce_Smt3), S. cerevisiae (Sc_Smt3), D. melanogastar (Dm_Smt3), S. pombe 
(Sp_Pmt3). As a comparison, H. sapiens ubiquitin (Hs_Ub1) has been aligned against 
the SUMO-1 homologues. Amino acid residues conserved in all SUMO-1 homologues 
and ubiquitin are highlighted in red, residues conserved in all SUMO-1 homologues but 
not ubiquitin are highlighted in yellow and residues conserved in at least 5 of the 7 
SUMO-1 homologues are highlighted in blue. Residues shown to contribute to the 
overall stability of the SUMO-1 protein (Bayer et al 1998) are highlighted (*). Aligned 
underneath are the sequences for Rad60 SLD1 and Rad60 SLD2. (B) Table showing the 
conservation of Bayer residues in ubiquitin, Rad60 SLD1 and Rad60 SLD2. Bayer 
residues are highlighted in red. 
Figure 6.3: Amino acid sequence comparison of proteins homologous to 
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Hs_SUMO-1                     MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSE--IHFKVKMTT  42  
Hs_SUMO-2                         MADEKPKEGVKTENNDHINLKVAGQDGSV--VQFKIKRHT  38 
Hs_SUMO-3                         MSEEKPKEGVKTEN-DHINLKVAGQDGSV--VQFKIKRHT  37  
Ce_Smt3                              MADDAAQAGDNAEYIKIKVVGQDSNE--VHFRVKYGT  35  
Sc_Smt3                     MSDSEVNQEAKPEVKPEVKPETHINLKV-SDGSSE--IFFKIKKTT  43  
Dm_Smt3                                MSDEKKGGETEHINLKVLGQDNAV--VQFKIKKHT  33 
Sp_Pmt3         MSESPSANISDADKSAITPTTGDTSQQDVKPSTEHINLKVVGQDNNE--VFFKIKKTT  56 
Hs_Ub1                                             MQIFVKTLTGKT--ITLEVEPSD  21  
                                                     *           * *        
 
Sp_Rad60_SLD1  ----------------------------------PNSNISLPRDWEAPLFFKVKSN- 249 
Sp_Rad60_SLD2 ----------------------------------ITLLLRSSKSED--LRLSIPVDF 354 
                                                    
 
 
Hs_SUMO-1       HLKKLKESYCQRQGVPMNS-LRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGG    97 
Hs_SUMO-2       PLSKLMKAYCERQGLSMRQ-IRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGG    93  
Hs_SUMO-3       PLSKLMKAYCERQGLSMRQ-IRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGG    92  
Ce_Smt3         SMAKLKKSYADRTGVAVNS-LRFLFDGRRINDDDTPKTLEMEDDDVIEVYQEQLGG    90 
Sc_Smt3         PLRRLMEAFAKRQGKEMDS-LRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGG    98  
Dm_Smt3         PLRKLMNAYCDRAGLSMQV-VRFRFDGQPINENDTPTSLEMEEGDTIEVYQQQTGG    88  
Sp_Pmt3         EFSKLMKIYCARQGKSMNS-LRFLVDGERIRPDQTPAELDMEDGDQIEAVLEQLGG   111 
Hs_Ub1          TIENVKAKIQDKEGIPPDQ-QRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG    76 
                 *  **  *   *         * *                     *         
 
Sp_Rad60_SLD1   QFRRVRIAYSERKK--VDN-VVLVFQNQRLWDYGTPKGAGMLKVDTRLVVHAYCHS   303  
Sp_Rad60_SLD2   TVKDLIKRYCTEVKISFHERIRLEFEGEWLDPNDQVQSTELEDEDQVSVVLD       406 
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has a hydrophobic side chains (I/L/V), it is often substituted for another residue with the 
same hydrophobic properties (I/L/V). Aside from residues R54 and R63 of SUMO-1, no 
other charged residue is substituted with a like charge (K/R, H, E/D). When the SUMO-1 
homologues are aligned with the amino acid sequence of Rad60 SLD1 and SLD2, very few 
residues are conserved with the SUMO-1 homologues (Figure 6.3A, B). The majority of 
those residues conserved differ for SLD1 and SLD2. As is the case for ubiquitin, many of 
the hydrophobic residues conserved amongst the SUMO-1 homologues are substituted for a 
residue with the same hydrophobic properties (I/L/V) in SLD1 and SLD2. These residues 
are likely to contribute to the hydrophobic core of SUMO/ubiquitin. Aside from S. 
cerevisiae, Y51 of SUMO-1 is conserved in all of the SUMO-1 homologues, but not 
ubiquitin Interestingly, SLD1 and SLD2 also have a tyrosine at this position. This may 
suggest a SUMO-specific residue.  
 
One feature that strongly distinguishes SUMO homologues from other ubiquitin-like 
modifiers is the large cluster of negatively charged residues (aspartate, glutamate) close to 
the C-terminus (Figure 6.3B). This negative patch has been suggested to define an 
important interaction surface of SUMO (Bayer, Arndt et al. 1998). In SUMO-1 the negative 
surface is formed by E83, E84, E85 and D86. Of these residues, only the negative charge of 
E83 is conserved in ubiquitin. Interestingly, a large negative cluster is conserved at the C-
terminus of Rad60 SLD2 (aa 394-399) but not SLD1. Unlike all SUMO homologues, the 
Rad60 SLDs lack the C-terminal diglycine motif required for conjugation to its substrate. 
This suggests that the domains are SUMO fusions that cannot conjugate to target proteins 
and must fulfil their SUMO-like role in some other manner.  
 
6.3.2  Conservation of structurally important residues 
The structure of SUMO-1 has been solved by NMR and X-ray crystallography (Bayer, 
Arndt et al. 1998; Song, Zhang et al. 2005). SUMO-1 consists of a ββαββαβ fold. With the 
exception of β4, which is twisted against the main plane, the β-sheets of SUMO-1 are 
aligned parallel to one another (Bayer, Arndt et al. 1998). Helix α1 is rotated 
approximately 45o relative to β1. Contacts between the hydrophobic side chains of L24, 
I34, F36, F64, F66, I88 on the β-sheet and L44, L47, K48, Y51, Q53 and Q55 of the α1 
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helix have been identified at the helix-sheet interface in SUMO-1 (Bayer, Arndt et al. 
1998). Despite the low sequence identity shared by SUMO-1 and ubiquitin, the two 
proteins share this same characteristic fold. With the exception of Q53 and Q55, the 
hydrophobic nature of residues forming the hydrophobic core is conserved in ubiquitin 
(Figure 6.3B). These residues are therefore thought to be of key importance in maintaining 
the ubiquitin fold (Bayer, Arndt et al. 1998). Of the residues identified to be of structural 
importance (Hereafter referred to as Bayer residues), the hydrophobic nature is better 
conserved in SLD2 than SLD1. Interestingly, the conserved tyrosine discussed in section 
6.3.1 is listed as one of the residues of the α1 helix required make contacts at the helix-
sheet interface in SUMO-1 (Bayer, Arndt et al. 1998). A tyrosine residue is found at the 
same position in both SLD1 and SLD2, but not ubiquitin, highlighting a possible SUMO-
specific residue. 
 
6.3.3  Comparison of the amino acid sequence of the RENi family protein members 
 identifies conserved residues 
The ubiquitin-like domains of proteins, including Rad23 and Dsk2, are believed to fulfil 
their cellular role by functionally mimicking ubiquitination (Funakoshi, Sasaki et al. 2002; 
Rao and Sastry 2002; Lambertson, Chen et al. 2003). With the discovery of the RENi 
family of SUMO-like domain proteins, it could be assumed that the SUMO-like domains 
are able to functionally mimic the role of SUMO (Novatchkova, Bachmair et al. 2005). 
However, the precise role of these domains has yet to be identified. If the SUMO-like 
domains do share a common function of mimicking SUMO, I would expect significant 
conservation between the SLDs of the RENi family. For this reason, a ClustalW 
(http://www.ebi.ac.uk/tools/clustalw2/index.html) alignment of RENi proteins against 
SUMO-1 was carried out (Figure 6.4).  
 
In proteins of the RENi family, the C-terminal SLD2 shares several features discriminating 
SUMO proteins from other ubiquitin-like modifiers. Firstly, the large cluster of negatively 
charged residues (aa 394-399) is indicative of a SUMO-like protein rather than a ubiquitin-
like protein. The negative surface patch formed by these residues has been suggested to 
form a SUMO-typical interaction surface (Bayer, Arndt et al. 1998). However, this 
Figure 6.4: Multiple sequence alignment of the RENi protein family members 
 
A ClustalW alignment of the amino acid sequences of members of the RENi protein 
family from S. pombe (Sp), S. cerevisiae (Sc), M. musculus (Mm), H. sapiens (Hs) and 
C. elegans (Ce_Smt3). The alignments show (A) SUMO-like domain 1 and (B) SUMO-
like domain 2 of the RENi proteins. As a comparison, H. sapiens SUMO-1 has been 
aligned against the RENi proteins. The alignment is CLUSTALW coloured (Thompson 
et al, 1994). (All Gly (orange), Pro (yellow) are coloured. Other residues matching a 
frequent occurrence of a property in a column are coloured: hydrophobic = blue; 
hydrophobic tendency = light blue; basic = red; acidic = purple; hydrophilic = green; 
unconserved = white). Residues shown to contribute to the overall stability of the 
SUMO-1 protein (Bayer et al 1998) are highlighted (*). 
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negative surface patch is absent in SLD1 of all RENi proteins. Although the sequence 
identity shared by proteins of the RENi family is low, the biochemical nature of the side 
chains is well conserved. When looking at the residues aligned to the structurally important 
‘Bayer’ residues of SUMO-1, with the exception of Q55, it can be seen that the 
hydrophobic nature of these residues is conserved. This supports the hypothesis that the 
SUMO-like domains adopt a SUMO/ubiquitin-like fold. As in the case of the SUMO-1 
homologues (Section 6.3.1) Y51 of SUMO-1 is conserved in SLD2 of most RENi proteins. 
This tyrosine is less well conserved in SLD1 of the RENi proteins, suggesting that the 
SLD2 of the RENi proteins more closely resembles SUMO-1 than SLD1. 
 
6.3.4  Residues known to contribute to the SBM binding pocket of SUMO-1 are 
 conserved in Rad60 SLD1 and SLD2  
The biological importance of SUMO modification is often mediated by proteins that are 
able to recognise and interact with SUMO via their SBMs. The structure of SUMO-1 in 
complex with an SBM has identified an SBM binding surface of SUMO-1 (Song, Zhang et 
al. 2005). The SBM binding surface of SUMO-1 is formed by a deep groove that is lined 
with hydrophobic and aromatic patches consisting of residues I34, H35, F36, V38, L47 and 
Y51 (Song, Zhang et al. 2005). Within the SBM binding pocket, the peptide containing the 
SBM also contacts E33 of SUMO-1. With the exception of H35, the biochemical nature of 
the side chain of these residues is largely conserved in both SLD1 and SLD2 (Table 6.1). 
E33 of SUMO-1 is substituted with E239 and D345 in SLD1 and SLD2 respectively, 
maintaining a negatively charged residue at this site. The hydrophobic nature of the I34, 
F36, V38 and L47 side chains is maintained in both SLD1 and SLD2. Interestingly, of 
these residues, I34, F36, L47 and Y51 have been described as key residues of structural 
importance to SUMO-1 (Bayer, Arndt et al. 1998) and Y51 has been highlighted as a 
SUMO-specific residue (Section 6.3.1; 6.3.2). Y51 is conserved in both SLD1 and SLD2 of 
Rad60.  
 
6.4 Comparative modelling of Rad60 SLD1 and SLD2 using MODELLER 
Despite the low sequence identity between the SLDs, SUMO and ubiquitin (Section 3.2), 
there is significant conservation of the biochemical nature of the amino-acid side chains, 
L359V255 L47
L348F244 F36
I348V246V38
Y363Y259Y51
R347F243H35
L346L242 I34
D345E239E33
SLD2SLD1SUMO-1
Table 6.1: Residues known to contribute to the SBM binding pocket of 
SUMO-1 are conserved in SLD1 and SLD2 
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for example hydrophobic residues (I, L, V) are substituted for one another. To test whether 
the Rad60 SLDs can adopt the characteristic ββαββαβ fold of SUMO, a computer-
modelling programme was used. In the absence of an experimentally determined structure, 
comparative or homology modelling can sometimes provide a useful 3D model for a target 
protein that is related to at least one known protein structure.  
 
With the help of Dr. Darren Thompson (University of Sussex) the SUMO-like domains of 
Rad60 were modelled using MODELLER. MODELLER is a comparative modelling tool, 
which models protein structure by satisfaction of spatial restraints (Sali, Potterton et al. 
1995; Sanchez and Sali 2000). MODELLER can be used in all stages of comparative 
modelling including template search, target-template alignment and model building (Sali, 
Potterton et al. 1995; Sanchez and Sali 2000). Since I wished to model the SUMO-like 
domains of Rad60 on SUMO, the template and target-template alignment were already 
known. In this instance, MODELLER was used only for model building. Since the X-ray 
crystal structure of the S. pombe Pmt3 (SUMO) structure has not yet been solved the 
structure of H. sapiens SUMO-1 was therefore used for comparative modelling. It is 
important to note that, unlike ubiquitin, SUMO has a flexible N-terminal tail but due to the 
packing constraints required for protein crystallisation only the structure of the ubiquitin-
like fold of SUMO has been determined. The alignment of Rad60 SLD1 (aa 227-303) and 
SLD2 (aa 334-406) with H. sapiens SUMO-1 (aa 21-97) were submitted to MODELLER 
along with the pdb coordinates of SUMO-1 (2asq.pdb). Once a target-template alignment is 
obtained, the calculation of the 3D model of the target by MODELLER is completely 
automated. The program ‘extracts atom-atom distance and dihedral angle restraints on the 
target from the template structure(s) and combines them with the general rules of protein 
structure such as bond length and angle preferences’ (Sanchez and Sali 2000). The 
program then uses an optimisation procedure that minimises violations of spatial restraints 
to calculate a model of the target protein (Sali, Potterton et al. 1995; Sanchez and Sali 
2000). Due to the nature of the program, slight variations in the final model can be 
achieved with different rounds of comparative modelling. For this reason the data were 
submitted to MODELLER on three independent occasions. With the help of Dr. Darren 
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Thompson (University of Sussex), the model with the most likely positioning of side chains 
(least steric hindrance) was selected for analysis.  
 
6.4.1  Comparative modelling suggests that Rad60 SLD1 and SLD2 can adopt a 
 βαββαββ  fold  
The predicted structures of Rad60 SLD1 and Rad60 SLD2 were visualised using Swiss-Pdb 
Viewer and compared to the known structures of H. sapiens ubiquitin (1ubq.pdb) and H. 
sapiens SUMO-1 (2asq.pdb). Like SUMO-1 and ubiquitin, both Rad60 SLD1 and SLD2 
are predicted to fold with the characteristic ββαββαβ fold (Figure 6.5A). The loops 
connecting the secondary structure elements in SUMO/ubiquitin are also similar in both 
SLD1 and SLD2. Recently, the structure of the H. sapiens Nip45 SLD2 has been solved 
(2jxx.pdb). Like SUMO-1 and ubiquitin, Nip45 SLD2 folds with a ββαββαβ fold (Figure 
6.5A). Comparison of the solved Nip45 SLD2 structure with SUMO-1 strengthens the 
hypothesis that the SUMO-like domains of the RENi protein family fold to resemble 
SUMO. 
 
As discussed in section 6.3.2, contacts between the hydrophobic side chains of L24, I34, 
F36, F64, F66, I88 on the β-sheet and L44, L47, K48, Y51, Q53 and Q55 of the α1 helix 
are thought to be of key importance in maintaining the ββαββαβ fold (Bayer, Arndt et al. 
1998). Residues within SLD1 and SLD2, which align to the Bayer residues of SUMO-1, 
were visualised using Swiss-Pdb Viewer. With the exception of the residues aligning to 
Q53 of SUMO-1, the side-chains of the Bayer residues are orientated towards the core of 
the predicted structure (Figure 6.6). Q53 of SUMO-1 aligns to E261 and T365, of SLD1 
and SLD2 respectively. These residues contribute part of the α1 helix and the side chains 
are orientated away from the core. This is also seen for residues of H. sapiens Nip45 SLD2, 
supporting the hypothesis that the Rad60 SLDs fold in a similar manner to SUMO. 
 
6.4.2  Comparative modelling suggests that the surface charge of Rad60 SLD2, but 
 not SLD1, resembles SUMO  
Although structurally similar, SUMO and ubiquitin molecules have different surface 
charges. If the ββαββαβ fold were to be assumed for SLD1 and SLD2 of Rad60, the 
Figure 6.5: Comparative modelling suggests that Rad60 SLD1 and SLD2 can 
adopt a βαββαββ fold  
 
Comparative modelling of Rad60 SLD1 and SLD2 with SUMO-1 was carried out using 
MODELLER. H. sapiens ubiquitin (1ubq.pdb), H. sapiens SUMO-1 (2asq.pdb), H. 
sapiens NIP45 SLD2 (2jxx.pdb) and the predicted structures of S. pombe Rad60 SLD1 
and Rad60 SLD2 were visualised with Swiss-Pdb Viewer. (A) Comparative modelling 
suggests that Rad60 SLD1 and SLD2 can adopt a βαββαββ fold. The tertiary folds of 
Rad60 SLD2 were compared with ubiquitin, SUMO-1 and Nip45. α-helices and β-
sheets are coloured in red and blue respectively. (B) Comparative modelling suggests 
that the surface charge of Rad60 SLD2, but not SLD1, resembles SUMO. Negative and 
positive regions are shown in red and blue, respectively. 
Hs ubiquitin                           Hs SUMO-1                         Sp Rad60 SLD1                         Sp Rad60 SLD2                  Hs NIP45 SLD2
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Figure 6.6: Comparing the position of Bayer residues within the predicted 
structures of Rad60 SLD1 and SLD2 highlights similarities with 
SUMO-1 
 
Comparative modelling of Rad60 SLD1 and SLD2 with SUMO-1 was carried out using 
MODELLER. The position of Bayer residues within H. sapiens SUMO-1 (2asq.pdb), 
H. sapiens NIP45 SLD2 (2jxx.pdb) and the predicted structures for S. pombe Rad60 
SLD1 and Rad60 SLD2 were visualised with Swiss-Pdb Viewer. α-helices and β-sheets 
are coloured in red and blue respectively. Amino acid side chains of the Bayer residues 
are shown in yellow. Side chains of residues aligning to Y51 of SUMO-1 are coloured 
in light blue. 
Hs SUMO-1 Hs Nip45 SLD2
Sp Rad60 SLD1 Sp Rad60 SLD2
Figure 6.6: Comparing the position of Bayer residues within the predicted 
structures of Rad60 SLD1 and SLD2 highlights similarities with 
SUMO-1
T356
E360
E261
Q53
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surface charges of Rad60 SLD1 and SLD2 would differ (Figure 6.5B, lower panel). The 
overall surface charge of SLD2 is predominantly negatively charged and therefore more 
closely resembles that of SUMO than ubiquitin. In contrast the overall surface charge of 
SLD1 is largely positive and therefore shows more resemblance to ubiquitin than SUMO. 
This supports the observation that SLD1 of the RENI proteins lacks the large cluster of 
negatively charged residues at the C-terminus that is characteristic of SUMO-1 homologues 
(Section 6.3.3). This suggests that the two domains may have different biochemical 
functions.  
 
6.5 Mutating residues, predicted to be of structural importance to SLD2, results 
in a DNA damage sensitive phenotype 
Whilst the above data support the hypothesis that the Rad60 SLDs fold in a similar manner 
to SUMO, further structural evidence is required. In an attempt to support the in silico 
evidence, I have created a series of S. pombe strains carrying mutations in residues 
predicted to be important for maintaining the hydrophobic core of the ββαββαβ fold.  
 
6.5.1  Selecting residues of structural importance in SLD2 for mutagenesis  
SUMO and ubiquitin share the same ββαββαβ structure. The hydrophobic nature of 
residues shown to contribute to the hydrophobic core of SUMO is conserved in ubiquitin 
(Section 6.3.2) (Bayer, Arndt et al. 1998). Due to its extremely stable structure, ubiquitin 
was selected as a model protein for a study into ‘stability-based selection’ and the 
‘sequence requirements for packing in the hydrophobic core’ (Finucane and Woolfson 
1999). In the study by Finucane and Woolfson, ubiquitin was shown to become completely 
destabilised when seven core residues; I3, V5, I13, L15, V17, V26 and I30 were substituted 
with leucine. Leucine was selected on the basis that polyleucine cores are known to 
increase the conformational heterogeneity of proteins, thereby lowering their 
conformational specificity and stability (Finucane and Woolfson 1999). Further 
mutagenesis was carried out to introduce combinations of the five hydrophobic residues (I, 
L, V, F and M) to replace the 7 mutated residues on the sequence encoding the destabilised 
ubiquitin. Proteolysis based selection was used to recover protease resistant, and therefore 
stable, mutants. The proteins recovered revealed a strong consensus for near wild-type 
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sequences, indicating that the hydrophobic core of ubiquitin is naturally optimised for 
stability and plays an important role in the specification of the ubiquitin (ββαββαβ) fold. 
Given that this degree of core conservation extends to other proteins sharing the ββαββαβ 
fold, I have determined whether these residues were conserved in the SUMO-like domains 
of Rad60. 
 
A ClustalW alignment of the Rad60 SLD1 and SLD2 protein sequence against the 
ubiquitin-like proteins H. sapiens ubiquitin, S. pombe ubiquitin, H. sapiens NEDD8, H. 
sapiens SUMO-1, and S. pombe SUMO (Pmt3) reveals that the hydrophobic nature of 
residues I3, V5, I13, L15, V17 and V26 is conserved between all proteins (Figure 6.7A). 
The hydrophobic nature of I30 is conserved amongst the ubiquitin and NEDD8 proteins, 
but in the SUMO proteins and SUMO-like domains is substituted for the ‘SUMO-specific’ 
tyrosine. The structure of the H. sapiens Nip45 SLD2 has recently been solved. When 
aligned with the proteins above, the same degree of conservation can be seen for Nip45 
SLD2 as for SLD1 and SLD2 of Rad60 (Figure 6.7A). The position of the seven residues 
within the ββαββαβ fold of the predicted Rad60 SLD1 and SLD2 structures (Section 6.4) 
are conserved as compared to their position in the known structures of H. sapiens ubiquitin 
(1ubq.pdb), SUMO-1 (2asq.pdb) and Nip45 SLD2 (2jxx.pdb) (Figure 6.7B). Five of the 
seven residues mutated by Finucane and Woolfson (I3, I13, L15, V26, I30), align to 
positions identified by Bayer et al to be structurally important in SUMO-1 (L24, I34, F36, 
L47, Y51). Due to the fact that these residues contribute to the stability of the hydrophobic 
core, it is likely that they are important for hydrogen bonding (H-bonding). Using Swiss-
Pdb Viewer to visualise H-bonding between residues in the ubiquitin structure, it can be 
seen that the residues selected by Finucane and Woolfson are important for H-bonding. 
With the exception of V17, these residues form H-bonds between each other (Figure 6.8A). 
V17 makes two H-bonds with M1. Finucane and Woolfson have shown that M1 (with I3, 
V5, I13, L15, V17, V26 and I30) forms part of a substructure in the hydrophobic core of 
ubiquitin. The conserved residues in SUMO-1, Rad60 SLD1 and SLD2 show the same 
bonding pattern. The H-bonding pairs of Rad60 SLD2 can be seen in figure 6.8A and are 
summarised in figure 6.8C. I have therefore selected to mutate residues in Rad60 SLD2 that 
Figure 6.7: Residues required for the correct folding of ubiquitin are conserved 
in Rad60 SLD1 and SLD2 
 
(A) A ClustalW alignment of the Rad60 SLD1 and SLD2 protein sequence against the 
ubiquitin-like proteins H. sapiens ubiquitin, S. pombe ubiquitin, H. sapiens NEDD8, H. 
sapiens SUMO-1, and S. pombe SUMO (Pmt3). Residues shown to disrupt the structure 
of ubiquitin when mutated (Finucane and Woolfson, 1998) are highlighted in yellow. 
Residues shown to contribute to the overall stability of the SUMO-1 protein (Bayer et al 
1998) are highlighted (*). 
AB Hs SUMO-1Hs ubiquitin
Sp Rad60 SLD1 Sp Rad60 SLD2 Hs Nip45 SLD2
Figure 6.7: Residues required for the correct folding of ubiquitin are conserved 
in Rad60 SLD1 and SLD2
Hs_Ubiquitin       -----------------------------------M---QIFVKTLTGKT-ITLEVEPSD  21 
Sp_Ubiquitin       -----------------------------------M---QIFVKTLTGKT-ITLEVESSD  21 
Hs_NEDD8           ---------------------------------------MIKVKTLTGKE-IEVDIEPTD  20 
Hs_SUMO-1          --------MSDQEAKPSTEDLGD------KKEGEYI---KLKVIGQDSSE-IHFKVKMTT  42 
Sp_SUMO            MSESPSANISDADKSAITPTTGDTSQQDVKPSTEHI---NLKVVGQDNNE-VFFKIKKTT  56 
Hs_Nip45_SLD2      -------------------------------TSQQL---QLRVQGKEKHQTLEVSLSRDS 359 
Sp_Rad60_SLD1      ------------------------------------PNSNISLPRDWEAP-LFFKVKSN- 250 
Sp_Rad60_SLD2      -----------------------------------I---TLLLRSSKSED-LRLSIPVDF 354 
 
 
Hs_Ubiquitin       TIENVKAKIQDKEGIPPDQ-QRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG      76 
Sp_Ubiquitin       TIDNVKSKIQDKEGIPPDQ-QRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG      76 
Hs_NEDD8           KVERIKERVEEKEGIPPQQ-QRLIYSGKQMNDEKTAADYKILGGSVLHLVLALRGG      75  
Hs_SUMO-1          HLKKLKESYCQRQGVPMNS-LRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGG      97 
Sp_SUMO            EFSKLMKIYCARQGKSMNS-LRFLVDGERIRPDQTPAELDMEDGDQIEAVLEQLGG     111 
Hs_Nip45_SLD2      PLKTLMSHYEEAMGLSGRK-LSFFFDGTKLSGRELPADLGMESGDLIEVW----G      419 
Sp_Rad60_SLD1 QFRRVRIAYSERKK--VDN-VVLVFQNQRLWDYGTPKGAGMLKVDTRLVVHAYCHSD    303 
Sp_rad60_SLD2      TVKDLIKRYCTEVKISFHERIRLEFEGEWLDPNDQVQSTELEDEDQVSVVLD         406 
*          * *
*  **  *   *         * *
Figure 6.8: Selecting residues for mutagenesis of Rad60 SLD2 
 
(A) Comparative modelling of Rad60 SLD2 with SUMO-1 was carried out using 
MODELLER. The hydrocarbon backbone of SUMO-1 and Rad60 SLD2 were 
visualised with Swiss-Pdb Viewer. The position of residues predicted to be of structural 
importance to SUMO-1 and Rad60 SLD2 are highlighted in red. Green lines indicate 
hydrogen bonding between the residues shown. (B) An example of a mutation designed 
to disrupt (L346G) and conserve (L346V) H-bonding between two residues (L346 and 
L338) in Rad60 SLD2. (C) Table summarising H-bonding between residues predicted 
to be of structural importance, and the mutations chosen to disrupt and conserve H-
bonding. 
Figure 6.8: Selecting residues for mutagenesis of Rad60 SLD2
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align to M1, I3, V5, I13, L15, V17, V26 and I30 of ubiquitin and compare the phenotype to 
the Rad60 SLD2 deletion mutant, rad60-ct.  
 
6.5.2  Point mutations within the predicted ubiquitin-fold of SLD2 can result in a 
 phenotype similar to that of the Rad60 SLD2 deleted strain, rad60-ct 
To further test the hypothesis that Rad60 SLD2 can fold to resemble SUMO, strains 
carrying point mutations in the coding sequence for I334, L336, L338, L346, L348, I350, 
L359 and Y363 (corresponding to M1, I3, F5, I13, L15, L17, V26 and I30 of H. sapiens 
ubiquitin, respectively) were created. In an attempt to disrupt the SLD2 structure, residues 
of interest were mutated to glycine. When mutated to glycine, a small non-polar amino 
acid, the ability to form H-bonds at this position should be abolished. For example, L336 is 
shown to H-bond to L348. By introducing either an L336G or L348G mutation into SLD2, 
H-bonding between this pair should be lost. Prior to creating mutant strains the mutations 
designed to disrupt H-bonding were tested in silico using the mutate tool in Swiss-Pdb 
Viewer. An example of the mutation made for L346 is shown in figure 6.8B.  
 
The RMCE system was used to replace the wild-type copy of rad60 with a copy of the 
rad60 gene carrying the point mutation of interest. Site-directed mutagenesis was used to 
introduce point mutations into the rad60 coding sequence of the pAW8prad60 construct. 
Primers used for site-directed mutagenesis are listed in Table 6.2. The rad60 base strain 
was transformed with the mutant pAW8prad60 constructs and RCME was achieved as 
described in section 2.1.5. For each construct, two 5-FOA resistant (ura4-) isolates were 
selected and their phenotype tested. Given the HU and MMS sensitivity of the rad60-ct 
strain, spot tests were carried out and the sensitivity of the 5-FOA resistant colonies to HU 
and MMS examined at 30oC. Of the mutations designed to disrupt H-bonding, and 
therefore destabilise the SLD2 structure, strains transformed with rad60-L336G, rad60-
I350G, rad60-Y363G and rad60-L359G constructs show a wild-type sensitivity to HU and 
MMS (Figure 6.9iA). However, the sensitivity of the strains transformed with the rad60-
L348G, rad60-L338G and rad60-I334G constructs is comparable with that seen for rad60-
ct. At high doses of HU and MMS, cells transformed with the rad60-L346G construct is 
more sensitive than wild-type cells but less sensitive than rad60-ct. Following the initial 
F    GCTCAAACGTGTAAACTTGGAACGTTGCTTTTGCG
R    CGCAAAAGCAACGTTCCAAGTTTACACGTTTGAGC
L241
L242
I334G
F    GCTCAAACGTGTAAACTTTTAACGTTGCTTTTGCG
R    CGCAAAAGCAACGTTAAAAGTTTACACGTTTGAGC
L239
L240
I334L
F    CTTCGTCTCTCAGGACCCGTCGATTTCAC
R    GTGAAATCGACGGGTCCTGAGAGACGAAG
L237
L238
I350G
F    CTTCGTCTCTCACTACCCGTCGATTTCAC
R    GTGAAATCGACGGGTAGTGAGAGACGAAG
L235
L236
I350L
F    GTAAGAGTGAGGATGGTCGTCTCTCAATACC
R    GGTATTGAGAGACGACCATCCTCACTCTTAC
L233
L234
L346G
F    GTAAGAGTGAGGATGTTCGTCTCTCAATACC
R    GGTATTGAGAGACGAACATCCTCACTCTTAC 
L231
L232
L346V
F    CGTGTATAACGTTGCTTGGGCGTTCGAGTAAGAG
R    CTCTTACTCGAACGCCCAAGCAACGTTATACACG
L229
L230
L338G
F    GATTTGATTAAGAGAGGTTGTACTGAAGTAAAG
R    CTTTACTTCAGTACAACCTCTCTTAATCAAATC
L225
L226
Y363G
F    GATTTGATTAAGAGATTTTGTACTGAAGTAAAG
R    CTTTACTTCAGTACAAAATCTCTTAATCAAATC
L223
L224
Y363F
F    CGATTTCACTGTTAAAGATGGGATTAAGAGATATTGTACTG
R    CAGTACAATATCTCTTAATCCCATCTTTAACAGTGAAATGG
L221
L222
L359G
F    CGATTTCACTGTTAAAGATGTGATTAAGAGATATTGTACTG
R    CAGTACAATATCTCTTAATCACATCTTTAACAGTGAAATGG
L219
L220
L359V
F    GTGAGGATCTTCGTGGCTCAATACCCGTCG
R    CGACGGGTATTGAGCCACGAAGATCCTCAC
L216
L217
L348G
F    GTGAGGATCTTCGTGTCTCAATACCCGTCG
R    CGACGGGTATTGAGACACGAAGATCCTCAC
L214
L215
L348V
F    CAAACG TGTAAACTTATAACGGGGCTTTTGCGTTCG AG
R    CTCGAACGCAAAAGCCCCGTTATAAGTTTACACGTTTG
L212
L213
L336G
F    CAAACGTGTAAACTTATAACGGTGCTTTTG CGTTCGAG
R    CTCGAACGCAAAAGCACCGTTATAAGTTTACACGTTTG
L210
L211
L336V
Primer sequence (5’to 3’)PrimerMutation
Table 6.2: Mutagenic primer sequences to mutate residues predicted to be 
important for maintaining the ββαββαβ fold of Rad60 SLD2
Figure 6.9: HU and MMS sensitivity of Rad60 SLD2 mutants 
 
(A) Cells transformed with rad60-I334G, rad60-L338G, rad60-L346 and rad60-L348G 
constructs are sensitive to HU and MMS. (Cells indicated in red were transformed with 
mutated rad60 constructs but were later sequenced and found to be wild-type). (B) Cells 
transformed with rad60-I334L, rad60-L338V, rad60-L346V and rad60-L348V 
constructs show wild-type sensitivity to HU and MMS. Cells were grown at 30oC in YE 
medium to mid-exponential phase. 10 µl of 10 fold serial dilutions were spotted onto 
YEA plates containing supplements at the indicated doses. Plates were incubated at (i) 
30oC, (ii) 36oC and (iii) 25oC for 72 hours and then photographed.  
A YEA                          + MMS                              + HU
0.005%             0.01%              4 mM 6 mM
B
YEA                        + MMS                                + HU
0.005%            0.01%                4 mM 6 mM
wild-type
rad60-ct
L348G 
wild-type
L338G 
wild-type
L346G 
I334G 
wild-type
wild-type
wild-type
rad60-ct
L348V 
L336V
I350L
Y363F
L359V
I334L
L346V
Figure 6.9i: HU and MMS sensitivity of Rad60 SLD2 mutants (30oC)
wild-type
rad60-ct
A YEA                        + MMS                                + HU
0.005%            0.01%               4 mM 6 mM
L348G 
wild-type
L338G 
wild-type
L346G 
I334G 
wild-type
wild-type
B YEA                        + MMS                                + HU
0.005 %           0.01 %              4 mM 6 mM
wild-type
rad60-ct
L348V 
L336V
I350L
Y363F
L359V
I334L
L346V
Figure 6.9ii: HU and MMS sensitivity of Rad60 SLD2 mutants (36oC)
A YEA                         + MMS                               + HU
0.005%             0.01%              4 mM 6 mM
B YEA                         + MMS                               + HU
0.005%             0.01%              4 mM 6 mM
wild-type
rad60-ct
L348G 
wild-type
L338G 
wild-type
L346G 
I334G 
wild-type 
wild-type
wild-type
rad60-ct
L348V 
L336V
I350L
Y363F
L359V
I334L
L346V
Figure 6.9iii: HU and MMS sensitivity of Rad60 SLD2 mutants (25oC)
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screening, colony PCR with primers L41 and L40 was used to amplify rad60. Sequencing 
with primer L18 was used to confirm the mutations of interest had been successfully 
integrated. Unfortunately, of the strains tested, only those transformed the rad60-L348G, 
rad60-L338G, rad60-I334G and rad60-L346G mutations had been correctly integrated. 
The remaining strains were wild-type. Interestingly, the strains in which the mutation of 
interest had been correctly integrated via RMCE, were also the strains that showed an 
increased sensitivity to HU and MMS as compared to wild-type. This suggests that the 
single I334G, L338G and L348G mutations are sufficient to disrupt the structure, and 
therefore the function, of SLD2 to the same extent as deleting SLD2 altogether. The L346G 
mutation appears to partially disrupt the structure and function of the Rad60 SLD2. To test 
for temperature sensitive mutations the sensitivity of cells to HU and MMS was also tested 
at 37oC (Figure 6.9iiA) and 25oC (Figure 6.9iiiA). No difference in sensitivity was 
observed. The UV and IR sensitivity of cells transformed with the rad60-I334G, rad60-
L338G, rad60-L346G and rad60-L348G was tested. As seen for the spot tests, the 
sensitivity of rad60-I334G and rad60-L338G to UV and IR is similar to that of rad60-ct 
cells. Additionally, rad60-L346G cells are more sensitive than wild-type cells but less 
sensitive than the rad60-ct cells. However, the rad60-L348G cells exhibit a much greater 
sensitivity than that seen by the rad60-ct cells (Figure 6.10 A, B). Watson et al suggest that 
following RMCE ~10% of 5-FOA resistant colonies will be wild-type (Watson, Garcia et 
al. 2008). However, given that two colonies were selected at random for each ‘mutation’, it 
seems highly likely that the rad60-L336G, rad60-I350G, rad60-Y363G and rad60-L359G 
mutations may be lethal. 
 
To test that the phenotypes described above are the result of the glycine substitutions, 
specifically designed to disrupt the structure, further mutations were made. The residues of 
interest (I334, L336, L338, L346, L348, I350, L359 and Y363) were therefore mutated to a 
residue designed to conserve H-bonding to this site. For example, L336 is shown to H-bond 
to L348. By mutating L336 or L348 to a residue with a biochemically similar side chain, 
e.g valine, H-bonding between L336 and L348 should be conserved. Using the mutate tool 
in Swiss-Pdb, conservation of the H-bonds was first tested in silico. An example of the 
mutation made for L346 is shown in figure 6.8B and the mutations selected are summarised 
Figure 6.10: UV and IR sensitivity of Rad60 SLD2 mutants 
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(A) UV and (B) IR. Cells were grown at 30oC in YE medium to mid-exponential phase 
and irradiated with UV (A) or γ (B) rays at the indicated doses. Cells were plated on 
YEA and grown at 30oC for ~72 hours. Colonies were counted and % survival was 
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in figure 6.8C. As predicted cells containing the conservative mutations all showed a 
phenotype similar to that of wild-type cells (Figure 6.9iB). As seen for the disruptive 
mutations, no difference in the sensitivity at 37oC and 25oC was observed. Unfortunately 
due to technical problems with mutagenesis, rad60-L338V was not tested. 
 
6.6 Discussion 
In previous chapters, I have shown the C-terminal SLDs of Rad60 to be important for 
Rad60 function. However, there is little evidence to show that the SLDs are in fact 
‘SUMO-like’. In this chapter I have carried out preliminary structure-function studies of 
the Rad60 SUMO-like domains to support the hypothesis that the Rad60 SLDs can fold to 
resemble SUMO. 
 
I have previously shown a rad60 mutant deleted for SLD2 (rad60-ct) to be defective in the 
response to DNA damage (Chapter 3). The SLD2 of Rad60 is also important for the correct 
localisation of the Rad60 protein (Chapter 5). It has recently been proposed that Rad60 
contains three SBMs (Raffa, Wohlschlegel et al. 2006). SMB3 is located within the very C-
terminal 6 amino acids of SLD2. A rad60-SBM3 mutant strain, containing valine to alanine 
substitutions in SBM3, showed no significant sensitivity to HU, MMS, UV and IR as 
compared to wild-type cells. This suggests that the phenotype observed for the SLD2 
deletion strain (rad60-ct) is not a consequence of deleting SBM3. Similarly a rad60-SBM1 
showed no significant sensitivity to HU, MMS, UV and IR, as compared to wild-type cells. 
Interestingly, a rad60-SBM2 mutant is more sensitive to HU, MMS, UV and IR than wild-
type cells, but less sensitive than the rad60-ct mutant. Visualisation, with Swiss-Pdb 
Viewer, of the Rad60 SBM2 and SBM3 residues in the predicted structures of SLD1 and 
SLD2 respectively, suggests that the amino acid residues of SBM2 are not located on the 
surface of SLD1 (data not shown). Rather, the side chains point towards the hydrophobic 
core. This is in contrast to the residues of SBM3, which are predicted to be surface residues 
and, therefore, more likely to contribute to a binding surface for interaction with SUMO. 
The VVLV motif of SBM2 consists of residues 268-271. L269 aligns to one of the residues 
identified to be of structural importance in SUMO-1 (Bayer, Arndt et al. 1998). 
Additionally, F272, immediately after SBM2 also aligns to a Bayer residue. It is therefore 
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likely that the phenotype observed for the rad60-SBM2 mutant (V268A, V270A) is a 
consequence of disrupting the structure of SLD1. Raffa et al have suggested that each SBM 
makes an independent contribution to the homodimerisation of Rad60 via the SUMO-like 
domains (Raffa, Wohlschlegel et al. 2006). For that reason, I would expect a triple SBM 
knockout strain to be phenotypically similar to the SLD2 deletion strain rad60-ct. Due to 
time constraints this experiment was not carried out. 
 
Ubiquitin-like domain proteins, such as Rad23 and Dsk2, interact with the proteosome, 
suggesting that the ubiquitin-like domains act to functionally mimic ubiquitination 
(Funakoshi, Sasaki et al. 2002; Rao and Sastry 2002; Lambertson, Chen et al. 2003). 
Unlike for the ubiquitin-like domain proteins, there is little functional evidence to suggest a 
SUMO-like role for the RENi family of SUMO-like domain proteins. However, previous 
studies on S. cerevisiae Esc2 and S. pombe Rad60 suggest a functional importance of 
SLD1. A region containing SLD1 of S. cerevisiae Esc2 and 80 amino acids in the N-
terminal fragment has been shown to be sufficient to supply Esc2 function in targeted 
silencing (Andrulis et al, 2004). In addition, the S. pombe mutants rad60-1 (K263E) and 
rad60-3 (F272V), which are defective in DSB repair, contain point mutations in SLD1 that 
align to Q55 and F66 of H. sapiens SUMO-1. Residues Q55 and F66 of SUMO-1 have 
been listed by Bayer et al as structurally important residues that contribute to the formation 
of the hydrophobic core of the ββαββαβ fold (Bayer, Arndt et al. 1998). With the 
exception of Q53 and Q55, the hydrophobic nature of the Bayer residues is conserved in 
ubiquitin (Bayer, Arndt et al. 1998). For example, isoleucines, leucines and valines are 
commonly substituted for one another. The hydrophobic nature of residues aligning to the 
Bayer positions in SUMO-1 is better conserved in SLD2 than SLD1. Interestingly, Y51 of 
SUMO-1 is conserved between almost all SUMO-1 homologues. Since this is not the case 
in ubiquitin proteins, this may suggest a possible SUMO-specific residue. Residues 
aligning to Y51 are better conserved in SLD2, than SLD1 of RENi proteins. However Y51 
is conserved in both Rad60 SLD1 and SLD2. In proteins of the RENi family, the C-
terminal region of SLD2 contains a cluster of negatively charged amino acid residues, 
which is indicative of a SUMO-like protein rather than a ubiquitin-like protein. The 
negative surface patch formed by these residues has been suggested to form a SUMO-
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typical interaction surface (Bayer, Arndt et al. 1998). In proteins of the RENi family, three 
factors suggest that SLD2 is more ‘SUMO-like’ than SLD1; 1) SLD2 has a greater 
sequence identity to SUMO, 2) SLD2 has a cluster of negatively charged amino acid 
residues (indicative of a SUMO-like protein) and 3) residues aligning to the SUMO 
specific residue, Y51, are better conserved in SLD2 than SLD1. This suggests that of the 
two SLDs of the RENi family SLD2 is more likely to adopt a SUMO-like fold and 
therefore function. 
 
The biological importance of SUMO modification is often mediated by proteins that are 
able to recognise and interact with SUMO via their SBMs. The SBM-SUMO interaction is 
stabilised by H-bonds between the SBM sequence and the SUMO surface side chains. The 
SBM binding surface of SUMO-1 is formed by a deep groove that is lined with 
hydrophobic and aromatic patches consisting of residues I34, H35, F36, V38, L47, Y51 and 
E33 (Song, Zhang et al. 2005). The biochemical nature of these residues is largely 
conserved in both SLD1 and SLD2. Interestingly, F36 of SUMO-1 aligns to F244 of Rad60 
SLD1. Substitution of F244 in the Rad60 SBM-binding pocket (F244A) abolishes the 
interaction between Rad60 and the STUbL, Rfp1 (Prudden, Pebernard et al. 2007). Since 
Rfp1 contains an SBM, this suggests that if the SLDs do fold to resemble SUMO they may 
function in a SUMO-specific manner by interacting with proteins containing an SBM.   
  
Comparative modelling of Rad60 SLD1 and SLD2 with SUMO-1 has strengthened the 
hypothesis that the SLDs of Rad60 are able to fold to resemble SUMO. However, if the 
ββαββαβ fold is assumed, the surfaces of Rad60 SLD1 and SLD2 would have opposite 
overall charges. This could indicate either an intra-molecular interaction between the SLDs 
or an inter-molecular interaction between domains in two different Rad60 molecules. Given 
that Rad60 has been shown to homodimerise (Raffa, Wohlschlegel et al. 2006), it is more 
likely that the opposing surface charges could contribute to an inter-molecular interaction 
between the two SLDs.  
 
In an attempt to support the in silico evidence for folding of the Rad60 SLDs, residues 
predicted to be of key importance in maintaining the hydrophobic core of the predicted 
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SLD2 structure were mutated. Cells containing I334G, L338G, L346G and L348G 
substitutions in SLD2 are more sensitive to HU, MMS, UV and IR than wild-type cells. 
rad60-L346G cells are less sensitive that the Rad60 SLD2 deletion mutant, rad60-ct, 
suggesting that the L346G  may partially disrupt the structure and function of the Rad60 
SLD2. rad60-I334G, and rad60-L338G cells show a sensitivity comparable with the rad60-
ct cells. This suggests that the single I334G and L338G mutations are sufficient to disrupt 
the structure, and therefore function, of SLD2 to the same extent as deleting SLD2 
altogether. rad60-L348G cells exhibit a much greater sensitivity than that seen by the 
rad60-ct cells. This may suggest that this mutation alters the structure of SLD2 in such a 
way that the SLD2-independent role of Rad60 protein is affected. Preliminary results of 
cells carrying mutations in the corresponding residues of SLD1 indicate similar phenotypes 
(F-X Ogi, University of Sussex-data not shown). The rad60-L336G, rad60-I350G, rad60-
Y363G and rad60-L359G mutations failed to be introduced into the S. pombe genome via 
RMCE. This suggests that these muations may not be viable. Additionaly, the 
corresponding residues of SLD1 have also failed to be isolated following RMCE (F-X Ogi, 
University of Sussex-data not shown). To confirm that these mutations are infact lethal, the 
substitutions should be introduced into the heterozygous diploid rad60 base strain (Section 
3.5) and the viability tested following sporulation. Due to time constraints this was not 
carried out.  
 
Interestingly, of the substitutions corresponding to the mutant phenotypes, L346 and L348 
of SLD2 align to I34 and F36 of SUMO-1. These residues have been shown to contribute 
to the SBM-binding pocket of SUMO-1. An F244A substitution in the predicted SBM-
binding pocket of SLD1 abolishes the interaction between Rad60 and the STUbL, Rfp1 
(Prudden, Pebernard et al. 2007). This may suggest that in the rad60-L346G and rad60-
L348G cells, Rad60 is unable to interact with an unknown regulatory protein through 
interaction with its SBM. This raises the possibility that the phenotypes observed maybe 
due to a loss of protein-protein interaction, rather than destabilisation of the hydrophobic 
core of the SLD.  
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Whilst the above data support the hypothesis that the Rad60 SLDs fold in a similar manner 
to SUMO, structural evidence is ultimately required to confirm this. As part of an 
undergraduate project, His-tagged Rad60 SLD2 (aa 333-406) was expressed and purified 
from E. coli. When the mutations corresponding to I334G, L338G, L346G and L348G 
point mutations were introduced into the Rad60 SLD2 coding sequence, the levels of all 
mutant proteins in cells was dramatically reduced compared to the levels of wild-type 
SLD2. Additionally, mutant proteins were found predominantly in the insoluble fraction, 
unlike the wild-type SLD2 protein. (T. Ahadome and F. Z. Watts, University of Sussex-
data not shown). This is consistent with the belief that these mutants contain an unstable 
SLD2 and further supports the hypothesis that the Rad60 SLDs can fold in a SUMO-like 
manner. 
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CHAPTER 7 
DISCUSSION 
 
Ubiquitin and ubiquitin-like proteins are post-translational modifiers that share a 
characteristic ββαββαβ fold. The best-defined role for ubiquitin conjugation is the 
targeting of proteins for degradation via the proteasome (Wilkinson 1995; Hochstrasser 
1996). SUMO is one of a number of UBLs, sharing ~18% sequence identity with ubiquitin. 
SUMO is covalently attached to lysine residues of target proteins in a post-translational 
modification process that is similar to, but distinct from, ubiquitination. Unlike ubiquitin, 
SUMO does not appear to have a role in protein degradation. Instead it has been shown to 
have roles in facilitating protein-protein interactions, altering protein localisation and in 
modulating protein activity. Analysis of protein databases indicates that ubiquitin-like 
sequences can also be found fused to other open-reading frames. The ubiquitin-fusion 
proteins, act to functionally mimic ubiquitination by interacting with the proteasome 
(Funakoshi, Sasaki et al. 2002; Rao and Sastry 2002). During the course of this project a 
family of SUMO-like domain proteins was identified and termed the RENi family after its 
best-studied members S. pombe Rad60, S. cerevisiae Esc2 and M. musculus Nip45. Rad60, 
Esc2 and Nip45 are all ~400 amino acids in length and share two C-terminal SLDs. Unlike 
SUMO, the SUMO-like domains of the RENi proteins do not have the C-terminal diglycine 
motif required for covalent attachment to target proteins, suggesting that the SLD2 of these 
proteins is likely to function as a protein-protein interface and is not conjugated to other 
proteins. 
 
The gene encoding the essential Rad60 protein was first identified in a screen to identify S. 
pombe mutants hypersensitive to MMS and synthetically lethal with rad2, suggesting a role 
in recombinational repair (Morishita, Tsutsui et al. 2002). Rad60 has been shown to 
physically and genetically interact with the Smc5/6 complex. Following replication stress, 
Rad60 is hyperphosphorylated by the checkpoint kinase Cds1 resulting in nuclear 
delocalisation (Boddy, Shanahan et al. 2003). Rad60 function is required after release from 
replication arrest, suggesting that Rad60 re-enters the nucleus upon HU release to carry out 
a late repair role in concert with the Smc5/6 complex (Ampatzidou, Irmisch et al. 2006; 
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Miyabe, Morishita et al. 2006). Three previously characterised temperature sensitive 
mutants, rad60-1 (K263E), rad60-3 (F272V) and rad60-4 (T72A, I232S, Q250R, K312N) 
contain point mutations that map to SLD1. This suggests that this domain is of importance 
for Rad60 function (Morishita, Tsutsui et al. 2002; Boddy, Shanahan et al. 2003). To 
determine whether the SLDs are required for cell viability and/or contribute to Rad60 
function, domain deletion mutants were created and their phenotypes analysed.  
 
To test the importance of SLD1 for Rad60 function, the RMCE system (Watson, Garcia et 
al. 2008)was utilised to replace the genomic copy of rad60 with a copy of rad60 deleted for 
SLD1 (aa 228-307). Although the previously published rad60-1, rad60-3 and rad60-4 
strains, carrying mutations within SLD1, are viable, it was possible that deletion of the 
entire domain would prove to be lethal for cells. For this reason the rad60-SLD1Δ allele 
was introduced into a heterozygous diploid rad60 base strain. Following sporulation and 
tetrad dissection, only two spores germinated, implying that deletion of SLD1 is lethal. 
Furthermore, the heterozygous diploid rad60-SLD1Δ cells showed a severely reduced 
sporulation frequency (~<1% forming zygotes), as compared to the diploid base strain. 
Analysis of the hypomorphic mutants nse1-1, nse2-1 and nse3-1 of the Smc5/6 complex 
has indicated a role for the Smc5/6 complex in meiosis (Pebernard, McDonald et al. 2004). 
The SLD1 deletion result implies that Rad60 also has a role in meiosis. 
 
Unlike the null and SLD1Δ mutants, a rad60 mutant deleted for SLD2 (rad60-ct) is viable. 
Initial characterisation of the rad60-ct cells showed a phenotype reminiscent of the smc6-X 
and smc6-74 mutants (Lehmann 1995; Verkade, Bugg et al. 1999). rad60-ct cells are 
elongated and are sensitive to UV, IR, HU and MMS as compared to wild-type cells. This 
implies that SLD2 is not required for the essential function of Rad60 but is required for the 
response to DNA damage. Rad60 is known to associate with the Smc5/6 complex and like 
the rad60-1 and rad60-3 mutants, rad60-ct is synthetically lethal with both smc6-X and 
smc6-74 (Morishita, Tsutsui et al. 2002; Boddy, Shanahan et al. 2003). Additionally, 
expression of rad60 but not rad60-ct in the smc6-X background can suppress the sensitivity 
of smc6-X to HU and MMS, suggesting that suppression is dependent on the SLD2 of 
Rad60. As is the case for other mutants defective in the Smc5/6 complex, rad60-ct is 
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epistatic with rhp51-d. This implies a role for rad60 in homologous recombination that is 
dependent on SLD2. The smc6 mutants are also sensitive to 4NQO. In normal cells DNA 
adducts caused by 4NQO are removed by the NER pathway. However, the smc6 mutants 
are not epistatic to mutants in the conserved NER pathway. Instead Smc6 is thought to be 
involved in UVER, a secondary pathway that involves the rad2 and rhp51 genes (Lehmann 
1995; Murray, Lindsay et al. 1997). Although rad60-ct and rad60-1 show a similar degree 
of sensitivity to UV, IR and MMS, unlike rad60-1, rad60-ct cells are sensitive to 4NQO. 
This suggests that the functional interaction shared between Rad60 and Smc5/6 may be in 
the UVER pathway and is SLD2 dependent. Presumably a rad60-ct rad2-d mutant would 
be lethal.  
 
Although Rad60 is a nuclear protein under wild-type conditions, a C-terminally GFP-
tagged strain showed that deletion of SLD2 disrupts the nuclear localisation of Rad60. This 
raises the possibility that the role of SLD2 is in protein localisation. Although I have been 
unable to confirm this phenotype with either N-terminally tagged strains, or 
immunofluorescence with anti-Rad60 antibodies, this observation corresponds well with 
the sensitivity of the strain to DNA damaging agents. Specifically, if Rad60 is not localised 
to the nucleus it presumably cannot fulfil its DNA repair role. Rad60 has been shown to 
exit the nucleus both upon treatment of cells with HU and by over-expressing cds1 (Boddy, 
Shanahan et al. 2003). HU causes replication forks to stall by causing dNTP starvation 
resulting in a replication checkpoint arrest that leads to the activation of the effector protein 
kinase Cds1. Cds1 acts to stabilise stalled forks by enforcing the cell cycle checkpoint that 
prevents mitosis during a replication arrest. With single stranded regions and DNA ends in 
close proximity to homologous sequences, stalled forks should be ideal substrates for 
recombination. It has been suggested that in the event of a stalled fork, Cds1 is activated to 
phosphorylate and concomitantly delocalise Rad60 from the nucleus to prevent HR 
(Boddy, Shanahan et al. 2003).  
 
There are two possible explanations as to why the deletion of SLD2 disrupts nuclear 
localisation; 1) Rad60 is continuously exported from the nucleus, or 2) Rad60 cannot be 
retained in the nucleus. The possibility that mis-localisation of the truncated Rad60 is the 
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result of continuous cds1 activation was tested. If this were the case, Rad60-ct would be 
nuclear in a cds1-d background. However, in the cds1-d background Rad60-ct is pan-
cellular. This suggests that mis-localisation of Rad60-ct is not the result of constitutive 
Cds1 activation. By the same argument, the mis-localisation of Rad60-ct is not a 
consequence of constitutive Chk1 activation. Interestingly, in chk1-d cells, full-length 
Rad60 is not localised to the nucleus. Delocalisation of Rad60 from the nucleus is believed 
to be S-phase specific and is not observed in G2 cells treated with IR (Boddy, Shanahan et 
al. 2003). This suggests that Chk1 may have a role in maintaining Rad60 in the nucleus.  
 
Since the mis-localisation of Rad60-ct is not the result of constitutive Cds1 or Chk1 
activation, it seems that SLD2 is required for the correct nuclear localisation of Rad60. 
Another possibility explored was that Rad60 SLD2 has an NLS-like property that when 
masked, results in delocalisation from the nucleus. Usng over-expression constructs, 
provision of an NLS to the Rad60-ct protein is capable of restoring wild-type localisation. 
However, expression of the Rad60-ctNLS protein in rad60-ct cells is unable to rescue the 
DNA damage sensitive phenotype of the rad60-ct cells and instead has a dominant negative 
effect in both wild-type and rad60-ct cells. Since a rad60-4 mutant unable to delocalise 
from the nucleus is proficient for the survival of UV-induced DNA damage (Boddy, 
Shanahan et al. 2003), it is unlikely that the dominant-negative phenotype observed is 
purely a consequence of Rad60-ctNLS being unable to delocalise from the nucleus 
following replication stress. Rather, it suggests that SLD2 is required not only to localise 
Rad60 to the nucleus for its role in the DNA damage response, but also for the DNA 
damage response itself. Unfortunately, over-expressed full-length Rad60 failed to 
delocalise from the nucleus following HU treatment. This meant that the ability of the over-
expressed Rad60-ctNLS protein to delocalise from the nucleus following replication stress 
could not be confirmed. Typically NLSs are found on the exposed surface of the protein 
and consist of a few short sequences of positively charged residues. Given that Rad60 does 
not contain a recognised NLS and that SLD2 alone is unable to localise GFP to the nucleus, 
it is likely that SLD2 maintains nuclear localisation by facilitating protein-protein 
interactions or as a result of being modified itself.  
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The SLDs of Rad60 are clearly important for its function. Despite this, there is little 
evidence to suggest that the SLDs are in fact ‘SUMO-like’. Proving a SUMO-like function 
is problematic given that SUMO itself does not have a clearly defined role. For this reason 
a structural perspective was taken. Despite the low sequence identity shared by SUMO and 
the Rad60 SLDs, there is significant conservation of the biochemical nature of the amino-
acid side chains. In proteins of the RENi family SLD2 has a) a greater sequence identity to 
SUMO than SLD1, b) a cluster of negatively charged amino acid residues, indicative of a 
SUMO-like protein and not found in SLD1 and c) a more highly conserved residue aligning 
to the SUMO specific residue, Y51 than SLD1. This suggests that of the two SLDs of the 
RENi family, SLD2 is more likely to adopt a SUMO-like structure and therefore function. 
However, comparative modelling suggests that both SLD1 and SLD2 can adopt the 
characteristic ββαββαβ fold shared by UBLs. The S. pombe mutants rad60-1 (K263E) and 
rad60-3 (F272V) contain point mutations in SLD1 that align to Q55 and F66 of H. sapiens 
SUMO-1. Q55 and F66 of SUMO-1 have been identified as structurally important residues 
that contribute to the formation of the hydrophobic core of the ββαββαβ fold (Bayer, et al 
1998). This suggests that disrupting the hydrophobic core of the SLDs may affect Rad60 
function. A novel ‘recombinase-mediated cassette exchange’ system was used to mutate 
residues in SLD2 predicted to help maintain the hydrophobic core of the ββαββαβ fold. 
The DNA damage sensitive phenotype of L348G, L338G, L346G and I334G substitutions 
support the hypothesis that the Rad60 SLD2 is able to fold in a manner similar to SUMO.  
Corresponding mutations have been introduced into SLD1 and their phenotypes analysed 
(F-X Ogi, University of Sussex). This provides further support for the ββαββαβ fold of the 
SLDs. Together, the sequence analysis, comparative modelling and mutation studies 
support the hypothesis that the Rad60 SLDs adopt a SUMO/ubiquitin-like fold. However, 
structural evidence is ultimately required to confirm this. Recombinantly expressed His-
tagged SLD2 can be purified in mg quantities and is currently being used for 
crystallography trials in an attempt to elucidate the structure (F. Z. Watts, T. Freche and B. 
Vintner, University of Sussex). With the intention of carrying out stability studies, 
mutations corresponding to those resulting in DNA damage sensitive phenotypes (Chapter 
6.5) were introduced into the SLD2 coding sequence cloned into the E.coli expression 
vector pET15b. The I334G, L338G, L346G and L348G point mutations resulted in 
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dramatically reduced levels of protein as compared to the levels of wild-type SLD2 that 
could be obtained (T. Ahadome and F. Z. Watts, University of Sussex). Although this 
prevents structural/folding analysis of the mutated protein, it is further suggestive that the 
Rad60 SLDs fold in a SUMO-like manner and is consistent with the hypothesis that the 
point mutants are able to disrupt the hydrophobic core and hence destabilise SLD2. 
 
If Rad60 SLD2 is really SUMO-like in both structure and function, I would expect 
substitution of SLD2 with authentic Pmt3 (SUMO) to restore nuclear localisation of Rad60 
and result in cells with a wild-type response to DNA damaging agents. As is the case when 
an NLS is provided at the C-terminal of Rad60-ct, replacement of SLD2 with SUMO is 
able to restore wild-type localisation to Rad60-ct but is unable to rescue the DNA damage 
sensitive phenotype of rad60-ct cells. In addition, expression of Rad60-ctPmt3 in both 
wild-type and rad60-ct cells has a dominant-negative effect. This suggests that once in the 
nucleus, SUMO (Pmt3) cannot functionally substitute for Rad60 SLD2.  
 
Rad60 has recently been identified as a potential target of the Slx8-Rfp SUMO-targeted 
ubiquitin ligase (Prudden, Pebernard et al. 2007). STUbLs interact with SUMO in a non-
covalent manner to promote the de-sumoylation and/or degradation of sumoylated target 
proteins. Rad60 is ubiquitinated in vitro by Slx8 in an Rfp1-dependent manner (Prudden, 
Pebernard et al. 2007). Interestingly, a mutation in the predicted SBM binding pocket of 
Rad60 SLD1 is able to abolish ubiquitination of Rad60 by Slx8 (Prudden, Pebernard et al. 
2007). This suggests that SLD1 mimics SUMO in its ability to bind the STUbL and that the 
Rad60-STUbL interaction is not reliant on SUMO-modification. However, given that a 
mutant encoding a ligase-dead version of the Nse2 protein, (nse2-SA) and rad60-ct are 
epistatic in their response to both UV and IR, the ability of Rad60 to be sumoylated in an 
Nse2-dependent manner was tested in vitro. Rad60 was found to be sumoylated in vitro and 
this was enhanced by the SUMO E3 ligase Pli1, but not by Nse2. Furthermore, Rad60 is 
sumoylated in a manner dependent on the C-terminus. A K342/357/361/368R quadruple 
mutant, where all four lysine residues in the C-terminus are knocked out, shows a 
modification pattern similar to the wild-type Rad60 protein. This suggests that although the 
site(s) of sumoylation are not within the C-terminal 73 amino acids (SLD2), SUMO 
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modification of Rad60 is dependent on the C-terminus. Rad60, but not Rad60-ct., is able to 
interact with the Hus5 conjugator in vitro, suggesting that SLD2 is required to recruit the 
Hus5 conjugator to Rad60. This is further supported by evidence that recombinant SLD2 
(aa 334-406) interacts with GST-Hus5 but not a GST control (F.Z.Watts and B. Vintner, 
University of Sussex). It is therefore possible that the SUMO-like roles of SLD1 and SLD2 
are to interact with the Slx8 STUbL and Hus5 conjugator, respectively. The differences 
identified in the SLD1 and SLD2 peptide sequence and predicted structures may explain 
their specificity for binding partners. Although the SLDs may fold like SUMO, the surface 
residues of each domain would be expected to define a different SUMO-/ubiquitin-like 
role.  
 
It is possible that Rad60 SLD2 not only acts to recruit Hus5 for the SUMO-modification of 
itself, but may also function as a scaffold to recruit Hus5 to the Smc5/6 complex for use in 
Nse2 ligase -dependent sumoylation events. This would explain the epistasis between nse2-
SA and rad60-ct; events in which either the ability to correctly localise the conjugator is 
impaired, or where SUMO ligase activity is lost, would result in loss of sumoylation of one 
or more specific proteins. The cellular consequence would, therefore, be the same. Given 
that Smc6 is sumoylated in an Nse2-dependent manner, and sumoylation of Smc6 is 
abolished in an nse2-SA background, it would be informative to know whether sumoylation 
of Smc6 is also abolished in the rad60-ct background. If sumoylation of Smc6 is dependent 
on Rad60, the transient interaction observed between Rad60 and the Smc5/6 complex could 
be explained (Morishita, Tsutsui et al. 2002; Boddy, Shanahan et al. 2003). Additionally, 
by assigning SLD2 a role in recruiting Hus5, the dominant negative effect observed when 
rad60 is over-expressed in a pli1-d background can be explained. If SLD2 is required to 
interact with Hus5, over-expression of Rad60 in pli1-d cells may result in the titrating out 
of Hus5 in cells where sumoylation activity is already reduced. The effect therefore might 
be similar to that observed in hus5 mutants. This effect is not seen with expression of 
rad60-ct, presumably because Rad60-ct cannot associate with Hus5. A possible 
experiment, which may give a better insight into the role of the Rad60-Hus5 interaction, 
may be to tether hus5 to Rad60-ct and assess whether Rad60 function is restored. 
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The N-terminal ubiquitin-like (UBL) and C-terminal ubiquitin-associated (UBA) domains 
of S. cerevisiae Dsk2 have been shown to interact, suggesting that the full length protein 
can form a closed conformation mediated by intramolecular binding of the UBL and UBA 
domains (Lowe, Hasan et al. 2006). The Dsk2 UBL-UBA interaction is weaker than that 
observed for the Dsk2 UBA-ubiquitin. This suggests that only when the UBA-UBL 
interaction is disrupted would the UBL domain be available for interaction with the 
proteasome. The UBA-UBL interaction may therefore play a regulatory role for Dsk2 
adaptor function during ubiquitin-mediated proteasomal targeting. A similar proposal has 
been made for H. sapiens Rad23 (Walters, Lech et al. 2003). Rad60 has been proposed to 
form a homodimer via association of the SLDs of one Rad60 molecule and the SBMs of 
another (Raffa, Wohlschlegel et al. 2006). However, it is possible that, like Rad23 and 
Dsk2, Rad60 may form a closed conformation mediated by intramolecular binding of the 
SBMs and the SLDs. Comparative modelling suggests that Rad60 SLD1 and SLD2 have 
opposing surface charges. If an intramolecular interaction does exist between the N-
terminal SBMs and the C-terminal SLDs, the result would be that the Rad60 molecule 
would fold back on itself. The opposing surface charges of the two SLDs may contribute to 
the stability of this strucure. In the closed conformation, the SLD2 surface residues 
required to interact with Hus5 may still be accessible and may help maintain Rad60 in the 
nucleus   
 
Although initially the functions of the RENi family proteins do not seem well conserved, 
there is evidence to suggest that rad60 and esc2 may share some genetic interactions and 
hence may be functional homologues. The S. pombe rad60 gene was first identified 
through its synthetic lethal interaction with rad2. Unlike rad60, esc2 is not essential but an 
esc2Δ strain is synthetically lethal with mutations of the rad27 (rad2 homologue) gene 
(Tong, Evangelista et al. 2001). In addition, like rad60-1 and rad60-3 esc2Δ is 
synthetically lethal with sgs1Δ, the S. cerevisiae homologue of rqh1 (Tong, Evangelista et 
al. 2001; Morishita, Tsutsui et al. 2002; Boddy, Shanahan et al. 2003). Recently, the crystal 
structure of H. sapiens Nip45 has been elucidated and shown to adopt a ββαββαβ fold, 
supporting the hypothesis that the SLDs of the RENi family are SUMO-like. As is the case 
for Rad60, H. sapiens Nip45 interacts with a STUbL. Interaction between RNF4 and Nip45 
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is increased following treatment with HU (Prudden, Pebernard et al. 2007). This suggests a 
model for the regulation of Rad60 into and out of the nucleus (Figure 7.1). In the nucleus, 
in the closed conformation, Rad60 SLD2 binds Hus5 facilitating its own sumoylation in a 
Pli1-dependent manner, thus maintaining Rad60 in the nucleus. Rad60 SLD2 also acts to 
recruit Hus5 to the Smc5/6 complex, to perhaps bring about the sumoylation of Smc6. 
Following replication stress, caused for example by a stalled replication fork, Cds1 is 
activated and Rad60 is phosphorylated on T72. This phosphorylation event may trigger a 
conformational change of Rad60 from a closed to an open conformation, allowing 
recruitment of Slx8 to SLD1. Alternatively, the Cds1-dependent phosphorylation event 
may act as a signal for the recruitment of Slx8. As is a similar case for the ubiquitin-like 
domain protein Dsk2, the affinity of Rad60 for the interaction with Slx8 may be greater 
than for the Rad60 SBM-SLD intramolecular interaction, thus switching from a closed to 
open conformation. Once bound, Slx8 replaces SUMO with ubiquitin and thus signals for 
delocalisation and degradation of Rad60. Presumably, in the case of the Rad60-ct protein, 
Rad60 cannot form a closed formation nor recruit Hus5 and can therefore not be 
maintained in the nucleus. This suggests a conserved role for the RENi proteins as scaffold 
proteins to regulate sumoylation and de-sumoylation events in the cell. 
Figure 7.1: Proposed model for the control of homologous recombination 
mediated by alternative post-translational modifications of Rad60.  
 
(A) Rad60 forms a closed conformation in the nucleus. (B) Rad60 SLD2 (indicated by 
red box) binds Hus5 facilitating its own sumoylation in a Pli1-dependent manner, as 
well as sumoylation of components of the Smc5/6 complex and permitting homologous 
recombination. (C) Following replication stress, Cds1-dependent phosphorylation of 
Rad60 on T72. signals for the recruitment of Slx8 to SLD1 (indicated by blue box), 
causing Rad60 to form. an open conformation. (D) Slx8 replaces SUMO with ubiquitin 
(E) Ubiquitination signals for delocalisation and degradation of Rad60. (SUMO, 
phosphorylation and ubiquitin modifications are denoted by S, P and U, respectively). 
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Figure 7.1: Proposed model for the control of homologous recombination 
mediated by alternative post-translational modifications of Rad60. 
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